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ABSTRACT 
Glucoamylase (GA) is an industrial enzyme involved in the production of glucose and 
fructose syrups from starch. Exhibiting a large spectrum of selectivities, GAs are able to cleave 
glucose from the nonreducing ends of a-(l,4) glycosidic bonds of maltooligosaccharide chains 
and the a-(l,6) bonds initiating their branches. The high temperatures and glucose concentrat­
ions occurring in saccharification lead to the formation of condensation products, reducing the 
overall glucose yield. Modified versions of Aspergillus GA that better satisfy industrial require­
ments are desirable. To achieve this, a scructure-based multisequence alignment of the primary 
sequences of the catalytic domains, linkers, and starch-binding domains of GAs from filamen­
tous fungal, yeast, eubacterial, and archaeal origin has been made to correlate structure to GA 
stability and selectivity. Evolutionary interpretation of the alignment has elucidated the improve­
ments undergone naturally by GA to improve its catalytic properties. To understand the mol­
ecular interactions between GA and its substrates, a protocol was formulated to combine the 
conformational characterization of substrates using MM3(92) and the Monte Carlo-based 
docking software AutoDock that allows the interaction of flexible ligands with proteins. This 
method was applied to study GA active-site interactions with 1) different inhibitors and 
monosaccharide substrates, yielding very good correspondence with results obtained by X-ray 
crystallography and so verifying the validity of the approach; 2) several isomaltose analogues, 
giving a structural basis for some unexplained kinetic properties; and 3) ten glucopyranosyl-
based disaccharides, identifying the different requirements that substrates need to satisfy for 
GA hydrolysis to occur, and revealing that flexibility of the second subsite explains GA 
properties and preferences. The combined method constitutes a successful approach to study 
protein-carbohydrate interactions. Finally, an extensive table of GA kinetic and inhibition 
properties of different natural and genetically modified GAs ha.s been compiled. An assessment 
of A. niger GA properties reveals that at higher temperatures larger amounts of condensation 
products are expected. 
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CHAPTER 1. GENERAL INTRODUCTION 
My original intent was to modify glucoamylase (GA) by protein engineering, according 
to my goal and that of Dr. Peter J. Reilly to produce GA variations more suitable for industrial 
use. Shortly after initiating my research in Spring 1991 at Iowa State University, the first GA 
structural models were obtained by X-ray crystallography by Dr. Richard B. Honzatko's group 
in the Department of Biochemistry and Biophysics. To better design modifications, I correlated 
the new structural information with published sequences, and this constituted the bulk of the 
M.S. thesis I defended in Fall 1993. This work directly led to three articles on GA structure/ 
function relations, one in collaboration with Dr. Bemard Henrissat from the CERMAV, Gren­
oble, France, published in Protein Engineering (Coutinho and Reilly, I994a,b; Henrissat et ai, 
1994). Indirectly, it contributed to the interpretation of different modification studies in both the 
catalytic and starch-binding domains of Aspergillus awamori GA obtained by my fellow grad­
uate students Ufuk Bakir, Nathalie Flory, and Luojing Chen, and this led to three articles pub­
lished in the same journal (Bakir et al., 1993; Flory et ai, 1994; Chen et al., 1995). Protein 
engineering work undertaken by Martin Allen and Yuxing Chen in Dr. Clark Ford's laboratory 
in the Department of Food Science and Human Nutrition, partially based on my suggestions, 
was successful in improving A. awamori GA thermostability, but positive modification of GA 
selectivity remained elusive until very recently, in the work of Tsuei-Yun Fang in the same 
laboratory. By a combination of events I was fonunate to 1) follow Dr. Alexander Aleshin and 
colleagues working under Dr. Honzatko's supervision, who obtained several models of GA-
inhibitor complexes; 2) initiate modeling of the GA interaction with isomaltose analogues, a 
suggestion of Professor Raymond Lemieux from the University of Alberta, Edmonton, Canada; 
3) leam conformational mapping of disaccharides using MM3(92) with Dr. Michael D. Dowd, 
then a postdoctoral fellow in Dr. Reilly's group; 4) find in the literature an abundance of 
unexplained GA inhibition and kinetics data. The first manuscript in this dissertation describes 
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structural and evolutionary relationships between GA sequences and associates both selectivity 
and stability characteristics to specific sequence features (Coutinho and Reilly, 1996). The quest 
to further understand GA structure and to establish a computational method to model GA 
interactions with a variety of compounds evolved into the establishment of a protocol to perform 
automated docking smdies of flexible compounds, and apply it to understand the wide range of 
GA selectivities. The next three manuscripts describe the application of the docking protocol in 
the study of the interaction of GA active site with 1) monosaccharide substrates and their 
analogues and with the inhibitor methyl a-acarviosinide (Coutinho et al., 1996a); 2) ten dif­
ferent isomaltose analogues (Coutinho et al., 1996b); and 3) all ten other differently linked 
glucopyranosyl disaccharides except isomaltose (Coutinho et al., 1996c). The method has also 
been applied to the study of the interaction of GA active site with a-(l,4) and a-(l,6)-linked 
glucosyl trisaccharides, and, in collaboration with undergraduate student John Andrews, the 
characterization of the interaction with different nitrogen-containing GA inhibitors, and these 
two smdies should lead to manuscripts submitted to journals in early 1997. 
The conformational studies included in this dissenation, the basis of the initial confor-
mers used for docking, were made by Michael Dowd, now a research engineer for the USDA 
Southern Regional Research Center in New Orleans, La. 
The better picture of the structural features and requirements for catalysis of GA 
achieved in this dissenation will open the way to further protein engineering of GA. 
Thesis Organization 
This dissenation is comprised of a literature review and four manuscripts, the first to be 
submitted to the journal Protein Engineering, the second accepted for publication in the journal 
Proteins: Structure, Function and Genetics, with the fourth submitted for publication to the 
same journal, and the third accepted for publication in the journal Carbohydrate Research. The 
literature review covers generic information on GA structure and properties, with an assessment 
3 
of the effect of temperature in Aspergillus niger GA selectivity, based on an extensive tabulated 
review of natural and mutant GA inhibition and kinetic studies given in the Appendix. 
The first manuscript updates the structural alignment of GA sequences. By initially 
analyzing the hydrophobic folding domains of the catalytic domain, differences in the different 
GAs associated with stability are found. Further analysis of the composition and length of 
different interhelical loops gives insights into both the stability and selectivity characteristics of 
GA. The different GA sequences are sorted based on common characteristics, giving an excel­
lent insight into GA evolution. 
The second manuscript establishes and verifies the validity of an automated docking 
protocol using AutoDock 2.1. A combined approach, where data from conformational mapping 
of ligands with MM3{92) to generate the initial conformers used in docking, was employed. 
The interaction of GA with a variety of monosaccharide substrates and inhibitors, as well as the 
pseudo-disaccharide methyl a-acarviosinide, was studied. By verifying that only small differ­
ences exist between the docked results and structures obtained by X-ray crystallography, the 
combined approach was validated. 
The third manuscript concerns the conformational mapping of three isomaltose anal­
ogues, two of them conformationally biased, with different kinetic properties. Their global and 
local minima structures, as evaluated with MM3(92), were docked using AutoDock 2.1 in the 
GA active site along with the structures of all seven monodeoxy derivatives of methyl a-
isomaltoside. The different behavior of the first three isomaltosides is explained by analysis of 
the docked results. More important is the assessment of the role of individual hydroxyl groups 
in binding and catalysis, establishing that an essential hydroxyl group at the reducing end is 
important to promote steric hindrance at the glycosidic oxygen, an event that probably is at the 
base of catalysis. 
The fourth manuscript reports a study of the interaction of differently linked glucopy-
ranosyl-containing disaccharides with the GA active site using AutoDock 2.2. All a-linked GA 
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substrates exhibit an important interaction at the second subsite that, by analogy with isomaltos-
ides, induces strain at the glycosidic oxygen. Most two-bond-linked substrates dock in a very 
similar mode. 
Following the fourth manuscript is a general summary followed by recommendations 
for future work. 
Except in the manuscript chapters, the references are presented in the format of Protein 
Engineering, a journal where both the group and 1 have published earlier work tiiat constitutes a 
reference in the field. All tables and figures within each section, including the general intro­
duction and conclusion chapters, are numbered independentiy. The manuscript chapters have 
their references formatted and their tables and figures numbered according to the respective 
journal requirements. 
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CHAPTER 2. LITERATURE REVIEW 
Introduction 
Glucoamylase [a-(l,4)-D-glucan glucohydrolase, EC 3.2.1.3], also known as amylo-
glucosidase and previously called gluc-amylase, y-amylase, and Z-amylase, produces glucose 
from different starchy materials. Traditionally involved in oriental food and beverage preparat­
ion (Sakaguchi et al., 1992), it is now one of the main components in industrial starch depol-
ymerization (Saha and Zeikus, 1989; Nikolov and Reilly, 1991; Schenck and Hebeda, 1992) to 
glucose, a raw material for imponant processes to produce high-fructose com syrup (HFCS) 
and ethanol. In HFCS production, a glucose yield up to 96% is obtained by OA in the sacchar-
ificanon step (Nikolov and Reilly, 1991: Teague and Brumm, 1992), due to formation of mainly 
a-(l,6)-linked condensation products at high glucose concentrations (Nikolov etal., 1989). 
Reducing the a-(l,6) activity of GA should increase glucose yield (Nikolov et al., 1989). Given 
the high volumes of starch processed to HFCS, even a marginal increase of selectivity could 
have an economic impact in the industry. 
The advent of protein engineering (Ulmer, 1984; Leatherbarrow and Fersht, 1986; 
Smith, 1990; Recktenwald et al., 1993) has allowed the improvement of enzymes of industrial 
interest to better suit process conditions and requirements (Bryan, 1987; Wells and Estell, 1988; 
Power et al., 1989; Imanaka, 1994). Since the structure of Aspergillus awamori var. XlOO GA 
was obtained by X-ray crystallography (Aleshin et al., 1992), a better knowledge of its structure 
and of its protein family (Coutinho ei al.. 1994a,b; Henrissat et at., 1994) permitted the design 
of more themiostable GA variants (Chen et al., 1996; Allen et al., unpublished results; Li et al., 
unpublished results), while the construction of mutants with changed selectivity was still 
tentative (Fierobe et al., 1996; Fang ei al., unpublished results). A better knowledge of the 
molecular basis of GA selectivity is required for the rational engineering of GAs with a reduced 
affinity to a-(l,6)-linked bonds. 
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Industrial Uses 
Filamentous fungi have been traditionally used in the Far East as catalytic sources in the 
production of fermented foods and beverages (Sakaguchi et ai, 1992). In Japan, different spec­
ies of Aspergillus have been used for the production of spirits like sake and sochu and sea­
sonings like soy sauce (Sakaguchi et al., 1992). Black koji molds (so-called Aspergilli) are 
commonly used in the saccharificarion of steamed rice and steamed potato. In China, the sacc­
harifying fungus traditionally has been Rhizopus, which reflects the use of uncooked ground 
grains as a fermentation starting material. In southeastern Asian countries, the filamentous yeast 
Saccharomycopsisfibuligera (previously known as Endomycesfibuligera) saccharifies amylo-
pectin-rich rice, used as the staner for brewing rice beer. 
Industrial degradation of starch was initially by acid hydrolysis, but limitations at the 
low and high ends of the conversion spectrum, coupled with the inflexible saccharide distrib­
ution and the excessive amounts of glucose degradation products, led to the investigation of 
enzymatic hydrolysis for making improved glucose-containing products (Schenck and Hebeda, 
1992). 
Rhizopus and Aspergiliioi have been used for the production of GA in such processes. 
In Japan, R. niveus and R. delemar (also known as Rhizopus oryzae) were selected for GA pro­
duction because Aspergillus GAs were initially contaminated with residual amounts of trans-
glucosidase, causing decreased saccharification yields. On the other hand, A. mger and A. 
awamori produce higher amounts of GA, and their identical enzymes have a higher optimal 
temperature and a wider pH range (Schenck and Hebeda, 1992). The Nonh American and Eur­
opean wet-milling industries mainly use A. niiier/awanwri GA (Teague and Brumm, 1992). 
GA is used in the production of high-glucose and other syrups. Starch is originally liq­
uefied by acid hydrolysis, but more commonly thermostable a-amylases hom Bacillus amylo-
liquefaciens. Bacillus licheniformis, and Bacillus stearothermophilus are used (Nikolov and 
Reilly, 1991; Teague and Brumm, 1992). This step can involve 5 min of jet cooking at temper­
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atures up to 140°C, followed by 1 to 2 h of dextrinization at 90°C and pH 5.5 to 7.0, resulting in 
cleavage of the amylose chains, which decreases viscosity and avoids the formation of nonsol-
uble fragments. 
In the saccharification process, the liquified starch solution of 30-35% (w/w) and DP 10 
to 15 is cooled to 58-62°C and adjusted to pHs between 4.2 and 5.0. Following GA addition, 
saccharification occurs in stirred reactors for 48 to 72 h. A glucose yield of 95-96% can be 
obtained (Nikolov and Reilly, 1991; Teague and Brumm, 1992). More than 80% of the high-
glucose syrup produced is converted to high-ftuctose com syrup (HFCS), with about 10% 
processed into crystalline dextrose (Nikolov and Reilly, 1991). 
For HFCS production, immobilized glucose isomerase (or xylose isomerase) of differ­
ent origins can be used (Teague and Brumm, 1992). For this process, glucose syrup is clarified 
and concentrated and its pH is adjusted to a value between 7.0 and 8.5. A continuous isom-
erization step is carried out at 60 to 65°C to yield approximately 45% (dry weight) fhictose 
(Kennedy et aL, 1988; Teague and Brumm, 1992; Hanover, 1992). A final moving-bed chrom­
atographic separation is required to obtain more concentrated fructose symps. An HFCS with 
55% fhictose is standard in industry, but fructose syrups with final values between 80 and 95% 
are also produced (Hanover, 1992). 
A way to improve the process could involve combining liquefaction and saccharification 
processes under one constant condition (Kennedy et al., 1988). This would require a GA with 
the same thermostability and pH stability as the liquifying a-amylase (Kennedy et al., 1988). A 
thermostable GA could eliminate the flash-cooling step and reduce the risk of microbial 
contamination (Nikolov and Reilly, 1991), while a GA stable at higher pHs would decrease the 
amount of salts resulting from pH corrections between steps. 
Another advantage of having a GA with a higher optimal pH concerns the possibility of 
simultaneous utilization of GA and glucose isomerase, preventing reversion reactions by main-
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raining low glucose concentrations, with the immediate conversion of glucose to fiructose in one 
step (Bakir et al., 1993). 
In the high glucose concentrations similar to those used in saccharification, the GAs 
from A. niger (Adachi et al., 1984; Shiraishi et al., 1985; Nikolov et al., 1989; El-Sayed and 
Laszlo, 1994), R. niveus (Watanabe era/., 1969a; Beschkov et al., 1984; Adachi et al., 1984; 
Shiraishi et al., 1985), and Saccharomycopsis (Watanabe et al., 1969b) all produce a variety of 
condensation products, reducing the yield of this step. The results of comparative condensation 
studies are unclear on which GA, A. niger or R. niveus, produces more isomaltose. An alter­
native to glucose yield improvement in saccharification to values higher than 96% could involve 
the use of a GA with no a-(l,6) activity, avoiding the formation of isomaltose at high glucose 
concentrations (Nikolov and Reilly, 1991). Given that no such GA has yet been found in nature, 
this hypothesis is the driving force of current GA protein engineering efforts. 
GA is also used in the production of ethanol for fuel, chemicals, or spirits (Nikolov and 
Reilly, 1991; Sakaguchi et al., 1992). Combined with Bacillus a-amylases, it can be used to 
saccharify com starch, wheat, sweet potato, and other starchy materials into fermentable sugars, 
later converted to ethanol by yeast fermentation. In Japan, fungal Aspergillus dsid Rhizopus 
species are used separately or together for ethanol production (Sakaguchi et al., 1992). 
To improve ethanol production by fermentation, newly characterized GA genes have 
been introduced in yeast and fungi (Ashikari and Yoshizumi, 1994). The introduction of a better 
and secretable GA was the reason for cloning of Saccharomyces diastaticus and Schwannio-
myces occidentalis GA genes into Saccharomyces cerevisae (Errat and Nasim, 1987; Dohmen 
et al., 1990), the cloning of the Aspergillus shirousami GA gene in Aspergillus oryzae (Shi-
buya et al., 1990), and the cloning of the GamP gene of Hormoconis resinae into Trichoderma 
reesei (Joutsjoki et al., 1993). 
GA is extensively used in the production of light beer (Sills et al., 1983b). In beer, a 
main source of calories are dextrins (70 to 75% branched), which traditional beer strains cannot 
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metabolize. These are easily hydrolyzed by added fungal GAs, resulting in a beer with lower 
caloric content. The yeast S. occidentalis produces a thermolabile GA that is practically elimin­
ated following the pasteurization step, 8 min at 60°C, avoiding the possibility of the beer be­
coming sweet due to hydrolysis of residual dextrins during storage (Sills et al., 1983a,b). The 
construction of hybrid beer-producing Saccharomyces strains able to secrete GA has also been 
attempted (Sills et al., 1983b; Hansen et al., 1990). 
Physicochemical Characteristics 
GA is produced by many filamentous fungi, yeast, bacteria, and even archaea, and it has 
been reported in plants and animals (Manjunath etal., 1983; Saha and Zeikus, 1989; Vihinen 
and Mantsala, 1989; Pandey, 1995). GA-producing fungi can be selected fnsm the microflora of 
cereal plants (Kvachadze et al., 1988). The most common sources for industrial use are fungi 
from the genera Aspergillus and Rhizopus, but yeast from the genus Saccharomycopsis also 
have potential. 
Varied forms of GA, called isoenzymes, have been found in fungi. A. niger can produce 
six forms (Ono et al., 1988). The smaller of the two major forms of GA in Aspergillus is 
obtained by proteolytic cleavage of the initial form (Svensson et al., 1982,1986a; Neustroev and 
Firsov, 1990) and is not able to degrade raw starch. Three forms resulting from differential 
proteolytic cleavage occur in R. oryzae (Tanaka et al., 1986a). Two different GAs with distinct 
catalytic properties are produced by H. resinae (Fagerstrom etal., 1990). In addition, 5. dias-
taticus and Schizosaccharomyces pombe produce diverse forms of yeast extracellular GAs 
(Yamashitaeffl/., 1985a). 
Molecular weights of fungal GAs vary between 48 and 112 kDa (Manjunath et al., 
1983; Saha and Zeikus, 1989; Vihinen and M^tsala, 1989; Pandey, 1995). Yeast GA molecular 
weights are normally found within these limits, but forms of up to 250 kDa have been reported 
for S. diastaticus GA (Yamashita et al., 1985a). Molecular weights associated with the mature 
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sequenced GAs (excluding carbohydrate moieties) vary between 55 kDa for S.fibuligera GAs 
and 104 kDa for S. occidentalis GA. 
GAs generally have pH optima between 4 and 5, but values of 3.5 and 6.5 have been ob­
served (Manjunath et al., 1983; Vihinen and Mantsala, 1989). Optima for pH stability are sit­
uated between pH 3 and 8, with isoelectric points (pi) between pH 3.4 and 7 (Saha and Zeikus, 
1989; Vihinen and Mantsala, 1989). Approximate pi values calculated from mature GA 
sequences vary from pH 4.0 in A. niger GA to 6.9 for R. oryzae GA. 
Fungal and yeast GAs are glycoproteins, with carbohydrate contents ranging from 3 to 
30% (Manjunath et al., 1983; Saha and Zeikus, 1989). N- and 0-glycosylation can be found in 
Aspergillus and Rfiizopus GAs (Pazur et al., 1990). A/-glycosylarion occurs in two distinct sites 
of the A. niger GA sequence (Svensson et al., 1983), and also occurs in GAs from the fungi R. 
niveus (Takegawa et al., 1988) and A. awamori var. XlOO (Aleshin et al., 1992) and the yeast S. 
diastaticus (Modena et al., 1986), S.fibuligera, and S.fibuligera KZ (Gasperik and Hostinova, 
1993; Solovicova et al., 1996). A role in protein thermostability, in pH and proteolytic stability, 
and in secretion has been ascribed to this modification. O-glycosylation occurs in localized seg­
ments in A. niger (Gunnarsson et al., 1984) and S. diastaticus GAs (Yamashita, 1989), and 
plays a role in stability and secretion. 
Modification of the carbohydrate component of A. awamori var. XlOO GA leads to vari­
ations in temperature and pH stability (Neustroev et al., I993a,b) and a hyperglycosylated GA 
produced by a strain of A. awamori var. kawachi has an enhanced ability to bind raw starch 
(Fukuda et al., 1992a). Differences in glycosylation levels might also cause the variety of GA 
forms found in some species. 
Functional Organization 
As with other glycosylases, GAs can have more than one domain (Jespersen et al., 
1991). The ability of GA to degrade starchy materials lies in a catalytic domain (CD), with 
11 
some fungal GAs being able to degrade raw starch (Svensson et al., 1986a). The modular struc­
ture of A. niger GA is given in Fig. 1.0-glycosylated regions close to the C-tertninus of Asper­
gillus GAs (Gunnarsson et al., 1984) and in the A/-terminal region of S. diastaticus GA (Yam-
ashita, 1989) have been reponed. The cell-bound GAs produced by Clostridium thermohydro-
sulfuricum, Clostridium sp. G0005, and Clostridium thermosaccharolyticum can be released 
following sonication or induction by starch (Hyun and Zeikus, 1985; Ohnishi et al., 1991; 
Specka and Mayer, 1993). These properties or functions can be associated with specific regions 
within the protein sequence. 
The three-dimensional models of the CD of A. awamori var. XlOO GA have a diameter 
of approximately 65 A (Aleshin et al., 1992, 1994a), which agrees with scanning tunnelling 
microscopy results (Kramer et al., 1993). A close Stokes radius of 33.5 A was found for C. 
thermosaccharolyticum GA (Specka et al., 1991). The Aspergillus domain is a globular struc­
ture partially surrounded by an O-glycosylated tail and contains conserved regions, designated 
S1 to S5, that are common to different GA sequences (Tanaka et al., 1986b; Itoh et al., 1987; 
Coutinho etal., 1994a,b). Interestingly, the protein sequence of S. occidentalis GA shows no 
homology to the remaining GA sequences (Naim et al., 1991) and has been ascribed to the 
independent maltase-glucoamylase family. The S. pombe GA sequence is homologous to that 
of of S. occidentalis (a funher description will be found in Chapter 3). 
The starch-binding domain (SBD) of fungal GAs is found at the A/-terminus, as in R. 
oryzae GA, or at the C-terminus, as in Aspergillus GA. Its action in the degradation of raw 
starch has been characterized (Dalmia and Nikolov, 1991). Several starch-degrading enzymes 
contain similar domains (Svensson ei al., 1989; Jespersen et al., 1991). The structure of the A. 
niger GA SBD has been recently determined by NMR (Jacks et al., 1995; Sorimachi et al., 
1996). A A^-terminal domain with some homology to that of the SBD R. oryzae exists in A. 
adeninivorans GA but the enzyme has no apparent ability to degrade raw starch (Bui et al., 
1996b). 
Aspergillus niger Glucoamylase 
Catalytic Domain Linker Starch-Binding Domain 
-60  A -100  A -30  A 
Figure 1. Schematic structure of A. niger GA. The catalytic domain from 3gly (Aleshin et al., 1994a) is connected by a linker, here 
built from repetitions of the 0-glycosylated belt around 3gly, to the starch-binding domain, here the homologous domain E of Icgt 
(Klein and Schultz, 1993). 
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The SBD is able to bind a variety of materials including starch, maltooligosaccharides, 
cyclodextrins, chitin, and cell-wall material (Savel'ev et al., 1989, 1990; Belshaw and Wil­
liamson, 1991, 1993; Fukuda et al., 1992b; Neustroev et al., 1993c), and appears to interact 
more strongly with starch-related substrates containing a-(l,6)-bonds (Cottaz et al., 1992; Sig-
urslgold et al., 1994; Apparu et al., 1995). A. niger GA, secreted only by the tips of leading 
hyphae, can remain bound to the cell wall long after secretion, being released or cleaved when 
rapid growth conditions are found (Wosten et al., 1991; Neustroev et al., 1993c). Rapid growth 
leads to a decrease in pH (Neustroev et al., 1993c; Jarai and Buxton, 1994) and that 
corresponds to an activation of proteases. The proteases will act more easily on those GA link­
ers that are less (^-glycosylated (Le Gal-Coeffet et al., 1995). 
The O-glycosylated region surrounds the CD in A. awamori GA and is important for 
stability of this domain (Evans et al., 1990). Part of the region in A. niger GA appears to be in 
extended conformation due to extensive 0-glycosylation (Williamson et al., 1992a,b), and acts 
as a linker. Such structures are not uncommon in fungal and bacterial cellulases (Beguin etal., 
1992; Wood, 1992), where deletions made in the long O-glycosylated linker of T. reesei cello-
biohydrolase 1 decreased total enzyme activity while the absorption to the substrate was main­
tained (Srisodsuk etal., 1993). In S. diastaticus GA, the 0-glycosylated A^-terminal region has 
an imponant role in secretion (Yamashita, 1989), and deletions in the central 0-glycosylated 
region of A. awamori GA led to difficulties in secretion (Libby et al., 1994). Beside this region, 
Saccharomyces GAs also have a segment of unknown function at the A/-terminus of the CD. 
Saccharomycopsis GAs are apparently composed only of a CD. 
Clostridium sp. G0005 GA is bound to the cell wall by a covalent bond to its C-tenninal 
Cys residue, as with other bacterial lipoproteins (Ohnishi et al., 1991, 1992). A /^-terminal reg­
ion corresponding to approximately a third of the mature GA makes the connection between the 
CD and the cell wall. The macromolecular model of C. thermosaccharolyticum GA, which has 
the same molecular weight, suggests a globular form for such a domain (Specka and Mayer, 
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1993). Limited amounts of GA are found in the medium following natural cleavage, and in C. 
thermosaccharolyticum the GA concentration in solution depends on the substrate, being high 
for starch and low for glucose (Specka and Mayer, 1993). This feature shows some parallel to 
the retention of A. niger GA by cell walls (Neustroev et ai, 1993c). A long iV-terminal is also 
found in Methanococcus jannaschii GA, but its function is still unknown. 
Structure of the Catalytic Domain 
The crystal structure of a 470 residue-long CD of A. awamori var. XlOO was deter­
mined in its native state at different pH values and in complexes with different inhibitors (Al-
eshin et ai, 1992, 1994a,b, 1996; Harris et al., 1993; Stoffer et ai, 1995) (Fig. 2). It contains 
thineen a-helices, twelve paired two by two forming an a/a barrel, a structure shared only with 
the bacterial Clostridium thermoceilum endoglucanases CelA and CelD (Juy et ai, 1992; Alzari 
et al., 1996), but where the catalytic regions show very different characteristics. Five conserved 
segments (Tanaka et al., 1986b; Itoh et ai, 1987) define the active site as the region involving 
the cavity in the center of the barrel, where all residues required for catalysis are present 
(Coutinho et aL, 1994a,b; Henrissat et al., 1994; Chapter 3). The last thirty residues of the 
model form an extended bell encircling pan of the catalytic domain that is present only in 
Aspergillus-relsited GAs (Courinho etal., 1994b). Ten Ser and Thr residues with a-(9-linked 
mannosyl residues are found in this belt. Two additional A/-glycosylation sites at Asnl71 and 
Asn395 have P-Cl-linked A/-acetyl-D-glucosamine residues integrated in five- and eight-res-
idue-long carbohydrate chains, respectively (Aleshin et al., 1994a). A water molecule, presum­
ably the catalytic water required for general acid-base catalysis to occur, is also found in the first 
subsite of the model of each complex. This water molecule is more tightiy bound with the native 
enzyme at pH 4.0 than at pH 6.0 (Aleshin et al., 1994a). 
Figure 2. Stereo plot of the catalytic domain of A. awamori var. XlOO glucoamylase (Aleshin et al., 1994a). Carbohydrates involved 
of yv-glycosylation (black) and m 0-glycosylation (white) are shown, as well as the three disulfide bonds (grey). Plot prepared with 
MOLSCRIPT (Kraulis, 1991). 
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Protein Sequencing, Cloning, and Genetics 
The complete nucleotide sequences of nineteen GAs from different origins have been 
obtained since the middle of last decade, mostly as result of specific characterization efforts but 
more recently as a result from different genomic projects. These are from the filamentous fungi 
A. awamori (Nunberg et al., 1984), A. awamori var. kawachi (Hayashida et al., 1989), A. awa-
mori var. XlOO QDiagne et al., 1996), A. niger (Boel et al., 1984a), A. niger T21 (Zhong et al., 
1994), A. oryzae (Hata et al., 1991), A. shirousami (Shibuya et al., 1990), Corticium rolfsii 
(Nagasaka et al., 1995), H. resinae GamP (Joutsjoki and Torkkeli, 1992), Humicola grisea var. 
thermoidea (Berka et al., 1993), Neurospora crassa (Stone et al., 1993), and R. oryzae 
(Ashikari et al., 1986), the yeast Arxula adeninivorans (Bui et al., 1996b), S. cerevisae 
(Yamashita et al., 1987), S. dlastaticus (Y amashita et al., 1985b), S.fibuligera (Itoh et al., 1987), 
S.fibuligera KZ (Hostinova et al., 1991) and S. occidentalis (Dohmen et al., 1990), the 
bacterium Clostridium sp. G0005 (Ohnishi et al., 1992), and the archaeon M.Jannaschii (Bult 
et al., 1996). All but one nucleic acid sequence coding for GA have the peptide signal required 
for secretion, S. cerevisae GA being the only exception. 
Studies of protein characterization have led to complete sequencing of A. niger GA 
(Svensson et al., 1983), or partial sequencing derived from peptide mapping, as for H. resinae S 
(Fagerstrom, 1991; Fagerstrom, personal communication) and T. reesei (Fagerstrom and Kalk-
kinen, 1995) GAs. A'-Terminai sequencing has been obtained from both Aspergillus phoenic-
iens (also known as Aspergillus saitoi) GAs (Inokuchi, etai, 1981), in Aspergillus sp. K-27 
GA (Abe et al., 1990), and in three Chalara paradoxa GA forms (Monma and Kainuma, 
1992). Most of these GAs appear to be related to A. niger GA. Further description of the 
sequences and their evolutionary relationships are given in Chapter 3. 
Cloning of GAs of fungal and yeast origin has been performed mostly in S. cerevisae, a 
host whose expression, giycosylation, and secretion are comparable to the native hosts (Ashikari 
et al., 1985; Innis et al., 1985; Cole et al., 1988). However, other hosts have been chosen for 
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cloning, such as the yeast Hansenula polymorpha for S. occidentalis GA (Gellissen et al., 
1991), Aspergillus oryzae for A. shirousami GA (Shibuya et al., 1990), and T. reesei for H. re-
sinae GA P (Joutsjoki and Torkkeli, 1992; Joutsjoki et al., 1993). Humicola GA was cloned 
back into the thermophile H. grisea var. thermoidea (Allison et al., 1992) and A. adeninivorans 
GA gene was cloned in Kluyveromyces lactis to improve secretion (Bui et al., 1996a). The bac­
terial Clostridium sp. G0005 GA was cloned and expressed in Escherichia coli (Ohnishi etal., 
1992) as was recently the yeast S.flbuligera GA (Solovicova et al, 1996). 
The GA gene glaA in A. niger and A. oryzae is expressed at high levels in the presence 
of starch. Deletion studies of their promoters have identified regions that direct high levels of 
expression in the presence of maltose and other substrates (Fowler et al., 1990; Hata et al. 
1992). As with other sequenced genes found in industrial filamentous fungi, Aspergillus glaA 
genes characteristically contain four to five introns and have CAAT and TATA motifs and CT-
rich regions in their promoter regions (Unkles, 1992). Four introns were found in the R. oryzae 
GA gene (Ashikari et al., 1986) but only three in the H. grisea GA gene and one in the N. 
crassa case (Stone et al., 1993). Two different A. niger GAs could result of alternative mRNA 
splicing (Boel et al., 1984b). 
In S. diastaticus the GA multigene family contains the three similar and unlinked genes 
STAI, STA2, and STA3 involved in starch utilization (Pretorius et al., 1991). STAl gene ex­
pression has been studied by identification of the genes involved in its regulation (Inui et al., 
1989) and by deletion analysis of upstream regions (Shima etal., 1989). The identification of 
the SGAl gene in S. cerevisae, involved in the production of a sporulation-specific GA (Yam-
ashita and Fukui, 1985), suggests that gene fusion was involved in the evolution of STAl by 
addition of a 5'-terminal region responsible, among other features, for GA secretion (Yamashita 
et al., 1987). At least 10 out of 33 Saccharomvces strains examined contained DNA hom­
ologous to SGA/ (Yamashita er a/., 1987). 
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Schwanniomyces castelli GA expression is induced by maltose and starch and is regul­
ated at the mRNA level (Dowhanick et al., 1990). With sugars like cellobiose, galactose, lactose, 
and xylose or in the absence of carbohydrates, only constitutive GA expression occurs. 
Applied Modiflcation of Glucoamylase 
Beside studies for enzyme characterization, changes in A. niger/A. awamori GA have 
been made by genetic engineering to modify prop)erties of industrial interest. 
GA selectivity has been altered based on local homology of active-site regions with the 
better characterized enzyme a-amylase, which lacks a-(l,6) activity (Sierks and Svensson, 
1992a,b; Sierks etal., 1993). Mutations Serll9->Tyr, Glyl83—>Lys, and Serl84->His GAs 
yielded small decreases in selectivity for isomaltose while maintaining the capacity to hydrolyze 
maltose. Unfortunately, the sequence homology had no structural basis. More successful were 
the recent efforts in copying some of the sequence features of the GA P from H. resinae, an 
enzyme with high a-(l,6) activity (Fagerstrom, 1991) into A. niger GA. Multiple mutation of 
three residues in conserved region S3 or of four in region S4, mutants L3 and L5, respectively, 
led to significant losses of enzyme activity with no significant decrease in selectivity (Fierobe et 
al., 1996). However the combined mutant L3L5 has a significantiy increased a-(l,6) activity 
with only a small decrease in the overall enzyme activity. 
Variations in active site residues at the first subsite, observed in different GAs (Coutinho 
and Reilly, 1994b) lead to different A. awamori mutants at Ser411, of which Ser411—> Gly 
significantly decreases the ability to degrade isomaltose while maintaining 70% of enzyme 
activity against maltose (Fang et al., unpublished results). Constructed to suppress the format­
ion of a hydrogen bond in the third GA subsite. found in complexes with acarbose and gluco-
dihydroacarbose (Aleshin et al., 1994b, 1996; Stoffer er al., 1995), the mutant Glyl21—)Ala ex­
hibits an equally significant decrease in A. awamori ability to degrade isomaltose while main­
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taining its activity towards maltose (Fang et al., unpublished results); however, an impaired 
activity toward long maltooligosaccharides occurred (Appendix, Table 1). 
Mutations in GA were made to increase optimal pH (Bakir et al., 1993). Unfonunately, 
all the mutants were constructed in a region essential for GA activity, as later verified by the GA 
crystal structure model, and this led to low-acrivity mutants with pH profiles similar to that of 
wild-type GA. 
Mutations affecting thermostability produced by site-directed (Sierks et al., 1993; Chen 
et al., 1994a,b, 1995,1996; Allen et al., unpublished results; Li et al., unpublished results) and 
random (Flory et al., 1994) mutagenesis have been characterized. Obtained by site-directed 
mutagenesis (Sierks et al., 1993), the Asnl82-^AIa mutant showed a 5°C increase in optimal 
temperature (Chen et al., 1994a). Thermostable mutants were also found by elimination of pro­
tein segments susceptible to inactivation by chain breakage (Chen etal., 1995). 
Based on the GA models, substitution of a-helix Gly residues to the less flexible Ala 
residue, led to mutants Gly 137—^Ala, Gly 139—>Ala, and Glyl37—>Ala/GIyl39—»Ala showing 
wild-type activity and decreased thermoinactivation (Chen et al., 1996). Homology relationships 
witii N. crassa and C. rolfsii GA sequences led to the introduction of a disulfide bridge at 
positions 20 and 27 and a more thermostable GA (Li et al., unpublished results). The mutant 
Ser30—>Pro, chosen by structural analysis, also has improved thermostability (Allen et al, un­
published results). Interestingly, the increase in enzyme thermostability is also linked to in­
creases in specific activity. That was not, however, the case for thermostable mutant Ala246—» 
Cys, which introduces a disulfide bridge with Cys320 in A. niger GA, but leads also to a two­
fold decrease in activity (Fierobe et al., 1996). The combination of several of the positive 
mutations as led to even more stable GAs (Allen et aL. unpublished results). 
Thermosensitive mutants obtained by random mutagenesis yielded the mutants 
Ala302—>Val, Gly396—>Ser, and Gly407—>Asp that retained 77, 94, and 100%, respectively, of 
wild-type activity (Flory et al., 1994). These mutants are interesting for light beer production. 
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since exposure to the pasteurization temperature for the standard time leads to total enzyme 
inactivadon. 
The inversion of domain order in A. awamori GA, yielding a GA with a A^-tenninal 
SBD, did not lead to improvement of starch-binding affinity (Geurkink and Ford, unpublished 
results). 
The fusion of A. shirousami a-amylase and GA cDNAs expressed in S. cerevisae 
yielded more digestion activity on rice starch than the simple combination of both enzymes 
(Shibuya et al., 1992a). The overproduction of this fusion in A. oryzae was recendy reported 
(Shibuya er a/., 1992b). 
Fusions incorporating A. awamori GA have also been used to improve protein purifi­
cation. P-Galactosidase or glutathione S-transferase fused to the GA SBD could be recovered 
in a single step using starch granules as an absorbent (Chen et al., 1991; Dalmia and Nikolov, 
1994a,b). Fusion of charged tails to the GA CD improved protein separation by polyelectrolyte 
precipitation (Suominen etai, 1992; Forney andGIatz, 1994). 
Kinetics and Inhibition 
GAs rapidly degrade a-( 1,4)-D-glycosidic bonds, and A. niger GA acts more slowly 
upon di- and trisaccharides with a,P-(l,l)-, a-(l,2)-, a-(l,3)-, and a-(l,6)-D-glycosidic bonds 
(Pazur and Kleppe, 1962; Meagher and Reilly, 1989). 
A. niger and R. delemar GAs hydrolyze the a-(l,4) linkage of maltose about thirty-fold 
faster than the a-(l,6) linkage of isomaltose (Pazur and Kleppe, 1962; Hiromi et al., 1966a). 
Significant a-(I,6) hydrolytic activity is found in Clostridium sp. G0005 GA and in H. resinae 
GA P, the value of (kcax/l^m) of the hydrolysis of isomaltose being 8(X) and 80 times higher than 
in A. niger GA, respectively (Ohnishi et al., 1992). However, low a-(l,6) activity is found in C. 
thermosaccharolyticum GA (Specka et al., 1991) and in H. resinae GA S (Fagerstrom et al., 
1990). Comparative studies indicate that in S. castelli GA the hydrolysis rates of maltose and 
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isomaltose are equivalent, while in A. oryzae and S.fibuligera GAs the latter is much slower 
(Sills et al., 1983a). S. diastaticus GA slowly cleaves a-(l,6) glycosidic bonds (Kleinman et al., 
1988), but its a-(l,4) / a-(l,6) selectivity is similar to that of A. niger GA. 
The action of R. niveus GA on both a- and P-D-glycosyl fluoride results in the liberat­
ion of P-D-glucose and hydrogen fluoride, a clear indication that GA is an inverting enzyme 
(Kitahata ef a/., 1981). 
Subsite affinities have been studied in GAs of different origins. Up to seven subsites 
were kinetically defined in studies with GAs from A. awamori (Savel'ev et al., 1982), A. niger 
(Meagher et al., 1989; Ermer et al., 1993), A. saitoi (Koyama et al., 1984), Aspergillus sp. K-
27 (Abe etal., 1990), C. paradoxa (Monma etal., 1989), Clostridium sp. G0005 (Ohnishi et 
al., 1992), H. resinae (Fagerstrom, 1991), R. delemar (Hiromi et al., 1973; Abe et al., 1985), 
and^. niveus (Ohnishi, 1990). All studies were performed with maltooligosaccharides, but in 
some cases isomaltooligosaccharides were also studied to better characterize GA a-(l,6) activity 
(Meagher ef a/., 1989; Fagerstrom, 1991, Tanaka and Takeda, 1994). The interaction with p-
nitrophenylmaltooligosaccharides and with maltooligosacharides up to 17 units long have been 
studied (Ermer et al., 1993). Only six subsites are significant in most cases, the catalytic 
efficiency increasing with increased substrate length. S. castelli GA is the exception, since it 
shows similar rates for maltose, isomaltose, soluble and insoluble starch, and dextrin (Sills et 
al., 1983b). 
Steady state stopped-flow kinetic studies of R. niveus GA (Tanaka et al., 1982a, 1983) 
and A. niger GAs (Olsen et al., 1992) indicate reaction model (1) holds for maltose hydrolysis. 
It involves the fast association of enzyme £ and substrate S, followed by a slow change in con­
formation of the first association complex. The same steps are found for longer maltooligo­
saccharides (Olsen et al., 1993). An additional step is required for isomaltose hydrolysis in A. 
niger (Olsen etal., 1992), as shown by reaction model (2): 
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The activation energies for free enzyme and free substrate for maltose and isomaltose 
are 28 and 80 kJ/mol, respectively (Olsen etal., 1992). In the acid-catalyzed hydrolysis of both 
maltose and isomaltose, a value of 93.7 icJ/mol was found. GA stabilizes the transition state of 
isomaltose only 14 kJ/mol, while that of maltose is stabilized by 66 kJ/mol 
The ratio k.i / ki, associated with the first enzyme/substrate encounter, is independent of 
the length of the maltooligosaccaharide, whereas the values k2 and k.2 increase and decrease, 
respectively, with the substrate length, in what could be seen in the forward direction as the 
sliding of the substrate to form a productive complex (Hiromi et al., 1983; Olsen et al., 1993). 
The equilibrium formation of oligosaccharides from glucose has also been modeled, 
leading in A. niger GA to the preferred formation of maltose but also to significant amounts of 
a-(l,6) linked oligosaccharides (Hehre et al., 1969; Nikolov et al., 1989). The higher the glu­
cose concentration, the more significant the reverse or condensation reaction. 
Two essential carboxyi groups with p^aS of 2.9 and 5.9, respectively, were found for the 
enzyme complex of R. delemar GA with maltose and panose (Hiromi et al., 1966b). With fi^e 
enzyme, both substrates give pATais of 1.9, while pKa2S of 5.9 and 6.4 was found for maltose 
and panose, respectively. In A. awamori GA pKa values of 2.3 and 5.75 for the enzyme-maltose 
complex and of 2.75 and 5.55 for the free enzyme occur (Savel'ev and Firsov, 1982). An 
optimal pH between 4.0 and 4.5 occurred in both cases. In A. awamori GA, pKa values and 
optimal pHs were higher for maltoheptaose than for maltose (Bakir et al., 1993). 
The binding of maltose to R. niveus GA is not affected at the pH range where the catal­
ytic groups were ionized, the substrate still binding the substrate at pH 7.9 (Ohnishi and Hir-
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omi, 1989), while in A. niger GA the Km for maltose decreased with pH in the 3.5 to 5.5 range 
(Meagher and Reilly, 1989). 
Chemical modification identified exposed residues and those involved in catalytic and 
starch-binding activity in A. awamori var. XlOO (Savel'ev and Firsov, 1983) and A. niger GAs 
(Clarke and Svensson, 1984a,b; Svensson et al., 1986b, 1988a, 1990). These studies followed 
the action of modifying agents on essential Trp, Tyr, Asp, and Glu residues. Chemical modif­
ication in the presence and absence of the inhibitor acarbose showed residues Asp 176, Glul79, 
and Glul80 as imponant for A. niger GA action (Svensson et al., 1990). In the SBD, the 
residues Trp590 and Trp6I5 of A. niger GA take part in the adsorption to starch granules 
(Svensson ef a/., 1986b). 
Site-directed mutagenesis has been employed for characterization of the identical A. 
awamori and A. niger GAs (Appendix, Table 1) and S.fibuligera GA (Itoh et al., 1989). The 
great number of mutants characterized would lead to an extensive list that is better smdied in a 
tabulated format, as found in the Appendix. 
Studies with substrate analogues showed that the 3,4',6'- and 4,4',6'-OH groups of 
maltosides and isomaltosides are required for rapid hydrolysis (Bock and Pedersen, 1987, 
1988; Bock et al., 1991; Lemieux ei al., 1996), implying the same position for the nonreducing 
end at the first subsite for both substrates. Again, for the many substrate analogues, a better 
description can be found later (Appendix, Table 1). 
Several inhibitors of catalytic activity have been found (Tanaka et al., 1982a; Bock and 
Pedersen, 1984; Clark and Svens.son, 1984a; Svensson etai, 1988b). The interaction of several 
GAs with gluconolactone, a transition-state analogue, has been studied to help characterize the 
binding mechanism, indicating that it binds to at least two subsites (Laszlo et al., 1978; Hiromi 
et al., 1982; Tanaka et al., 1982a; Olsen et al., 1992). The action of the inhibitor 1-deoxy-
nojirimycin in R. niveus GA has been studied (Tanaka et al., 1982b). The suggested binding to 
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the first and second subsites was verified following crystallographic studies (Harris et al., 
1993). 
The pseudotetrasaccharide acarbose is a potent GA inhibitor (Bock and Pedersen, 1984; 
Clarke and Svensson, 1984a; Svensson et al., 1988b), whose complex with A, awamori var. 
XlOO GA has also been characterized by protein crystallography (Aleshin et al., 1994b). 
Acarbose behaves as maltotetraose in the first and second steps of the enzyme reaction, only 
revealing its inhibitory action in the step corresponding to the catalytic reaction (Olsen et al., 
1993). Information about this and other inhibitors are found in the Appendix. 
Wide but scattered information on kinetic properties on both native and mutated GAs is 
found throughout the literature. Few reviews describe either the behavior of different GAs on a 
variety of substrates (Vihinen and Mantsala, 1992), or that of mutated GAs (Svensson, 1994). 
No comprehensive review of GA inhibition studies has been made. Furthermore, the effect of 
temperature on both properties has been disregarded in GA comparisons of GA kinetics. A 
attempt to simultaneously compare kinetics and GA inhibition is made later (Appendix, Table 
1). Thermodynamic parameters for binding and catalysis of malto- and isomalto-
oligosaccharides were also calculated there. They were used for both enzyme comparison and to 
calculate the effect of temperature in A. niger GA activity and selectivity. 
Research Objectives 
The protein engineering of GAs for changes in selectivity needs a deeper understanding 
of the molecular basis of the interaction of the enzyme with substrates. As in the subtilisin 
family (Wells and Estell, 1988; Bott ei al., 1992). structural comparison can be used as a guide 
for protein engineering. But to be u.sed effectively, knowledge on the properties of different 
GAs has to be compared in similar situations. In the absence of that information a literature 
review was conducted, in a manner that A. niger GA properties can be extrapolated for the con­
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ditions of a given smdy to facilitate interpretation of selectivity properties. These interpretations 
might be correlated with homology information. 
On the other hand, some of the selectivity properties of the structurally known Asper­
gillus GA are still unexplained. Structural information on GA has been employed effectively in 
the engineered improvement of its thermostability. Better understanding of the molecular basis 
of GA interaction with a variety of substrates, only partially inferred from the study of GA-
inhibitor complexes, is needed. A protocol to systematically search the best interactions of sacc­
harides, which are flexible in nature, with the GA active site was needed- Earlier group expertise 
in the conformational studies of saccharides was used to generate libraries of structures to be 
docked by simulated annealing in the enzyme active site. 
The first manuscript (Chapter 3) is an update of the structural information known for 
the GA family of glycosyl hydrolases. There, besides considerations of purely structural prop­
erties, an attempt is made to identify regions that are likely to influence selectivity. The struc­
ture-based alignment obtained is a strong tool for GA protein engineering. 
In the second manuscript (Chapter 4) a selection of docking parameters was made that 
produced bound structures comparable to those obtained by protein crystallography, identifying 
already some of the active-site interactions imponant for catalysis. In the second and third 
manuscripts (Chapters 5 and 6, respectively) imponant interactions, first with isomaltoses, a-
(l,6)-linked glucosyl disaccharides, and later with the remaining glucosyl disaccahrides, were 
described. Especially significant were the identification of the important role of key hydroxyl 
groups in placing stress at the glycosidic oxygen, obviously necessary for catalysis to take 
place. 
These studies correlate GA activity with both substrate and active site features opening 
the doors for more rational engineering of GA selectivity. 
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CHAPTER 3. GLUCOAMYLASE STRUCTURAL, FUNCTIONAL, 
AND EVOLUTIONARY RELATIONSHIPS 
A paper to be submitted to Protein Engineering 
Pedro M. Coutinho and Peter J. Reilly 
Abstract 
To correlate structural feanires with glucoamylase properties, a multisequence alignment 
was constructed based on features of existing catalytic and starch-binding domain models. Two 
new glucoamylase sub-families were defined based on homology criteria. The catalytic domain 
is cut into three hydrophobic folding units, the more labile and least hydophobic of them not 
being present in the most stable glucoamylase. Differences in both length and composition of 
interhelical loops are correlated with stability and selectivity characteristics. The role of 
glycosylation in stabilizing the most hydrophobic folding unit, die only one where mutations 
increasing thermostability have been made, is described. Protein parsimony analysis suggests 
an ancient bacterial origin for the glucoamylase gene. Increases in length of the belt 
surrounding the active site, degree of (9-glycosylation, and in die length of the linker probably 
correspond to evolutionary steps in increasing stability and secretion levels of Aspergillus-
related glucoamylases. 
Introduction 
Glucoamylase [a-(l,4)-D-glucan glucohydrolase, EC 3.2.1.3, GA] is an enzyme em­
ployed in the industrial depolymerizarion of starch, given its ability to degrade raw starch and a 
variety of other carbohydrate polymers and oligomers into glucose. Different microorganisms 
produce GAs (Manjunath et al., 1983; Vihinen and Mantsala, 1989; Pandey, 1995), but the 
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industrial focus has been on Aspergillus niger (identical to Aspergillus awamori GA) and 
Rhizopus oryzae (also known as Rhizopus delemar) GAs. Both enzymes are characterized by 
having a catalytic domain (CD) and a starch-binding domain (SBD) connected by an 0-glycos-
ylated linker. Partial or total proteolytic excision of the SBD leads to enzyme forms able to de­
grade solubilized starch but not its raw or granular form. Extensive characterization of both 
GAs has been made through the years (Takahashi et al., 1985; Ashikari et al., 1986; S vensson 
et al., 1986; Neustroev and Firsov, 1990; Dalmia and Nikolov, 1991) but more recent efforts to 
modify GA properties to better suit industrial uses require a better knowledge of GA struc­
ture/function relationships. 
The three-dimensional model of the CD of A. awamori var. XlOO GA has been obtained 
by protein crystallography in its native state and when complexed with different inhibitors 
(Aleshin et al., 1992, 1994a,b, 1996; Harris et al., 1993; Stoffer et al., 1995), and the structure 
of A. niger GA SBD has been recentiy determined by NMR (Jacks et al., 1995; Sorimachi et 
al., 1996). The catalytic domain is an ((x/a)6-bairel surrounded by an O-glycosylated belt, the 
active site lying in its center. In contrast to the high a-helical content of the CD, the SBD is 
comprised of a set of eight P-strands, in a fold characteristic of SBDs found in other 
glucohydrolases (Svensson et al., 1989; Jespersen et ai, 1991). Belonging to Family 15 of 
glycosyl hydrolases (Henrissat, 1991, Henrissat and Bairoch, 1993, 1996), GA has a CD whose 
topology is similar to those of glycosidases of Families 8 and 9, represented by Clostridium 
thermocellum endo-glucanases CelA (Alzari et al., 1996) and CelD (Juy etal., 1992), respec­
tively. Unlike these enzymes, whose active sites are surface grooves where the substrate binds 
before undergoing e/Kfo-cleavage, the GA active site consists of a pocket where the non-reduc-
ing end of substrates binds and is hydrolyzed in a characteristic exo-acting mode to release (3-
glucose (Hehre et al., 1969). In A. niger GA, the CD is independent of the SBD, the O-
glycosylated linker physically separating the two domains (Williamson et al., 1992a,b). 
Differential scanning microcalorimetry studies of A. niger GA have recentiy indicated that the 
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constitutes an independent folding domain and that the CD contains three independent folding 
units (Tanaka era/., 1995). 
The GA active site is composed of conserved loops (Tanaka et al., 1986; Itoh et al., 
1987; Coutinho and Reilly, 1994a,b; Henrissat et al., 1994) where the conserved amino acid 
residues interacting with substrates and inhibitors lie (Harris etal., 1993; Coutinho and Reilly, 
1994a,b; Henrissat et al., 1994). Five sub-families of related GAs have been assigned based on 
hydrophobic cluster analysis of GA sequences (Coutinho and Reilly, 1994b; Henrissat et al., 
1994), and were designated by the most common genera of the species that made them: Asper­
gillus, Rhizopus, Saccharomycopsis, Saccharomyces, and Clostridium. The different GA sub­
families share the same overall CD arrangement. 
Only Aspergillus-rtXaxod and Rhizopus GAs possess a SBD, the former at the C-termi-
nus and the latter at the A^-terminus. In Aspergillus-xdzi&i GAs, most conserved SBD residues 
are either structurally important or are putatively involved in substrate binding (Coutinho and 
Reilly, 1994b), substrate interactions being based in the interactions of the homologous SBD 
from Bacillus circulans strain 251 cyclodextrin glucosyltransferase (CGTase) with maltose 
(Lawson er a/., 1994). 
In this study, a division of the CD into hydrophobic folding units, which are Ukely to 
have an important role in GA stability, is made. Different GA sequences are characterized, based 
on newly released sequence information and on the new NMR model of the SBD, with the 
identification of two new GA sub-families, Arxula and Methanococcus. The new structure-
based alignment allows a more complete comparison of expected structural features in the dif­
ferent GAs and suggests that the omission of the least stable hydrophobic folding unit in bac­
terial and archaeal GA would help to increase the stability of these proteins. Protein parsimony 
analyis of the alignment gives a powerful insight into the evolution of the CD, linker, and SBD 
structures. 
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Methods 
Secondary and Tertiary Structures. All A. awamori var. XlOO CD models in the 
Brookhaven Protein Databank, structures 3gly, Iglm, Idog, lagm, Igah, and Igai (Aleshin et 
al., 1992,1994a,b, 1996; Harris et al., 1993; Stoffer et al., 1995), were partitioned into hydro­
phobic folding domains by the World Wide Web service of the National Cancer Institute (Tsai 
and Nussinov, 1996; http://fcirislO.ncifcrf.gov: 1025/hfu/hfu.html). The results were averaged, 
yielding a typical uncertainty of ± 3 amino acid residues. 
Secondary strucure information was extracted from three-dimensional models of the 
CD from A. awamori var. XlOO GA (Aleshin et al., 1992, 1994a) and that of the SBD of A. 
niger GA (Sorimachi et al., 1996) (structures 3gly and Ikum of the Brookhaven Protein 
Databank, respectively) using STRIDE (European Molecular Biology Laboratory, Heidelberg, 
Germany; Frishman and Argos, 1995). 
Primary Structure. GA gene sequences have been collected from the filamentous fungi 
A. awamori (Nunberg et al., 1984), A. awamori var. kawachi (Hayashida et al., 1989), A. 
awamori var. XlOO (Diagne et al., 1996), A. niger (Boel et al., 1984), A. niger var. T21 (Zhong 
et al., 1994), Aspergillus oryzae (Rata et al., 1991), Aspergillus shirousami (Shibuya etal., 
1990), Corticium rolfsii (Nagasaka et al., 1995), Hormoconis resinae GamP (Joutsjoki and 
Torkkeli, 1992), Humicola grisea var. thermoidea (Berka et al., 1993), Neurospora crassa 
(Stone et al., 1993), and R. oryzae (Ashikari et al., 1986), the ycust Arxula adeninivorans (Bui 
et al., 1996), Saccharomyces cerevisae (Yamashita et al., 1987, Barrell et al., 1994; Churcher et 
al., 1994), Saccharomyces diastaticus (Yamashita et al., 1985), Saccharomycopsis fibuligera 
(Itoh etal., 1987), Saccharomycopsis fibuligera KZ (Hostinova etal., 1991), Schizosaccharo-
mycespombe (Pearson and Churcher, 1995) and Schwanniomyces occidentalis (Dohmen etal., 
1990), the eubacterium Clostridium sp. G0005 (Ohnishi etal., 1992), and the archaeonMer/i-
anococcus jannaschii (Bult et al., 1996). 
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Partial protein sequence information derived from peptide mapping from H. resinae GA 
S (Fagerstrom, 1991; Fagerstrom, personal communication) and Trichoderma reesei GA (Fag-
erstrom and Kalkkinen, 1995) and from A^-terminal sequencing of both Aspergillus phoenic-
iens (also known as Aspergillus saitoi) GA (Inokuchhi, et al., 1981), of Aspergillus sp. K-27 
GA (Abe et al., 1990), and of three Chalara paradoxa GA forms (Monma and Kainuma, 1992) 
was also collected. 
Significant errors in some sequences were manually corrected. These can have strong 
effects on data interpretation, as in obscuring the identification of conserved residues involved in 
catalysis in Saccharomyces GA sequences (Henrissat et al., 1994) that were only definitely 
corrected following sequencing of S. cerevisae chromosome IX (Barrell et al., 1994; Churcher 
et al., 1994). The corrected sequences were those of A. niger var. 72/,where the catalytic acid 
was missing, and A. awamori var. XIOO GAs, where a shift in die position of a small set of 
residues between helices Hll and HI2 was found. Also, only segments of the partial peptide 
mapping of H. resinae GA S and T. reesei GA (Fagerstrom 1991; Fagerstrom and Kalkkinen, 
1995) that could be matched to segments of other GAs were considered. An unidentified resi­
due in one of the H. resinae GA S fragments was assumed to be A^-glycosylated. 
Multisequence Alignment. A structure-based alignment of both complete and partial 
GA protein sequence information was constructed and edited using DCSE 3.4 (University of 
Antwerp, Belgium; De Rijk and De Wachter. 1993), an algorithm that allows simultaneous 
assignment of primary and secondar\' structure to protein sequences. Based on the principles of 
hydrophobic cluster alignment (HCA) (Gaboriaud et at., 1987; Lemesle-Verloot et al., 1990), a 
multisequence alignment of all related GA sequences was constructed manually. Identification 
of secondary structural elements was made by homology to the existing three-dimensional 
models, and was mostly based on HCA assignments, with the maintenance of hydrophobic 
residues in a regular arrangement in helices and P-strands, and by placing most insertions or 
deletions in nonstructured segments often associated with the positioning of turns. a-Helical, 3-
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sheet, and turn assignments were based on the description of the three-dimensional models used 
(Aleshin etal., 1992, 1994a; Jacks era/., 1995; Sorimachi etal., 1996), but 3io-helical infor­
mation, along with SBD turn assignments made by STRIDE, were also followed. The alignment 
served as a template for manual correction of some GA sequences and for alignment of peptide 
sequences derived fix)m partial peptide mapping. 
Evolutionary Analysis. An evolutionary tree was constructed for all complete GA 
sequences following protein parsimony analysis. An unrooted distance tree was calculated 
using the Protpars and Drawtree programs, both components of the PHYLIP package (Felsen-
stein, 1982,1988). 
Results and Discussion 
Hydrophobic Folding Units. The different GA models were cut into hydrophobic 
folding units (Table 1). Even though large differences on the limits of the folding units some­
times appeared, they tended to vary around the same values. Averaged results in the assignment 
of three folding units is shown in Figure I. The least hydrophobic unit (Table 1) comprises 
helix Hll, which is not pan of the (a,a)6 barrel structure, and ponions of helices HIO and 
H12. The most hydrophobic unit contains pans of helices HI and H7, helices H2 to H6, and 
the N-terminal portion of the 0-linker. The unit with medium hydrophobicity contains the rest. 
Three folding units have been assigned to the A. niger GA CD in differential calorimetric 
studies (Tanaka et ai, 1995), with a founh unit being assigned to the SBD. A recent combin­
ation of site-directed mutagenesis and differential calorimetry of the resulting mutated A. awa-
mori GA shows that stabilization of helix HI 1 increased the melting temperature of only the 
first folding unit and did not affect overall enzyme thermostability (Li et at., unpublished 
results). On the other hand, ail mutated amino acid residues whose expressed proteins possess 
43 
Table 1. Hydrophobic folding units of different A. awamori var. XlOO GA models. The 
hydrophobicity of each unit is indicated as well as an average. Segments follow A. niger GA 
numbering. Some segments were not assigned in some protein models. 
Hydrophobic Folding Units® 
(Hydrophobicity Index) 
GA Model Conditions Lh LMh Mh MHh Hh 
3gly Native, 2.2 A 335—377 
pH 6.0 (0.73) 
Iglm Native. 2.4 A 335—377 
pH 4.0 (0.73) 
lagm Complex, 2.4 A 328—382 
pH 6.0 (0.75) 
Idog Complex, 2.4 A 332—378 
pH 6.0 (0.74) 
Igah Complex, 2.0 A 
pH 6.0 
Igai Complex, 1.7 A 327—381 
pH 4.0 (0.75) 
269—279 
326—382 
(0.79) 
224—334 
378—410 
411—423 
(0.79) 
224—334 
378—411 
(0.79) 
1—14 
173—194 
218—327 
382—452 
(0.82) 
1—14 
170—195 
218—331 
380—452 
(0.83) 
280—325 
383—411 
(0.76) 
1—14 
173—194 
218—326 
381—452 
(0.81) 
10—134 
202—209 
(0.79) 
1—223 
451-471 
(0.82) 
135—160 
458—471 
(0.74) 
15—172 
195—217 
452—471 
(0.84) 
15—169 
196—217 
453-^71 
(0.84) 
15—169 
195—217 
452—472 
(0.84) 
15—172 
195—217 
452-473 
(0.83) 
Average 330—379 I—14 15—171 
172—194 195—217 
218—329 453—470 
380—452 
^Classified by hydrophobicity units: Lh, lower; Mh, medium; Hh, higher. For mixed results, two other 
categories, not based on hydrophobicity, were used: LMh, lower/medium; MHh, medium/higher. 
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a 
Figure 1. Hydrophobic folding domains of CD of A. awamori var. XlOO GA visualized widi 
MOLSCRIPT (Kraulis, 1991). Stereoscopic plots of a) the front view of the active site; b) the 
view from below. Hydrophobic intensity of the CD is indicated by color: (clear) low hydro-
phobicity; (medium grey) medium hydrophobicity; and (dark grey) high hydrophobicity. N-
and (9-glycosylation are indicated with the colors of the respective folding domains. 
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increased thermostability and at least wild-type activity (Chen et al., 1996; Li et al., unpublished 
results; Allen et al., unpublished results) are located in the most hydrophobic domain. 
Sequence Alignment. A structure-based alignment of GA CDs and SBDs is shown in 
Figure 2. This alignment contains all existing GA sequences except those from S. occidentalis 
and 5. pombe (a fission yeast), which are not structurally related to the remaining GAs. They 
instead belong to glycosyl hydrolase Family 31 (Henrissat, 1991; Henrissat and Bairoch, 1993, 
1996), a diverse family also containing a-glucosidases and sucrase-isomaltases, and will not be 
further discussed in this study. The SBDs of only the Aspergillus-relatcd GAs were considered 
in this alignment, given that homology of the A/^-terminal SBD of R. oryzae GA with the 
corresponding A^-terminal segment of A. adeninivorans GA invalidated some of the assump­
tions necessary to relate this domain to the remaining SBDs (Coutinho and Reilly, 1994b), 
making its relation with the existing SBD three-dimensional model less credible. 
Two new sub-families of GA sequences, named Arxula and Methanococcus after their 
two members, can now be assigned, based on homology criteria described in the past (Coutinho 
and Reilly, I994a,b). The latter is the first archaeal GA sub-family described. 
The alignment shows a clear relationship between the Aspergillus-io^diVsd GAs, some 
homology between Rhizopus and Arxula GAs, and some between Saccharomycopsis and Sacc-
haromyces GAs. Both Methanococcus and Clostridium GAs show significant differences from 
the other GAs, the latter more than the former. However, they share some unique features with 
each other, namely the location of imponant deletions in regions present in all other GAs that 
could have both important stability and functional functions. 
Alignment of partial sequences revealed that H. resinae GA S also contains an SBD 
domain, likely placed at the CD C-terminus as in all Aspergillus-Telated GAs. T. reesei GA seg­
ments are closely related to the Aspergillus sub-family, as are the A^-termini of both C. para-
doxa and Aspergillus sp. K-27 GAs. The inclusion of the short A. phoeniciens GA segment in 
Figure 2. Structure-based alignment of glucoamylase sequences. Secondary structures as described in 3gly (Aleshin et al., 1994) and 
Ikum (Sorimachi et al., 1996), or as determined by STRIDE (Frishman and Argos, 1995). Structural elements: (B) P-bridges; (E) P-
strands; (G) 3io-helices; (H) a-helices; (T) turns. Secondary structure in each sequence is indicated by background colors: (yellow) 
a-helices; (brown) 3io-helices; (green) P-strands or P-bridges; (beige) turns. Other important features are: (purple background) 
catalytic acid or base; (black background) Cys residues involved in disulfide bridges or Asn, Thr, or Ser residues potentially involved 
in N- or 0-glycosylation. Active-site or binding residues are indicated along with the residues conserved in more than 90% of the 
sequences. Sub-families: A. Aspergillus (A. awamori var. XlOO; A. shirousami; A. awamori var. kawachi', A. niger/A. awamori-, A. 
niger T21\ A. terreus-, A. oryzae\ C. paradoxa; C. rolfsii; H. grisea var. thermoidea', H. resinae P; H. resinae S; N. crassa; T. 
reesei); B. Rhizopus {R. oryzae)-, C. Arxula (A. adeninivorans)-, D. Saccharomycopsis {S. fibuUgera, S.fibuligera KZ)-, E. 
Saccharomyces (S. cerevisae; S. diastaticus)', F. Methanococcus (M. jannaschii); G. Clostridium {Clostridium sp. G0005). 
Underlined sequence names indicate partial sequences. Minor errors were eliminated from different sequences manually. 
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the same category is only tentative, but is likely because of the obvious close relationship of this 
species to other sub-family members. 
Catalytic Domain Analysis. Most GA CDs share the same architecmre, being com­
prised of thirteen helices, twelve paired two by two, in an (a/a)6-barrel. The extra helix HI 1 
along with the terminal segments of helices HIO and H12 are missing from both M.jannaschii 
and Clostridium GAs. This suggests that the least hydrophobic folding unit, the one that un­
folds first with an increase of temperature, is not present in these enzymes. Given that these two 
GAs are thermostable, especially the one from M.jannaschii, a thermophilic organism that lives 
above 85°C (Bult et ai, 1996), the absence of this folding unit could be associated with stability. 
It could also simply indicate that these two more divergent enzymes are more primitive than the 
remaining GAs and never developed such a domain. 
In H. grisea var. thermoidea GA significant segments of helices H2 and H3 are deleted, 
the remnants of the helices being connected by a much shorter loop than those found in other 
GAs. Small variations in length of the loop between the two helices in different GA sequences 
are also found. Typically, short interhelical loops are found on the side of the CD opposite the 
active site in Aspergillus GAs in the regions between helices H2 and H3, H4 and H5, and H6 
and H7. The loop between H2 and H3 contains small insertions in Arxula, Saccharomycopsis, 
and Rhizopus GAs, while that between H4 and H5 is longer in GAs firom all three yeast sub­
families. The loop between H6 and H7 appears to be significantiy longer only in Methanococ-
cus and Clostridium GAs, but their highly divergent sequences render interpretation difficult in 
this region. In Aspergillus-vt\z.is.d. GAs, a highly structured region exists between the short helix 
H8 and H9, containing both P-sheet S6 and the Cys262-Cys270 disulfide bridge (A. niger 
numbering) (Fig. 2e). This region is shoner in the other GAs, an identical deletion being found 
in Rhizopus, Arxula, Saccharomycopsis, and Saccharomyces GAs. As mentioned before, the 
extra helix HI 1 is sequentially placed between the two long helices HIO and H12, the two inter­
connecting loops forming the anti-parallel P-sheet S7 (Aleshin et ai, 1992). Such features are 
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apparently shared by all sequences other than those of M. jarmaschii and Clostridium GAs 
(Fig. 2f), with insertions in both Saccharomycopsis and Saccharomyces GAs. 
The interhelical loops surrounding the active site contain most of the residues conserved 
in GA. The majority of them are involved in the active site (Coutinho and Reilly, 1994a,b; Hen-
rissat et al., 1994), as can be observed in the active site and consensus residues indicated in Fig. 
2. The segment between helices HI and H2 is a long structured region containing several active-
site residues, most found between the second strand of P-sheet S1 and the first loop of a-helix 
H2. As found in earlier studies (Coutinho and Reilly, 1994b), a major insertion is found in that 
region in the Clostridium GA. Also, significant deletions occur in the loop between both S1 P-
strands in both Rhizopus and Arxula GAs. Significantiy, both N. crassa and C. rolfsii GAs 
form a disulfide bridge (Fig. 2a) between Cys20 and Cys27 (A. niger numbering). Both this 
bridge and the mutation SerSO—»Pro lead to a more thermostable A. awamori GA when 
incorporated into it (Li et al., Allen et al., unpublished results). This segment might be 
associated with GA stability in all cases. 
The long structured loop between helices H3 and H4 also contains several active-site 
residues. Most are found in the two S2 |3-strands up to the first loop of H4. Some small inser­
tions and deletions are found after |3-sheet S3, but the most significant feature is the deletion of 
a large segment containing the two S2 P-strands in both Methanococcus and Clostridium GAs. 
It is unclear which residues in these two obviously related sequences take the role of LyslOS 
(Fig. 2b), and if the assignment of a leucine residue to substitute for the critical Trpl20 (Fig. 
2b) (Sierks et al., 1989) is correct in the M.jannaschii GA case. 
The shon but critical loop between helices H5 and H6 holding the catalytic acid Glul79 
(Sierks et al., 1990) has the same structure in all cases, with a minor deletion in M. jarmaschii 
GA. However, when three H. resinae GA P residues in the second segment of S4 and in S5, 
which are between H5 and H6, and four other residues in the loop between H9 and HIO re­
placed the corresponding seven residues in A. niger GA, a doubling of GA isomaltose hydrol­
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ysis catalytic efficiency occurred (Fierobe et al., 1996). Separate replacement of the two sets of 
residues decreased activity with no significant changes in selectivity. 
A longer and less conserved loop is found between H7 and H8. Residues in this region 
support some active-site residues through both side-chain contacts (Coutinho and Reilly, 
1994a) and participation in P-sheet S5, but do not interact direcdy with the substrate in the first 
subsite. Large insertions appear to exist after the S5 P-strand segment in Clostridium GA, and 
to a minor degree in Saccharomycopsis and Saccharomyces GAs. 
No significant regular structural features are described in the active-site loop between 
helices H9 and HlO, apan from a 3io-helical segment derived from the STRIDE analysis in A. 
niger GA residues 311 to 313 (Fig. 2e). Several active-site residues are found around this seg­
ment (Coutinho and Reilly, 1994a,b). All GAs except those of the Aspergillus sub-family and, 
most interestingly, M. jannaschii GA have an insertion of four residues following the segment 
that could affect both stability and selectivity, with Clostridium GA having a very long insert in 
addition. This region could have an imponant role in GA selectivity, as the inclusion of four H. 
resinae GA P residues found here into A. niger GA mentioned earlier (Fierobe et al., 1996) has 
shown. In fact, mzmy of its residues appear to interact with the second subsite (Coutinho and 
Reilly, 1994a; Lemieux et al., 1996), different GA substrates exhibiting slightiy different inter­
actions with the active site (Coutinho et al., 1996a,b; Chapters 5, 6). Funhermore, the large in­
sert in Clostridium sp. G0005 GA found here could be associated with its unusually high iso-
maltose hydrolytic activity (Ohinishi etal., 1992). 
The last active-site loop is delimited by helices H12 and HI3. Being a very structured 
loop, it contains several imponant active-site residues including the catalytic base Glu400 
(Harris et al., 1993; Frandsen et al., 1994). Here a one-residue insertion around the second (3-
strand of S9 is found only in Clostridium GA. Some selectivity properties might also be assoc­
iated with the composition of this loop. The substitution of an active-site serine conserved in 
Aspergillus-xtlzxsd GAs and some others with a glycine residue, the only other alternative, leads 
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to a reduced ability to form isomaltose from glucose by A. awamori GA (Fang et al., unpub­
lished results). A similar natural variation in this residue betwen the closely related S.fibuligera 
and S. fibuligera KZ GAs might explain some of their differences in kinetics and thermo­
stability (Gasperik and Hostinov^, 1993). 
Rhizopus, Saccharomycopsis, Saccharomyces, and Methanococcus GAs have their C-
termini shortly after the end of helix HI3, with slightiy longer sequences in Arxula and Clos­
tridium GAs. The Aspergillus sub-family, on the other hand, has a long and putatively 0-gly-
cosylated belt surrounding the active site. In this sub-family the belt has been considered to ex­
tend to Pro467, the last conserved CD residue (Coutinho and Reilly, 1994b) (Fig. 2g), and in 
fact deletions in this belt until Ser460 lead to loss of secretion and stability in recombinant A. 
awamori GA (Evans etai, 1990). Interestingly, the recendy reponed sequence of C. rolfsii GA, 
the only one in the Aspergillus sub-family that comes from a Basidiomycetes instead of an 
Ascomycetes (of which the three yeast sub-families are also members) is missing pan of the 
belt, suggesting that this is a more primitive GA than other members of the sub-family. 
The C. rolfsii GA CD possesses the Cys222-Cys449 disulfide bridge (Fig. 2d,g) that 
connects the belt to the rest of the CD in Aspergillus sub-family GAs and appears to be an old 
feature helping to stabilize their most hydrophobic folding unit. It also contains the common 
Cys262-Cys270 bridge (Fig 2e) and, along with N. crassa GA, an extra bridge between Cys20 
and Cys27 (Fig 2a). However, it is the only Aspergillus-rtlated GA to lack a Cys210-Cys213 
bond (Fig 2d). 
Starch-Binding Domain Analysis. The SBDs aligned in this study belong uniquely to 
Aspergillus sub-family GAs. Their sequences are mostly conserved, suggesting that they all 
contain the eight P-strands found in the NMR structures of A. niger GA SBD (Jacks et al., 
1995; Sorimachi et al., 1996). Many conserved residues are found here, most near the binding 
sites assigned earlier (Coutinho and Reilly, 1994b), and others that appear to have a staictural 
role. The major divergence is again that of C. rolfsii GA, which has two features that render it 
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unique: 1) no disulfide bridges are found, unlike all other SBDs from Aspergillus-rtlsxeA GAs 
(Williamson et al., 1992a; Coutinho and Reilly, 1994a,b), but like SBDs in other enzymes ex­
cept an A. niger acid-stable a-amylase (Kaneko et aL, 1996); 2) a deletion of four residues in 
the loop of binding site 2, using the numbering used with B. circulans strain 251 CGTase 
(Lawson et al., 1994) and in NMR structural studies of the A. niger OA SBD (Sorimachi et al., 
1996). This loop in die GAs is different from that in cyclodextrin glucosyltransferase and in all 
other glycosidases possessing an SBD (Svensson et al., 1989; Jespersen et al., 1991), and these 
could explain differences in their abilities to degrade raw starch. 
Beside allowing raw starch hydrolysis, SBDs also support GA adsorption to cell walls 
(Wosten et al., 1991; Neustroev et al., 1993), where a local increase of enzyme concentration 
may result in enhanced glucose flow to the cell. At more favorable substrate concentrations, the 
linker can be cleaved proteolytically to release the CD. This has a parallel in the release of cell-
bound Clostridium thermosaccharolyticum GA in rapid growth conditions (Specka and Mayer, 
1993). 
Role ofN- and 0-glycosylation. Only three potential A/-glycosylation sites, all located 
in the CD, appear to be conserved in GAs from different sub-families. They are not otherwise 
involved in secondary structural elements, given that they typically are located in backbone 
turns. Two sites, located at Asnl71 and Asn395 following helices H5 and HI2, respectively 
(Fig. 2c,g), have been identified following both peptide mapping (Svensson et al., 1983) and X-
ray crystallography of both A. niger and A. awamori var. XlOO GAs (Aleshin et al., 1992), 
respectively. The first site is shared by most Aspergillus-xtlditd. and Saccharomyces GAs and 
the second by several Aspergillus-xt\2ix&d and Rhizopus GAs. Elimination of the latter site in 
recombinant A. awamori GA greatiy decreases enzyme secretion and thermostability (Chen et 
al., 1994). A potential third site is shared by GAs from N. crassa, H. resinae (GA P), Rhizo­
pus, and Saccharomycopsis, but also by H. grisea var. hermoidea GA using an alternative 
alignment (Coutinho and Reilly, 1994b) (Fig. 2b). Given that glycosylation is found in 
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Saccharomycopsis GAs (Gasperik and Hosdnovi, 1993; Solovicovl et al., 1996) that lack the 
two other conserved yV-glycosylation sites and that this site is both at the surface and between 
secondary structural elements, it is probably /V-glycosylated. The three-dimensional model sug­
gests that glycosylation at this point in A. awamori var. XI00 and closely related GAs could 
make steric contacts with the linker, and so negatively affect stability. 
(9-glycosylation is found in a 72-residue-long segment in A. niger GA comprising the 
belt circling part the CD, as well as the linker and the C-terminus of the SBD (Svensson et al., 
1983; Gunnarsson et al., 1984; Coutinho and Reilly, 1994b). Glycosylation density is lower in 
the belt than in the linker. This suggests that in the former it helps the rigidification of the CD 
or of only the corresponding hydrophobic folding unit adjacent to it, with mostly hydrophobic 
residues anchoring the belt to the rest of the protein. Of the ten O-glycosylarion sites that occur 
in the CD of A. awamori var. XlOO GA, seven are found around the most hydrophobic unit. 
Extensive C?-glycosylarion further rigidifies the 40-residue-long linker in a solvated environ­
ment, contributing for the physical separation of the CD and SBD (Williamson et al., 1992a,b; 
Tanaka et al., 1995). Such separation has been estimated to be of about 100 A (Coutinho and 
Reilly, 1994b), which agrees with the interdomain distance in the order of 95 A obtained by 
scanning tunneling microscopy (Kramer et al., 1993). All this agrees witii recent differential 
scanning microcalometry studies indicating that the carbohydrate moiety in A. niger GA and 
other glycoproteins not only has a stabilizing effect, but also prevents unfolded and partially 
folded protein from aggregating (Wang et al.. 1996). 
Heavily glycosylated segments are predicted for all Aspergillus GAs except A. oryzae. 
All other GAs in the Aspergillus sub-family have shoner linkers with a predicted 0-glycosylat-
ion pattern similar to that of the belt, indicating that their SBDs may be physically close to their 
CDs. Deletion studies in the linker region of A. awamori GA have shown its importance for 
high levels of GA expression (Libby ei al., 1994), so a long (9-glycosylated segment might im­
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prove enzyme secretion. O-glycosylation of the iV-terminal region of S. diastaticus GA also has 
a definite role in enzyme secretion (Yamashita, 1989). 
The microheterogeneity pattern observed in (9-glycosylation (Neustroev et aL, 1993) 
probably is explained by the diverse lengths of the carbohydrate moieties present (Gunnarsson 
et aL, 1984). Given that one of the roles of (9-glycosylation is to protect the enzyme from pro­
teolysis, those GA forms with lower degrees of glycosylation are more susceptible to protease 
action (Le Gal-Coeffet et aL, 1995). The preferred cleavage sites are found at the N-terminus of 
the SBD, after Pro512 in A. niger GA (Svensson et aL, 1986), or at the beginning of the linker 
region shortiy after the conserved Pro467 in both A. niger GA (Williamson et aL, 1992b; Le 
Gal-Coeffet et aL, 1995) and H. resinae GA P (Fagerstrom, 1994). 
Evolution of Glucoamylases. Parsimony analysis of the different complete GA protein 
sequences is shown in Figure 3. The sequence alignment leading to this evolutionary plot 
shows that Clostridium sp. G0005 GA, the only GA of eubacterial origin, possesses uniquely 
long insenions and deletions when compared to the remaining GAs, that are only partially 
present in the GA from the archaeon M.Jannaschii. Given that the only other enzymes sharing 
the same architecture, the glycosyl hydrolases from Families 8 and 9 (Henrissat, 1991; 
Henrissat and Bairoch, 1993, 1996), are present only in bacteria, it is suspected that the remote 
common origin of all these enzymes (Alzari ei aL, 1995) is indeed bacterial. The assumption 
that all GAs are derived from a bacterial ancestral gene is further justified by their presence in 
both archaeal and fungal organisms. 
Seven sub-families of related GAs. Clostridium (bacterial), Methanococcus (archaeal), 
Arxula, Saccharomyces, and Saccharomycopsis (yeast), and Rhizopus and Aspergillus (fila­
mentous fungal), have now been described. The evolution of fungal and yeast GAs has not fol­
lowed phylogenetic lines, probably due to the multiplicity of GA forms existing in ancestral 
fungi. Only that can explain why A. adeninivorans GA shares with R. oryzae GA several feat­
ures, including a putative newer-type SBD ai the C-terminus, even though Basidiomycetes like 
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Figure 3. The evolution of GA sequences from a common bacterial ancestral gene as obtained from protein parsimony analysis 
(Felsenstein, 1982,1988). Microorganisms are indicated in italics while GA sub-families are indicated in bold. 
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Rhizopus diverged from Ascomyctes (which includes all other fungal and yeast species des­
cribed here) before the appearance of yeast. The yeast GA sub-families Saccharomyces and 
Saccharomycopsis are closely related to each other, sharing the apparent lack of SBDs. 
The Aspergillus sub-family definitely corresponds to a successful GA design. The evol­
utionary tree suggests that upon the attachment of a primitive SBD, exemplified by that of C. 
rolfsii GA ±at lacks an internal disulfide bridge and has a gap in one of the binding sites, an 
evolution by stages occurred. The more evolved H. resinae GA P acquired both a full belt sur­
rounding the Q) and a disuMde bridge in the SBD (in fact a second disulfide bridge might also 
be present there). Longer linkers and more O-glycosylation in the belt surrounding the QD are 
found in N. crassa and H. grisea var. thermoidea GAs, with a variation in the position of one 
of the cysteines involved in the SBD disulfide bridge in the latter enzyme (Fig. 2i). A slightly 
shorter linker region is found in A. oryzae GA, which becomes a fully (9-glycosylated linker in 
A. terreus GA. The latter also has two A^-glycosylation sites not present in the former. A longer 
fully 0-glycosylated linker is found in the remaining Aspergillus GAs, where now only minor 
variations in sequence are found. 
Upon addition of the SBD, much of the later GA evolution appears to be oriented 
toward increased secretion and more effective GAs. The gradual increase in length and (9-gly-
cosylation of the belt surrounding the most hydrophobic unit of the CD suggests a gradual 
effon to increase its stability. Also, the increased length of the linker with its heavy glycosylat-
ion, beside affecting enzyme secretion (Libby et al., 1994), can increase overall GA stability by 
physically separating two domains that unfold independently (Williamson etai, 1992; Tanaka 
et al., 1995), avoiding protein denaturation by contact of partially or totally unfolded CD and 
SBD domains in the same GA molecule. 
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Conclusions 
In this study, the three CD hydrophobic folding units described by differential calori-
metric studies of A. niger GA (Tanaka et al., 1995) were physically identified, which will help to 
guide efforts to genetically engineer more thermostable GAs. A structure-based alignment of 
known GA amino acid sequences was presented. Two new GA sub-families were identified, 
from the archaeal Methanococcus and the yeast Arxula. Imponant structural elements in each 
sequence were identified, with a tentative correlation of these features with specific GA proper­
ties. The least hydrophobic folding unit identified in existing GA models is not found in the 
thermostable M.jannaschii and Clostridium sp. G0005 GAs. 
An evolutionary tree of GA sequences was generated by protein parsimony analysis, 
allowing identification of the traits that are hkely to lead to increased stability and secretion in 
Aspergillus-xt\zx&d GAs. Better understanding of GA strucmre and stability derived from this 
study constitutes a base for protein engineering to improve the properties of industrially used 
GAs. 
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CHAPTER 4. AUTOMATED DOCKING OF MONOSACCHARIDE SUBSTRATES 
AND ANALOGUES AND METHYL a-ACARVIOSINIDE IN 
THE GLUCOAMYLASE ACTIVE SITE 
A paper acccepted by Proteins; Smicmre, Function, and Genetics^ 
Pedro M. Coutinho.^- 3 Michael K. Dowd,'^ and Peter J. Reilly^ ^  
Abstract 
Glucoamylase is an important industrial glucohydrolase with a large specificity range. 
To investigate its interaction with the monosaccharides D-glucose, D-mannose, and D-galactose 
and with the substrate analogues 1-deoxynojirimycin, D-glucono-I,5-lactone, and methyl a-
acarviosinide, MM3(92)-optimized structures were docked into its active site using AutoDock 
2.1. The results were compared to structures of glucoamylase complexes obtained by protein 
crystallography. Charged forms of some substrate analogues were also docked to assess the 
degree of protonation possessed by glucoamylase inhibitors. Many forms of methyl a-
acarviosinide were conformationally mapped using MM3(92), characterizing the conformation­
al pH dependence found for the acarbose family of glucosidase inhibitors. Their significant 
confonners, representing the most common states of the inhibitor, were used as initial stmctures 
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for docking. This constitutes a new approach for the exploration of binding modes of 
carbohydrate chains. Docking results differ slightly from X-ray crystallographic data, the dif­
ference being of the order of the crystallographic error. The estimated energetic interactions, 
even though agreeing in some cases with experimental binding kinetics, are only qualitative due 
to the large approximations made by AutoDock force field. 
Introduction 
Glucoamylase [a-(l,4)-D-glucan glucohydrolase, EC 3.2.1.3, GA] hydrolyzes terminal 
a-(l,4)-D-glycosidic bonds from the nonreducing ends of maltooligosaccharides to produce p-
D-glucose, and is used industrially to digest liquefied starch. OA also more slowly hydrolyzes 
diglucosyl disaccharides with a,P-(l,l)-, a-(l,2)-, a-(l,3)-, and a-(l,6)-D-glycosidic bonds.^ 
At high D-glucose concentrations, condensation products containing these same glycosidic 
bonds occur.2 GA also catalyzes condensation reactions involving 2- and 3-deoxy-D-glucose^ 
and D-mannose and D-galactose.'* 
Fungal GAs have a catalytic domain, a starch-binding domain required for raw starch 
digestion, and an 0-glycosylated linker connecting the two.^ The three-dimensional structure of 
the Aspergillus awamori var. XlOO GA catalytic domain has been obtained by X-ray crystal­
lography at different pHs®-^ and when complexed with the inhibitors 1-deoxinojirimycin, 
acarbose, D-^ /wco-dihydroacarbose, and D-glucono-l,5-Iactone®-^ 2 and the monosaccharides D-
glucose, D-mannose, and D-galactose (A. E. Aleshin and R. B. Honzatko, personal commun­
ication, 1996). The highly rigid GA active site is a well in the center of an (cx/a)6 barrel, with the 
two catalytic residues, the acid Glul79 and the base Glu400, at opposite sides of the cavity that 
also encloses a water molecule presumably required for catalysis.^ Up to seven subsites have 
been found in the A. nigerlA. awamori GA active site by subsite mapping.^2-14 Crystal­
lographic models define the positions of maltooligosaccharide residues in the first four subsites 
and identify some of the interactions between substrates and amino acid side-chains. Residues 
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comprising fungal, yeast, and bacterial GA active sites are conserved, as is the overall catalytic 
domain structure.^-
The GA active site can accommodate the a-(l,4)-linked substrate methyl a-maltoside in 
its solution conformation. This conformation is close to the steric energy minimum of a-mal-
tose^^ and is similar to the crystallographic conformations of the nonreducing ends of the in­
hibitors acarbose and D-^/Mco-dihydroacarbose in GA^-^^ and to the NMR conformation of the 
GA-bound inhibitor methyl 5'-thio-4-N-a-maltoside.i8 Displacement titration calorimetric 
studies of complexes with maltooligosaccharide and D-glucose analogues that are significant 
GA inhibitors suggest good structural fits with efficient solvent displacement.^® Binding of 
acarbose and 1-deoxynojirimycin is strongly pH-dependent, suggesting that their protonated 
forms are the stronger inhibitors. The formation of a salt link between Glul79 and the imino 
linkage of protonated acarbose explains the unusually tight association between GA and acar-
bose.^*^^ 
Conformational studies of 4-thiomaliose and uncharged acarviosine, the pseudo-disacc-
haride moiety of acarbose, showed that these glucosidase inhibitors share with maltose a com­
mon conformational space with very similar low-energy minima.On the other hand, signif­
icant pH-dependent conformational differences occur around the amino linkage of acarbose.^^ 
Protein-substrate interactions can be modeled by several methods^^. With protein-car­
bohydrate interactions, the many degrees of freedom in carbohydrates caused by the rotation of 
hydroxyl and hydroxymethyl groups and glycosidic linkages pose significant limitations. The 
problem has been addressed by limited spatial searching coupled with energy minimization to 
study the interaction between proteins and monosaccharides^^-^'^ and between enzymes and 
flexible carbohydrate chains-^^-^' Systematic spatial searches of the binding modes of mono­
saccharides to concavalin A have been performed using extended atom representation for hy­
droxyl groups.28 
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Many different approaches used to search the spatial and confonnational space available 
to ligands in their interaction with proteins were reviewed in recent docking studies.^®*^® Monte 
Carlo methods have been successful in the automated docking of flexible substrates to a static 
protein of known structure by simulated annealing,31-33 reproducing the binding mode of p-A^-
acetylglucosamine in lysozyme.3i Genetic algorithms have also docked both rigid and flexible 
|i-D-glucose to the periplasmic binding protein.34 
In this study, docking of monosaccharides and their analogues in the A. awamori var. 
XI00 GA active site was performed by simulated annealing with AutoDock 2.1, and the results 
were compared with those from X-ray crystallography of the corresponding GA-complexed 
structures. Also, a new combined molecular mechanics/Monte Carlo approach for performing 
docking studies of disaccharides and their analogues was developed, where the significant 
conformers obtained from conformational analysis are the initial structures for docking. The 
approach was used to study GA interaction with neutral and protonated forms of methyl a-
acarviosinide in what constitutes the base for the docking smdies of ten isomaltose analogues35 
and ten differently linked diglucosyl disaccharide substrates.36 
Computational Methods 
Generation of Monosaccharide and Monosaccharide Analogue Structures. Start­
ing structures of the monosaccharides a- and P-D-giucose, a- and P-D-mannose, and a- and P-
D-galactose (Fig. 1) were obtained from the previously exhaustively searched global optima at e 
= 3.0.3"' Starting structures of the monosaccharide analogues D-glucono-l,5-lactone and 
uncharged and protonated 1-deoxynojirimycin (Fig. 1) were generated and preoptimized using 
PC-Model (Serena Software, Bloomington. Ind.). All structures were minimized with 
MM3(92)38-40 (Technical Utilization Corporation, Powell, Ohio). As with disaccharides,^^-'^!" 
^ the bulk dielectric constant (e) was set to 4.0, as this yielded optimal structures similar to 
those in condensed-phase systems.''^ 
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Figure 1. Structures of some of the docked monosaccharides and analogues: a) 1-deoxy-
nojirimycin; b) D-glucono-l,5-lactone; c) a-D-glucose; d) a-D-mannose; ande) a-D-galactose. 
OH 
HO 
HO 
CH 
OCH 
Figure 2. Methyl a-R-acarviosinide (Ri = H; R2 = nothing), methyl a-S-acarviosinide 
(Ri = nothing; R2 = H), and protonated methyl a-acarviosinide (Ri = H; R2 = H) with angles <{) 
and \|/ denoted. Critical hydroxyl groups required for catalysis in maltose^^ are in bold. 
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Conformational Analysis of Methyl a-Acarviosinides. Starting structures of 
methyl a-R- and methyl a-S-acarviosinide and protonated methyl a-acarviosinide, with differ­
ent placement of hydrogens around N-4B (Fig. 2), were also generated and preoptimized with 
PC-Model. Eighteen and twelve sets of exo-cyclic orientations were used for the uncharged and 
protonated forms, respectively. They were combinations of clockwise (c) and reverse-clockwise 
(r or rO orientations of the secondary hydroxyl groups for each ring, since these orientations 
form partial crowns of weak hydrogen bonds around the valiemine and pyranosyl rings of the 
acarviosinides. Two sets of reverse-clockwise orientations were necessary for the nonreducing 
ring of the uncharged methyl a-acarviosinides, since a C-3A-C-2A-0-2A-H(0-2)A torsional 
angle of 60° yields an inter-ring hydrogen bond that cannot occur in the protonated form. In the 
valiemine moiety three sets of stable C-7A-C-5A-C-6A-0-6A torsional angles were considered 
as before^o with values of approximately -130°, -10°, and 100°. Following docking, torsion 
angles close to these values were subdivided into groups Xh X2. and X3, respectively, the relative 
position of the OH-6A group to the valiemine ring being analogous to the related gg, gt, and ig 
conformers of maltose. 
The torsional angles representing the orientations of the rings about the imino linkage 
were defined as 0 = ©(H-1A-C-1A-N-4B-C-4B) and \}/^ = 0(C-1A-N-4B-C-4B-H-4B) (Fig. 2). 
The conformational space for the two linkage torsional angles was evaluated with MM3(92) at 
20° intervals, leaving all remaining geometric features relaxed. 
The lowest energy value at each grid point from the different sets was used to construct 
contour maps of the methyl a-acarviosinides with Surfer (Golden Software, Golden, Co.). For 
the uncharged methyl a-acarviosinides a combined map using the lower energy from the R-
and S-cases was produced, since MM3(92) without explicit parameterization of lone electron 
pairs was unable to maintain the stereochemistry around N-4B. Shifts in the position of H(N-
4b) were noted in the final structures of both initial R- and S-structures. 
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Local minima were found by a multi-step procedure. All starting structures that could 
contribute to a local minimum were rotated to a local low-energy grid point, optimized there, and 
then reoptimized without torsional angle restrictions. The lowest energy structure was taken as 
the global minimum. Local minima within 8 kcal/mol of the global minimum were used as 
initial starting structures for docking of the protonated methyl a-acarviosinide. 
Given the inability of MM3(92) to maintain the stereochemistry around N-4B to 
generate complete and independent sets of R- and S- structures of uncharged methyl a-
acarviosinide, the initial structures used in docking were regenerated from MM2(85) results.^® 
their energies being evaluated with MM3(92) at e = 4.0. 
Docking Simulations. Docking simulations were conducted with AutoDock 2.pi-33 
(Scripps Research Institute, La Jolla, Cal.). The GA crystal structure obtained in the complex 
with D-^/Mco-dihydroacarbose^^'^^ was used. All water molecules were removed from the 
structure except the putative catalytic molecule,^ whose 0.2-A shift compared to its position in 
the GA-acarbose complex'' less constrains the space available to the ligand. All polar 
hydrogens created for structural resolution purposes were maintained, and nonpolar hydrogens 
were added using Quanta 3.3 (Molecular Simulations, Inc., San Diego, Cal.). Atomic partial 
charges for GA and for each uncharged ligand to be docked were calculated by the Gasteiger 
method.'^ A positive charge was initially shared among the N-bonded hydrogen atoms in the 
protonated forms of l-deoxynojirimycin and methyl a-acarviosinide before partial equalization 
of orbital electronegativity by this method. 
The interaction of a probe group, corresponding to each type of atom found in the lig­
and, with the GA structure was computed at 0.5-A grid positions in a 40 A cubic box centered 
in the active site using AutoGrid.^^ These grids provide a lookup table for rapid evaluation of 
interaction energies,^^-'^^ which are summations of a distance-derived potential energy and an 
electrostatic contribution for each atom of the ligand plus the internal ligand energy. For the 
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electrostatic calculations a sigmoidal distance-dependent dielectric function'*® was used to 
account for the solvent screening effect. 
Two independent sets of Lennard-Jones coefficients, one from AutoDock 1.0 and the 
other provided as an alternative in AutoDock 2.1, were initially tested for the grid calculation. 
Since the first gave a better correlation of docking and crystallographic results, it was used for 
the complete study. Different coefficients were employed for apolar and polar hydrogens, and a 
distance criterion with directional attenuation in tiie grid calculation was used to account for 
hydrogen bonding. 
The docking mechanism used the Metropolis method, also known as Monte Carlo sim­
ulated annealing, with the ligand performing a random walk in space around a static GA active 
site. At each simulation step, small random displacements in each of the six spatial degrees of 
freedom and in an arbitrary number of torsional degrees of freedom of the ligand were made. 
The new configuration was either accepted or rejected on probability grounds based on the 
annealing temperature of the system.^^ 
At the start of each docking study, the nonreducing end ring of each ligand was super­
imposed on the corresponding ring of D-^/wco-dihydroacarbose in the active site. Initial studies 
with uncharged 1-deoxynojirimycin had shown that successful docking occurred in 96% of the 
simulations by this method, while only 2% docking was obtained when the ligand was initially 
placed 10 A from the active site. However, the best results by both approaches were equivalent. 
Each docking simulation followed six criteria: 1) for each starting structure 100 indep­
endent Monte Carlo simulations using a variation of the short schedule^^ were made where 2) 
for each simulation there were 100 constant temperature cycles with a maximum of 1,500 steps 
accepted or rejected; 3) the temperature started with a high value (RT = 100 cal/mol) and was re­
duced by a 0.95 factor each cycle, giving RT = 0.6 cal/mol for the last cycle; 4) an initial maxi­
mal torsional rotation of 15°/step was reduced by a 0.9875 factor each cycle, to give a maximum 
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of ~4° for the last cycle; 5) there was a maximal translational step of 0.2 A per step; and 6) the 
minimal energy structure obtained in a temperature cycle was passed to the next cycle. 
Docking simulations were made on each initial structure of the optimized mono­
saccharide and monosaccharide analogue structures, as well as on five methyl a-R- and three 
methyl a-S-acarviosinide conformers from the MM2(85) study,20 and of seven protonated 
methyl a-acarviosinide conformers, the local minima 8 kcal/mol or less above the global min­
ima given by MM3(92). Following docking, cluster analysis of all structures generated for a 
single compound was performed. Once sorted by total energy of interaction, the structures were 
sequentially assigned to cluster families, represented by top of cluster structures. Structures not 
satisfying a tolerance of 1 A in the root mean square (RMS) deviation for all atoms to each top 
of cluster structure previously found defined new clusters. A redocking of each compound was 
conducted on its optimal structure and top structures of significant clusters. Occasionally other 
significant top structures were also redocked. Cluster analysis of all redocking results for a 
single compound was again performed, and the results were compared to existing crystallo-
graphic stmctures. 
AutoDock's internal energy calculation, based on the same set of Lennard-Jones coef­
ficients used for the grid calculation, was susceptible to truncation errors due to ligand coordin­
ate manipulation prior to docking. These may have a some impact in energy evaluation with a 
Lennard-Jones potential energy function for very close atoms. For this reason, all ligand inter­
nal energy results were referenced to the MM3(92) relative energy. Only the AutoDock (AD) 
variation in the small molecule internal energy, negligibly affected by those errors, was consid­
ered for each run. Internal energies for docking and redocking were then 
Intemal Energy = Relative MM3 Energy + A [AD Internal Energy] 
(Docking) (Docking) 
80 
Internal Energy = Internal Energy + A [AD Internal Energy] 
(Redocking) (Docking) (Redocking) 
These steps were required not only to analyze the results when there was more than one 
initial structure, but also to obtain consistent ligand internal energies for the docking and re­
docking runs. 
Results and Discussion 
Conformational Analysis of Methyl a-Acarviosinides. A combined MM3(92) 
map for methyl a-R- and methyl a-S-acarviosinide and a map for protonated methyl a-
acarviosinide are given in Figure 3, with isoenergy contour lines at 1 kcal/mol increments above 
the global mimimum. The former map has only three minima below 8 kcal/mol (Table I), and is 
globally close to diat previously found for methyl a-S-acarviosinide.^o Its global minimum, an 
S-conformer, is located at = -59°,-40°, with significandy higher second and third minima at 
= 17°,26° and ()),\}/ = -62°, 166°, an R- and an S-structure, respectively. These minima are 
found in the region containing the main local maltose analogue minima,^® which in turn are 
close to the minima of a-maltose.'^ A global minimum had been previously found at = 
-34°, -19° by a combination of NMR analysis and HSEA modeling.'*^ 
Protonated methyl a-acarviosinide has seven minima (Table I), with the global mini­
mum at ((),\|/ = -53°, 162°, an energetically close second minimum at (1),\|/ = -58°,-58°, and a third 
minimum at = -52°,-6°. These three minima have a hydrogen bond between 0-2a and 
different H(N-4B) atoms. 
1 I i_ 
-150-120 -90 -60 -30 0 30 60 90 120 150 
(i) 
-150-120 -90 -60 -30 0 30 60 90 120 150 
<t> 
oo 
iMgiirc 3. MM3(92)-generated steric energy maps for a) methyl a-R- and methyl a-S-acarviosinide and for b) protonated methyl a-
acarviosinide. Contours are graduated in 1 kcal/mol increments above the global minimum, (•) global minimum; (+) local minima; 
(o) GA-acarbose complex; (a) docked methyl a-R-acarviosinidc; (v) dockcd methyl a-S-acarviosinide; (A) dockcd methyl a-acar-
viosinide-H+. 
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Table L Calculated Minima for the Methyl a-Acarviosinides 
Compound 
Dihedral 
angle (") 
(j> \jr 
MM3 
energy 
(kcal/mol) 
Reladve 
energy 
(kcal/mol) 
Starting 
conformei 
Methyl a-acarviosinide' -59.4 -39.8 19.562 0.000 S-tgr'r 
17.3 25.8 21.425 1.864 R-tgr'c 
-62.3 165.5 21.449 1.888 S-tgcc 
Methyl a-R-acarviosinide"'' -40.4 -22.6 21.361 1.799 ggr'c 
29.2 24.6 21.542 1.980 ggr'c 
-19.6 -166.1 21.843 2.281 ggr'c 
-77.7 173.4 22.452 2.890 ggr'c 
160.1 -39.3 28.438 8.876 ggr'c 
Methyl a-S-acarviosinide"^ -40.0 -19.9 19.570 0.008 ggr'r 
-60.6 169.0 21.525 1.963 ggr'r 
22.7 21.8 21.609 2.047 ggr'r 
Methyl a-acarviosinide-H'*' -53.0 162.0 24.823 0.000 tgcc 
-58.5 -58.5 25.603 0.780 ggrc 
-51.6 -6.2 26.856 2.033 tgcc 
-22.3 61.3 28.300 3.477 ggcc 
23.4 40.2 29.145 4.322 tgcc 
-141.8 -21.8 31.716 6.893 tgcc 
178.5 -47.0 32.560 7.377 tgcc 
'Combined MM3(92) results for the R- and S-isomers in this study. 
' Based in the MM2(85) conformational analysis of Raimbaud et al.^® Relative energy referenced to the global 
minima found in the MM3(92) combined conformational analysis. 
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The lcx:ation of the global minimum in the methyl a-acarviosinides changes after pro-
tonation from (l),\|r = -59®,-40° to -53°, 162°. Changes in the acarbose imino linkage confonnat-
ion after protonation had been previously found by NMR studies,^^ with two major minima fol­
lowing modeling with the Discover force field at (|),\|/ = -51°,-10° and -30°,178° for the un­
charged form and at (|),\jr = -41°, -21° and -26°,176° for the protonated form, the latter minimum 
becoming more imponant in the protonated form. In protonated methyl a-acarviosinide, four 
local minima were found in this study between = -60°,-60° and (|>,V = 30°, 65°, which ex­
plains the problem in assigning corresponding structures from available nuclear Overhauser 
effects. 
Docking of Monosaccharide and Monosaccharide Analogues. Clusters of docked 
structures based on MM3-referenced energies for uncharged and protonated l-deoxynojirimy-
cin as well as for D-glucono-l,5-lactone, a- and p-D-glucose, a- and P-D-mannose, and a- and 
P-D-galactose are presented in Table 11. The results include the total energy of interaction, the 
partial internal energy of the ligand to observe how constrained it is, and the significant dihedral 
angle values. Average values obtained for clusters of docked structures are shown with the 
number of structures in each cluster. The docked studies are based on 100 simulations from 
one single initial structure. 
A clear preference was shown for the gg conformer (0-6 gauche to both C-7 or 0-5 
and C-4 by opposition to trans for the relative position to any of the atoms) in the active site. 
This is analogous to the conformation found in studies of GA complexed with different inhib­
itors,^"^' most structures making a hydrogen bond with Asp55 as maltosides do.'^-^® Both gt 
and tg conformations of the hydroxymethyl group are also possible and often lead to distinct 
clusters of docked structures, but they cause a molecular interaction energy penalty. The 0H-6A 
group is not only essential for hydrolysis of maltose and isomaltose,^®-^^ 5^ jg equally neces­
sary for the condensation of D-glucose and its deoxy derivatives.The positional 
TABLE 11. Docking of Monosaccharides and Analogues in the GA Active Site" 
Exo-cyclical 
Cluster Total Internal dihedral angle RMS deviation 
Monosaccharide [no. of energy'' energy'' from reference'' 
or analogue structures] (kcal/mol) (kcal/mol) Optimal gglgtltg ratio (A) 
1 -Deoxynojirimycin*^ 1 187) -68.2 (-60.7) -0.9 (1.0) 88 58/1/28 0.25 (0.48) 
2 [9] -61.3 (-56.6) -1.0 (-0.8) 81 0/8/1 0.76 (0.76) 
1 -DeoxynojirimycinH'^'^ 1 184] -73.0 (-64.0) -1.6 (0.1) 88 45/1/38 0.43 (0.51) 
2 12] -63.8 (-63.3) -1.3 (-1.0) 8t 0/2/0 0.80 (0.76) 
3 112] -62.2 (-58.9) 0.6 (0.3) 18 0/0/12 0.75 (0.68) 
D-Glucono-1,5-lactone'' 1 145] -61.9 (-55.5) 1.7 (2.6) 88 26/5/14 0.34 (0.58) 
2 149] -59.6 (-53.8) 0.3 (1.5) 81 0/49/0 0.72 (0.79) 
a-D-Glucose^ 1 186] -70.9 (-60.3) 0.1 (1.4) 88 51/0/35 0.46 (0.63) 
2 15] -62.9 (-56.1) -2.6 (0.8) tg 0/1/4 0.73 (0.74) 
3 14] -61.1 (-57.9) -0.6 (-0.6) 81 0/4/0 0.69 (0.84) 
P-D-Glucose^'S 1 127) -66.8 (-57.1) 3.0 (4.0) 88 19/6/2 0.40 (0.64) 
2 [8] -64.0 (-53.2) -0.9 (3.9) 18 0/0/8 0.73 (0.78) 
3 [37] -62.6 (-55.1) -0.2 (2.2) 8t 0/37/0 0.93 (0.87) 
a-D-Mannose/^ 1 [65] -65.8 (-52.1) -2.7 (2.2) 88 19/1/45 0.59 (0.71) 
2 [8] -51.5 (-46.9) 7.4 (3.2) 18 0/0/8 0.76 (0.83) 
3 [4] -51.3 (-45.7) 2.4 (2.1) 81 om 0.96 (0.98) 
TABLE II. (continued) 
Exo-cyclical 
Cluster Total Internal dihedral angle RMS deviation 
Monosaccharide | no. of energy'' energy'' from reference'' 
or analogue structures! (kcal/niol) (kcai/mol) Optimal gglgtltg ratio (A) 
P-D-Mannose/^« 1 154) -63.4 (-53.6) -0.7 (2.7) Sg 17/0/37 0.74 (0.70) 
2 (61 -56.7 (-48.1) 0.2 (2.8) Ht 0/6/0 0.84 (0.88) 
3 171 -55.5 (-49.5) -1.7 (1.8) 18 0/0/7 0.86 (0.85) 
a-D-Galactose^'S 1 |36| -59.6 (-51.2) 5.4 (4.0) fig 34/2/0 0.48 (0.49) 
2 1251 -50.2 (-42.8) 2.3 (3.7) M I A K )  0.77 (0.81) 
P-D-Galactose'-* I 1461 -65.6 (-52.0) -0.1 (2.8) Rg 35/9/2 0.34 (0.54) 
2 1271 -51.4 (-45.3) 0.0 (2.4) 8' 0/27/0 0.83 (0.64) 
^Dockcd structures arc grouped into clusters, the best clusters from 100 simulations being shown. 
''Values for the optimal structure in each cluster are to the left and duster averages are in parentheses. 
•^Referenced to the crystal structure of the GA-l-dcoxynojirimycin complex.® 
'^Referenced to the crystal structure of the GA-D-glucono-1,5-lactone complex (A.E. Alcshin and R.B. Honzatko, personal 
communication). 
^Referenced to the ciysial structure of the GA-a-D-glucosc complex (A.E. Alcshin and R.B. Honzatko, personal communication). 
/Referenced to the crystal structure of the GA-a-D-mannose complex (A.E. Aleshin and R.B. Honzatko, personal communication). 
^The deviation of the 1-OH is not calculated in P-anomers and that of the 4-OH is not calculated in D-galactose. 
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flexibility of this hydroxyl group in the GA active site could have some mechanistic im­
plications both in substrate binding and in catalysis. Significandy, all top clusters of monosacc­
harides and monosaccharide analogues following the first docking simulations are the closest to 
the binding mode found in crystallographic structures. 
The best structures for each compound were redocked. Given the large number of rot­
ational, translational, and torsional degrees of freedom, redocking allowed an optimization of 
only the most representative structures, constituting an economical and efficient use of the short 
schedule in docking studies with AutoDock.^^ xhe top cluster structures following redocking 
are listed in Table HI, with the best one shown in Figure 4a-e. Again gg structures were optimal. 
Most structures when redocked maintained the conformation of their hydroxymethyl and 
hydroxyl groups, with a few changing from either the gt or tg conformation to the gg 
conformation, yielding significant energy improvements. Redocking often led to converging 
results from structures initially found in different clusters, the optimized structures representing 
a wider cluster. Significant numbers of structures were redocked without changing their initial 
coordinates, especially when the overall gains of the optimization were small in energy terms, as 
with protonated 1-deoxynojirimycin. In other cases, significant improvements in total 
interaction energy were obtained, as with P-D-glucose and a-D-gaiactose. 
Redocking of D-glucono-l,5-Iactone, P-D-glucose, and both forms of 1-deoxy­
nojirimycin yielded average deviations from the corresponding structures in the first subsite of 
crystallographic GA complexes in the order of the estimated coordinate precision of 0.3 A. The 
1-deoxynojirimycin forms were among the best ligands, the protonated form binding more 
effectively than the uncharged one. D-Glucono-I.5-lactone was the least successful ligand, 
yielding the least negative total energy. This result contrasts with the differences in the magnit­
ude of the binding constants of 0.03 mM,'^ 1.3-2.1 mM,55.56^ gg mM^^ and 160 mM^^ for the 
inhibition of A. niger GA by 1-deoxynojirimycin, D-gIucono-l,5-lactone, and a- and p-D-
glucose, respectively (Table 111). We should note that incorporating ring flexibility of the 
TABLE III. Redocking of Monosaccharides and Analogues in the GA Active Site" 
Monosaccharide 
or analogue 
Clu.stcr 
(no. of 
structures] 
Total 
energy 
(kcal/mol) 
Exo-cyclical 
Internal dihedral angle 
enerpv 
(kcal/mol) Optimal gg/gl/tg ratio 
RMS deviation 
from reference (A) Ki (mM) 
1-Dcoxynojirimycin 1327/400] -72.0 (-67.8) -1.5 (1.0) S8 242/85/0 0.26 (0.42) 
l-Deoxynojirimycin-H+ [172/300] -74.5 (-72.7) -1.7 (-2.6) 88 172/0/0 0.28 (0.33) 0.03 
D-Glucono-1,5-lacione (247/400] -65.4 (-61.5) -2.5 (1.2) 88 129/118/0 0.41 (0.54) 1.3-2.1 D-' 
a-D-Glucosc (336/500) -72.0 (-66.5) -1.4 (-1.0) 88 179/59/98 0.43 (0.61) 60 f 
P-D-GIUCOSC [299/400] -74.0 (-66.5) -in (1.2) 88 185/18/96 0.36 (0.61) 160/ 
a-D-Mannosc 169/100] -69.2 (-66.9) -2.2 (-2.4) 88 69/0/0 0.47 (0.53) 160/ 
P-D-Mannosc [79/100] -69.1 (-65.4) -0.5 (-0.8) 88 79/010 0.56 (0.64) 100/ 
a-D-Galaciose [98/100] -67.2 (-62.4) -0.6 (3.2) 88 98/0/0 0.54 (0.51) 210/ 
P-D-Galactosc [79/100] -70.3 (-66.8) -4.2 (-0.9) 88 79/0/0 0.41 (0.36) 220 f 
"Explanaiions in Table II. 
''Inhibition constant for interaction with A. niger GA. 
<Tlcf. 19. 
''Rcf. 55. 
«Rcf. 56. 
^ef. 57, inhibition constant for the interaction with R. delemar GA.. 
Figure 4. Stereo plots of docking in the GA active site. Residues surrounding the first and sec­
ond subsites, the catalytic water, and hydrogen bonding between protein residues and between 
the protein and a reference structure are shown, a) Docked uncharged 1-deoxynojirimycin (dark 
grey) and docked charged 1-deoxynojirimycin (light grey) vs. complexed l-deoxynojirimycin^ 
(black); b) docked l-glucono-l,5-lactone (grey) w. complexed l-glucono-l,5-lactone (black); 
c) docked P-D-glucose (light grey) and docked a-D-glucose (dark grey) V5. complexed a-D-
glucose (black); d) docked (3-D-mannose (light grey) and docked a-D-mannose (dark grey) v^. 
complexed a-D-mannose (black); e) docked P-D-galactose (grey) and docked a-D-galactose 
(black); f) docked methyl R-a-acarviosinide (dark grey), docked methyl S-a-acarviosinide 
(medium grey), and docked protonated methyl a-acarviosinide (light grey) vs. complexed acar-
bose^ (black). Unless otherwise indicated, reference structures are from recent GA complex 
structures (A. E. Aleshin and R. B. Honzatko, personal communication). The plots were pre­
pared with Molscript.54 
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different ligands, not yet possible with AutoDock, could lead to more favorable docking 
energies. Distoned rings at the first subsite, due to the steric stress imposed by GA on both 
substrates and analogues, have been noticed in several GA-complex studies. 
P-D-Glucose, a-D-mannose, and p-D-galactose fit the active site more tightly than their 
opposite anomers, P-D-glucose being energetically the best ligand (Table HI). Both anomeric 
forms of D-glucose and D-mannose fit very closely to each other, while the two anomeric 
forms of D-galactose dock in slighdy different binding modes (Fig. 4c-e). a-D-mannose lacks 
the weak hydrogen bond between OH-2 and Arg305, partiy compensating for it with a close 
interaction with the catalytic water (Fig. 4d). These results partly contrast with crystallographic 
and inhibition studies. a-D-glucose and a-D-mannose are the anomers are found in the first 
subsite in crystal structures, while a-D-galactose, the poorest docking of the six monosacc­
haride forms, appears only in the second subsite of its crystallographic complexes with GA (A. 
E. Aleshin and R. B. Honzatko, personal communication). a-D-glucose is a better inhibitor 
than p-D-glucose,5^ but both (i-D-mannose and P-D-galactose are better inhibitors than their 
a-anomers.^^ 
All the final results yield negative MM3-referenced internal energies. Since these are 
measures of the differences between MM3(92) and AutoDock force fields, they should be pos­
itive for every case, and so are a reflection of the significant approximations made by 
AutoDock. Nevertheless, the results are close to those obtained by crystallography, as the low 
RMS deviations to existing stmctures shown in Table III indicate. 
Docking of Methyl a-Acarviosinides. Clusters of docked methyl a-acarviosinides 
are listed in Table IV. More simulations were needed for these compounds since each of the 
several starting structures was docked separately. Multiple conformations were found for the 
exocyclic dihedral angle in the nonreducing end, Xi (analogous to gg) being the preferred 
cluster conformation. A smaller number of successful docked structures for these disaccharide 
analogues was expected, because random rotation of the imino bond linkages is more likely to 
TABLE IV. Docking of Methyl-a-Acarviosinides in the GA Active Site* 
Substrate analogue 
Cluster 
Ino. of 
struciurcs) 
Total 
energy^ 
(kcal/niol) 
Internal 
energy^ 
(kcal/nwl) 
Inter-ring Exo-cyclical 
dihedral angles dihedral angle RMS deviation 
from referencet't 
()) y Optimal X1/X2/X3 ratio (A) 
Methyl-a-R-acarvioslnide 1 198/5001 -l(K).8 (-69.6) -3,8 (7.0) -17 (22) 4 (5) Xi 62/2/34 0.48 (0.64) 
2 |3/5(K)1 -81.0 (-68.2) 4.4 (8.7) -29 (-27) 9 ( I I )  X2 0/2/1 0.71 (0.73) 
3 |8/5(X)1 -78.9 (-67.2) 3.4(10.9) -33 (31) 10 (4) X 3  0/0/8 0,84 (0.73) 
4 [3/5001 -78.7 (-67.9) 9,0 (4,9) -17 (-22) 6 (4) Xl 3/0/0 0.75 (0.83) 
Mclhyl-a-S-acarviosinidc 1 (81/3001 -92..5 (-74.7) 0.8 (6.2) -20 (-14) 6 (8) Xl 46/1/34 0.55 (0.62) 
2 116/3001 -81.7 (-65.1) 1.7 (6.7) 2 (0) 12 (9) Xl 6/0/10 0.83 (0.92) 
Methyl-a-acarviosinide'H+ I [7^001 -89.5 (-79,9) 6.7 (6.3) -42 (-31) 28 (22) Xl 6/0/1 0.61 (0.70) 
2 (1^00) -82.7 9.8 -7 14 Xl 1/0/0 0.47 
*Oocked slructurcs are grouped into clusters, the best dusters from 100 simulations being shown, 
Walues for (he optimal structure in each duster are to the left and cluster averages are in parentheses. 
^Using equivalent atoms of acarbose as reference.^ 
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lead to serious steric contacts than rotation of hydroxyl and hydroxymethyl groups, the only 
rotatable bonds found in the monosaccharides and their analogues. Nevertheless, a significant 
number of structures of both uncharged methyl acarviosinides docked effectively. The relative 
lack of success in docking protonated methyl a-acarviosinide could have been caused by the 
decrease in space available in the fixed GA active site when the new hydrogen was added to N-
4a and from the greater restriction of rotation around the imino bond. 
Final results for the methyl a-acarviosinide redocking studies are shown in Table V, the 
optimal structures being shown in Figure 4f. Based on RMS deviations, the three possible 
methyl a-acarviosinide forms were closely aligned with the equivalent residues of acarbose in 
the GA active site.^ The RMS values are slightly higher than the estimated coordinate precision 
of 0.33 A for the acarbose residues in the first and second subsites. The sets of imino linkage 
dihedral angles were similar to those of acarbose, with the top clusters of the protonated form 
deviating the most. Steric limitation caused by the positioning of hydrogen atoms around N-4a 
was the main reason for the differences in MM3-referenced internal energy of the acarviosin­
ides. The lowest total and internal energy was found for the R-form, with the S-form next, and 
with the highest energy occurring for the protonated form. However, a reversed order of inter-
molecular interaction energies was obtained when the internal energy contribution was ignored 
(see below). The RMS deviations to the structure of GA-compIexed acarbose were only slightiy 
larger than those obtained for the monosaccharide substrates and analogues, a good result 
considering that the second subsite was exposed to the solvent and no solvent contribution was 
considered in this study. 
Conformational mapping indicated that the docked uncharged acarviosinides had 
angles on the saddle between the global and the second minimum (Fig. 3a) with relative MM3 
energies of 3 kcal/mol. The two docked charged acarviosinides had dihedral angles corres­
ponding to relative MM3 energies of 4-4.5 kcal/mol on the saddle between the third, fourth. 
TABLE V. Redocking of Methyl-a-Aciirviosinides in the GA Active Site* 
Intcr-ring Exo-cyclical 
Cluster Total Internal dihedral angle dihedral angle RMS deviation 
I no. of energy energy fromrefercncc 
Substrate analogue su-ucturesj (kcal/mol) (kcal/mol) (j) y Optimal (A) 
Methyl-a-R-acarviosinide 1 (11/1001 -103.0 (-101,8) -2.8 (^.2) -19 (-14) 8 (4) Xl 11/0/0 0.49 (0.46) 
Methyl-a-S-acarviosinide 1 (93/1001 -102.2 (-96.5) 1.4 (1.4) -20 (-20) 7 (7) Xl 93/0/0 0.48 (0.52) 
Mcthyl-a-acarviosinidcH+ 1 1222/4001 -100.5 (-90.1) 5.0 (6.7) -24 (-28) 13 (18) Xl 222A)/2 0.48 (0.56) 
2 (88/4001 -95.1 (-86.8) 4.8 (4.5) -34 (-34) 21 (22) Xl 86/0/2 0.56 (0.66) 
Acarbose in GA active site -16 6 Xl 
*Rxplanaiions as in Table IV. 
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and fifth local minima (Fig. 3b). The conformations of the acarviosinides and acarbose in the 
GA active site differ from their optimal (t),^ angles, suggesting that a significant amount of inter­
ring strain occurs upon binding. This does not seem excessive, since up to 3 kcal/mol excess 
(l),Vjr bond energy was observed within maltosyl crystal structures.It also does not seem to 
impair the significant inhibitory power of methyl a-acarviosinide, whose inhibition constant is 
5.0 X 10'5 mM.I9 The suggested salt bond between N-4B of acarbose and Glul79^'^^ is prob­
ably a key element in methyl a-acarviosinide inhibition, but unfortunately the AutoDock force 
field is not able to represent it quantitatively. 
Atomic Interactions in the GA Active Site. Individual energy contributions to inter-
molecular interaction between substrates or substrate analogues and the GA active site are given 
in Tables VI and VII for monosaccharides and acarviosinides, respectively. Hydrogen atom 
contributions were added to those of adjacent heavy atoms. For monosaccharides, the strongest 
interactions in the first subsite are by OH-4 except in D-galactose, by OH-6, and, interestingly, 
by C-6. These interactions suggest that these atoms or groups serve as substrate anchors in 
binding, and that the combined strong action upon OH-6 and C-6 causes the ring distortion 
observed around C-5 in several crystallographic studies.^^ All hydroxyl groups tend to form 
strong interactions, the exceptions being OH-1 in the monosaccharide a-anomers, in close 
contact with Glul79; OH-2 in D-mannose, close to tiie catalytic water, and OH-4 in D-galactose, 
which makes close contacts with both the catalytic water and Asp55. Epimerization around C-2 
and C-4, respectively, leads in the last two substrates to stronger interactions with OH-3. 
Weaker interactions occur with 0-5 in all substrates and in D-glucono-1,5-lactone, with C-1 and 
OH-1 in all a-anomers, and with C-1 and 0-1 in D-glucono-1,5-lactone, suggesting some strain 
at these atoms caused by Glu400. Such strain is not found at the C-1 or N-5 of 1-deoxynojiri-
mycin, giving the protonated form the best interaction with N-5. Steric pressure on 0-5 in sub­
strates can more quickly lead to formation of the oxycarbonium ion expected to 
TABLE VI. Atomic Contributions to Intermolecular Energy (kcal/mol) in the Interaction of the Optimal 
Structures of Monosaccharides and Analogues with the GA Active Site 
l-Dcoxynojirimycin 
D-Glucono- a-D- P-D-
Glucosc 
a-D- P-D-
Mannosc 
a-D- P-D-
Galaciose Alom Uncharged Protonatcd 1,5-laclonc Glucose Mannosc Galaciosc 
C-1 -5.3 -5.2 -3.7 -4.9 -3.8 -4.7 -4.0 -4.5 -3.7 
C-2 -5.2 -5.1 -5.3 -5.1 -5.1 -5.0 -5.0 -5.0 -4.9 
C-3 -5.4 -4.9 -5.2 -5.5 -5.9 -4.9 -4.7 -4.2 -5.3 
C-4 -5.2 -5.2 -5.1 -5.1 -5.2 -5.3 -5.3 -5.9 -5.7 
C-5 -4.8 -5.1 ^.6 -4.8 -4.9 -5.1 -5.2 -5.2 -5.2 
C-6 -8.8 -8.8 -7.9 -8.7 -8.6 -8.3 -8.4 -8.8 -8.4 
0-1 0.3 -2.1 -5.6 -1.6 -6.6 -4.1 -6.2 
0-2 -5.3 -6.1 -5.8 -6.1 -5.7 -1.6 -1.5 -3.3 -4.6 
0-3 -7.7 -5.8 -7.8 -7.2 -7.0 -8.3 -8.9 - 1 1 . 1  -8.7 
0-4 -9.8 - 1 1 . 1  -9.5 -9.8 -8.4 -9.5 -9.4 -2.8 -2.1 
N-5 -2.7 -4.5 
0-5 -1.8 -1.9 -1.8 -1.9 -1.9 -0.8 -2.0 
0-6 -10.3 - 1 1 . 1  -6.6 -9.3 -9.1 -10.9 -7.6 -10.9 -9.4 
GA-L* -70.6 -72.8 -62.9 -70.5 -71.2 -67.0 -68.5 -66.6 -66.2 
Lt -1.5 -1.7 -2.5 -1.4 -2.7 -2.2 -0.5 -0.6 -4.2 
Total -72.0 -74.5 -65.4 -72.0 -74.0 -69.2 -69.1 -67.2 -70.3 
*Tolal intcnnolccular energy. 
tRelativc internal energy of the ligand. 
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TABLE Vn. Atomic Contributions to Intennolecular 
Energy (kcal/mol) in the Interaction of the Optimal Methyl 
a-Acarviosinide Structures with the GA Active Site* 
Methyl a-R- Methyl a-S- Methyl a-
Atom acarviosinide acarviosinide acarviosinide-H"*" 
c-u -4.8 -4.7 -4.3 
C-2A -4.7 -4.3 -3.7 
C-3A -4.8 -4.6 -5.2 
C-4A -5.1 -5.2 -5.0 
C-5A -3.4 -3.8 -3.4 
C-6A -8.9 -8.3 -8.9 
C-7A -0.8 -0.7 -1.5 
0-2A -5.1 -4.8 -4.0 
0-3A -5.1 -8.1 -4.7 
0-4A -10.4 -9.6 -10.5 
0-6A -6.2 -8.2 -9.1 
C-1B -1.8 -1.7 -1.7 
C-2B -3.3 -3.2 -2.3 
C-3B -4.0 -4.2 -4.0 
C-4B -4.0 -3.8 -3.8 
C-5B -3.8 -3.2 -3.8 
C-6B -4.2 -7.7 -7.0 
N-4B -3.9 -1.9 -7.4 
0-2B -2.7 -1.8 -1.8 
0-3B -8.4 -7.7 -7.8 
0-5B -1.0 -1.0 -1.0 
C-lc -2.8 -4.1 -3.7 
0-lc -1.0 -1.1 -0.9 
GA-LA -59.2 -62.3 -60.3 
GA-LB -37.2 -36.2 -40.5 
GA-Lc -3.8 -5.2 -4.6 
GA-L -100.2 -103.6 -105.5 
L -2.8 1.4 5.0 
Total -103.0 -102.2 -100.5 
*GA-Li; imermolecular energy per subsiie, GA-L: loial iniermolecular energy per ligand, L: relative internal 
energy of the ligand. Arfirst subsite, Brsecond subsiie, Crihird subsite. 
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correspond to the transition state in GA hydrolysis by an SNi reaction, as found in the hydrol­
ysis of a-D-glucopyranosyl fluoride.^® 
In comparing results of the three monosaccharides, it should be remembered that the 
active site remained static in this study, although crystallography shows that both the catalytic 
water and Asp55 can change positions.'-Therefore it is quite possible that alternative active 
site side-chain conformations could lead to better interactions of D-mannose and especially D-
galactose. Another factor to be considered is the absence of solvent contributions, when varying 
solubilities of the monosaccharides and analogues in water could explain differences in binding 
energy, as well as the lack of correlation between values of total energy of intermolecular inter­
action and inhibition levels. 
Similar individual atomic or group interactions are found for the valiemine moiety of the 
acarviosinides and the first GA subsite (Table VII), with strong interactions with 0H-4A, OH-
6A, and C-6A, and a steric contact with C-l\ (corresponding to 0-5 in D-glucose). Strong 
interactions occur with 0H-3B and for C-6B at the second subsite. Besides a weaker energy of 
interaction for N-4b in methyl a-S-acarviosinide, compensated by better atomic and electrostatic 
interactions in the R-isomer and the protonated acarviosinide, the lower interaction energy 
values found for other atoms or groups reflect increased distance from the protein and un­
accounted exposure to the solvent. 
The strong interaction of OH-4A, 0H-6A, and 0H-3B, groups also involved in inter­
molecular hydrogen bonds (Figure 4f), in acarviosinide binding correlates with the importance 
of the same groups for effective maltose hydrolysis.^^-52.59 These hydrogen bonds are also 
found in the acarbose-GA complex.'-" The strong interaction with C-6b correlates well with 
the predicted hydrophobic environment for the 6-position in the GA active site found in kinetic 
studies of 6-substituted maltose derivatives.®® The nonexistence of a 6-OHB hydroxyl group 
contributes to the inhibitory effect of the acarviosinides and hence of acarbose. On the other 
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hand, there is only a small interaction with OH-2B, which forms a weak hydrogen bond with 
GluISO in the GA-acarbose complex'-^! and the GA-maltosc transition complex. 
Conclusions 
Favorable docking between monosaccharide substrates and monomeric and dimeric in­
hibitors, especially with protonated inhibitors, has been simulated by Monte Carlo techniques. 
Especially noteworthy is the correspondence with numerous crystallographic results, which 
suggest that tight binding leading to strong inhibition is obtained by charged forms forming 
salt-like links with Glul79.^ Small observed discrepancies between crystal structures and dock­
ing results can be explained by errors introduced by the simplified Lennard-Jones coefficient-
based force field used by AutoDock and, less significantly, by small distortions in the crystal 
structures not incorporated in the docked structures. Other potential causes of discrepancies 
are the methods used for estimation of partial atomic charge and for calculation of the 
electrostatic potential grid maps. 
Both anomeric forms of D-glucose, D-mannose, and D-galactose could be docked in the 
OA active site. Small differences in total docking energies were found, although as expected D-
glucose tended to bind better than the other two. Crystallographic studies of GA complexes of 
the three monosaccharides (A. E. Aleshin and R. B. Honzatko, personal communication, 1996) 
showed that a-D-glucose and a-D-mannose bound in the first subsite, while a-D-galactose was 
found only in the second subsite. The docking results indicated minor differences in the posit­
ioning of the different compounds in the active site. Upon substrate binding, changes in charge 
distribution and protonation state in both active-site chains and the substrate molecule can 
occur. This might favor the binding of one substrate over the other, but unfonunately this 
characterization is beyond the scope of AutoDock. 
Conformational mapping of uncharged and charged methyl a-acarviosinide explains the 
conformational changes found by NMR upon protonation of this compound as well as that of 
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acarbose. In addition, the combined conformational mappin^docking study of all the possible 
uncharged and charged forms yielded structures close to those obtained in crystallographic 
studies. The use of different minima representing the possible conformational states of the 
ligand as initial structures for docking insures that the docking results come from the ex­
ploration of significant conformational space. AutoDock's ability to dock flexible substrates 
can be exploited for the study of carbohydrate-protein interactions, giving results close to those 
obtained by crystallography not only for monosaccharides and their analogues but also for a di-
saccharide analogue. This combined approach is therefore an ideal method to explore the inter­
action of disaccharides with GA, extending our knowledge of GA selectivity beyond what is 
obtained by protein crystallography. 
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CHAPTER 5. AUTOMATED DOCKING OF ISOMALTOSE ANALOGUES 
IN THE GLUCOAMYLASE ACTIVE SITE 
A paper accepted by Carbohydrate Research^ 
Pedro M. Coutinho,^' 3 Michael K. Dowd,^ and Peter J. Reilly^ ^  
Abstract 
Low-energy conformers of analogues of the disaccharide isomaltose were determined 
with MM3(92) and were then flexibly docked into the glucoamylase active site using AutoDock 
2.1. This procedure has produced bound complexes of saccharides with glucoamylase compar­
able to those obtained by protein crystallography. Conformational energy surfaces of three 
methyl a-isomaltosides, two with a second methyl group at C-6B, were determined to character­
ize the steric limitations introduced by that group. Their most probable conformers were used as 
initial structures for docking. Seven sets of monodeoxy methyl a-isomaltoside structures were 
also generated based on the methyl a-isomaltoside conformational map and were docked to 
probe the contribution of individual hydroxyi groups to binding. The optimized docking modes 
are similar for most analogues, and energies of intermolecular interaction per extended atom 
agree with the assignment of key hydroxyi groups made from kinetic studies. This new 
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approach to study saccharide-protein interactions complements the results of protein crystal­
lography, allowing a better understanding of the interaction of glucoamylase with its substrates. 
Introduction 
Glucoamylase [a-(l,4)-D-glucan glucohydrolase, EC 3.2.1.3, GA] hydrolyzes terminal 
a-(l,4)-D-glycosidic bonds from the nonreducing ends of maltooligosaccharides to produce P-
D-glucose, and is used industrially to digest liquefied starch. Its ability to hydrolyze (X,|3-(l,l)-, 
a-(l,2)-, a-(l,3)-, and a-(l,6)-D-glycosidic bonds [1] can at high D-glucose concentrations lead 
to the formation of different condensation products [2,3]. Among these, the disaccharide 
isomaltose and the trisaccharides isomaltotriose and panose, which contain a-(l,6)-D-glucosidic 
linkages, are thermodynamically favored. Reduction of the yield of these compounds by protein 
engineering requires understanding of GA selectivity at the molecular level. 
The structure of the Aspergillus awamori var. XlOO GA catalytic domain has been ob­
tained by X-ray crystallography under different pH conditions and while complexed to different 
inhibitors [4-9], The GA active site, a well in the center of an (a/a)^ barrel, is rigid under these 
different conditions. The two catalytic residues, the acid Glul79 and the base Glu400 [5,10,11], 
are found at opposite sides of the active-site cavity that also encloses the putative catalytic water 
molecule [5]. Other essential residues, conserved in fungal, yeast, and bacterial GAs where they 
constitute the active-site walls, are equally important in catalysis [12-14]. 
Seven and six subsites have been found in the A. awamorilAspergillus niger GA active 
site through kinetic measurements of malto- [15-17] and isomaltooligosaccharide [16] 
hydrolysis, respectively. The positions of maltooligosaccharide residues in the first four sub-
sites can be defined from crystallographic data for the acarbose and ^/«co-dihydroacarbose GA 
complexes [7-9], two alternative positions for the third and fourth subsites being found [8,9]. 
Unfortunately, no crystallographic data exist for a-(l,6)-linked substrate analogues complexed 
with GA. 62-Thiopanose and different 6'^-5-a-D-glucopyranosyl-6'^-thiomaltooligosaccharides, 
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containing a-(l,6) thioglucosidic linkages at their nonreducing ends, have limited if any 
interaction with the GA catalytic domain [18,19]. Only recently, a pseudo-disaccharide derived 
from isofagomine that is analogous to an a-l,6-linked disaccharide has been reponed as a 
strong GA inhibitor [20]. 
Conformational studies have shown that isomaltose is a very flexible disaccharide [21], 
since three-bond a-(l,6) glycosidic linkages contribute to a reduced interaction between di­
saccharide pyranosyl rings [21,22]. However, inter-ring torsional potentials yielded fairly sharp 
minima. A limited conformational search on the transition-state complex of isomaltose with GA 
showed that the GA active site can accommodate this substrate [23], with the critical 0H-4A, 
OH-6A. and OH-4B groups of isomaltose [24] taking the position of the critical OH-4A, OH-
6A, and 0H-3B groups of maltose [25] as taken from the GA-acarbose complex [6]. Kinetic 
studies with conformationally biased isomaltose analogues [26,27] suggested that the preferred 
conformation of methyl a-isomaltosides (Mis) is important in GA hydrolysis. 
The role of individual substrate hydroxyl groups in GA catalysis has been explored 
kinetically for isomaltose [23,24] as well as for maltose [25,28,29]. Key saccharide hydroxyl 
groups not only provide the complementary structure required for protein binding through 
hydrogen bonding [30,31], but they also establish essential polar interactions to anchor the sub­
strate in the enzyme active site and to induce catalysis [32], 
Monte Carlo methods can be used for automated docking of flexible substrates to pro­
teins by simulated annealing [33-35]. A new combined molecular mechanics/simulated anneal­
ing approach recently yielded GA interactions with monosaccharide substrates and mono- and 
disaccharide analogues that closely matched results obtained by X-ray crystallography [36]. 
Individual docking of the most significant conformers of three different forms of methyl a-
acarviosinide allowed the exploration of their interactions with the active site. Upon redocking, 
which entailed the optimization of the original docking results by repetition of the docking prot­
ocol, the active-site conformations were similar to the experimentally determined conformations 
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of the nonreducing end of the inhibitor acarbose in the A. awamori var. XI00 GA-acarbose 
complex [6]. 
In this study, ten different me±yl a-isomaltosides in the A. awamori var. XlOO GA 
active site were docked by simulated annealing with AutoDock 2.1. This was preceded by con­
formational analysis using MM3(92) of MI and of two conformationally biased analogues, 
methyl 6R-C-MI and methyl 6S-C-MI, to select low-energy conformations of each compound 
for docking. A systematic study of the structural interaction of monodeoxy Mis with GA was 
performed to assess the role of individual hydroxyl groups in binding and catalysis. 
Computational Methods 
Conformational analysis of methyl a-isomaltosides.—^The MM3(92) force field [37-
39], obtained from Technical Utilization Corporation, Powell, OH, but now available from 
Quantum Chemistry Program Exchange, Bloomington, IN, was used in this study. As in 
previous disaccharide conformational studies [21,22,40-43], the bulk dielectric constant (£) was 
set to 4.0. Starting structures of MI and of the conformationally biased methyl 6R-C-MI and 
methyl 6S-C-MI (Fig. 1) were generated and preoptimized using PC-Model (Serena Software, 
Bloomington, IN). Eight sets of exo-cyclic orientations were considered for each disaccharide. 
These were all combinations of clockwise (c) and reverse-clockwise (r) orientations of the 
secondary hydroxyl groups for each ring, where partial crowns of weak hydrogen bonds tend to 
be formed. For the C-5A-C-6A bond, orientations gauche to both C-4A and 0-5A, referred to 
as gauche-gauche (gg), and gauche to 0-5A and trans to C-4A , referred to as gauche-trans 
(gt), where considered, since these are favored by giucopyranosyl rings in both solution and 
crystals. 
The torsional angles representing the orientations of the rings about the glucosidic link­
age were defined as 0 = 0(H-1A-C- 1A-0-6B-C-6B), y/= 0(C-1A-O-6B-C-6B-C-5B), and TY = 
I l l  
OH 
HO 
HO 
QH OCH 
OH 
Figure 1. MI (Ri = H; R2 = H), methyl 6R-C-MI (Ri = CH3; R2 = H), and methyl 6S-C-MI 
(Ri = H; R2 = CH3) with angles <(>, y/, and co denoted. The critical hydroxyl groups required for 
isomaltose hydrolysis are shown in bold [11].  
0(O-6B-C-6FF-C-5B-H-5B), where A and B represent the non-reducing and reducing end glyco-
syl units, respectively (Fig. 1). The conformational space for the three linkage torsional angles 
was evaluated with MM3(92) at 20° intervals, relaxing all remaining geometric features. The 
lowest energy value at each grid point from the different sets was used to draw contour maps 
with Surfer (Golden Software, Golden, CO) and three-dimensional isoenergy surfaces using 
Dicer (Fortner Research LLC, Sterling, VA). 
Local minima were found by a multi-step procedure where all starting structures that 
could contribute to a local minimum were rotated to a local low-energy grid point, optimized 
there, and then reoptimized without torsional angle restrictions using the full-matrix option of 
MM3. The lowest-energy structure was taken as the minimum. Local minima within 8 kcaJ/mol 
of the global minimum were used as initial starting structures for docking. 
Structures of 2'-, 3'-, 4'-, 6'-, 2-, 3-, and 4-deoxy MI were generated using the 
procedure described above. Since no significant conformational differences were expected 
between MI and its monodeoxy analogues, conformers were generated for each analogue by 
rotating the glycosidic dihedrals to the values found in each of the MI minima, optimizing the 
structures there, and finally reoptimizing without restrictions. 
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Docking simulations.—Automated docking simulations were conducted with 
AutoDock 2.1 [33-35] (Scripps Research Instimte, La Jolla, CA). The GA crystal structure as in 
the complex with D-g/wco-dihydroacarbose [8,9] (Brookhaven Protein Databank entry IGAI) 
was used. The inhibitor and all water molecules with the exception of the putative catalytic 
molecule were removed, and nonpolar hydrogens were added using Quanta 3.3 (Molecular 
Simulations, Inc., San Diego, CA). Atomic partial charges for GA and ligands were calculated 
by the Gasteiger method [44]. 
Atomic interaction energy grids were calculated using probes corresponding to each 
atom type found in the substrate, at 0.5-A grid positions in a 40-A cubic box centered on the 
GA active site. The electrostatic interaction energy grid used a sigmoidal distance-dependent 
dielectric function [45] to account for the solvent screening effect. The Lennard-Jones coeffic­
ients of AutoDock 1.0 with different parameters for apolar and polar hydrogens were used, 
along with a distance criterion with directional attenuation to account for hydrogen bonding. 
At the start of each docking study, the nonreducing end ring of each substrate was 
placed in the active site. Each docking experiment consisted of 100 independent Monte Carlo 
simulations per starting structure. As in the previous study [36], a shon schedule [34] with 100 
constant temperature cycles was used. Each cycle had a maximum of 1,500 steps accepted or 
rejected, the minimal energy structure being passed to the next cycle. The temperature was 
reduced by a 0.95 factor per cycle from an initial value of T = 50.33 K (or RT = 100 cal/mol) 
and the maximal torsional rotation per step was reduced by a factor of 0.9875 per cycle from 
the initial 15°. A constant maximal translational step of 0.2 A per step was used. All disacc-
haride exocyclic and inter-ring dihedral angles were allowed to rotate. 
Docking simulations were made for each of seven Ml, seven methyl 6R-C-MI, and six 
methyl 6S-C-MI conformers having local minima 8 kcal/mol or less above their respective glob­
al minima given by MM3(92). For each monodeoxy MI, seven different conformers generated 
from the equivalent MI conformers were used as initial stmctures in docking simulations. 
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Following docking, all structures generated for a single compound were subjected to 
cluster analysis, cluster families being based on a tolerance of 1 A for an all-atom root mean 
square (RMS) deviation from an optimal structure. For each substrate, the global minimum 
structure, optimal structures of significant clusters, and occasionally other significant structures 
were subjected to redocking and cluster analysis. Redocking, or repetition of the docking prot­
ocol using a previously obtained result [36], allows an economic and efficient use of the shon 
protocol [34] where only promising structures of the many initial docking results are further 
optimized. All results were compared to the best result for MI. To obtain consistent results of 
substrate internal energies among all experiments, only AutoDock's (AD) variation on internal 
energy was considered as before [36], all values being referenced to the MM3(92) relative 
energy: 
Internal Energy = Relative MM3 Energy + A [AD Internal Energy] 
(Docking) (Docking) 
Internal Energy = Internal Energy + A [AD Internal Energy] 
(Redocking) (Docking) (Redocking) 
Results and Discussion 
Conformational analysis of methyl a-isomaltosides.—Isoenergy surfaces 2, 4, 6, and 
8 kcal/ mol above their global minima are shown in Figs. 2-4 for MI, methyl 6R-C-MI, and 
methyl 6S-C-MI, respectively. Six corresponding contour plots for the staggered and eclipsed 
orientations of O) of each compound are shown in Figs. 5-7. Local minima within the lowest 8 
kcal/mol of the global minima of the three Mis appear in Table 1. Conforming to the exo-
anomeric effect, all minima have Rvalues between -18° and -46° except the seventh minimum of 
methyl 6R-C-MI. The results for MI are very similar to those obtained for a-isomaltose [21], 
the order of the energetically close first two minima being reversed. The extra methyl groups of 
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Figure 2. MM3(92)-generated isoenergy surfaces for MI: (a) 2 kcal/mol, (b) 4 kcal/mol, (c) 6 
kcal/mol, and (d) 8 kcal/mol. For ease of viewing, the (p axis runs from -180° to 180° and the y/ 
and CO axes run from 0° to 360°. 
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Figure 3. MM3(92)-genenited isoenergy surfaces for metliyl 6R-C-MI. Panels as in Fig. 2. 
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Figure 4. MM3(92)-generated isoenergy surfaces for methyl 6S-C-MI. Panels as in Fig. 2. 
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Figure 5. MM3(92)-generated steric energy maps for MI at constant co: (a) co = 0°, (b) uj = 60°, 
(c) co= 120°, (d) Q)= 180°, (e) = 240°, and (f) C!j = 300°. The <p, y/'planes are contoured at 1 
kcal/mol increments to 8 kcal/mol above the global minimum. 
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Figure 6. MM3(92)-genenited steric energy maps for methyl 6R-C-MI at constant co: Notes as 
in Fig. 5 caption. 
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Table 1. Calculated minima for the methyl a-isomaltosides from conformational analysis 
Compound Dihedral angle (degrees) MM3 Relative Starting 
energy energy conformer 
(f> Y CO (kcal/mol) Gccal/mol) 
MI 
Methyl 6R-C-MI 
Methyl 6S-C-MI 
-44.1 -172.9 -50.2 21.871 0.000 gtrr 
-41.5 -173.5 177.8 21.923 0.052 gtrc 
-43.8 -179.6 60.1 22.540 0.669 gtcc 
-46.9 82.1 -52.5 23.592 1.721 gtrr 
-44.3 100.5 175.4 24.547 2.677 gtrr 
-27.4 -61.1 -28.7 25.302 3.432 gtrr 
-23.2 -77.8 41.4 26.760 4.889 gtcc 
-32.4 163.7 61.4 25.872 0.000 ggcc 
-46.1 85.8 -48.3 26.226 0.354 gtrr 
-30.4 170.0 -48.6 26.772 0.901 gtrr 
-30.2 167.8 173.7 27.085 1.241 gtrr 
-43.9 102.5 172.8 27.567 1.696 gtrr 
-30.0 -53.4 -33.2 29.533 3.662 gtrr 
-8.9 -62.3 44.3 31.346 5.475 gtrr 
-40.8 -161.7 -179.7 24.795 0.000 gtrc 
-40.4 -151.4 -52.7 26.243 1.447 gtrr 
-44.6 -154.4 59.8 26.661 1.866 gtcc 
-26.3 -61.4 -.^0.7 29.554 4.759 gtrr 
-36.7 81.4 168.7 29.584 4.789 ggcc 
-37.6 62.8 -70.3 29.798 5.002 gtrr 
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the methyl 6-C-MIs cause a negative and a positive deviation of ^ in the several minima of the 
R- and S-isomers, respectively, constraining the available conformational space differently. For 
methyl 6R-C-MI all staggered orientations of co (Rgs. 6b,d,f) are slightly constrained compared 
to MI (Figs. 5b,d,f) but the eclipsed orientation at G) = -120° (Fig. 6e) is especially constrained, 
as seen in the relaxed-residue energy surfaces (Fig. 3). For methyl 6S-C-MI the eclipsed 
orientations of O) (Figs. 7b,d,f) are even more constrained, with a stronger impairment of 
movement in all staggered orientations of co (Figs. 7a,c,e), limiting the movement to the spatial 
regions close to the different minima (Fig. 4). 
For methyl 6R-C-MI in solution, the set ^lyr/co = -50°/90%60° estimated by NMR 
[26] corresponds to the values obtained for the second minimum by MM3. Likewise, for 
metiiyl 6S-C-MI the NMR stt 0/\f/lco = -50°/-l65°/180° [26] is very close to the conformation 
of the global minimum. 
Docking of methyl a-isomaltosides.—Following docking (data not shown) the optimal, 
or lowest energy, structures of the energetically significant clusters and some others were 
redocked. Significant clusters of redocked Mis are listed in Table 2. The optimal structures of 
the different Mis are gg conformers except for a gt conformer of MI. However, the optimal gg 
structure of Ml, representing the second cluster, is close to the gt conformer in total interaction 
energy. The gg or equivalent conformation of the exocyclic hydroxymethyl group at the 
nonreducing end of substrates and inhibitors is the most significant binding mode found in 
previous docking studies [36] and occurs in all crystal structures of GA complexes. This struc­
ture will be therefore considered the optimal "productive" structure for MI and will be used as 
reference in this study. The structures representing energetically significant docked clusters of 
the ten different Mis are shown in Fig. 8. 
The generally low RMS deviations of the different docked structures from the reference 
MI structure indicate that most find similar productive docking modes. Especially close are the 
structures of methyl 6R-C-MI and all the Mis lacking a hydroxyl group at the nonreducing end 
Table 2. Redocking of methyl-a-isomaltosides in the GA active site a 
Compound Cluster Total Internal Inicr-ring dihedral angles Exo-cyclical angle RMS dev-|no. of energy'' energy'' iationfrom 
structures) (kcal/mo!) (kcal/mol) ({> v|/ (o Optimal gg/gi/ig ratio ref. (A) 
Ml 11136/3001 -97.5 (-90.9) 0.50 (5.6) -I9(-18) 132 (137) 18 (9) gi 99^10 0.57 (0.47) 
2 (43/3001 -96.0 (-91.9) 10.2 (11.1) -20 (-23) 146 (148) 4 (8) gg 43/0/0 0.00 (0.24) 
Methyl 6R-C-M1 11212/3001 -102.3 (-96.5) 8.0 (1.4) -27 (-30) 137 (141) 16 (17) gg 93/0/0 0.31 (0.40) 
Methyl 6S-C-MI 1 (61/3001 -76.0 (-70.9) 14.8 (15.4) -41 (-43) 127 (126) 36 (34) gg 61A)/0 0.62 (0.69) 
2'-Deoxy MI 1 (97/3001 -93.8 (-87.1) 7.4 (8.9) -17 (-28) 144 (150) 5 (11) gg 97/0/0 0.24 (0.37) 
3'-Dcoxy Ml 1 (272/3001 -%.8 (-88.9) 7.1 (4.6) -39 (-30) 148 (144) 20 (18) gg 186/86/0 0.38 (0.43) 
4'-Dcoxy MI 1(164/3001 -96.5 (-87.1) 1.4 (2.2) -14 (-30) 140 (140) -3 (21) gg 161/3/0 0.19 (0.47) 
6'-Deoxy MI 1(210/4001 -96.5 (-90.5) 2.4 (2.9) -16(-3I) 139 (141) 0 (20) 0.31 (0.54) 
2-Deoxy MI 1 (46/3001 -96.9 (-91.9) 1.7 (5.4) -14 (-4) 129 (143) 12 (-5) gg 45/1/0 0.46 (0.48) 
3-Oeoxy Ml 1(177/4001 -97.7 (-91.8) -0.8 (1.8) -34 (-32) 143 (138) 43 (35) gg 155/22/0 0.68 (0.64) 
2(118/4001 -97.6 (-89.2) -0.8 (1.3) -21 (-28) 138 (136) 20 (24) gl 2/116/0 0.52 (0.67) 
4-Dcoxy MI 1 (74/5001 -90.8 (-84.8) 3.8 (4.9) 4 (-6) -162 (-117) 34 (46) gg 121210 2.00 (1.79) 
2 [7/500] -88.4 (-83.9) 5.9 (4.8) -31 (-18) 166 (124) 81 (60) gg 7/0/0 1.54 (1.51) 
3 195/500] -87.3 (-82.8) 2.8 (4.2) -27 (-31) 143 (141) 11 (17) gt 2211310 0.61 (0.60) 
^ Docked structures are grouped into clusters, the best clusters being shown. 
Values for the optimal structure in each cluster are to the left and cluster averages are in parentheses. 
Using equivalent atoms of the best productive binding mode of Ml following redocking. 
Figure 8. Stereoscopic plots of docked structures in the GA active site. Residues surrounding 
the first and second subsites and the catalytic water are shown, along with hydrogen bonding 
between protein and substrate residues indicated by dashed lines, (a) MI (black), methyl 6R-C-
MI (dark grey) and methyl 6S-C-MI (light grey); (b) 2'-deoxy-MI (black), 3'-deoxy-MI (dark 
grey), 4'-deoxy-MI (medium grey), and 6'-deoxy-MI (light grey); (c) 2-deoxy-MI (black), 3-
deoxy-MI (dark grey) and 4-deoxy-MI (light grey). Plots were prepared with Molscript [46]. 
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(Figs. 8a,b). The remaining monodeoxy compounds, 2-, 3-, and very significantly 4-deoxy MI, 
deviate increasingly from the MI productive mode (Fig. 8c). This suggests that 0H-4B is im­
portant in proper binding and that 0H-3B could play a role in the interaction. For methyl 6S-C-
MI the global minimum docked structure shows a RMS deviation of 0.62 A due to both an 
extreme set of ^Ixirlco angles and an incomplete penetration of the active site due to internal and 
protein-substrate steric contacts. 
The global minimum productive binding modes and the respective cluster averages of 
the different Mis, except for the methyl 6S-C-MI and 2-, 3-, and 4-deoxy MI cases, have 0/v 
/O) angles between -39° and -147137° and 150%3° and 21°. This ground-state conformation 
range contrasts with the MI transition-state model where (plx^lo) = -47°/134°/47°, suggested 
recentiy following limited conformational exploration with GEGOP [23]. The flexibility of the 
three-bond glycosidic linkage allows a large set of possible conformations in the GA active site. 
This could explain the low rate of GA-catalyzed isomaltose hydrolysis, since not all binding 
modes would directly lead to catalysis. Thus, the extra step found by steady-state kinetic studies 
[47] could have a conformational basis. 
The number of possible conformations is reduced for methyl 6R-C-MI, where the extra 
methyl group limits conformational space, restricting the docking results. In the first round of 
docking experiments (data not shown), this compound exhibited the largest energy difference 
between the first and second clusters and the largest number of conformers in the first cluster. 
The reduced number of possible conformers upon binding correlates with the low ATm of methyl 
6R-C-MI [27]. In fact, the binding mode and total interaction energy are similar to those of MI, 
suggesting that entropic limitations could explain their different behavior in GA catalysis. 
The extra methyl group in methyl 6S-C-MI is unfavorably placed for GA binding. 
Docking is accomplished only at the expense of the glycosidic bond torsional energy—at nor­
mal 0 and (^values for docked Mis, lower co values are penalized for this compound (Fig. 7a) 
—and a weak interaction with active-site residues due to an incomplete penetration of the active-
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site pocket (Fig. 8a). Flexibility of GA active-site residues, notably that of TyrSll, which were 
not considered in this study, could render the binding of this compound less difficult 
In fact, according to the three-dimensional conformational maps produced by MM3(92) 
(Figs. 2-4), estimated energies (mostly dependent on glycosidic torsions) of the global 
minimum productive MI, methyl 6R-C-MI, and methyl 6S-C-MI conformers are 5.7,4.0, and 
8.3 kcal/mol, respectively. Even though the conformers were found using AutoDock's simple 
force field, less strain is found upon docking for the best substrate, methyl 6R-C-MI, while the 
most was found in the worst substrate of the three [27], methyl 6S-C-MI. This result confirms 
that different strains on the glycosidic bond can be very important for GA hydrolysis of 
isomaltose analogues. 
A rough estimation of the glycosidic three-bond conformational energy of the different 
global minimum monodeoxy MI structures can be obtained by comparing the inter-ring dihed­
ral angles with the MI map. Energies for the series 2'-, 3'-, 4'-, and 6'-deoxy MI are 6.0,4.5, 
5.4, and 6.5 kcal/mol, respectively, while for the global minimum 2-, 3-, and 4-deoxy Mis values 
of 7.0,4.4, and 6.0 are obtained, respectively. The results are, as expected, in the order of those 
obtained for MI but also reflect some fluctuation. However, further rationalization would require 
specific MM3 maps for these compounds. 
Since the Lennard-Jones-based force field of AutoDock, which allows the rapid energy 
evaluation used in simulated annealing, is relatively unsophisticated, the calculated internal ener­
gies of the docked Mis vary significantly and show weak correlation with MM3(92) results 
(data not shown). This could explain why a gt conformer, with low internal energy, is found as 
the global minimum MI structure, while the optimal gg structure, which exhibits high internal 
energy but also has a lower intermolecular energy of interaction, appears only as the second 
cluster. The high internal energies exhibited by some docked results are unrealistic, and should 
be considered qualitatively. In most cases the differences appear to be related to orientation of 
the hydroxyl groups, which were allowed to rotate but which were optimized in a force field 
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(AutoDock) that does not include torsional energy parameters. Also, even though hydroxyl 
groups are rotated in the same way as inter-ring bonds, AutoDock tends to optimize the latter to 
the detriment of the fomier, given their larger role in defining the binding mode. The positioning 
of all hydroxyl groups is then not ideal in all cases, which can cause some internal steric 
contacts. Given the longer interatomic distances, more confidence can be placed in the 
AutoDock's intermolecular component of the total energy of interaction. The fact that no 
solvent contribution is considered beyond a solvent screening effect included in the electrostatic 
calculations [45] should also affect the results. However, the structures find consistent binding 
modes in most cases (Figs. 8a-c). 
Past studies showed good correlations between acarviosinide docking and the crystallo-
graphic data of corresponding acarbose residues [36]. In the absence of reference crystallo-
graphic structures we tried other possible correlations with experimental data. However, no sig­
nificant correlations between kinetic parameters [23,27] and the energy terms obtained by 
AutoDock or with docking structural deviations could be obtained that cover all ten substrates. 
Atomic interactions in the GA active site.—Individual energy contributions to inter­
molecular interactions between the different Mis and the GA active site are given in Table 3. 
Hydrogen atom contributions were added to those of adjacent heavy atoms. The strongest inter­
actions of the nonreducing ends of the different Mis in the first GA subsite are made by 0H-4A. 
and OH-6A, the key hydroxyl groups except when they are absent in the corresponding deoxy 
Mis, and by C-6A, as in the previous study I36|. The removal of these key hydroxyl groups, 
which strongly affects ^ cai values of the corresponding 4'- and 6'-deoxy Mis but not their Km 
values [23], still leads to regular binding modes. In addition, these compounds exhibit less 
negative interaction energies at the first subsite (GA-SA in Table 3), compensating for their 
missing intermolecular hydrogen bonds by having stronger contacts through 0H-6A and OH-
3a, respectively. 
Table 3. Atomic contributions to intermolecular energy (kcal/mol) in the interaction of the optimal structures of methyl a-
isomaltosides with the GA active site ® 
Atom Ml Mclhyl 6R- Methyl 6S- 2'-Dcoxy 3'-Dcoxy 4'-Deoxy 6'-Deoxy 2-Dcoxy 3-Dcoxy 4-Dcoxy 
C-Ml C-Ml Ml MI Ml Ml Ml Ml Ml 
C-1a -4.9 -4.9 -4.6 -4.7 -5.0 ^.9 -4.8 -4.4 -5.0 -5.2 
C-2a -4.8 -5.2 -5.1 -6.4 -3.9 -4.9 -4.9 -4.9 -4.8 -3.8 
C-3a -5.6 -5.7 -5.5 -5.3 -7.3 -4.5 -4.6 -4.4 -5.6 
C^a -5.2 -5.3 -4.5 -5.0 -5.4 -6.4 -5.3 -5.1 -5.2 -5.3 
C-5a -4.9 ^.9 -3.1 -4.6 -4.7 -5.3 -5.3 -5.1 -4.8 -5.2 
C-6a -8.8 -8.7 -6.5 -7.5 -8.3 -9.1 -9.8 -8.6 -8.7 -8.8 
0-2a -5.4 -4.H -4.8 -5.8 -4.1 -4.8 -4.0 -4.2 -4.4 
0-3a -3.6 -7.2 -4.9 -8.0 -5.8 -8.6 -5.9 -6.2 -7.8 
0-4a'> -9.6 -11.4 -9.8 -9.8 -11.5 -9.2 -9.6 -11.4 -i0.0 
0-5a -1.9 -1.8 -1.5 -1.8 -1.9 -1.4 -1.6 -1.9 -1.9 -1.3 
-10.5 -5.7 -7.2 -7.5 -9.9 -10.9 -10.1 -8.9 -9.1 
C-1b -2.8 -2.3 -1.7 -2.4 -2.8 -2.9 -2.8 -1.9 -1.6 -2.3 
C-2b -1.5 -1.6 -1.4 -1.5 -1.5 -1.5 -1.5 -1.9 -2.1 -1.5 
C-3b -3.8 -3.9 -3.3 -3.7 -3.2 -"in -3.3 -3.7 -3.5 -3.2 
C-4b -4.0 -4.0 -3.7 -3.9 -3.8 -3.9 -3.7 -3.8 -4.3 -3.8 
C-5b -3.6 -3.6 -3.6 -3.9 -3.5 -3.6 -3.4 -3.5 -3.4 -3.4 
C-6b -4.8 ^.0 -3.0 -4.7 AJ -5.1 -5.1 -4.8 ^.8 -4.8 
C-7b -7.0 -3.2 
0-2b -0.8 -1.1 -0.7 -0.8 -0.6 -0.8 -0.7 -0.8 -0.7 
0-3b -1.5 -2.6 -1.7 -2.5 -4.0 •4.8 -4.0 -2.8 -1.9 
0-4b'' -8.2 •6.6 -5.7 -8.1 -6.0 •5.9 -5.1 -6.3 -3.8 
0-5b -1.2 -1.1 -1.0 -1.1 -1.3 -1.2 -1.2 -1.0 -0.9 -0.6 
Table 3. (continued) 
Atom Ml Methyl 6R- Methyl 6S- 2'-Dcoxy 3'-Dcoxy 4'-Dcoxy 6' '-Deoxy 2-Deoxy 3-Dcoxy 4-Deoxy 
C-MI C-Ml Ml Ml Ml MI Ml MI Ml 
0-6B 0.6 0.6 5.4 1.0 -0.0 0.3 0.4 2.2 0.2 -1.2 
C-lc -7.9 -6.1 -8.3 -7.2 -7.0 -6.5 -7.6 -5,6 -3.7 •4.6 
0-lc -1.4 -1.4 -1.4 -1.7 -1.9 -1.1 -1.9 -1.5 -1.2 -0.7 
GA-SA -65.3 -65.6 -57.4 -60.7 -63.6 -57.4 -59.0 -63.9 -66.8 -65.8 
GA-SB -31.6 -37.1 -23.7 -31.6 -31.5 -32.9 -30.4 -27.7 -25.2 -23.4 
GA-Sc -9.3 -7.5 -9.6 -9.0 -8.8 -7.6 -9.4 -7.1 -4.8 -5.3 
GA-S -106.2 -110.2 -90.8 -101.2 -103.9 -97.9 -98.9 -98.7 -96.8 -94.6 
Siniernal 10.2 8.0 14.8 7.4 7.1 1.4 2.4 1.7 -0.8 3.8 
Total -96.0 -102.2 -76.0 -93.8 -96.8 -96.5 -96.5 -96.9 -97.7 -90.8 
kcM (S ')«= 0.88 0.68 l.I 0.18 0.95 1.3 X lO"* 1.5 X 10" 0.50 0.036 6.7 X 
KiA (mM) c 22.4-24.5 0.71 90.0 21.2 56.9 21.2 39.0 19.1 24.1 8.8 
0.039- 0.96 0.012 0.0085 0.017 6.0 X 10 6 3.9 X 10 6 0.026 0.0015 7.6 X 
= 0.042 
Distance 2.65 
06B-G1U179 
2.66 2.48 2.58 2.74 2.72 2.71 2.56 2.69 3.09 
» GA-Si: intermolecular energy per subsite, GA-S: total intermolecular energy per substrate, Siniemai: relative internal energy of the substrate. A: first 
subsite, B: second subsite, C: third subsite. 
^ Bold; Interaction with critical hydroxy] groups. 
c Refs. 23 and 27. 
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Of all the energetic interactions at the first subsite, the weakest occurs at 0-5A in all 
Mis, suggesting some strain due to combined mildly unfavorable van der Waals interactions, as 
found for monosaccharide substrates [36]. Strain is similarly found at the glycosidic 0-6B, 
being major for the conformarionally impaired methyl 6S-C-MI and less stringent for the global 
minimum 4-deoxy MI conformer as the distances between this atom and OEl of Glul79 equal­
ly suggest. When combined with the strong interactions at C-6A and 0-6A [36], probably 
associated with the distortions at C-5A found in different crystallographic studies [9], this pres­
sure leads more easily to the oxycarbonium ion expected in the transition state of an SNi reac­
tion, which is suggested by GA hydrolysis of a-D-glucopyranosyl fluoride [48]. 
The strongest interaction of the reducing end with the GA active site clearly occurs with 
OH-4B. The removal of this hydroxyl group forces 4-deoxy MI into alternative binding modes 
less strained at 0-6B, leading to very different docking clusters (Table 2). The global minimum 
structure is represented in Fig. 5c, where the glycosidic oxygen is distant by more than 3 A of 
atom OEl of the catalytic acid Glu 179, a larger distance than the 2.6—2.7 A interval found for 
most Mis (Table 3). Conformers closer to the global minimum structures of other Mis are 
however found in the third cluster (Table 2). Even though strongly affecting kczi, these struc­
tures must be reasonably stable because there is a significant decrease in Km [23]. Relatively 
strong interactions of 0H-3B are found in the Mis missing a nonreducing-end hydroxyl group, 
partially compensating for the interaction energy lost at the first subsite. Beside the strained 
interaction with 0-6B (except in 4-deoxy Ml), weaker interaction energy values found for other 
atoms or groups reflect the increased distance from the protein and the unaccounted for 
exposure to the solvent. Interestingly, the decrease of the intermolecular energy contribution at 
the second subsite (GA-SB in Table 3) of 2-, 3-, and 4-deoxy MI correlates with their RMS 
deviations from the reference structure and with their kcai/K^ values. The critical hydroxyl 
group 0H-4B could then have a crucial role in catalysis, promoting strain in the glycosidic bond 
by imposing a less favorable conformation and steric contacts with the GA active site at 0-6B. 
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The 0H-3B group appears to cause a milder but equally important version of this interaction. It 
is no coincidence that the conformations of the noncharged forms of methyl a-acarviosinide, a 
maltose analogue, in the GA active site are found in the saddle point between the two lowest 
minima [36], where conformational strain can be maximized in a stable environment. 
Also at the second subsite, a strong nonpolar interaction is found for C-7B of methyl 
6R-C-MI. As with the C-6B of acarviosinides [36], nonpolar interactions involving both Trp52 
and Trpl20 could have a role in the stabilizing both substrates and inhibitors. Such interactions 
do not occur for the corresponding methyl group in methyl 6S-C-MI, where steric contacts 
cause an incomplete penetration into the active-site pocket (Fig. 8a). 
The overall scheme of hydrogen-bonding interactions found for ground-state MI (Fig. 
8a) is similar to that recently described for the MI transition state [23], as well as for the 
nonreducing end of methyl a-maltoside [ 12,23]. All the monodeoxy MI forms except 4-deoxy 
MI have binding modes similar to that of MI. The strong impact of the removal of OH-4A and 
0H-6A on hydrolysis kinetics [23,24] should then not only be attributed to the loss of impor­
tant hydrogen binding forces but equally to the imbalance of forces and charges found in the 
active site, especially those promoting the distortions occurring at C-5A [9] and, in the 6'-deoxy 
MI case, to the loss of the interaction with the catalytic water, perturbing its nucleophilic attack 
at C-1A [7]. Steric contact of the giycosidic 0-6B with Glul79 is promoted by the hydrogen 
bonding of 0H-4B with Arg305, the backbone of Trpl78, and remotely with GlulSO, and to a 
minor degree by hydrogen bonding between 0H-3B and GlulSO. These are levers to distort the 
nonreducing-end ring into the transition state and to perturb the bond between C-1A and 0-6A. 
In isomaltose hydrolysis, mutation of the catalytic acid and base, GIul79 and Glu400 
respectively, led to complete loss of GA activity [10,11]. An equally deleterious effect on activity 
toward isomaltose was caused by mutations of residues Arg54 [49] and Asp55 [50], which 
interact with the key hydroxyl groups in the first subsite. Interestingly, while the ATm of the 
Asp55—»Gly mutant is identical to that of the wild-type GA in the hydrolysis of 6'-deoxy MI 
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[23], ifeiat for the same reaction is one order of magnitude higher, suggesting that the presence of 
0H-6A helped stabilize the catalytic water for catalysis. 
At the second subsite, the conservative GA mutation Arg305—>Lys [49], affecting inter­
action with the key hydroxyl group OH-4B, has in isomaltose hydrolysis the same ifecat value as 
does wild-type GA in the hydrolysis of 4-deoxy MI and of 4-0-methyl MI [23], while the Km 
values for isomaltose hydrolysis by both wild-type and mutant GA are similar. The Km of 4-
deoxy MI hydrolysis by wild-type GA is lower than for MI hydrolysis because less strain at O-
6b can be obtained in the alternative optimal conformer of the former, while the higher/sTm in 4-
0-methyI MI hydrolysis is caused by steric contacts with the methyl group. Removal of the 
weaker hydrogen bond between GIulSO and OH-3B affected k^^KM similarly in the hydrolysis 
of isomaltose by the mutant GlulSO—>Gln GA and of both 3-deoxy and 3-(9-methyl Mis by 
wild-type GA [10,23], Of the remaining mutants affecting the second subsite, a low Km 
occurred in isomaltose hydrolysis by mutant Trpl20—>TyrGA [51]. Given the small interaction 
between most Mis and Trpl20, it can be speculated that the catalytic acid Glul79, normally 
hydrogen-bonded to Trpl20, is stabilized in a slightly different position in the mutant where the 
glycosidic 0-6B is less subjected to strain, so that isomaltose binds more easily. However, 
without stress at the glycosidic bond, hydrolysis would proceed slowly. 
Conclusions 
The interaction of Ml and some of its substrate analogues with the GA active site has 
been simulated by Monte Carlo techniques with the formation in most cases of productive 
binding modes. Energetic discrepancies were caused by AutoDock's simplified Lennard-Jones 
coefficient-based force field, by the rigidity of the pyranosyl rings, and by the random nature of 
the approach. 
Conformational mapping of methyl 6R-C-M1 and methyl 6S-C-M1 revealed that in 
these compounds the rotation around the three-bond glycosidic bond is unequally but signif­
133 
icantly impaired, rendering the transitions between different minima more difficult This impair­
ment, coupled with the positioning of the extra methyl group around C-6B, introduces dramatic 
differences in the allowed docking modes in the GA active site, strongly favoring the binding of 
methyl 6R-C-MI over that of metiiyl 6S-C-MI. The results agree with the kinetic parameters 
[27] and suggest that entropic factors, along with a lower energy penalty in the torsion of the 
glycosidic linkage, render methyl 6R-C-MI a better substrate than MI, and that the slower 
hydrolysis of methyl 6S-C-MI is due to both conformational and steric limitations. 
Based on conformational studies on MI, all the monodeoxy Mis except 4-deoxy MI 
yielded similar binding modes upon docking. Mapping of individual atomic interactions 
revealed that removal of the hydroxyl groups contributing the most binding energy at each 
subsite correlates with the key hydroxyl groups defined by chemical mapping [23,24], In the 
extreme case of 4-deoxy MI, an alternative nonproductive binding mode was found. Variation 
of the binding modes is linked to flexibility of the three-bond glycosidic bonds found in all the 
substrates. 
The study also indicated which atoms of the ground-state conformer are more stressed 
upon binding, indicating the pressures exened by the GA active site that lead to formation of the 
transition state and then to catalysis. 
The use of different minima representing the possible substrate conformational states as 
initial structures for docking insured the exploration of significant conformational space. This 
study confirms that the ability of AutoDock to dock flexible substrates can be effectively used 
to extend the understanding of carbohydrate-protein interactions, as indicated by a previous 
study [36]. Funher exploration of the interaction of substrates with the GA active site could 
improve our knowledge of its selectivity beyond what is possible by protein crystallography. 
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CHAPTER 6. AUTOMATED DOCKING OF GLUCOSYL DISACCHARIDES 
IN THE GLUCOAMYLASE ACTIVE SITE 
A paper submitted to Proteins; Structure, Function, and Genetics 
Pedro M. Coutinho, Michael K. Dowd, and Peter J. Reilly 
Abstract 
To better understand the molecular basis of glucomylase selectivity, low-energy con-
formers of glucosyl disaccharides obtained from relaxed-residue conformational mapping were 
flexibly docked into the glucoamylase active site using AutoDock 2.2. This procedure assures 
that significant conformational space is searched and can produce bound structures comparable 
to those obtained by protein crystallography. a-Liiiked glucosyl disaccharides except (x,a-tre-
halose dock easily into the active site while exclusively P-linked disaccharides do not, explain­
ing why only die former are glucoamylase substrates. The optimized docking modes are similar 
at the nonreducing end of the different substrates. Individual atomic energies of intermolecular 
interaction allow the definite identification of key hydroxyl groups for each substrate. This 
approach confirmed the versatility of the second subsite of the glucoamylase active site in 
binding different substrates. 
Introduction 
Glucoamylase [a-(l,4)-D-glucan glucohydrolase, EC 3.2.1.3, GA] is industrially used 
to digest liquefied starch. GA releases p-D-glucose units from the nonreducing ends of malto-
oligosaccharides by the hydrolysis of terminal a-( 1,4)-D-glucosidic bonds. However, kinetic 
characterization revealed that Aspergillus niger OA is also able to more slowly hydrolyze a,P-
(1,1)-, a-(l,2)-, a-(l,3)-, and a-(l,6)-D-glucosidic bonds of glucopyranosyl disaccharides.^>2 At 
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high D-glucose concentrations, thermodynamics dictates the formation of differently linked 
condensation products by GA,^.^ including the disaccharides a,P-trehalose, kojibiose, nigerose, 
maltose, and isomaltose and several a-(l,4)- and a-(l,6)-linked trisaccharides. Understanding 
the molecular basis of GA interaction with substrates linked differendy is necessary to effectiv­
ely engineer GA selectivity. 
Subsite mapping of Aspergillus GAs revealed that seven and six subsites were involved 
in malto- and isomaltooligosaccharide hydrolysis, respectively.^'^ The structure of the Asper­
gillus awamori var. XlOO GA catalytic domain obtained by X-ray crystallography in its native 
state or complexed with different inhibitors^'^^ was the basis for modeling the approximate 
interaction of GA with the substrates methyl a-maltoside and methyl a-isomaltoside in the first 
and second subsites.The main interactions of these substrates with active-site residues and 
the catalytic water molecule were identified, with most of these residues being conserved in 
fungal, yeast, and bacterial GAs.^"*'^^-^"^ 
Automated docking with AutoDock, combining Monte Carlo methods with simulated 
annealing, has allowed the study of the interaction of proteins with small flexible molecules^^'^® 
and with other proteins.^' Flexible docking of p-acetylglucosamine in lysozyme^® suggested 
that it could characterize protein-carbohydrate interactions. Recently, automated docking of D-
glucose and D-mannose and monosaccharide inhibitors yielded binding modes close to those 
found in the first subsite of GA complexes.22 After conformational analysis, binding modes of 
methyl a-acarviosinide matched the pseudosaccharide moiety of the inhibitor acarbose in its 
complex with GA.^^ The approach yielded consistent binding modes of different isomaltose an-
alogues,23 revealing that the presence of a key hydroxyl group in the reducing end of isomal­
tose is essential for correct binding in the second subsite and therefore for catalysis. Beside 
providing the stereochemical complementarity required for binding of carbohydrates to 
proteins,^'^'^ key hydroxyl groups also establish essential polar interactions required for cat­
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alysis. Such groups have been identified in GA hydrolysis of maltose^^-^s and isomaltose^^-^® 
and also have been suggested for other a-linked glucopyranosyl disaccharides.30 
Conformational analysis of differentiy linked glucopyranosyl disaccharides has been 
conducted using MM3,^^-^ a force field whose low-energy conformations of glucose-contain-
ing disaccharides are in good agreement with the torsion angles of crystal structures.^^ Dif­
ferently linked trehaloses exhibit large differences in accessible conformational space.^^ Two-
bond-linked a- and P-linked glucopyranosyl disaccharides exhibit similarly limited degrees of 
flexibility in different conformational regions,32;}3 while three-bond-linked reducing disacchar­
ides are more flexible.^ 
In this study, docking of a- and p-kojibiose, methyl a-kojibioside, methyl a-nigeroside, 
methyl a-maltoside, methyl P-sophoroside, methyl P-laminarobioside, methyl P-cellobioside, 
and methyl P-gentiobioside in the A. awamori var. XlOO GA active site was performed by 
simulated annealing with AutoDock 2.2 to estimate GA selectivity to differently linked regular 
oligosaccharides. Also docked were a,a-, a,P-, and P,P-trehalose, which cannot represent 
longer chains in their interaction with GA. Low-energy conformers obtained following 
conformational analysis^i-^'^ were reoptimized with MM3(92) and employed as initial struc­
tures for docking, using the same approach recently described for docking monosaccharides 
and inhibitors22 as well as different methyl a-isomaltosides.23 This study closes the systematic 
study of the structural interaction of glucopyranosyl disaccharides with GA, clarifying the 
molecular determinants for both substrate binding and catalysis. 
Computational Methods 
Initial Structures of Disaccharides. The MM3(92) force field^^-^s (Technical Utiliz­
ation Corporation, Powell, Ohio) with the bulk dielectric constant (e) set to 4.0 was used to opti­
mize the different conformers representing the low-energy minima described in previous disacc-
haride conformational studies with Starting structures using the exo-cyclic orien-
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rations described in those studies were first generated and preoprimized using PC-Model 
(Serena Software, Bloomington, Ind.). The number of conformers of each disaccharide varied: 
a,a-trehalose (2); tx,P-trehalose (2); p,P-rrehalose (3); a- and P-kojibiose and methyl a-koji-
bioside (4 each); methyl a-nigeroside (3); methyl a-maltoside (3); methyl -^sophoroside (4); 
methyl P-laminarabioside (4); methyl |3-cellobioside (4); and methyl P-gentiobioside (10). 
Methyl disaccharosides were considered as simple representations of longer regular polysacc­
harides, the configuration of the methyl group (a- v^. P-) being the same as that found for the 
glycosidic bond. Both anomers of reducing disaccharides were considered only for kojibiose, 
where the extra methyl group was likely to sterically hinder an imponant interaction with the 
GA active site. 
The torsional angles representing ring orientations about the glucosidic linkage of two-
bond-linked disaccharides are defined as 0 = ©(H-LA-C-LA-O-iB-C-Je) and 0(C-1A-O-
iB-C-iB-H-ZB) where i = I for a,a-, a,p-, and p,p-trehalose; i = 2 for a- and P-kojibiose, methyl 
a-kojibioside, and methyl P-sophoroside; / = 3 for methyl a-nigeroside and methyl P-
laminarobioside; i = 4 for methyl a-maltoside and methyl P-cellobioside (Fig. 1); A denotes 
atoms at the nonreducing end; and B denotes atoms at the reducing end. For the three-bond-
linked methyl P-gentiobioside, as for methyl a-isomaltoside,23 the torsional angles are 0 = 
0(H-1A-C-1A-O-6B-C-6B), i^= 0(C-1,V-O-6„-C-6B-C-5B), and o) = 0(O-6B-C-6B-C-5B-H-
5b) (Fig. 1). 
Docking Simulations. Automated docking simulations were conducted with Auto-
Dock 2.2^8-20 (Scripps Research Institute. La Jolla, Gal.). The GA crystal structure as in the 
complex with inhibitor D-g/i^co-dihydroacarbose''-'^ (Brookhaven Protein Databank entry 
Igai) was used. All water molecules except the putative catalytic molecule were removed, and 
nonpolar hydrogens were added using Quanta 4.0 (Molecular Simulations, Inc., San Diego, 
CA). Atomic partial charges for GA and ligands were calculated by the Gasteiger method.'^ 
Figure 1. a: P-Glucose, b: a,a-Trehalose, c; a,P-Trehalose, d: p,P-Trehalose, e: P-Kojibiose, f: Methyl a-nigeroside, g: Methyl a-
maltoside, h: Methyl a-isomaltoside, i: Methyl p-sophoroside, j: Methyl P-laminarobioside, k: Methyl P-cellobioside, and i: Methyl 
P-gentiobioside. The underlined hydroxyl group of P-kojibiose represents a-kojibiose when inverted, that gives methyl a-kojibioside 
upon methylation. In bold are the suggested critical hydroxyl groups of substrates required for hydrolysis.^O Atomic numbering of 
carbon atoms in each disaccharide giucopyranosyl moiety is shown only for P-glucose. 
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Probes corresponding to each atom type found in the substrate were tested every 0.5 A 
to calculate atomic interaction energy grids^o.^i in a 30-A cubic box centered in approximately 
the second subsite of the GA active site. To account for the solvent screening effect, the electro­
static interaction energy grid used a sigmoidal distance-dependent dielectric function.'^^ 
Lennard-Jones coefficients of AutoDock 1.0 with different parameters for apolar and polar 
hydrogens were used, along with a distance criterion with directional attenuation to account for 
hydrogen bonding. 
The docking of a single compound consisted of two stages. Initially, the nonreducing-
end ring of each conformer of the substrate derived from conformational studies was placed in 
the active site and 100 independent Monte Carlo simulations per starting structure were per­
formed using a variation on the short schedule'^ with 100 constant temperature cycles for sim­
ulated annealing. Each cycle had a maximum of 1,500 steps accepted or rejected, the minimal 
energy structure being passed to the next cycle. The temperature was reduced by a 0.95 factor 
per cycle from an initial value of RT =\00 cal/mol, and the maximal rotation per step for the 
exocyclic torsion angles was reduced by a 0.9875 factor per cycle from the initial 15°. A cons­
tant maximal translational step of 0.2 A per step was used. Following docking, all structures 
generated for the same compound were subjected to cluster analysis, cluster families being 
e 
based on a tolerance of 1 A for an all-atom root mean square (RMS) deviation from a lower 
energy structure. 
For the second stage, the global minimum structure, the low-energy structures of signifi­
cant clusters, and occasionally other significant structures of a given compound were subjected 
to redocking under the same conditions and to cluster analysis. This two-stage approach allows 
a more complete exploration of conformational space in the first stage with optimization of only 
the successful docking modes in the second. To overcome some of the limitations of the 
AutoDock force field, substrate internal energies in both docking and redocking were refer­
enced to the MM3(92) relative energy as defined before.^^ 
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Since both ends of a,a- and p,P-trehalose can potentially fit in the first subsite of the 
GA active site, three and four starting structures, respectively, were used for each, to accommo­
date all asymmetric cases. The binding of each of the two starting conformers of a,P-trehalose 
in the first subsite was studied from both ends of the molecule. 
Results and Discussion 
Docking of Glucosyl Disaccharides. All a-linked disaccharides except a,a-trehalose 
docked by occupying both first and second subsites, while only methyl P-cellobioside and P-
gentiobioside among the P-linked disaccharides were able to do so (data not shown). The 
representative structures of their energetically significant clusters and some others were redock-
ed, with the significant clusters obtained from this step being listed in Table I. Heavy-atom root 
mean square (RMS) deviations of the different low-energy structures from the docked global 
minimum of each compound are also indicated. The different global minima docked in the GA 
active site are depicted in Figure 2, including the optimal productive methyl a-isomaltoside 
found in the previous study.^^ 
Most of the glucosyl residues docked at the first subsite are gg conformers, as found 
previously for monosaccharides and isomaltose analogues.22.23 xhg same conformation of the 
exocyclic hydroxymethyl group at the nonreducing end of GA inhibitors occurs in all crystal 
structures of their complexes with GA,^-i^-i2 promoting interactions that distort not only their 
rings^^ but presumably the nonreducing-end glycopyranosyl rings of substrates in the path to 
the transition state. 
Neither a,a- nor P,p-trehalose is able to dock at the first subsite, a not entirely unexpec­
ted result since the only trehalose hydrolyzed by GA is a,P-trehalose.2 Only the orientation that 
places the a-glucopyranosyl moiety at the first subsite leads to productive docking of a,P-
trehalose. All known substrates have an a-glucosyl residue at the reducing end.^ Furthermore, 
among all four pseudotrehaloses containing an a-D-glucopyranosyl unit and a 5a-carba-D- or 
TABLE I. Redocking of Disaccharides in the OA Active Site" 
Cluster Total Internal Inter-ring dihedral angles Exo-cyclical angle RMS dev-
[no. of energy'' energy'' ialion from 
Compound structures] (kcal/mol) (kcal/niol) ()) V|/ to Optimal gg/gt / lg  rat io  ref.''(A) 
ot,P-Trehalose 11102/200] -93.4 o
c 00 1 -2.1 (0.2) -3 (-4) -4 (2) 88 102/0/0 0.00 (0.32) 
2 184/200] -87.2 (-79.6) -6.7 (-3.6) -7 (4) 20 (16) 88 84/0/0 0.90 (0.90) 
a-Kojibiose 11177/300] -92.1 (-83.6) 5.6 (4.8) 0 (-4) -33 (-28) 88 99/78/0 0.00 (0.45) 
2 (57/3001 -87.9 (-84.0) 1.3 (-1.2) A (-9) -50 (-45) 0/57/0 0.92 (0.86) 
P-Kojibiose 1(190/500] -96.6 (-89.3) 0.9 (1.8) -15 (-11) -8 (-2) 88 171/0/19 0.00 (0.51) 
2 164/500] -93.5 (-85.8) 1.3 (1.3) -14 (-17) -19 (-20) 88 4/0/60 0.82 (0.93) 
Methyl a-kojibiosidc 11127/300] -85.4 (-81.3) 0.5 (3.2) -24 (-17) -7 (-10) 88 45/0/82 0.00 (0.37) 
2 185/300] -81.4 (-76.9) 4.8 (5.4) -36 (-36) 3 (5) 88 85/0/0 1.02 (1.02) 
Methyl a-nigcroside 11122/300] -99.7 (-91.5) -2.9 (2.6) -19 (-16) -9 (-9) 88 50/0/72 0.00 (0.57) 
Methyl a-maltoside 11122/300] -101.8 (-92.5) 0.5 (4.4) -5 (-4) -8 (-10) 88 122/0/0 0.00 (0.41) 
Methyl a-isomalloside'' -96.0 10.2 -20 146 4 88 
Methyl P-cellobiosidc 1 196/600] -72.3 (-55.1) -2.0 (0.0) 9 (11) 158 (152) 81 1/95/0 0.00 (0.32) 
2 (99/600] -68.8 (-60.3) 16.5 (18.5) -6 (-^) 164 (164) 88 97/0/2 0.73 (0.82) 
3(109/600] -68.7 (-61.3) -2.1 (-0.4) 42 (42) -4 (-3) 88 13/96/0 5.97*' (6.05) 
Methyl P-gentiobioside 1 (87/200] -70.8 (-63.6) 6.3 (6.5) -38 (36) 75 (71) -68 (-75) 88 87/0/0 0.00 (0.42) 
"Doclced structures are grouped into clusters, the best clusters being shown. 
^Values for the optimal structure in each cluster are to the left and cluster averages are in parentheses. 
'^Using equivalent atoms of the best productive binding mode of the same compound following redocking. 
'^op productive binding mode found with AutoDock 2.1.^^ 
'Structure docked in second and third subsites. 
Figure 2. Stereoscopic plots of docked ligands in the GA active site. Residues surrounding the 
first and second sub sites and the catalytic water are shown, along with hydrogen bonding 
indicated by dashed lines. All docked structures (in black) are compared to methyl a-maltoside 
global minimum unless otherwise indicated (in grey): a: (x,P-Trehalose. b: P-Kojibiose. c: a-
Kojibiose compared to P-kojibiose. d: Methyl a-kojibioside compared to P-kojibiose. e: 
Methyl a-nigeroside. f: Methyl a-maltoside compared to docked protonated methyl a-
acarviosinide.22 g: Methyl a-isomaltoside.23 h: Methyl P-cellobioside, i: Methyl P* 
gentiobioside. Plots were prepared with Molscript.'*^ 
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L-glycopyranosyl moiety in either the a- or P-fonn, only a-D-glucopyranosyl 5a-carba-P-D-
glycopyranoside is hydrolyzed by GA,^ definitely positioning the a-glucopyranosyl unit at the 
first subsite and confirming its imponance for catalysis. The giycosidic torsion is 0l\jf= -3%4° 
for the optimal docked conformer, a value similar to those found for the remaining two-bonded 
a-linked disaccharides but significandy different from the global minimum of -42°/50° found 
by MM3 for a,P-trehalose.2^ Even though a large conformational space is available to this 
compound, a significant torsional component should adversely affect the internal energy of the 
optimal docked result. However, the absence of torsional terms in AutoDock's force field leads 
to unrealistically negative values here. 
Total interaction energies and giycosidic torsional angles are different for methyl a-
kojibioside and both kojibiose anomers. Both the presence of a terminal methyl group and the 
anomeric orientation strongly impact the interaction of kojibiose with GA. Low-energy P-koji-
biose clusters interact more strongly than those of a-kojibiose, and both have stronger interact­
ions than the corresponding methyl a-kojibioside clusters. The giycosidic dihedrals (P/y/ are 
-24%7°, 0%33°, and -15%7° for methyl a-kojibioside, a-kojibiose, and P-kojibiose, respect­
ively. The first two compounds are within 2 and 3 kcal/mol of the a-kojibiose global minimum 
at -39°/-41° calculated with MM3,2- and docked P-kojibiose is within approximately 2 kcal/mol 
of the global minimum of its MM3 conformational map,^^ next to the second lowest minimum 
of 0lyf= -357-26°. P-Kojibiose is clearly the form preferred for GA binding and might be the 
only one accepted for catalysis. 
Both methyl a-nigeroside and methyl a-maltoside have only one significant cluster of 
docked structures, while a,P-trehalose has two. The number of clusters may correlate with the 
degree of complementarity of different disaccharides to GA active site, as suggested by the 
docking of methyl 6R-C-methyl a-isomaltoside and methyl a-isomaltoside.^ The more limited 
conformational space available to the former compound favors convergence of the docking 
results. a-Nigerose and a-maltose have significantly more limited conformational space avail­
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able than does a,P-trehalose.3i-32 The extra methyl group in methyl a-nigeroside and methyl 
a-maltoside should not significantly affect their confonnational behavior, as the extra methyl 
group in methyl a-isomaltoside did not change the available conformational space^^ when com­
pared to that of a-isomaltose.^ Therefore the best redocked result of methyl a-nigeroside with 
(()/y/= -l9°f-9° lies close to the second lowest minimum of -24%19° obtained for a-nigerose 
and within 1 kcal/mol of the MM3 global minimum.^^ -phe best redocked methyl a-maltoside 
conformer has (l>/\i/= and is within 1 kcal/mol of the global minimum at -23°/-22°, 
according to the a-maltose conformational map with MM3.^2 This result differs only slightly 
from the solution conformation of -25% 15° obtained for methyl a-maltoside by used 
earlier to model the interaction of maltosides with the GA active site,'"' but contrasts signific­
antly with the GEGOP-based set of -51°/-22° in the recent model of the corresponding transit­
ion state in the GA active site.^^ An equivalent dihedral set of -24°/13° in the imino bond of 
protonated methyl a-acarviosinide, the charged form of a transition-state analogue docked in a 
prior study22 in a more systematic approach, is a closer result. Significantly, the recent equival­
ent sets of -6°/8° for acarbose, a transition-state analogue related to the acarviosinides, and 
-17°/5° for D-g/Mco-dihydroacarbose in their complexes with GA^^ do not differ significantly 
from our results. The GA active site therefore accommodates maltosides and nigerosides at 
favorable glycosidic torsions. 
Of the exclusively P-linked ligands, only methyl (3-celIobioside and methyl P-gentio-
bioside can dock at the first and second subsites, but then only with a total interaction energy 
significandy less favorable than those of the correspondent a-linked compounds. Methyl P-
laminarobioside and methyl P-sophoroside do not dock at this subsite, since more favorable en­
ergy interactions occur at the enzyme surface. Their interactions with GA, along with those of 
a,a-trehalose, will not be discussed in this study since no systematic approach to study putative 
surface sites was undertaken. 
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Methyl P-cellobioside yields three significant clusters of docked structures. The first is 
mostly composed by gt conformers, an indication of an incomplete fit at the first subsite. The 
second, mosdy gg, cluster has an extremely high internal energy, indicating that a very unfavor­
able conformation is necessary to accommodate this compound at the first subsite. Significant­
ly, the third cluster of docked structures is found outside the first subsite, as shown by its very 
high RMS deviation from the global niinimum. This suggests that methyl (3-cellobioside is at 
the edge of productive docking, surface sites being able to energetically compete in binding it. 
The glycosidic dihedrals (() /yr= 9°/158° found for the best docked result are unfavorable, 
approximately 6 kcal/mol above the global minimum, according to the MM3 conformational 
map of a-cellobiose.33 
Docking of the more flexible three-bonded methyl p-gentiobioside converged easily 
with just one significant cluster, represented by a gg conformer with glycosidic bond dihedrals 
of <(>ly//co = -38°/75%68°. This corresponds to a torsional energy of approximately 5 kcal/mol 
above the global minimum in the p-gentiobiose conformational map obtained by 
High-energy glycosidic torsions had already been found in the docking study of the equally 
flexible isomaltosides,^^ and this could be an indication of AutoDock's difficulty in optimizing 
results when large conformational spaces are available. Unlike the methyl a-cellobioside case, 
the convergence of results observed might correlate with the lower Ki of 100 mM observed for 
gentiobiose with Rhizopus delemar The Ki of 180 mM obtained for cellobiose is in the 
order of that obtained for a,a-trehaiose,^^ a compound that did not dock productively. How­
ever, none of these values is as low as that found for a-glucose. 
We observe in Fig. 2a-g that most two-bond a-linked substrates that are shown dock in 
a quite similar mode. However, this is true only for p-kojibiose among the three a-( 1,2)-linked 
disaccharides. In fact, P-kojibiose, methyl a-nigeroside, methyl a-maltoside, and a,p-trehalose 
exhibit very similar glycosidic 0/1/values upon docking in the GA active site. Variations in 
these dihedral angles are related to the random nature of the approach, to the expected variability 
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of the results, and to specific details of each substrate that singularize the binding modes. How­
ever, similarity in the binding modes found for a variety of compounds, already observed in the 
studies with ten different isomaltose analogues,^^ indicates that AutoDock behaves consistendy. 
The use of several initial conformers derived from conformational mapping of disaccharides 
assured that the significant conformational space is explored in all cases. 
The Lennard-Jones-based force field, which allows the rapid energy evaluation used in 
simulated annealing, is relatively unsophisticated. However, the calculated total energies of the 
docked substrates show some correlation with the kinetic parameters, either Km or kcaJKui, ob­
tained in earlier studies.^-^^ The major deviations appear to be the slightiy lower values of total 
energy of interaction obtained for docked a,P-trehalose in this study and for methyl a-isomal-
toside obtained in an earlier study with AutoDock 2.1. Interestingly, a,P-trehalose is the most 
flexible of the disaccharides productively docked, and methyl a-isomaltoside is even more flex­
ible due to its three-bond glycosidic bond.^-^'-^"' A larger number of degrees of freedom and a 
wider conformational space available will render convergence more difficult under simulated 
annealing. It is likely that better energies of interaction could be found with an appropriate 
method, even with AutoDock's simple force field. 
Atomic Interactions in the GA Active Site. Individual energy contributions to 
intermolecular interactions between the different compounds and GA active site are given in 
Table II. To facilitate the interpretation and because of variations in contributions of the polar 
hydrogens due to different positioning upon docking, both polar and apolar hydrogen-atom 
contributions were added to those of their adjacent heavy atoms. 
The strongest interactions at the first GA subsite of the nonreducing ends of the differ­
ent compounds are made by OH-4A and OH-6A, the key hydroxyl groups identified in chemical 
mapping studies with maltose and isomaltose,and by C-6A, as found in docking studies 
with inhibitors, monosaccharides and methyl a-isomaltosides.22.23 'phe strong interaction at C-
6A is likely associated with the distonions observed at C-5A in maltooligosaccharide inhib-
Table II. Atomic Contributions to Intermolecular Energy (kcal/mol) in the Interaction of Optimal Disaccharide Structures 
with the GA Active Site«-V 
Methyl Mclhyl Methyl Methyl Methyl Methyl 
Aiom a,P-Trchulosc a-Kojibiosc P-Kojibiosc a-kojibioside a-nigcrosidc a-maltoside a-isoniaiioside^a-cellobiosidea-gentiobioside 
C-!A -5.2 -4.9 -5.1 -5.4 -5.2 -5.0 -4.9 0.1 1.7 
C-2A -5.2 -5.0 -5.1 -5.1 -5.1 -5.3 -4.8 -5.3 -5.4 
C-3A ^.0 -4.2 -4.9 •A.l -5.0 -5.6 -5.6 -6.2 -6.1 
C-4A •A.l -5.2 -5.2 -4.9 -5.1 -4.7 -5.2 -4.3 -5.2 
C-5A -A.l -5.3 -4.8 -5.1 -5.4 ^.5 -4.9 -0.5 -3.7 
C-6A -8.4 -8.9 -8.3 -7.8 -8.9 -8.6 -8.8 -7.2 -8.1 
0-2A •A2 -5.4 -4.3 -5.4 -4.1 -4.2 -5.4 -4.5 ^.4 
0-3A -6,0 -5.8 -8.1 -7.2 -6.2 -5.1 -3.6 -3.5 -1.9 
0-4A -9.1 •9.4 -9.4 -8.9 •7.3 -9.1 -9.6 -7.8 -7.1 
0-5A -1.3 -1.3 -1.6 -1.0 -1.2 -1.5 -1.9 -1.5 -1.5 
0-6A -7.2 -9.5 -8.6 -8.4 -9.3 -7.5 -10.5 0.6 -3.0 
C-ln -4.5 ^.9 -4.4 -4.4 -3.3 -1.9 -2.8 -2.6 -3.4 
C-2B ^.3 -4.4 ^.4 -1.3 ^.1 -3.2 -1.5 -3.6 -2.3 
C-3B -3.8 -3.7 -4.1 -4.5 -4.3 A.l -3.8 -4.5 -1.9 
C-4B -2.1 -3.0 -2.9 -1.0 -4.0 -4.0 -4.0 3.0 -3.9 
C-5B -0.8 -2.5 -2.2 -2.5 -2.4 -3.8 -3.6 -3.5 -3.7 
C-6B -2.7 -3.1 -2.1 -0.0 -3.6 -6.1 ^.8 -2.4 -5.4 
0-1B -0.5 -4.6 -7.7 
0-2B -6.5 -QJ QJ. 
-m -2.5 -1.9 -0.8 -0.9 -0.8 
0-3B -1.9 -3.0 -2.8 0.8 -9.4 -1.5 -8.9 -0.7 
0-4B -0.9 -1.1 0.2 0.1 -4.8 -8.2 •JJi -2.9 
0-5B -1.0 -1.5 -1.2 -0.3 -0.7 -0.9 -1.2 -0.8 0.5 
0-6B -2.5 -0.6 -0.5 -1.1 -1.6 -2.0 -2.2 zLfi 
Table 11. (continued) 
Mclhyl Mclhyl Metliyl Methyl Methyl Methyl 
Atom a,P-Trchalosc a-Kojibiosc P-Kojibiosc a-kojibioside a-nigcroside a-maltosidc a-isomaltoside^a-ccllobiosidea-gentiobioside 
C-lc -8.1 -3.4 -3.2 -7.9 -2.1 -5.6 
O-lc -1.3 0.6 -1.2 -1.4 -0.4 -0.6 
GA-LA -60.0 -64.8 -65.5 -63.3 -62.7 -61.1 -65.3 -40.5 -44.6 
GA-L|) -31.4 -32.7 -31.9 -23.0 -34.6 -40.0 -31.6 -27.2 -31.9 
GA-Lc 0.0 0.0 0.0 -1.3 0.6 -1.2 -9.3 -2.5 -0.6 
GA-L -91.3 -97.6 -97.4 -87.6 -96.7 -102.3 -106.2 -70.3 -77.1 
Liniernal -2.1 5.5 0.9 0.5 -2.9 0.5 10.2 -2.0 6.3 
Toial -93.4 -92.1 -%.5 -87.2 -99.6 -101.8 -96.0 -72.3 -70.7 
^at (S ')' 0.81 0.24 0.33 10.6 0.88 
ATM or 'fl 
(mM)«/ 
146.3 143.5 37.1 1.7 22.4 180 100 
^al/^M 
(mM'^s"')' 
0.0056 0.0017 0.0089 6.1 0.039 
"GA-Lj: iniennolecular energy per subslie, GA-S; total intcrmolecular energy per ligand, Lintemal- relative internal energy or the substrate. A; flrst subsite, H: second 
subsite, C; third subsite. 
''Bold; Critical hydroxyl groups for binding and catalysis. 
'^Underline; Glycosidic oxygen. 
''Results with AutoDock 2.1.^^ 
'Kinetic data at AS'C for hydrolysis of kojibiose, nigeiose, maltose, and a,P-trehalose by A. niger GA^ and of methyl a-isomaltoside by A. awamori GA..''^ 
.Anhibition data of Rhizopus delemar GA at 2S°C by cellobiose and gentiobiose.'*^ 
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itors,^3 and should facilitate the formation of the glucopyranosyl cation expected to occur dur­
ing an SNi reaction.'*^ A relatively weak interaction at 0-6a is found for both methyl P-cello-
bioside and methyl  p-gentiobioside,  even though the low-energy conformer of  the lat ter  is  gg.  
Removal of the 0-4^ and 0-6a groups in methyl a-isomaltosides strongly affects kcai but does 
not affect leaving the docking modes of the corresponding monodeoxy compounds 
essentially identical to those of methyl a-isomaltoside.23 A similar effect is expected for the 
remaining a-linked substrates, given the variations on ^ai/^M found at the nonreducing-end 
monodeoxy analogues of maltose.^^ These hydroxyl groups are essential for catalysis, by 
taking approximately the same position in all cases in promoting interactions with the conserved 
residue (Fig. 2). 
The least energetic interactions at the first subsite occur at 0-5A in all docked com­
pounds, suggesting that an unfavorable combination of steric contacts occurs here, probably 
contributing to the formation of the an oxycarbonium ion found in the transition state. This has 
already been suggested in the docking of monosaccharides and isomaltose analogues.^2.23 
The strongest interactions in the second subsite occur at the hydroxyl adjacent to the 
glycosidic bond: 0H-2B for a,P-trehalose; 0H-1B for both kojibiose anomers; 0H-4B for 
methyl a-nigeroside; 0H-3B for methyl a-maltoside; 0H-4B for methyl a-isomaltoside, as 
found the previous study;23 and, most curiously, 0H-3B for methyl a-cellobioside. No such 
interaction exists for methyl a-kojibioside, eliminating the hydrogen bonding of O-lc (equiv­
alent to 0-1B in kojibiose) with Arg305. Removal, epimerization, or modification of critical 
hydroxyl groups impairs GA hydrolysis, as found with maltose and isomaltose anal­
ogues. ^ ^•26.28.49 IN methyl a-isomaltoside, removal of 0H-4B leads to a strong drop in ^CAT but 
to a more favorable while docking of 4'-deoxymethyl a-isomaltoside yielded an alternat­
ive conformation with reduced strain at the glycosidic oxygen.23 
Another imponant interaction at the second subsite is with C-6B of methyl a-maltoside, 
similar to the interaction already observed with methyl a-acarviosinide,22 whose C-6B belongs 
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to a more hydrophobic methyl group (Fig. 2f). This extra hydrophobic interaction leads to the 
best energy interaction of a glucosyl residue at the second subsite (GA-LB in Table II), and 
could explain the low ATm obtained for maltose when compared to the remaining diglucosyl 
substrates 2 
Of all these factors, the strain found at the glycosidic oxygen, as interpreted by the less 
favorable energy of interaction at this atom (underlined energies in Table II), appears as the 
major contribution for the perturbation of the ground state upon binding, and probably is the 
factor defining which disaccharides are substrates. This unfavorable interaction is found only 
for a-linked disaccharides, being less marked for methyl a-kojibioside and to a lesser degree 
for a-kojibiose, and is not imponant for the docked (3-linked disaccharides. Favorable interact­
ions exist, however, between the nitrogen atom involved in the imino bond of protonated methyl 
a-acarviosine and the catalytic acid Glu 179. -13.22 in fact, the flattened valiemine ring of this 
transition-state analogue (Fig. 2f) allows the positioning of the imino N-4B 2.9 A from Glul79, 
a distance ideal for hydrogen bonding, while a stressed 2.6 A is obtained for the equivalent gly­
cosidic 0-4B of methyl a-maltoside, explaining why acarviosinides and acarbose are successful 
GA inhibitors. 
Upon substrate binding, strain at the glycosidic oxygen is dependent on the configur­
ation of the critical free hydroxy 1 group found next to the glycosidic bond that hydrogen bonds 
with the conserved Trpl78 and Arg305. Stress, thought to weaken the exo-anomeric effect and 
so activate the anomeric carbon, is more likely to come from steric contact with the catalytic acid 
Glul79 than from rotation about the glycosidic bond.^® 
All docked substrates form an identical hydrogen-bond network at the first subsite (Fig. 
2a-b,e-g). This network is mostly identical to that described for methyl a-maltoside and methyl 
a-isomaltoside.i'^-15-23 The differences come at the second subsite, where the critical hydroxyl 
group described earlier establishes critical hydrogen bonds with Trpl78, Arg305, and GlulSO, 
methyl a-nigeroside having somewhat different bonds due to steric contacts. An extra hydrogen 
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bond with GlulSO is found forOH-2B of methyl a-maltoside, 0H-3B of a,p-trehalose, OH-6B 
of methyl a-nigeroside, and 0H-3B of methyl a-isomaltoside, the first two in a very similar 
mode. The fact that (J-kojibiose has only one hydroxyl group available for hydrogen bonding 
with Trpl78, GlulSO, and Arg305 might explain why it has the lowest kcax/Ku among the 
disaccharide substrates.^ 
Docking of methyl a-nigeroside yields an unfavorable contact between O-lc and the 
hydroxyl group of Tyr311 that leads to a small shift in the binding mode of this compound 
compared to that of the remaining disaccharide substrates. Some difficulties in degrading a-
(1,3)-Iinked oligosaccharides might then be found. In the absence of an a-anomeric oxygen at 
the second subsite that leads to steric contacts, both methyl P-nigeroside and |5-nigerose should 
bind more effectively than methyl a-nigeroside, with a stronger interaction between the critical 
hydroxyl 0H-4B and both Trpl78 and GlulSO. 
Methyl a-kojibioside is not a GA substrate because its a-linked methyl group causes 
steric contacts and loss of hydrogen bonds with key active-site residues. Therefore oligogluc-
osylsaccharides containing an a-(l,2)-bond at the nonreducing end are not GA substrates, 
explaining why S^-O-a-kojibiosyl maltose is not hydrolyzed by GA^® while kojibiose is.^ That 
a-kojibiose appears not to be a GA substrate has a parallel in the inability of GA to hydrolyze 
the 3-epimer of methyl P-maltoside,''^ since both hydroxyl groups are axially oriented relative 
to the glucopyranosyl ring, losing a key hydrogen bond with Arg305 (Fig. 2c). 
2-Deoxy-maltooIigosaccharides are GA substrates.^^ Moreover, the synthesis of 2-de-
oxy-glucooligosaccharides containing a-(l,3), a-(l,4), and a-(l,6) bonds by GA condensation 
of 2-deoxy-D-glucose,^2 clearly confirms that OH-2A and 0H-2B groups are not critical for 
nigerose, maltose, or isomaltose hydrolysis. Even though 0H-2B of methyl a-maltoside forms 
a hydrogen bond with GlulSO,^^ no critical interaction is lost when this bond is not present. 
The reduced number of condensation products obtained from 3-deoxy-D-glucose is probably 
associated with the inability of GA to form a-(l,4)-linked products from this compound, and 
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the inability to form condensation products from 6-deoxy-D-glucose^^ is caused by OH-6 be­
ing a critical hydroxyl group at the second subsite. 
Modification of the noncritical hydroxyl group that also forms an extra hydrogen bond 
at the second subsite can affect the ability of GA to degrade saccharides in a different way. GA 
is not only able to degrade 3-0-methyl methyl a-isomaltoside,i5 5^ can also excise the 
exposed glucosyl residue a-(l,6)-bound to a novel alternating a-(l,3)-a-(l,6)-Iinked cyclic 
tetrasaccharide,^^ even though 0-3B is modified in both substrates. However, it cannot hydro-
lyze the nonredudng-terminal a-(l,4)-glucosyl residue adjacent to an a-(l,2)-galactosyl residue 
in heterogeneous branched maltooligosaccharides,^'^ where 0-2B is modified. Such behavior 
must be explained by the different flexibility of a-(l,4)- and a-(l,6)-linked glycosidic bonds. 
Two-bond linkages are fairly rigid compared to the longer three-bond a-(l,6)-linkages.32J'^ In 
isomaltosyl-containing saccharides steric contacts in binding due to a bulky residue at 0-3B can 
still be accommodated, albeit with a kinetic penalty due to the lost hydrogen bond, by the wider 
conformational space available and the lesser complete penetration of the second residue in the 
active site. Still limitations to modification of the residue that binds at the second subsite should 
occur for derivatives of a,P-trehalose. nigerose, and maltose that interact with GA in a relatively 
similar manner. 
Modification of key hydroxyl groups in oligo- and poly-glucosylsaccharides should 
block their digestion by GA. In fact, maltose and maltotriose analogues with halogeno substit-
uents at 0-6A are not GA substrates.Funhermore, GA digestion is affected when phos­
phate groups are found at 0-6A and 0-3B in the nonreducing ends of starch chains,^^-^^ which 
are equivalent in structure to methyl a-maltoside. probably an important factor in the incomplete 
digestion of gelatinized starch from several sources.^' 
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Conclusions 
The interaction of glucosyl disaccharides with the GA active site has been simulated by 
Monte Carlo techniques to investigate the molecular basis of the wide range of specificities 
possessed by GA. A docking protocol developed in recent studies.^^s using results from the 
conformational mapping of disaccharides with determined which disaccharides are 
likely to bind simultaneously to the first and second subsites, where catalysis takes place. 
Similar binding was found at the first subsite for all a-linked substrates, with the same 
two critical hydroxyl groups, OH-4A and 0H-6A, that had been identified by chemical mapping 
of maltose and isomaltose analogues'^-^^'^' serving as the anchors required for catalysis. At the 
second subsite, a critical unmodified hydroxyl group that promotes a strong interaction has 
been identified in each substrate. Such a group in the correct configuration appears essential for 
strong binding and possibly for catalysis. Methyl a-kojibioside, a-kojibiose, and P-kojibiose 
should be bound differently by GA, the last being presumably the only substrate. 
The study indicates which atoms of the ground-state conformer of each substrate are 
more stressed upon binding, the pressures exened by the GA active site being a leading factor 
in the formation of the transition state. Earlier studies had indicated that the presence of a critical 
hydroxyl group in the substrate at the second subsite was essential for the correct application of 
stress in the glycosidic oxygen.^^ Here the importance of having the critical hydroxyl unmodif­
ied and in the correct configuration explains the results for the different kojibioses. 
The use of different minima representing the possible substrate conformational states as 
initial structures for docking insured the exploration of significant conformational space and led 
to binding modes sharing some common features among all the a-linked substrates. This study 
reaffirms the ability of AutoDock to dock flexible substrates can be effectively used to further 
extend understanding of carbohydrate-protein interactions. Exploration of the interaction of a 
large number of substrates and their analogues with the GA active site, started recentiy,22.23 
160 
demonstrated the versatility of the second GA subsite and is extending our knowledge of its 
selectivity. 
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CHAPTER 7. GENERAL CONCLUSIONS 
General Discussion 
A new structure-based alignment of GA sequences is given in the first manuscript 
(Chapter 3), replacing that determined earlier by hydrophobic cluster analysis (Coutinho et al., 
1994b; Henrissat et al., 1994). Based on new GA mutational studies, new GA sequences, and 
diverse results from structural studies of the enzyme that include the simple division of the 
model into hydrophobic folding units, a better image of the GA catalytic unit is emerging. Both 
biochemical and engineering studies give new insight into GA selectivity that can be correlated 
with different sequence characteristics. This alignment can be very useful for engineering GA 
thermostability and selectivity. 
In the second manuscript (Chapter 4), a new approach for the study of carbohydrate-
protein interactions was introduced, validated, and employed to understand the molecular basis 
of GA selectivity. The approach requires the use of a library of conformers, derived in this 
study from conformational mapping of disaccharides using MM3(92), to ensure that the 
significant conformational space of the carbohydrate is searched. The different initial confor­
mers are flexibly docked automatically by a Monte Carlo method combined wi± simulated 
annealing available from the AutoDock package. A two-phase approach was devised for dock­
ing studies, where the most significant conformational space was searched using a short dock­
ing protocol, and then the best results from the first series were redocked or optimized, an econ­
omical use of computer resources. 
The wide range of selectivities exhibited by GA make it a good candidate for a docking 
study. Also, the existence of abundant crystallographic data of complexes with different inhibit­
ors permitted not only a variety of GA structures potentially useful as rigid components in 
docking, but also the validation of the approach by docking compounds whose interactions with 
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GA were already known, as shown in the second manuscript (Chapter 4). The data obtained was 
in the ordCT of that obtained by X-ray crystallography; however, the use of only a simple van der 
Waals-based force field suggests that in future studies optimization of the final docking results 
under more parameterized force fields would give better results. 
In the third and fourth manuscripts (Chapters 5 and 6, respectively), automated docking 
with AutoDock of a variety of substrates and their analogues was able to explain some of the 
behaviors found experimentally. In a study with isomaltoside analogues the importance of the 
critical interaction of a key hydroxyl group in stressing the glycosidic oxygen, and in that way 
in promoting hydrolysis of the glycosidic bond, was shown. An equivalent hydroxyl group is 
found in all known substrates, as demonstrated in the fourth manuscript. Other features, such as 
the number and "quality" of hydrogen bonds formed with the enzyme as well as other non­
specific contacts, explain some of the differences in binding and probably catalysis. 
The concept that the GA active site promotes stress at different points of the substrate 
nonreducing end is now emerging, the results agreeing in some points with the latest descrip­
tions of distortions found in some inhibitors upon binding (Aleshin et al., 1996). One of the 
key points appears to be the steric interaction of the catalytic acid in promoting catalysis. This 
interaction does not occur in inhibitors, since both flattened rings and the wider angle observed 
for imino bonds facilitate the formation of salt bonds with the catalytic acid (Aleshin et al., 
1994,1996; Stoffer er a/., 1995), ver\' different from the stress promoted on substrate glycosid­
ic bonds. The question now is how the application of this pressure occurs differently for dif­
ferent substrates and enzymes. 
Recommendatiuns for Future Research 
We now know the key points for the interaction of substrates with the active site. For 
instance, we know that Arg305 appears very central in the interaction (Frandsen et al., 1995; 
Berland et al., 1995). Also central are the different active-site residues that interact at the first 
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subsite (Coutinho et al., 1994a). Some of the amino acid residues interacting with first-row 
residues, those that interact directly with the substrate, are surprisingly conserved in some cases, 
but the minor variations in their homology should be investigated. Some mutations like 
Ser411->Gly (Fang et al., unpublished results) show very promising properties, so that 
approach should be continued, concentrating now on less visible residues where contact rather 
than polar interactions appear essential. Variations in length in the fourth conserved loop, where 
long loops are observed in all GA sub-families except in some Aspergillus-rtldXtA. and in M. 
jannaschii OAs, are starting to be exploited (Liu, personal communication). These leads should 
be pursued, especially because they allow a large number of mutations close to the catalytic 
residues. 
We also know that selectivity can be linked to a concerted flexible movement of active-
site loops, as suggested by the coupled variations in the positioning of flexible and rigid resi­
dues at key points (Fierobe et al., 1996). The recent data from point mutations based on homol­
ogy, such as Ser411—>Gly (Fang et al., unpublished results) can be interpreted in the same way. 
On one hand, some notion of the movement of such loops coupled with their interaction with 
substrates (using for instance the docked results obtained in this study as a starting point) could 
be studied by molecular dynamics, given that both software and computer time are easily 
available. On the other hand, a systematic investigation of the flexible/rigid residues that might 
affect the movement of the catalytic loops should be made. The alignment provided in the first 
manuscript (Chapter 3) is a good basis to stun compiling such a list. 
As a final note, the investigation of temperature effects on selectivity appears to be ad­
verse based on indusnial objectives. In fact, the promising thermostable mutants obtained rec­
ently (Allen et al., unpublished result.s; Li et d., unpublished results) can be combined with mut­
ations that increase selectivity, such as the Ser411—»Gly mutation, and this could lead to the 
production of more effective enzymes that perform at higher temperatures. 
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An extensive array of GA kinetic and inhibition studies are found in the literature. In 
this Appendix, data from those studies are collected and analyzed in a uniform manner. First, 
the equations used to interpret the data are described. Second, a compilation of kinetic and in­
hibition data collected from the literature, using different substrates, substrate analogues, and 
inhibitors as well as different natural and mutated enzymes, is subjected to simple analysis us­
ing the equations already described. Third, the references from which the data came are listed. 
Enzymatic Rate and Equilibrium Equations 
A general set of equations describing enzyme behavior was used to interpret data. The 
general rate equation for enzyme kinetics is the Michaelis-Menten equation, which describes a 
reaction in which a single substrate and product are reversibly interconvened. The system where 
enzyme E reacts with substrate S to give an enzyme-substrate complex ES, which then gives 
enzyme and product P, can be described as follows: 
*1 *2 
E + s z e s z e ^ P  
*-l k-2 
where k \ ,  k . \ ,  k i ,  and k.j are rate coefficients for the individual reaction steps. By assuming that 
no product exists initially, that quasi-steady state holds so that the rate of change of [£5] is zero, 
and that the total enzyme concentration in the system is [£f] = [£] + [fSl, the Michaelis-Menten 
equation results: 
, ,  V^\S] 
where = /:2[£f] and =  k \ /  k . \  = [£][5] / [£5] are the maximal rate and Michaelis con­
stant, respectively. By dividing each term in Equation (2) by [£,], we obtain 
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r=-M3_ 
[^j + ATm 
where r is the reaction rate and kz can also be designated as kcat- The ratio kcat / Km often is 
called the catalytic efficiency. 
Enzyme-catalyzed reaction rates can be decreased by adding inhibitors that combine 
with the enzyme to prevent its normal binding to the substrate. There are several types of in­
hibition, but here only competitive inhibitors or those that can combine reversibly with the en­
zyme active site and compete with the substrate for it will be considered. The binding of one 
such inhibitor / with the the enzyme can be written as done for the substrate, although the 
inhibitor is not transformed into a product: 
E  +  I ^ E I  (4) 
where K i  =  [£][/] / [ E l ]  is the inhibition constant. Both and ^/describe equilibria between 
dissociated and associated species that can be designated by the binding constant Kb- The free 
energy of binding AGb ca.n be obtained by the thermodynamic relationship 
AGb~~^^ ^ '^Kb (5) 
where T is the absolute temperature and R is the gas constant. The enthalpy and entropy of 
binding, AHb and ASb respectively, are given by 
AGb — AHb~TASb (6) 
AHb is also as the standard heat of binding. It is now possible to calculate the variation of Kf, as 
a function of temperature by combining Equations (5) and (6): 
-{AHb-TASbV 
K b  =  e  (7) 
At steady state, the variation of kcai with temperature can be modeled by the Arrhenius equat­
ion: 
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kcat= Ae^i^ (8) 
where A is the preexponential factor and Ea is the activation energy. These two equations give 
us variations of both kcat and ^6 as functions of temperature. 
When comparing different binding experiments at the same conditions, either when a 
given enzyme form is compared with a reference enzyme or when a given inhibitor or substrate 
is compared to a reference compound, the difference in free energy of binding MAG)b can be 
obtained by the relationship 
where the reference case is designated by ref. 
Under the same conditions, the varying kinetics obtained for different enzymes or for 
the action of a given enzyme on different substrates are due to differences in stabilization of the 
transition state. The variation of the free energy of stabilization of die transition state A{AG)i, 
again compared to a reference case, is best given by a ratio of catalytic efficiencies 
If only differences in binding cause differences in catalytic behavior, A{AG)b = A{AG)t. 
Introduction to Glucoamylase Kinetic and Inhibition Data Analysis 
Data collected from the literature are shown in Table I. Extensive studies at different 
temperatures have been conducted with both A. niger and A. awamori GAs, which have identi­
cal sequences. Variations in data obtained with latter are probably due to different degrees of 
glycosylation, as some of the results were obtained with recombinant GAs produced by yeast. 
A. niger OA was therefore used as the reference for this study. The extensive data obtained for 
this enzyme with a wide range of both substrates and temperatures make it an ideal reference. 
A { A G ) ,  =  { A G t ) - { A G b ) , , ^  (9) 
(10) 
Table 1 - Review of native and modified glucoamylase action on different substrates and the effect of 
inhibitors on their properties. Kinetic terms obtained at different temperatures are used for a 
thermodynamic characterization of GA kinetics and binding. In most classes of compounds consistent data 
for A. niger GA provide the necessary reference. Mosdy GAs belonging to the different sub-families 
described in Chapter 3 were considered for this description. The (kcai/ Km) ratios are always related to that 
of maltose in the same or similar study, except for pannose were isonialtose is the reference. For substrates 
less reactive than maltose the ratio is inversed (i). Different shades correpond to a comparison to a 
reference compound using the same shade. 
COMPOUND Source Fonn or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pom <o Ratio (U m^l) (s-lmM-l) 
- POLYSACCHARTOES -
Amylopectin (n=lS) (#) A. niger A 4 .5 40 68 3 .7e+02 4.85e-»02 
Soluble Starch A. niger G1 A 4 .3 25 3 2.2e+02 
Soluble Starch A. niger G2 A 4 .3 25 2 1.5e+02 
Soluble Starch (potato) A. niger G1 A 4 .3 25 2 1.7e+02 
Soluble Starch (potato) A. niger G2 A 4 .3 25 2 1.3e+02 
Starch (waxy maize) A. niger G1 A 4 .3 37 17011 6 .2e+05 
Starch (waxy maize) A. niger G2 A 4 .3 37 238 8 .7e+03 
Starch A. niger A 4 .8 60 3 l.Oe+02 
Amylose (85) A. awamori A 4, .5 37 1455 5.36e+03 
Amylose (20) A. awamori A 4, .5 37 260 9.56e+02 
Amylose (16) A. awajBori A i. .5 37 99 3.65e+02 
Amylose (6.86) A. awamori A 4. .5 37 46 X.69e+02 
Soluble Starch (n-40) A. bacatae A 4. 8 30 18 
Soluble Starch A. ficuum A 5. .0 37 3. .9e+01 4.76e+01 
Soluble Starch A. oryzae A 5. .0 30 
Soluble Starch (potato) A. oryzae A 5. .0 40 2. .5e+02 
Amylopeain A. oryzae A 5. .0 40 9 7.9e+01 
Soluble Starch A. oryzae A 5. .0 40 6 5.5e+01 
Amylose A. oryzae A 5. ,0 40 4 3.7e+01 
Dextrin (beta-limit) A. oryzae A 5. ,0 40 4 3.3e+01 
Dextrin (residual) A. oryzae A 5. .0 40 4 3.9e+01 
Dextrin A. oryzae A 5. .0 40 3 3.le+01 
Dextrin A. saitoi Ml A 6. .0 37 1. .6e+02 
Amylopectin A. sai toi Ml A 6. .0 37 2. .3e+02 
Soluble Starch A. sai toi Ml A 6. .0 37 1. .5e+02 
Dextrin A. saitoi M2 A 6. .0 37 1, .4e-)-02 
Soluble Starch A. saitoi M2 A 6. ,0 37 1. .le+02 
Amylopectin A. sai toi M2 A 6. ,0 37 9. ,7e+01 
Amylose A (n=25) A. sai toi Ml A 6. ,0 37 227 3. ,3e+02 4.93e+02 
Amylose A (n=25) A. sai toi M2 A 6. 0 37 164 2. ,2e+02 3.37e+02 
Amylopectin A. cerreus NA-•170 A 5. 0 25 22 
Soluble Starch A. terreus NA-•170 A 5. 0 25 18 
Amylose A. terreus NA-•170 A 5. 0 25 13 
Amylopectin (potato) Asp. sp. K-27 A 4. 5 45 37556 4.33e+05 
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Vmax kcat KmorKi ICSO Sab/ d(dG)t d(dG)b -dG -dH TdS dS Reference 
(Umc-l) (s-1) (mM) (mAf) Mcth •> -> (kcal/mol) <• <• (kcal/moLK) 
2.2e+01 5.9e-02 -0.0 0.0 6.1 
4.3e+02 
4.3e+02 
7.0a-04 « 
S.Oe-02 % 
3.43e-i-01 e.4a-03 
3.0ee+01 3.2«-02 
2.9261-01 8.0a-02 
3.21e+01 1.9«-01 
1.7e-02 
3.561-00 9.0«-02 % 
4.9«-Q2 % 
l.lei-01 4.4a-02 % 
9.0a-02 % 
5.4e-)-01 3.3a-01 % 
8.6e-^01 3.7a-01 * 
6.2e-t'01 4.2a-01 % 
l.le+02 7.3a-01 * 
9.8ei-01 9.2a-01 % 
1.6e-i-02 l.fia'fOO % 
2.5e•^01 7.7a-02 
3.3e+01 1.5a-01 
2.8a-01 % 
4.3a-01 % 
4.58+00 % 
8.676+01 2.0a-04 
-1.5 -i.3 7 . 4  
-0.4 -0.3 6 . 4  
0.2 0.2 5 . 8  
0.6 0.8 5 . 3  
- 0 . 6  6 . 6  
- 0 . 0  
0 . 2  
0 . 2  
0 . 6  
-4.3 -3.7 
5 . 8  
5 . 4  
9 . 8  
Abeetal., 1985 
Svensson et al.. 1982 
Svensson et al., 1982 
Svensson et al.. 1982 
Svensson et al.. 1982 
McCIearly and Anderson, 1980 
McOearly and Anderson, 1980 
Schumacher and Kroh. 1994 
Savel'ev et al., 1982 
Savel'ev et al.. 1982 
Savel'ev et al., 1982 
Savel'ev et al., 1982 
Bendetskii et al., 1974 
Vandersoll et al., 1995 
Mitsuc el al., 1979 
Nagashima et al., 1995 
Sahaetal.. 1979 
Sahaetal.. 1979 
Sahaetal.. 1979 
Sahaetal.. 1979 
Sahaetal.. 1979 
Sahaetal.. 1979 
Takahashi et al., 1981 
Takahashi et al., 1981 
Takahashi et al., 1981 
Inokuchi et al., 1981 
Inokuchi et al., 1981 
Inokuchi et al.. 1981 
Takahashi et al., 1981 
Inokuchi et ai., 1981 
Ghosh etal., 1991 
Ghosh etal.. 1991 
Ghosh etal., 1991 
Abeetal.. 1990 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activitf Vmax/Km Iccat/Km 
Inhibitor or Substrate Organkm Mutant Fan (C) Ratio (Unit-l) (s-l mM-I) 
Amylopectin beta-LD (waxy rice) Asp. sp. K-27 A 4.5 45 238 2 .7Se+03 
Soluble Starch C. paradoxa A 5.0 25 32488 2 .22e+05 
Soluble Starch H. resinae P A 4.3 37 6.7e+05 
Starch (waxy maize) H. resinae P A 4.3 37 6.7e+05 
Amylopectin (potato) H. resinae P A 4.3 37 6.7e+05 
Soluble Starch H. resinae s A 4.3 37 6.9e+05 
Starch (waxy maize) H. resinae s A 4.3 37 6.9e+05 
Amylopectin (potato) H. resinae s A 4.3 37 6.9e+05 
Soluble Starch H. grisea cherm. A 5.0 55 7 8 .3e+01 l.Oe+03 4 .33e+03 
Amylopectin H. ffrisea cherm. A 5.0 55 6 6 .8e+01 6.7e+02 2 .81e+03 
Amylose H. grisea cherm. A 5.0 55 5 6 .le+01 6.8e+01 2 .84e-f02 
Soluble Starch T. Ictnuginosus A 5.0 50 8 8 .3e+01 
Dextrin T. lanuginosus A 5.0 50 7 8 .Oe+01 
Amylopectin T. lanuginosus A 5.0 50 8 8 .6e+01 
Soluble Starch T. reesei A 5.5 30 2 .59e+03 
Maltodextrin (n=15J) R. delemar B 4.5 25 S8 3 .69e+02 
Amylopectin (n=IS) R. delemar G3 B 4.5 40 52137 2.0e+05 2 .64e+05 
Amylopectin (n=15) R. delemar G2 B 4.5 40 1921 1.2e+04 1 .42e+04 
Amylopectin (n=lS) R. delemar G1 B 4.5 40 1821 l.le+04 1 .07e+04 
Soluble Starch R. nzveus B 5.0 25 72721 1 .47e+05 
Soluble Starch A. adeninivarans C 4.5 50 1.4e+01 6 .15e+00 
Soluble Starch A. adeninivarans c 4.5 50 3.5e+00 3 .56e+00 
Soluble Starch A. adeninivarans c 5.0 60 
Soluble Starch S. fibuligera GLAl • 5.6 40 9 4 .5e+01 
Dextrin S. diascacicus STA2 E 5.0 30 6 
Starch s.  diascacicus STA2 E 4.6 37 6 3 .7e+01 
Amylose s.  diascacicus STA2 E 4.6 37 1 5 .9e+00 
Soluble Starch s.  cerevisae E - 30 9.9e+00 4 .lle+01 
Amylopectin s.  cerevisae E 
- 30 1.4e+01 5 .69e+01 
Dextrin s.  cerevisae E - 30 6.8e-02 2, .81e-01 
Glvcofren 
Glycogen 
A. 
I A. 
A. 
niger 
niger 
niger G1 
A 
A 
A 
4.5 
4.5 
4.3 
40 
40 
25 
6 
6 
3 2. .4e-t-02 
3.4e+01 4, 
3.5e+01 4, 
.44e*01 
.49e+01 
Glycogen A. niger G: A 4.3 25 2 1. ,8e+02 
Glycogen A. oryzae A 5.0 40 9 8. ,2e+01 
Glycogen A. sai coi Ml A 6.0 37 2.1e+02 2. ,72e+02 
Glycogen A. saicoi M2 A 6.0 37 4.4e+01 5. 68e+01 
Glycogen (rabbit liver) Asp. sp. K-27 A •!.5 45 3. ,72e+05 
Glycogen H. resinae P A 4.3 37 1.6e+05 
Glycogen(beta-limit dextrin) H. resinae P A 4.3 37 1.2e+05 
Glycogen H. resinae S A 4.3 37 l.Se+05 
Glycogen(beu-limit dextrin) H. resinae S A 4 . 3 37 5 .  Oe-t-04 
Glycogen H. grisea cherm. A 5.0 55 5 5. 9e*01 
Glycogen T. lanuginosus A 5.0 50 5 5. 7e+01 
Glycogen (rabbit liver n-IO) R. delemar G3 B 4 .  5 40 16026 6.3e+04 8. 13e+04 
Glycogen (oyster n-7.3) R. delemar G3 B 4.5 40 7407 2.9e+04 3. 76e+04 
Glycogen (oyster n-7.3) R. delemar G1 B 4.5 40 53 3.le+02 3. 15e+02 
Glycogen (rabbit liver n-10) R. delemar G1 B 4.5 40 49 2.8e+02 2. 88e-i-02 
Glycogen (oyster n-7.3) R. delemar G2 B 4.5 40 45 2.8e+02 3. 3le+02 
Glycogen (rabbit liver n-IO) R. delemar G2 B 4.5 40 36 2.3e+02 2. 68e->-02 
Glycogen S. diascacicus STA2 E 4.6 37 2 1. 7e*01 
Glycogen S. cerevisae E - 30 1.4e+00 5. 72e*00 
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Vmax 
(U ms-I) 
kcat 
(»-i) 
KmorKi 
(mM) 
IC50 
(mM) 
Sab/ d(dG)t 
Meth •> 
d(dG) b 
-> 
•dG -dH 
(kciltaol) <-
TdS dS Reference 
<• (kcalAnoLK) 
5 .50e+01 2.0a-02 -1.1 -0.8 6.8 Abe et al>. 1990 
4 .44e+01 2.0«-04 -3.6 -3.1 9.1 Moninaetal.. 1989 
4.7e+02 7.0a-04 % McCIeariy and Anderson. 1980 
4.7e+02 7.0«-04 % McOearly and Anderson. 1980 
4.7e+02 7.0a-04 % McClearly and Anderson. 1980 
4.8ei-02 7.0a-04 % McOearly and Anderson. 1980 
4.8e-f'02 7.0a-04 « McClearly and Anderson. 1980 
4.8e-^02 7.0a-04 % McClearly and Anderson, 1980 
1.2e+02 l.la-01 % Tosi et al.. 1993 
8.7e+01 1.3a-01 % Tosi et al.. 1993 
6.2e+01 9.1a-01 % Tosietal.. 1993 
4.6a-03 % Raoetal.. 1981 
l.la-02 % Raoetal.. 1981 
Raoetal., 1981 
2, .85e+01 t.la-02 % Fagerstrom and Kalkkinen, 199S 
2. .40e+01 6.5a-02 0.2 0.3 5.7 Hiromi et al.. 1973a 
6.1e+01 3.0a-04 -3.9 -3.3 9.3 Abeetal.. 1985 
7.4e+01 6.1a-03 -2.1 -1.4 7.5 Abeetal., 1985 
7.8e+01 7.4a-03 -1.9 -1.3 7.4 Abeetal., 1985 
1. ,47e*01 t.Oa-04 -3.4 -3.5 9.5 Monma et al., 1989 
1.6e+00 1.2a-01 % Buttner et al.. 1987 
2.7e+00 7.7a-01 * Bui et al.. 1996 
3.2a-02 % Buttner et al.. 1991 
Solovicova' et al.. 1996 
Tucker etal.. 1984 
Modena et al., 1986 
Modenaet al„ 1986 
7.7e-01 7.8a-02 % 1.5 0.4 5.7 Kleintnam et al.. 1988 
1.2e+00 9.0a-02 % 1.3 0.4 5.6 Kleinmara et al., 1988 
7.4e-01 l.la«01 % 4.5 3.7 2.7 Kleinmam et al.. 1988 
2.8e+01 8.2e-01 0.0 -0.1 4.4 Abe et al.. 1985 
3.8e+01 l.la-fOO -0.0 0.1 4.2 Abe et al.. 1985 
Svensson et al., 1982 
Svensson et al.. 1982 
Sahaetal.. 1979 
4.Oe+01 1.9a-01 % Takahashi et al.. 1981 
5.5e+01 1.2a'fOO % Inokuchi et al.. 1981 
1. 12e»02 3.0a-04 -5.7 -5.2 9.5 Abe et al.. 1990 
4.7e+02 3.08-03 « McClearly and Anderson. 1980 
3.7e+02 3.0a-03 % McClearly and Anderson. 1980 
4.8e+02 3.0a-03 % McClearly and Anderson. 1980 
2.5e+02 5.0a-03 % McClearly and Anderson, 1980 
Tosi et al.. 1993 
2.2a-03 % Raoetal., 1981 
S.0e*01 8.0a-04 -4.7 -4.4 8.7 Abeetal., 1985 
5.2e+01 1.8e-03 
-4.2 -3.9 8.2 Abeetal.. 1985 
6.5et-01 2.1a-01 
-1.2 -0.9 5.3 Abeetal.. 1985 
6.8e+01 2.4a-01 
-1.2 -0.9 5.2 Abeetal.. 1985 
7.1e+01 2.Sa-01 
-1.2 -0.8 5.2 Abeel al.. 1985 
6.9e+01 3.0a-01 -1.1 -0.7 5.0 Abeetal., 1985 
Modena et al.. 1986 
5.9e-01 4.3e-01 % Kleinmam et al., 1988 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Orgnntem Mutant Pan (a Ratio (Umg-l) (<-1 mM-l) 
fullulm 
PiiUulan A. niger G1 A 4.3 25 13 (i) e.5e-i-00 
PuUulan A. niger G2 A 4.3 25 19 (i) 4.2e*00 
PuUuIan A. aiger G1 A 4.3 37 1 .9e+01 
PuUulan A. niger G2 A 4.3 37 1 .5e+01 
PuUulan A. oryzae A 5.0 40 1 (i) 1.2e+01 
PuUulan H. resinae P A 4.3 37 3 .le+02 
PuUulan H. resinae S A 4.3 37 1 .7e+01 
PuUulan T. reesei A 5.5 30 4 .71e+00 
PuUulan R. delemar G3 B 4.5 40 77 3 .Oe+02 3 .90e+02 
PuUulan S. diascacicus STA2 E 4.6 37 43 (•) 1.6e-01 
4-nitiophenyl-alpha-
-D-maltoheptadecaoside A. niger G2 A 4.5 25 111 3 .90e+02 
4-nitrophenyl-alpba-
-O-maltoundecaoside A. niger G2 A 4.5 25 97 3 .41e+02 
• DECASACCHARIDES -
D-maliodecaose (#) C. paradoxa A 5.0 25 200 1 .36e+03 
D-isomaltodecaose R. niveus B 4.5 25 0.1 6 .16e-02 
- NONASACCHARIDES -
D-maliononaose (#) A. niger G2 A 4.5 25 87 3 .06e+02 
D-maltononaose C. paradoxa A 5.0 25 178 1 .21e+03 
- OCTASACCHARIDES -
4-niin)phenyl-alpha-
-D-malioheptaoside A. niger G2 A 4.5 25 100 3 .48e+02 
D-maltooctaose (#) A. niger G2 A 4.5 25 101 3 .53e+02 
D-maltooctaose C. paradoxa A 5.0 25 148 1 .Ole+03 
- HEPTASACCHARIDES -
Inhibitors and Analog 
oligosatin-E R. niveus B - -
4-nilrophenyl-alpha-
-D-maltohexaoside A. niger G2 A 4.5 25 108 3 .77e+02 
Maltoheotaose - Hvdrolvsis 
D-maltoheptaose (#) A. niger G2 A 4.5 25 104 3 .66e*02 
D-maltoheptaose ((f) A. niger G2 A 4.5 35 214 4 .53e+02 
D-maltoheptaose (#) A. niger G1 A 4.5 35 86 4. .08e+02 
D-maltoheptaose (#) A. niger A 4.5 40 73 4. Oe+02 5, .20e+02 
D-malloheptoose (#) A. niger G1 wc A 4.5 45 51 5, .15e*02 
D-malioheptaose (#) A. niger G1 wt A 4.5 45 56 4. .98e+02 
D-maltoheptaose A. niger A2 A 3.8 25 92 2, .06e+02 
D-maltoheptaose A. niger A3 A 4.2 25 53 5, .42e+02 
D-maltoheptaose A. niger B1 A 5.0 25 182 2, .06e+02 
D-maJtoheptaose A. niger B2 A 4.2 25 109 3. .32e+02 
D-malioheptaose A. niger B3 A 4.0 25 75 2. .09e+02 
D-maltoheptaose A. niger A 4.5 55 139 5. .64e-i-02 
D-maltoheptaose A. awamori wt A 4.5 35 3 . .77e+02 
D-maltoheptaose A. awamori wt A 4.4 45 43 8. ,71e+02 
D-maltoheptaose A. awamori wt A 4.5 45 56 3 . 47e+02 
D-maltoheptaose A. awamori wt A 4.5 45 63 4, .16e+02 
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Vmax kcat KmorKi IC50 Sub/ d(dG)t d(dG)b -dG -dH TdS dS 
(U mt-t) (s-l)  (mM) (mM) Meth •> •> (keaVmoO <- <• (kcal/inoLK) 
Reference 
2.9e+02 
2.2e+02 l .Sa-i-01 « 
1.8e-)-02 5.8e-01 % 
2.5e-H02 l .Sa^-Ol % 
e.eoe-^oo i.4«-i-oo « 
5.4e-K00 1.80-02 0.1 -0.4 6.8 
Svensson et al.. 1982 
Svensson et ol.. 1982 
McOeariy and Anderson. 1980 
McOearly and Anderson. 1980 
Sabaetal.. 1979 
McClearly and Anderson. 1980 
McClearly and Anderson. 1980 
Fagerstrom and Kalkkinen. 1995 
Abeetal.. 1985 
Modenaetal.. 1986 
7.8064-00 2.0a-02 
9.20e'<-00 2.7a-02 
0.1 -0.0 6.4 
0 . 2  0 . 1  6 .2  
Ermeretal.. 1993 
Ermeretal.. 1993 
B.OOe-fOl 2.2a-02 
8.87e-01 1.4a+01 
-0.0 0.0 6.4 
5.9 3.8 2.5 
Monma et al.. 1989 
Tanaka and Takeda. 1994 
1.10e*01 3.6a-02 
3.28e+01 2.7a-02 
-0.0 0.0 6.1 
-0 .8  -0 .2  6.2 
Ermeret al.. 1993 
Monma etai.. 1989 
1.01e»01 2.9a-02 
1.06e-01 3.0a-02 
3.43e-^01 3.4a-02 
0.0 -0.0 6.2 
-0.0 0.0 6.2 
-0.6 0.1 6.1 
Ermeretal.. 1993 
Ermeretal.. 1993 
Monma et al„ 1989 
1.3e-03 S? -0.8 7.4 Itoh et al.. 1981 
1 .13e+01 3.0a-02 -0 .0 -0 .1 6.2 Ermeretal.. 1993 
1 .17e»01 3.2a-02 -0 .0 -0 .0 6.1 11, .7 -5. .6 -1, .9e-02 Ermeretal., 1993 
2 .76e»01 6.1a-02 -0, .0 -0 .0 5.9 11, .7 -5. .8 -1, . 9e-02 Meagher et ol.. 1989 
3 .39e+01 8.3a-02 0, .0 0. 1 5.8 11, .7 -5. .8 -1, . 9e-02 Meagher et ol.. 1989 
3.6e+01 4, .68e-01 9.0a-02 -0, 0. 0 5.8 11, .7 -5. .9 -1. .9e-02 Abeetal.. 1985 
5, .67e-01 l . la-01 0, .0 -0 .1 5.8 11, .7 -5. 9 -1. . 9e-02 Fnindsen et al.. 1994a 
5, .97e+01 1.2a-01 0, .0 0. 0 5.7 11, .7 -5. .9 -1. . 9e-02 Frandsen et al.. 1994b 
8. .24e»00 4.0a-02 0, ,3 0. 1 6.0 Onoetal., 1988 
3 , .25e-01 
O
 i • 
o
 -0. ,2 0. 3 5.8 Onoetal., 1988 
1. .65e»01 M 
O
 1 • 
o
 
00 0. .3 0. 5 5.6 Ono et al.. 1988 
1. .66e*01 5.0a-02 0. , X 0. 2 5.9 Onoetal.. 1988 
1. .46ei-01 7.0a-02 0. .3 0. 4 5.7 Ono et al.. 1988 
1. .24e-02 2.2a-01 0. .1 0. 0 5.5 Nugy etal.. 1992 
3 . 66e-01 9.7a-02 0. .1 0. 2 S.7 Bakir et al.. 1993 
7. .23e»01 8.3a-02 -0, 3 -0 .2 5.9 Fang, unpublished results 
4. .10e•^01 1.2a-01 0. ,3 -0 .0 5.7 Fierobe et al., 1996 
5. 41e+01 1.3a-01 Q . 0. 1 5.7 Natarajan and Sierks, 1996 
Table 1. (continued) 
COMPOUND 
Inhibitor or Substrate 
Source 
Otganisin 
Form or 
Mutant 
Sub 
Pom 
pH T 
(C) 
Activity 
Ratio 
Activity 
(U mt-t) 
Vmax/Km kcat/Km 
(s-t mM-I) 
D-nudtobeptaose A. aweuBori wt: A 
in 45 4.71e+02 
D-maltobeptaose A. awamori wt: A 4.5 45 58 3.82ei-02 
D-maltoheptaose A. awamori wt: A 4.4 50 46 3.82e-^02 
D-maltobeptaose A. saitoi A 5.0 25 91 1.74e+02 
D-maltobeptaose Asp. sp. K-27 A 4.5 45 73 8.47e+02 
D-maltobeptaose C. paradoxa A 5.0 25 117 7.98e+02 
D-maltobeptaose H. resinae P A 4.3 25 63 2.22e+02 
D-maltobeptaose H. resinae S A 4.3 25 68 2.4261-02 
D-maltoheptaose T. reesei A 
in in 30 37 1.04e+02 
D-maltobeptaose R. niveus B 4.5 0.5 47 3.45e+01 
D-maltobeptaose Rhizopus sp. B 5.0 25 171 3.69e+02 
D-maltoheptaose R. delemar B 4.5 25 67 2.82e-i-02 
D-maltobeptaose R. delemar G1 B 
in 40 170 9 .8e+02 9.98e+02 
D-maltobeptaose R. deiemax G2 B 4.5 40 184 1 .2e+03 1.35e+03 
D-maltoheptaose R. delemar G3 B 4.5 40 120 4 .7e+02 6.07e+02 
D-maltobeptaose S. cerevisae E 
-
30 13 3 .6e-01 1.49e+00 
D-maltobeptaose closcridium G0005 F 4.5 25 75 3.95e+02 
D-maltobeptaose Clostridium G0005 wt F 
in 25 90 2.52e+02 
MaltoheDtaose- Mutants 
D-maltoheptaose A. awamori L3 A 4.5 45 118 1.86e+02 
D-maltobeptaose A. awamori L5 A 
in 45 33 2.13e+01 
D-maltobeptaose A. awamori L3L5 A 4.5 45 89 3.14e+02 
D-maltoheptaose A. niger Y48W A 4.5 45 148 4.54e+00 
D-maltobeptaose A. awamori (Y48F49)W A 4.4 45 17 4.09e-01 
D-maltobeptaose A. niger R54L A 4.5 45 66 2.0Se-01 
D-maltohepiaose A. niger R54K A 4.5 45 77 1.03e+00 
D-maltobeptaose A. awamori D55G A 4.5 45 45 1.21e+00 
D-maltobeptaose A. niger D112Y A 4.5 45 70 4.79e+02 
D-maltobeptaose A. awamori Y116A A 4.5 45 75 8.14e+01 
D-maltobeptaose A. awamori Y116W A 4.4 45 40 4.75e+02 
D-maltobeptaose A. awcimori S119Y A 4.5 45 39 3 .60e+02 
D-maltobeptaose A. awamori W120F A 4.4 50 37 7.27e+00 
D-maltoheptaose A. awamori W120H A 4.4 50 61 4.39ei-00 
D-maltoheptaose A. awamori W120L A 4.4 50 16 7.486+00 
D-maltoheptaose A. awamori W120Y A 4.4 50 40 7.41e+00 
D-maltoheptaose A. awamori G121A A 4.4 45 3 7.36e-<-01 
D-maltoheptaose A. awamori G121Y A 4.5 45 180 4.43e+02 
D-maltobeptaose A. awamori R122Y A 4.5 45 19 e.88e-i-00 
D-maltobeptaose A. awamori P123G A 4.5 25 49 1.32e+02 
D-maltobeptaose A. awamori Q124H A 4.5 45 58 5.00e+01 
D-maltobeptaose A. awamori R125K A 4.5 45 15 1.62e+02 
D-maltobeptaose A. niger D153N A 4.5 45 47 3.34e+02 
D-maltobeptaose A. awamori D176E A 4.5 35 1.06e+02 
D-maltoheptaose A. awamori D176N A 4.4 50 111 1.30e+01 
D-maltoheptaose A. awamori 176.5D A 4.5 35 1.52e-05 
D-maltoheptaose A. awamori L177D A 4.5 35 7.82e+01 
D-maltobeptaose A. awamori L177H A 4.4 50 108 5.30e+01 
D-maltobeptaose A. awamori W178D A 4.5 35 1.26e-01 
D-maltoheptaose A. awamori W178R A 4.4 50 52 6.38e+01 
D-maltoheptaose A. awamori E179D A 4.5 35 3.22e-02 
D-maltobeptaose A. awamori E179Q A 4.4 50 3 .13e-01 
D-maltoheptaose A. awamori EISOD A 4.5 35 4.66e+01 
D-maltoheptaose A. awamori E180Q A 4.5 45 31 l.lle+00 
D-mal[obeptaose A. awamori E180Q A 4.4 50 89 3.29e+00 
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Vmax kcat KmorKi IC50 Sobf d(dG)t d(dG)b -dG -dH TdS dS Rrference 
(Umt-I) ((-I) (mM) (niM) McCh -> -> (kcaVmofl <- <- (kalAnoUO 
e.eoe+oi 1.4«-01 0.1 0.1 5.6 Sieiks and Svensson. 1994 
8.40e-i-01 2.3«-01 0.2 0.4 5.3 Sieilcs and Svensson. 1993 
8.40e-^01 3.3*-01 0.3 0.2 5.4 Sierksetal„ 1989 
2.24e-i-01 1.3«-01 0.4 0.8 5.3 Koyamaetal„ 1984 
1.02e+02 1.3«-01 -0.3 0.0 5.7 Abeetal.. 1990 
3.43e-^01 4.3*-03 -0.5 0.1 6.0 Moiuna et al.. 1989 
1.91e+01 8.6a-03 0.3 0.5 5.5 Fagerstrom. 1991 
4.98e-)-01 2.1a-01 0.2 1.1 5.0 Fagerstrom. 1991 
3,34e+01 3.2a-01 0.8 1.1 4.8 Fagerstrom and Kalkidnen. 
3 .aOe-i-OO l . la-01 1.0 1.6 5.0 Tanaka et al., 1983 
3.62e+01 9.8a-02 -0.0 0.6 5.5 Koyanueial.. 1984 
3.10e+01 l . la-01 0.2 0.7 5.4 Hiromi et aL. 1973a 
l.le+02 l . la-01 -0.5 0.1 5.7 Abeetal.. 198S 
1.2e+02 l .Oa-01 -0.6 0.1 5.7 Abeetal.. 1985 
7.0e+01 1.5a-01 -0.1 0.3 5.5 Abeetal.. 1985 
1.5e+00 4.2a-4-00 3.4 2.7 3.3 Kleinitum et al.. 1988 
8.69e+01 2.2a-01 -0.0 1.1 5.0 Ohnishi et al.. 1992 
6.0Se+01 2.4a-01 0.2 1.1 4.9 Ohnishi et al.. 1994 
3.18e+OI 1.7a-01 0.4 0.2 5.5 Fierobe el al.. 1996 
2.66e'i-00 1.2a-01 1.8 0.0 5.7 Fierobe et al., 1996 
3.17e+01 l .Oa-01 0.1 -0.1 5.8 Fierobe et al.. 1996 
7.62e-01 1.7a-01 3.0 0.2 5.5 Frandsen et al.. 1994b 
1.99e+00 4.9a'«-00 4.8 2.6 3.4 Fang, unpublished restilts 
4.30e-02 2.1a-01 5.2 0.4 5.4 Frandsen et al., 1995 
3.20e-02 3.1a-02 4.2 -0.9 6.6 Frandsen et al., 1995 
2.30e-01 1.9a-01 3.6 -0.1 5.4 Sierks and Svensson, 1993 
6.71e+01 1.4a-01 0.0 0.2 5.6 Frandsen et al., 1994a 
2.3 6e+01 2.9a-01 1.0 0.5 5.1 Sierks and Svensson, 1996 
5.60e+01 1.2a-01 0.4 0.2 5.7 Fang, unpublished results 
5.69e-01 1.6a-01 0.2 0.1 5.5 Sierks and Svensson, 1994 
1.57e+00 2.2a-01 2.5 -0.0 5.4 Sierks etal., 1989 
1.40e+00 3.2a-01 2.9 0.2 5.2 Sierks et al.. 1989 
l.SXe+OO 2.4a-01 2.5 0.1 5.3 Sierks et al.. 1989 
4.40e-01 S.9a-02 2.5 -0.8 6.2 Sierks et al.. 1989 
4.93e+01 6.7a-0l 1.6 1.3 4.6 Fang, unpublished results 
5.32e+01 1.2a-01 -0.0 -0.1 5.7 Natarajan and Sierks. 1996 
5.71e+00 8.3a-01 2.6 1.2 4.5 Natarajan and Sierks. 1996 
7.95e+00 6.0a-02 0.7 0.3 5.8 Natarajan and Sierks, 1996 
4.55e+00 9.1a-02 1.3 -0.2 5.9 Natarajan and Sierks, 1996 
2.10e+01 1.3«-01 0.6 0.0 5.7 Natarajan and Sierks, 1996 
6.0Ie+01 1.8a-01 0.3 0.3 5.5 Frandsen et al., 1994a 
3.25e+01 3.1e-01 0.8 0.7 5.0 Bakiretal.. 1993 
8.23e+00 6.3a-01 2.2 0.7 4.7 Sierks etal., 1990 
3.20e-06 2.1a-01 10.4 0.5 5.2 Bakiret al.. 1993 
7.S2e+00 9.6e-02 1.0 -0.0 5.7 Bokiretal.. 1993 
1.59e+01 3.0a-01 1.3 0.2 5.2 Sierks etal.. 1993 
S.40e-02 4.3a-01 4.9 0.9 4.7 Bakiretal., 1993 
1.66e+01 2.6a-01 1.1 0.1 5.3 Sierks ei al., 1993 
2.90e-03 9.0a-02 5.7 -0.0 5.7 Bakiretal., 1993 
4.70e-02 1.5a-01 4.6 -0.2 5.7 Sierks etal.. 1990 
2.15e+01 4.ea-01 1.3 1.0 4.7 Bakiretal.. 1993 
1.17e+01 l .Oa-fOl 3.7 2.4 2.9 -4.6 7.4 2.3e-02 Sierks and Svensson. 1993 
3.09e+01 9.4a-»00 3.1 2.4 3.0 -4.6 7.6 2.3e-•02 Sierks etal.. 1990 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Fam (O Racio (U mc-I) (s-1 mM-I) 
D-maltobeptaose A. awaaori V181D A 4.5 35 1.31e+02 
D-maltobeptaose A. awamori N182A A 4.4 50 30 2.50e+02 
D-maltofaeptaose A. awamori N182A A 4.5 50 57 3.81e*02 
D-maltobeptaose A. awamori N182D A 4.5 35 2.49e+02 
D-maltobeptaose A. awamori Gia3K A 4.5 45 53 5.14e+02 
D-maltoheptaose A. awamori S184H A 4.5 45 52 5.64e+02 
D-maltobeptaose A. awamori R241K A 4.4 45 46 4.11e+02 
D-maltobeptaose A. awamori A246C A 4.5 45 172 2.91e+02 
D-maltoheptaose A. niger E2590 A 4.5 45 65 6.95e+02 
D-maltobeptaose A. aiger E259Q A 4.5 45 79 7.45e+02 
D-maltobeptaose A. aiger R305K A 4.5 45 27 g.58e-02 
D-maltoheptaose A. awamori Y306F A 4.5 45 66 1.48e+02 
D-maltobeptaose A. niger D309E A 4.5 45 41 7.11e+00 
D-maltobeptaose A. awamori D309N A 4.5 45 78 4.99e+00 
D-maltoheptaose A. niger W317F A 4.5 45 37 1.57e+01 
D-maltoheptaose A. awamori C320A A 4.5 45 117 3.55e+02 
D-maltobeptaose A. niger E389D A 4.5 45 48 4.42e-i'02 
D-maltoheptaose A. niger E389Q A 4.5 45 54 3.29e+02 
D-maltoheptaose A. niger A392D A 4.5 45 37 4.38e-i-02 
D-maltoheptaose A. niger E400Q A 4.5 45 138 2.79e+00 
D-maltobeptaose A. niger E400Q A 4.5 45 137 2.76e+00 
D-maltobeptaose A. niger Q401E A 4.5 45 78 2.49e+02 
D-maltobeptaose A. niger Q401E A 4.5 45 82 2.49e+02 
D-maltobeptaose A. awamori S411G A 4.4 45 44 S.36e+02 
D-maltoheptaose A. awamori S411A A 4.4 45 38 5.71e+02 
D-maltoheptaose A. awamori S411C A 4.4 45 32 4.71e+02 
D-maltobeptaose A. awamori S411H A 4.4 45 67 9.65e+01 
D-maltobeptaose A. awamori S411D A 4.4 45 88 1.07e+02 
D-maltoheptaose Closcridium G0005 W321F F 4.5 25 67 1.47e+02 
D-maltobeptaose (W52) Closeridium GOODS W337F p 4.5 25 92 l.lOe+00 
D-maltoheptaose (WI78) Closcridium G0005 W433F F 4.5 25 94 1.54e+02 
D-maltoheptaose Closcridium G0005 WS69F F 4.5 25 87 2.25e+02 
hamaltoheotaose - Hvdrolvsis 
A. awamori wt A 4.5 45 24 2.20e-01 
D-isomaltoheptaose H. resinae P A 4.3 25 20 2.60e+00 
D-isomaltobeptaose H. resinae S A 4.3 25 7 3.12e-02 
D-isomaltobeptaose R. niveus B 4.5 25 17 7.16e-02 
IsomaltoheDtaose - Mutants 
D-isomaltobeptaose A. awamori L3 A 4.5 45 4 4.20e-02 
D-isomaltobeptaose A. awamori L5 A 4.5 45 12 1.99e-02 
D-isomaltobeptaose A. awamori L3L5 A 4.5 45 15 3.14e-01 
Other-Hvdrolvsis 
6{3)-alpha-g!ucosyI-
-6(3)maltotriosyl-maltotiiose A. niger G1 A 4.3 37 1 1 .8e+01 
6(3)-alpha-glucosyl-
-6(3)maltotriosyl-maltotriose A. niger G2 A 4.3 37 1 2. 4e+01 
6(3)-alpha-glucosyl-
-6{3)maltotriosyl-maltotriose H. resinae P A 4.3 37 18 1, .Oe+03 
6(3)-alpba-glucosyI-
-6(3)maltotriosyl-maltotriose H. resinae S A 4.3 37 2 2, .7e+01 
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Vmax 
(Umf-I) 
kcat Km or Ki 
(s-l)  (mM) 
IC50 
(mM) 
Sob/ d(dG)t 
Meth -> 
d(dG)b 
"> 
•dG -dH 
(kcalAnoO <• 
TdS dS Reference 
<- (kal/moLK) 
1.75e+01 1.3«-01 0.6 0.2 5.5 Bakiretal.. 1993 
6.50e-f01 2.6a-01 0.3 0.1 5.3 Sierlcs et al.. 1993 
S.Ole-i-Ol 2.1*-01 0.0 -0.0 5.4 Qien et al.. 1994 
2.05e+01 8.2a-02 0.3 -0.1 
CO 
•
 
in Bakiretal.. 1993 
7.20e+01 1.4«-01 -0.1 0.0 5.6 Sterks and Svensson. 1994 
7.90e+01 l .4«-01 -0.1 0.0 5.6 Sierks and Svensson. 1994 
8.06e-)-01 2.0«-01 0.5 0.5 5.4 Fang, unpublished lesults 
3.49e-i-01 1.2a-01 0.1 0.0 5.7 Fierobe et al., 1996 
6.53e+01 9.4a-02 -0.2 -0.1 5.9 Frandsen et al.. 1994a 
6.93e+01 9.3a-02 -0.2 -0.1 5.9 Frandsen et al., 1994a 
5.9 Frandsen et al.. 1995 
9.90e+01 6.7a-01 0.6 0.7 4.6 Sierks and Svensson. 1993 
6.71e-c01 9.4a-i-00 3.0 2.8 2.9 Frandsen et al., 199S 
4.94e+00 9.9a-01 2.7 1.0 4.4 Sierks and Svensson. 1993 
5.18e+01 3.3a-)-00 2.5 2.1 3.6 Frandsen et al.. 1995 
4.62e->-01 1.3a-01 -0.0 0.1 5.7 Fierobe et al.. 1996 
6.19e-f01 1.4a-01 0.1 0.2 5.6 Frandsen et al., 1994a 
4.61e-i-01 1.4a-01 0.3 0.2 5.6 Frandsen et al., 1994a 
7.44e+01 1.7a-01 0.1 0.3 5.5 Frandsen et al., 1994a 
1.06e-f00 3.aa-01 3.3 0.8 5.0 Frandsen et al., 1994a 
l.OSe-i-OO 3.8a-0X 3.3 0.7 5.0 Frandsen et al., 1994b 
2.09e-)-01 8.4a-02 0.5 -0.2 5.9 Frandsen et al.. 1994a 
2.09e->'01 8.4a-02 0.4 -0.2 5.9 Frandsen et al.. 1994b 
8.40e-i-01 1.3a-01 0.2 0.3 5.6 Fang, unpublished results 
S.94e+01 l .Oe-01 0.3 0.1 5.8 Fang, unpublished results 
3.30e+01 7.0a-02 0.4 -0.1 6.0 Fang, unpublished results 
3.24e-H01 3.4a-01 1.4 0.9 5.1 Fang, unpublished results 
1.58e+01 1.5«-01 1.3 0.4 5.6 Fang, unpublished results 
2.94e+01 2.0a-01 0.3 -0.1 5.0 Ohnishi et al.. 1994 
4.40e-02 4.0«-02 3.2 -1.1 6.0 Ohnishi et al.. 1994 
4.92e+01 3.2«-01 0.3 0.2 4.8 Ohnishi et al.. 1994 
6.546-^01 2.9a-01 0.1 0.1 4.8 Ohnishi et al.. 1994 
2.51e»00 l . la+01 -0.0 0.0 2.8 Fierobe et al.. 1996 
5.52e-^00 2.1a-)-00 -^-5 -0.8 3.6 Fagerstrom. 1991 
7.53e-01 2.4a+01 1.2 0.6 2.2 Fagerstrom. 1991 
l.lle+00 1.6a+01 0.7 0.4 2.5 Tanaka and Takeda. 1994 
1.07e*00 2.6a+01 1.0 0.5 2.3 Fierobe et al.. 1996 
9.90e-01 5.0a+01 1.5 0.9 1.9 Fierobe et al.. 1996 
1.58e+00 S.Oe-fOO . -0.2 -0.5 3.3 Rerobe et al., 1996 
l .Sa-fOO 2.0 3.9 McCIeorly and Andetson. 1980 
1.8a-)-00 2.0 3.9 McCIearly and Andetson. 1980 
2.0a-01 0.6 5.2 McCIearly and Anderson, 1980 
3.0e-f00 2.3 3.6 McCIearly and Anderson, 1980 
3.3e+01 
4.3e+01 
2.0e+02 
8.2e+01 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pam (Q Ratio (Untfl) (s-1 mM-1) 
• HEXASACCHARIDES -
rnhihitnr«and Analnos 
oligosaiin-D R. niveus B - -
4-aitiophenyI-alpha-
-D-tnaltopentaoside A. niger G2 A 4.5 25 4.79e+02 
Maltohexaose - Hvdrolvsis 
D-maltohexaose (#) A. niger G2 A 4.5 25 91 3.19e+02 
D-maltohexaose (#) A. aiger G2 A 4.5 35 72 3.79e+02 
D-tnaltohexoose (#) A. niger G1 A 4.5 35 103 4.21e+02 
D-maltohexaose (#) A. niger A 4.5 40 64 3 .5e+02 4.55e+02 
D-maltohexaose (#) A. niger G1 wt A 4.5 45 58 5.11e+02 
D-maltobexaose A. niger A2 A 3.8 25 «9 1.09e+02 
D-maltohexaose A. niger A3 A 4.2 25 35 3.56e+02 
D-maltohexaose A. niger B1 A 5.0 25 121 1.37e+02 
D-maltobexaose A. niger B2 A 4.2 25 95 2.92e+02 
D-maltohexaose A. niger B3 A 4.0 25 64 1.79e+02 
D-maltobexaose A. niger A 4.5 55 119 4.81e+02 
D-maltohexaose A. awamori A 4.5 37 61 2.24e-t-02 
D-maltohexaose A. awamori wt A 4.4 45 34 6.89e+02 
D-maltohexaose A. awamori wt A 4.5 45 80 4.98e->-02 
D-maltohexaose A. awamori wt A 4.5 45 44 2.89e+02 
D-maltobexaose A. awamori wt A 4.4 50 52 4.30e+02 
D-maltobexaose A. saiCoi A 5.0 25 85 1.62e-i-02 
D-maltobexaose Asp. sp. K-27 A 4.5 45 60 6.89e+02 
D-maltohexaose C. paradoxa A 5.0 25 82 5.59e+02 
D-maltohexaose H. resinae p A 4.3 25 43 1.54e+02 
D-maltohexaose H. resinae p A 4.3 37 104 5 .8e+03 
D-maltohexaose H. resinae S A 4.3 25 77 2.73e+02 
D-maltobexaose H. resinae S A 4.3 37 90 2. .4e+03 
D-maltobexaose T. reesei A 5.5 30 35 l.OOe+02 
D-maltobexaose R. niveus B 4.5 0.5 38 2.79e+01 
D-maltobexaose Rhizopus sp. B 5.0 25 150 3 .22e+02 
D-maltohexaose R. delemar B 4.5 25 56 2.33e+02 
D-maltohexaose R. delemar G1 B 4.5 40 167 9, .7e+02 9.83e*02 
D-maltobexaose R. delemar G2 B 4.5 40 180 1. .le+03 1.33e+03 
D-maltobexaose R. delemar G3 B 4.5 40 123 4 . 8e-^02 6.26e*02 
D-tnaltobexaose S. diastacicus STA2 E 5.0 30 8 
D-maltohexaose S. diascacicus STA2 E 4.6 37 14 3.3e+01 5. 4e->-00 2.72e+01 
D-maltobexaose S. cerevisae E - 30 13 3 . 5e-01 1.47e*00 
D-maltobexaose Closcridium GO005 vz F 4.5 25 107 3 .OOe-i-02 
D-maltobexaose Closcridium C0005 F 4.5 25 92 4.86e+02 
Maltohexaose - Mutant Analysis 
D-maltohexaose A. awamori L3 A 4.5 45 118 1.86e*02 
D-maltohexaose A. awamori L5 A 4.5 45 40 2.53e-»-01 
D-maltobexaose A. awamori L3L5 A 4.5 45 97 3.44e*02 
D-maltobexaose A. niger Y48W A 4.5 45 121 3.69e+00 
D-maltohexaose A. awamori Y116A A 4.5 45 78 8.54e*0X 
D-maltohexaose A. awamori yii6w A 4.4 45 31 3.72e+02 
D-maltobexaose A. awamori S119Y A 4.5 45 27 2 .44eH.02 
D-maltobexaose A. awamori W120Y A 4.4 50 34 e.28e+00 
D-maltobexaose A. awamori G121A A 4.4 45 2 6.52e+01 
D-maltobexaose A. awamori G121Y A 4.5 45 158 3.90e*02 
D-maltobexaose A. awamori R122Y A 4.5 45 26 9.18e+00 
D-maltobexaose A. awamori P123G A 4.5 25 52 1.41e*02 
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Vmax kcat KmorKi ICSO SaV d(dG)t d(dG)b -dG •dH TdS dS Reference 
(U in(-l)  (s-1) (mM) (mM) Meth •> -> (kalAnoO <• <- (kcalAnoLK) 
5.1e-05 S? -3.3 9.1 Itohetol.. 1981 
1.15e+01 2.4a-03 -0 .3 -0.3 6.3 Eimerecal.. 1993 
1.15e+01 3.6«-03 -0 .0 -0.1 6.1 10 .7 -4, .7 -1 . 6e-02 Eimeretal.. 1993 
2.84e+01 7.5«-02 0 .0 0.0 5.8 10 .7 -4. .9 -1.6e-02 Meagheretal.. 1989 
3 .45e+01 8.2a-02 -0 .0 0.1 5.8 10 .7 -4. .9 -1 .6e-02 Meagheretal.. 1989 
3 .5e+01 4.55e+01 l.Oa-01 -0 .0 0.0 5.7 10 .7 -4. .9 -1 .6e-02 Abeetal.. 1985 
S.62e+01 l.la-01 -0 .0 -0.1 5.8 10 .7 -5. .0 -1 . 6e-02 Ftondsen et al., 1994b 
7.63e+00 7.0a-02 0 .6 0.3 5.7 Ono et al.. 1988 
3.20e+01 9.0a-02 -0 .1 0.5 5.5 Ono et al.. 1988 
1.64e+01 1.2e-01 0 .5 0.7 5.3 Ono et al.. 1988 
1.46e+01 5.0a-02 0 .0 0.1 5.9 Ono et al.. 1988 
1.61e+01 9.0a-02 0 .3 0.5 5.5 Ono et al.. 1988 
1.25e+02 2.6a-01 0 .2 0.1 5.4 Nagyetal., 1992 
3.59e+01 1.6a-01 0 .4 0.4 5.4 Savel'ev et al., 1982 
7.37e+01 l.la-01 -0 .2 -0.1 5.8 Fang, unpublished results 
5.38e+01 l.la-01 0 .0 -0.1 5.8 Fierobe et al.. 1996 
4.62e+01 1.6a-01 0 .4 0.2 5.5 Natotajon and Sierks. 1996 
8.60e+01 2.0a-01 0 .2 0.1 5.5 Sierks et al., 1989 
2.25e+01 1.4a-01 0, .4 0.7 5.3 Koyama et al., 1984 
1.03e-02 1.5a-01 -Q, _ 2 0.1 5.6 Abe et al.. 1990 
4.14e+01 7.4e-02 -0 .3 0.4 5.6 Monmaetal., 1989 
l.Vle-i-Ol l.la-01 0 .4 0.6 5.4 Fagerstrom, 1991 
4 .7e+02 8.0e-02 -0.0 5.8 McCIeorly and Anderson, 1980 
4.83e-01 l.Ba-Ol 0, _ X 0.9 5.1 Fagerstrom, 1991 
4, .8e->'02 2.0a-01 0.6 5.2 McQearly and Anderson, 1980 
3.31e»01 3.3a-01 0. .8 1.1 4.8 Fagerstrom and Kalkidnen. 1995 
3.90e+00 1.4a-01 0. ,9 1.6 4.8 Tanakaetal.. 1983 
3.45e-01 l.la-01 -0. .0 0.6 5.4 Koyama etal.. 1984 
2.80e-01 1.2e-01 Q. .2 0.7 5.3 Hiromi et al., 1973a 
1. .26-^02 1.2a-01 -0 . 5 0.1 5.6 Abeetal., 1985 
1. .2e+02 l.la-01 -0. ,7 0.1 5.7 Abeetal., 1985 
7. .7e+01 1.6a-01 -0. 2 Q .3 5.4 Abe et al., 1985 
Tucker etal., 1984 
5. ,3e+00 9.8a-01 1. 7 1.5 4.3 Modenaetal., 1986 
1. 3e-00 3.6e-f00 3 . 3 2.5 3.4 Kleinman et al.. 1988 
5.40e*0i l.Sa-Ol 0. 0 0.9 5.1 Ohnishi et al., 1994 
8.75e-01 1.8a-01 -0. 3 0.9 5.1 Ohnishi et al., 1992 
2.47e»01 1.3a-01 0. 6 0.1 5.6 Fierobe et al., 1996 
2.94e+00 1.2a-01 X .  9 0.0 5.7 Fierobe et al., 1996 
3.41e*01 9.9e-02 Q .  2 -0.1 5.8 Rerobe et al., 1996 
5.87e-01 l.fia-Ol 3. X 0.2 5.5 Frandsen et al.. 1994b 
2.22e-01 2.6a-01 0. p 0.3 5.2 Sierks and Svensson, 1996 
5.31e-<-01 1.4a-01 0. 4 0.2 5.6 Fang, unpublished results 
5.03e+01 2.1a-01 0. 4 0.1 5.4 Sierks and Svensson, 1994 
4.66e-01 7.4a-02 2. 7 -0.6 6.1 Sierks et al.. 1989 
5.12e-01 7.9a-01 X . t i .  3 4.5 Fang, unpublished results 
5.07e»01 1.3a-01 -0 .  -I -0.1 5.7 Natarajan and Sierks, 1996 
5.05e-^00 5.5a-01 2. 2 0.8 4.7 Natarajan and Sierks, 1996 
9.89e+00 7.0a-02 3 . •; C . 3 5.7 Notarajan and Sierks, 1996 
Table 1. (continued) 
COMPOUND 
Inhibitor or Substrate 
Soorce Former 
Organisin Mutant 
Sub 
Fam 
pH T 
(O 
Activity 
Ratio 
Activity 
(Unig-l) 
Vmax/Km Iccat/Km 
(s-lmM-l) 
D-inaltobexaose A. awamori Q124H A 4.5 45 43 3.69e+01 
D-maltohexaose A. awamoci R125K A 4.5 45 15 1.6Se+02 
D-maltohexaose A. awamori D176N A 4.4 50 70 8.21e+00 
D-maliobexaose A. awamori E180Q A 4.5 45 29 1.04e+00 
D-maltobexaose A. awamori N182A A 4.5 50 55 3.57e+02 
D-maltobexaose A. awamori R241K A 4.4 45 42 3 .73e+02 
D-maltobexaose A. awamori Y306F A 4.5 45 65 1.45e+02 
D-maltobexaose A. awamori D309N A 4.5 45 42 2.71e+00 
D-maltobexaose A. niger E400Q A 4.5 45 128 2.58e+00 
D-maltobexaose A. niger Q401E A 4.5 45 70 2.12e+02 
D-maltobexaose A. awamori S411G A 4.4 45 42 6.07e+02 
D-maltohexaose ClosCridium G0005 W321F F 4.5 25 69 1.51e+02 
D-tnaltobexaose (W52) Closcridium GQ005 W337F F 4.5 25 85 1.02e+00 
D-maltohexaose (W178) ClosCridium G0005 W433F F 4.5 25 94 1.54e+02 
D-maltobexaose closcridium G0005 W569F p 4.5 25 97 2.53e+02 
Isomaltohexaose - Hvdrolvsis 
A. niger G1 A 4.5 35 13 9.47e-02 
D-isiomatoJieTO6i»tft :A. niger G2 A 4.5 35 14 8.20e-02 
D-isomaltohexaose A. awamori wt A 4.5 45 25 2.30e-01 
D-isomaltobexaose H. resinae P A 4.3 25 22 2.85e+00 
D-isomaltohexaose H. resinae S A 4.3 25 8 3.34e-02 
D-isomaltohexaose R. niveus B 4.5 25 12 5.12e-02 
Isnmaltohexaose - Mutants 
D-isomaltohexaose A. awamori L3 A 4.5 45 4 4.31e-02 
D-isomaltohexaose A. awamori L5 A 4.5 45 11 1.78e-02 
D-isomaltohexaose A. awamori L3L5 A 4.5 45 18 3.79e-01 
D-isomaltohexaose A. awamori N182A A 4.5 50 10 2.19e-01 
- PENTASACCHARIDES -
Inhibitors and Analoes 
oligosatin-C R. niveus B 
- -
4-mtrophenyl-alpha-
-D-maltotetnioside A. niger G2 A 4.5 25 4.00e+02 
MaltODentaose -  Hvdrolv<ns 
D-maltopentaose (#) A. niger G1 WC A 4.5 S 109 2.00e+02 
D-maltopentaose (#) A. niger G2 A 4.5 25 85 2.97e+02 
D-maltopentaose (#) A. niger G2 A 4.5 35 60 3.17e+02 
D-maltopentaose (#) A. niger G1 A 4.5 35 77 3.15e+02 
D-maltopentaose (#) A. niger A 4.5 40 55 3, .Oe+02 3.90e+02 
D-maltopentaose (#) A. niger G1 W t  A 4.5 45 49 4.3 6e+02 
D-maltopentaose A. niger A2 A 3.8 25 37 8.22e+01 
D-maltopentaose A. niger A3 A 4.2 25 32 3.25e+02 
D-maltopentaose A. niger B1 A 5.0 25 90 l.Ole+02 
D-maltopentaose A. niger B2 A 4.2 25 60 1.84e+02 
D-maltopentaose A. niger B3 A 4.0 25 45 1.27e-H02 
D-maltopentaose A. niger A 4.5 55 78 3.14e+02 
D-maltopentaose A. awamori A 4.5 37 67 2.47e+02 
D-maltopentaose A. awamori W t  A 4.5 45 63 3 .92e+02 
D-maltopentaose A. awamori wt A 4.4 45 32 6.53e+02 
D-maltopentaose A. awamori wt A 4.5 45 34 2.24e+02 
D-maltopentaose A. awamori wt A 4.4 50 36 3.03e+02 
D-maltopentaose A. ficuum A 5.0 37 5 5. .2e+00 6.41e+00 
D-maltopentaose A. oryzae A 5.0 40 9 1. .8e+01 2.08e+01 
D-maltopentaose A. saicoi A 5.0 25 73 X.406+02 
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Vmaz kcat KmorKi IC50 s<M d(dG)t d(dG)b -dG -dH TdS 
(U nif-I) (f-I) (mM) (mM) Meth 
dS Reference 
-> .> (kcalAnoI) <- <. (kdiAaoLK) 
1 .3 -0.2 5.7 Naiarajan and Sierks. 1996 
0 .3 -0.2 5.8 Naiarajan and Sierks. 1996 
2 .5 1.1 4.4 Sierks et al„ 1990 
3 .8 2.7 2.8 Sierks and Svensson, 1993 
0, .1 
o
 
o
 
1 5.5 Qien et al.. 1994 
0, .4 0.4 5.4 Fang, unpublished results 
0, .7 0.9 4.6 Sierks and Svensson. 1993 
3. .2 1.4 4 .0 Sierks and Svensson. 1993 
3.  .3 0.9 4.9 Frandsen et al.. 1994b 
0. .6 0.0 5.8 Frandsen et al.. 1994b 
0. .1 0.1 5.7 Fang, unpublished results 
0. .4 -0.1 5.2 Ohnishi et al.. 1994 
3. .4 -0.9 6.0 Ohnishi et al., 1994 
0. ,4 0.2 4.9 Ohnishi et al., 1994 
0. 1 0.1 5.0 Ohnishi et al., 1994 
4.e5e-)-00 
1.83e+01 
8.4ee'<-00 
1.27e+01 
6.78e+01 
7.58e+01 
1.03e+02 
4.616-1-00 
l.lSe-i-OO 
2.386-1-01 
7.596-1-01 
2.42e-^01 
4.106-02 
3 .856-^01 
5 .57e-f01 
1.3a-01 
1.0a-»00 
1.2a-i-Cl 
1.9a-01 
2.0a-01 
7.18-01 
1.784-00 
4.5a-01 
l . la-01 
1.2a-01 
1.6a-01 
4.0a-02 
2.5a-01 
2.2a-01 
8.96e-01 S.Sa-t-OO 
7.596-01 9.3a-i-00 
2.446-^00 l . le-t-Ol 
7.37e-^00 2.6a+00 
8.146-01 2.48-1-01 
7.986-01 l .«a+01 
-0.1 0.0 
- 0 . 0  0 . 0  
-0.7 -0.0 
-2.1 -0.7 
0.5 0.7 
0.3 0.4 
2.9 
2.9 
2.9 
3.5 
2 . 2  
2.5 
Meagher etal.. 1989 
Meagher etol., 1989 
Rerobe et al.. 1996 
Fagerstrom. 1991 
Fagerstrom. 1991 
Tanaka and Takeda. 1994 
9.00e-01 2.18-fOl 
7.606-01 4.3e-t-01 
1.616-^00 4.2a<t-00 
3 .686-t-OO 1.7a-f01 
0.4 
1.0 
-1.0 
-0 .6  
0.4 
0.9 
- 0 . 6  
0 . 2  
2.4 
2 . 0  
3.5 
2 . 6  
Fierobe et al., 1996 
Fierobe et al., 1996 
Fierobe et al.. 1996 
Chen etal.. 1994 
1.046-^01 2.6a-02 
3.6e-05 S? -3.2 9.3 
-0.2 -0.4 6.3 
Itohetal.. 1981 
Ermeretal.. 1993 
3.6e-^00 
l.let-01 
4 .  406•^00 2.2a-02 -0 .0 0.0 6.0 
1 .13e-<-01 3.88-02 -0 .c -0.2 6.0 
2 .916-^01 9.28-02 0 .0 0.1 5.7 
3 .036-^01 9.68-02 0 . i 0.1 5.7 
4 .686t-01 1.28-01 -0 .0 C.l 5.6 
4 .806-^01 l . la-Ol -0 -0.1 5.8 
8 .226-^00 l .Oa-01 0 .7 0.4 5.5 
3 .25e+01 0
 
•
 1 o
 
-0 .1 0.4 5.5 
1 .42e-t-01 1.48-01 0, .6 0.6 5.3 
1 . 66e-^01 9.08-02 0, . 3 0.3 5.5 
1 .276-«-01 1.08-01 0, .5 0.4 5.5 
1 .136-«-02 3.68-01 0, . 3 0.4 5.2 
3 .486+01 1.48-01 0. .2 0.3 5.5 
3, .840-^01 VO
 00
 
•
 
1 o
 
0, .0 -0.2 5.8 
7 , .186-fOl l . la-Ol -0. .3 -0.1 5.8 
4. .92e-f01 2.28-01 0. .4 0.3 5.3 
9. .40e•^01 3.18-01 0, ,2 0.4 5.2 
6.8a-01 2. ,5 1.2 4.5 
e.Oa-Ol I. .3 1.1 4.6 
2. ,196-01 1.68-01 0 . C.7 5.2 
8, . 9  - 2  . 9  - 1  • Oe-• 0 2  Olsen et al.. 1993 
a .  .9 -3 . 0  -1, -Oe-• 0 2  Ermeretal., 1993 
8 .  .9 - 3 ,  .1 - 1 ,  . Oe-• 0 2  Meagher et al.. 1989 
3. . 9  -3, .1 - 1 ,  . 0 6 -• 0 2  Meagher et al., 1989 
8. .9 -3, . 2  -1. • Oe-• 0 2  Abe et al., 1985 
9. .9 -3 , 2 - 1 ,  • Oe-• 0 2  Frandsen et al., 1994b 
Ono et al.. 1988 
Ono et al., 1988 
Ono et al.. 1988 
Ono et al., 1988 
Ono et al., 1988 
Nagy et al., 1992 
Savel'ev et al., 1982 
Fierobe et al., 1996 
Fang, unpublished results 
Nataiajan and Sierks, 1996 
Sierks et al.. 1989 
Vandersall et al., 1995 
Nagashima et al., 1995 
Koyama et al.. 1984 
Table 1. (continued) 
COMPOUND Sonrce Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pam (Q Ratio (Unt-i) (s-imM-i) 
D-maltopentaose Asp. sp. K-27 A 4.5 45 42 4.90e-c02 
D-nialtopentaose C. paradojca A 5.0 25 57 3.92e+02 
D-n>alcopeniaose H. resiaae P A 4.3 25 28 9.97e+01 
D-maltopentaose H. resinae P A 4.3 37 20 1 .le+03 
D-maltopeniaose H. resinae S A 4.3 25 51 1.82e+02 
D-maltopentaose H. resinae s  A 4.3 37 84 2 .3e+03 
D-maltopentaose T. reesei A 5.5 30 41 1.18e+02 
D-maltopentaose R. niveus B 4.5 0.5 28 2.05e+01 
D-malcopentaose Rhizapus sp. B 5.0 25 118 2.S5e+02 
D-maltopentaose R. delemar B 4.5 25 48 2.00e+02 
D-maltopentaose R. delemar G1 B 4.5 40 114 6. .6e+02 6.74e+02 
D-maltopentaose R. delemcir G2 B  4.5 40 116 7. .4e+02 8.58e+02 
D-maltopentaose R. delemar G3 B 4.5 40 110 4. .3e+02 5.58e+02 
D-maltopentaose S. diascacicus STA2 E 5.0 30 9 
D-maltopentaose S. diascacicus STA2 E 4.6 37 5 3.1e+01 
D-maltopentaose s. cerevisae E 
-
30 12 3. .3e-01 1.39e+00 
D-maltopentaose ClosCridium G0005 wc F 4.5 25 100 2.82e+02 
D-maltopentaose Closcridium C0005 F 4.5 25 81 4.28ei-02 
Maltooentaose - Mutants 
D-maltopentaose A. awamori L3 A 4.5 45 93 1.47e+02 
D-maltopentaose A. awamori L5 A 4.5 45 33 2.11e+01 
D-maltopentaose A. awamori L3L5 A 4.5 45 82 2.91e+02 
D-maltopentaose A. niger Y48W A 4.5 45 109 3.32e+00 
D-maltopentaose A. awamori Y116A A 4.5 45 73 7.96e+01 
D-maltopentaose A. awamori Y116W A 4.4 45 29 3.50e+02 
D-maltopentaose A. awamori S119Y A 4.5 45 27 2.46e-i-02 
D-maltopentaose A. niger W120F A 4.5 8 11 2.17e+00 
D-maltopentaose A. awamori W120Y A 4.4 50 38 7.14e+00 
D-maltopentaose A. awamori G121A A 4.4 45 3 7.18e+01 
D-maltopentaose A. awamori G121Y A 4.5 45 152 3.75e+02 
D-maltopentaose A. awamori R122Y A 4.5 45 26 9.34e+00 
D-maltopentaose A. awamori P123G A 4.5 25 34 9.22e+01 
D-maltopentaose A. awamori 012<:H A 4.5 45 51 4.33e*01 
D-maltopentaose A. awamori R125K A 4.5 45 16 1.74e+02 
D-maltopentaose A. awamori 3176N A 4.4 50 41 4.79e+00 
D-maltopentaose A. awamori EieOQ A 4.5 45 26 9.29e-01 
D-maltopentaose A. awcunori N182A A 4.5 50 34 2.30e+02 
D-maltopentaose A. awamori R241K A 4.4 45 42 3 .68e+02 
D-maltopentaose A. awamori Y306F A 4.5 45 61 1.35e+02 
D-maltopentaose A. awamori D309N A 4.5 45 31 1.96e*00 
D-maltopentaose A. niger E400Q A 4.5 45 113 2.28e+00 
D-maltopentaose A. niger 0401E A 4.5 45 52 1.58e+02 
D-maltopentaose A. awamori S411G A 4.4 45 55 7.99e+02 
D-maltopentaose Closcridiuw G0005 W3 21F p 4.5 25 67 1.47e+02 
D-maltopentaose (W52) Closcridium G0005 W337F p* 4 .  5 25 48 5.78e-01 
D-maltopentaose (W178) Closcridium G0005 W433F p 4.5 25 116 1.90e+02 
D-maltopentaose Closcridium G0005 W569F c* 4.5 25 96 2.51e+02 
Isomaltooentaose - Hvdmlvns 
D-isomaltopentaose A. niger G1 A 4.5 35 12 8.53e-02 
A. niger G2 A 4.5 35 13 7.56e-02 
D-isomaltopentaose A. awamori wt A 4.5 45 19 1.76e-01 
D-isomaltopentaose H. resinae P A 4.3 25 17 2.30e*00 
D-isomaltopentaose H. resinae S A 4.3 25 8 3 .33e-02 
D-isomaltopentaose T. reesei A 5.5 30 10 2.02e-01 
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Vmax 
(Umf-l) 
kcat Km or Ki IC50 Sub/ <l(dG)t d(dG)b •dG -dH TdS dS Reference 
(s-I) (mM) (mM) Mcth •> •> (kcal/inol) <- <• (kcalAnoLK) 
8.33e+01 1.7«-01 -0.1 0.2 5.5 Abeetal.. 1990 
3.57e+01 9.1«-02 -0.2 0.3 5.5 Monmaetol^ 1989 
1.33e+01 1.3«-01 0.6 0.6 5.3 16. 9 -11.6 -3 . 9e-02 Fagemrom. 1991 
> 4 .0«-01 0.9 4.8 16. 9 -12.0 -3 .96-02 McOearly and Anderson. 1980 
4.27e-i-01 2.3«-01 0.3 0.9 5.0 -2. 5 7.4 2 .56-02 Fagerstrom. 1991 
> 2 .0a-01 0.5 5.2 -2. 5 7.7 2 . 5e-02 McOearly and Anderson. 1980 
3.18e+01 2.7«-01 0.6 0.9 5.0 Fagerstrom and Kalkkinen. 199S 
3.90e-f00 1.9«-01 1.1 1.4 4.7 Tanaka et al.. 1983 
3.59e+01 0.1 0.6 5.3 Koyama et al.. 1984 
3.20e+01 1.6«-01 0.2 0.7 5.2 Hiromietal., 1973a 
1.6«-01 -0.4 0.3 5.4 Abeetal„ 1985 
1.4«-01 -0.5 0.2 5.5 Abe et al.. 1985 
1.7e-01 -0.2 0.3 5.4 Abeetal, 1985 
Tucker etal.. 1984 
Modenaetal.. 1986 
«.3«-t-00 3.3 2.5 3.3 Kleinman et al.. 1988 
5.92e+01 2.1a-01 0.0 0.8 5.0 Ohnishi et al.. 1994 
1.16e+02 2.7«-01 -0.2 1.0 4.9 Ohnishi et al.. 1992 
3.38e+01 2.3«-01 0.6 0.5 5.3 Fierobe et al.. 1996 
2.99e+00 1.4«-01 1.8 0.2 5.6 Fierobe et al.. 1996 
3.466-1-01 1.2e-01 0.2 0.1 5.7 Fierobe et al.. 1996 
6.81e-01 2.0a-01 3.1 0.4 5.4 Frandsen et al.. 1994b 
1.91ef01 2.4a-01 0.7 0.1 5.3 Sierks and Svensson. 1996 
S.OOe-^Ol 1.4«-01 0.4 0.2 5.6 Fang, unpublished results 
4.18e-H01 1.7«-01 0.1 -0.3 5.5 Sierks and Svensson. 1994 
S.20e-02 2.4a-02 2.5 0.0 5.9 Olsen et al.. 1993 
5.34e-01 7.5a-02 2.4 -0.9 6.1 Sierks et al.. 1989 
4.87e-^01 6.8a-01 1.4 1 . 1  4.6 Fang, unpublished results 
4.886-^01 1.3a-01 -0.3 -0.3 5.7 Natarajan and Sierks. 1996 
5.70e-^00 S.la-Ol 2.0 0.6 4.7 Natarajan and Sierks. 1996 
9.226-1-00 l .Oa-01 0.5 -0.1 5.5 Natarajan and Sierks. 1996 
4.29e-f00 9.9a-02 1.0 -0.5 5.8 Natarajan and Sierks. 1996 
2.09e-01 1.2a-01 0.2 -0.4 5.7 Natarajan and Sierks. 1996 
6.08e-^00 1.3a<f00 2.7 0.9 4.3 Sierks etol.. 1990 
1.120-^01 1.2a+01 3.7 2.4 2.8 Sierks and Svensson. 1993 
8.736-^01 3.8a-01 0.2 0.1 5.1 Qien et al.. 1994 
7.07e-^01 1.9a-01 0.4 0.4 5.4 Fang, unpublished results 
l .OOe-02 7.4a-01 0.5 0.6 4.6 Sierks and Svensson. 1993 
S.lOe-^00 2.6a-t-00 3.2 1.4 3.8 Sierks and Svensson. 1993 
l.Ole-'OO 4.4a-01 3.3 0.9 4.9 Frandsen et al.. 1994b 
2.59e-01 1.6e-01 0.6 0.3 5.5 Frandsen et al.. 1994b 
7.51e»01 9.4a-02 
-0.1 -0.1 5.9 Fang, unpublished results 
2.65e-01 1.8a-01 0.4 -0.1 5.1 Ohnishi et al., 1994 
5.20e-02 9.0a-02 3.7 -0.5 5.5 Ohnishi et al.. 1994 
4.55e+01 2.4e-01 0.2 0.1 4.9 Ohnishi et al.. 1994 
6.02e-f01 2.4e-01 0.1 0.1 4.9 Ohnishi et al.. 1994 
9.75e-01 l . la+Ol - o . i  0.0 2.7 Meagher et al.. 1989 
7.97e-01 l . la-fOl 
-0.0 0.0 2.8 Meagher et al.. 1989 
2.066+00 1.2a<)-01 
-0.5 -0.0 2.8 Fierobe et al.. 1996 
6.53e-»00 2.8a-i>00 
-2.0 -0.7 3.5 Fagerstrom. 1991 
7.54e-01 2.3a-f01 0.5 0.5 2.2 Fagerstrom. 1991 
2 . 2 0 e * 0 0  l . la+01 
-0.6 0 . 1  2.7 Fagerstrom and Kalkkinen. 1995 
l.le+02 
l.Oe+02 
7.3e+01 
1.4e+00 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pan (O Racio (Umc-I) (s-t niM-I) 
D-isomaltopentaose R. nlveus B 4.5 25 13 5.61e-02 
D-isomaltopentaose A. awamorz L3 A 4.5 45 3 2.91e-02 
D-isomaltopentaose A. awcunori L5 A 4.5 45 9 1.37e-02 
D-isomaltopentaose A. awamorz L3L5 A 4.5 45 14 2.96e-01 
D-isomaltopentaose A. awamori N182A A 4.5 50 10 2.23e-01 
- TETRASACCHARIDES -
Inhibitors and AnaJoes 
acaitwse A. niger G2 A 4.5 27 
acaitose A. niger G1 A 4.5 25 
adiposin-2 R. aiveus B 5.0 40 
acarixjse A. awamori A 4.5 45 
D-gluco-dihydroacarbose A. aiger G1 A 4.5 25 
D-gIuco-dihydroacart>ose A. niger G2 A 4.5 27 
L-ido-dihydroacarbose A. niger G2 A 4.5 27 
L-ido-dihydroacarbose A. niger G1 A 4.5 25 
4-nitrophenyl-alpha-
-D-maltotrioside A. niger G2 A 4.5 25 7.62e+02 
Acarbose - Mutant Analysis 
acaitxise A. niger wt G1 A 4.5 27 
acartxise A. niger wc G2 A 4.5 27 
acaitose A. niger Y48W A 4.5 27 
ocarixjse A. niger ysoF A 4.5 27 
acarirase A. niger W52F A 4.5 27 
acartrase A. niger R54K A 4.5 27 
acarbose A. niger R54L A 4.5 27 
acarbose A. niger S119y A 4.5 27 
acarbose A. niger W120F A 4.5 27 
acartxjse A. niger N171S A 4.5 27 
acarbose A. niger Q172N A 4.5 27 
acarbose A. niger T173G A 4.5 27 
acartiose A. niger G174C A 4.5 27 
acarbose A. niger Y175F A 4.5 27 
acarbose A. niger D176N A 4.5 27 
acarbose A. niger E180Q A 4.5 27 
acarbose A. niger S185H A 4.5 27 
acartx)se A. niger R305K A 4.5 27 
acarbose A. niger D309E A 4.5 27 
acarbose A. niger W317F A 4.5 27 
Maltotelraose - Hvdrolvsis 
D-maltoteiraose (#) A. niger G1 WC A 4.5 8 55 l.OOe+02 
D-mallotetraose (#) A. niger G2 A 4.5 25 75 2.63e+02 
D-maltotetraose (#) A. niger G2 A 4.5 35 36 1.87e+02 
D-malloietraose (#) A. niger G1 A 4.5 35 50 2.02e+02 
D-tnalloietraose (#) A. niger A 4.5 40 47 2.6e+02 3.34e+02 
D-maltotetraose (#) A. niger G1 wc. A 4.5 45 39 3 .44e-i-02 
D-maltoietraose A. niger A2 A 3.8 25 19 4.23e+01 
D-maltotetraose A. niger A3 A 4.2 25 21 2.19e*02 
D-mallotetraose A. niger B1 A 5.0 25 48 5.38e+01 
D-maltoietraose A. niger B2 A 4.2 25 46 1.42e+02 
D-maltotetraose A. niger B3 A 4.0 25 30 8.47e+01 
D-maltotetraose A. niger A 4.5 55 128 5.19e+02 
D-maltotetraose A. niger G2 A 4.3 37 57 2.1e-^03 
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Vmax kcat KmorKi IC50 Sob/ d(dG)t d(dG)b -dG -dH TdS dS Reference 
(U mf-l) (»-l) (mM) (mM) Meth -> •> (kalAnDt) <- <- (kcalAnoLK) 
l.Ole+OO l .Sc+Ol .~;p^ 0.4 2.4 Toimka and Takeda. 1994 
6.80e-01 2.3«-i-01 0.4 2.4 Fierobe et ol.. 1996 
7.22e-01 5.3a-i-01 0.9 1.9 Fierobcetal.. 1996 
1.44e-^00 4.9e-^00 -0.6 3.4 Fierobe et al.. 1996 
3.72e+00 1.7a+01 0.2 2.S Chenetal., 1994 
l . la-09 -10.7 ie.4 9 .7 6 .6 2 . 2e-02 Sigurskjold et al.. 1994 
fi .Oa-09 sp -9.6 15.3 Svenssoa and Sierks. 1992 
2.1a-06 S -6.9 12.4 Kangouri et al.. 1982 
2.4a-05 M -5.6 11.1 Dong et al.. 1996 
1.4a-05 M -5.0 10.7 Svensson and Sierks, 1992 
3.1a-05 
-
-4.7 10.3 7 .1 3 .2 1 . le-02 Sigurskjold et al.. 1994 
4.5a-03 
-
-1.7 7.3 2 .3 5 .0 1 .7e-02 Sigurskjold et al.. 1994 
5.3a-03 pd -1.5 7.2 Svensson and Sierks, 1992 
1.22e*01 1.6a-02 -0.8 -0.9 6.5 Ermeretal. 1993 
l . la-09 - -10.8 16.4 7, .8 8, .6 2 . 9e-02 Berland et al., 1995 
l . la-09 
-
-10.7 16.4 9, .7 6, .7 2, .2e-02 Berland et al., I99S 
5.0a-03 
- -1.6 7.3 2. .6 4, .7 1, . 6e-02 Berland et al., 199S 
6.3e-10 
-
-11.1 16.8 9. .5 7 , .3 2 . 4e-02 Berland et al.. 1995 
4.2e-09 
-
-10.0 15.6 12 .7 2, .9 9 .7e-03 Berland et al., 1995 
1.2a-04 
- -3.8 9.5 9. .8 -0 .4 -1, . 2e-03 Berland et al., 1995 
2.ea-04 
-
-3.4 9.1 8. .6 0, .4 1, . 5e-03 Berland et al.. 1995 
l . la-09 
-
-10.8 16.4 7. .1 9, .3 3. le-02 Berland et al.. 1995 
l .Oa-04 
- -4.0 9.6 6. 9 2. .7 8. . 9e-03 Berland et al.. 1995 
7.18-10 
-
-11.0 16.7 12 .3 4. .4 1. . 5e-02 Berland et al.. 1995 
4.0a-10 
-
-11.4 17.0 11 .3 5 . 8 1. . 9e-02 Berland et ol.. 1995 
6.3a-10 
- -11.1 16.8 12 .8 4. 0 1. . 3e-02 Berland et al.. 1995 
2.9a-10 
-
-11.6 17.2 8. 4 8. 8 2. 9e-02 Berland et al., 1995 
7.1a-ll  
-
-12.4 18.1 8. 9 9. 2 3 . le-02 Berland et al.. 1995 
5.9e-09 
- -9.8 15.4 0 _ 4 6 . 0 2. Oe-02 Berland et al., 1995 
3.6a-02 
-
-0.5 6.1 4. 7 1. 4 4. 6e-03 Berland et al., 1995 
8.3e-09 
-
-9.6 15.2 13 .0 2. 2 7. 5e-03 Berland et al., 1995 
l . la-02 
- -1.2 6.8 7. 3 -0 .4 -1. 5e-03 Berland et al., 1995 
S.Oa-08 
- -8.5 14.1 7. 4 6. 7 2. 2e-02 Berland et al.. 1995 
1.2e-05 - -5.2 10.9 8. 5 2. 4 8. le-03 Berland et al., 1995 
3.20e»00 3.2a-02 0.0 0.0 5.8 8. 2 -2 .4 -8. 5e-03 Olsen et al., 1993 
1.13e»01 4.3a-02 -0.2 -0.3 6.0 8. 2 -2 .5 -8. 5e-03 Ermeretal. 1993 
2.93e*01 1.6e-01 0.2 0.2 5.4 8. 2 -2 .6 -8. 5e-Q3 Meagheretal.. 1989 
3.09e-01 1.5a-01 0.1 0.2 5.4 8. 2 -2 .6 -8. 5e-03 Meagheretal., 1989 
4.68e»01 1.4a-01 -0.1 0.0 5.5 8. 2 -2 .7 -8. 5e-03 Abeetal.. 1985 
4.13e*01 1.2a-01 -0.0 -0.2 5.7 8. 2 -2 .7 -8. 5e-03 Frandsenet al., 1994b 
6.77e»00 l .Sa-01 0.9 0.5 5.2 Onoetal., 1988 
3.28e»01 1.5e-01 
-0.1 0.5 5.2 Onoetal.. 1988 
1.56e*01 2.9a-01 0.7 0.8 4.8 Onoet al., 1988 
1.28ei-01 9.08-02 0.2 0.2 5.5 Ono et al., 1988 
1.44e+01 1.7a-01 0.5 0.5 5.1 Onoetal.. 1988 
1.09e+02 2.18-01 
-0.1 -0.1 5.5 Nagy et al., 1992 
2.08-01 0.3 5.2 McClearly and Anderson, 1980 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Paa (O RaCio (U ms-l) (s-lmM-I) 
D-maltotetraose A. awaaiori A 4.5 37 36 1.34e+02 
D-maltotetiaose A. awamori wt A 4.4 45 29 5.81e+02 
D-maltotetraose A. awamori wt A 4.5 45 52 3.22e+02 
D-roaltotetraose A. awamori wt A 4.5 45 24 1.58e+02 
D-maltotetraose A. awamori wt A 4.4 50 20 1.64e+02 
D-maltotetraose A. ficuum A 5.0 37 3 .8e+00 4.e3e-f00 
D-maltotetraose A. sai Coi A 5.0 25 60 1.16e+02 
D-maltotetraose Asp. sp. K-27 A 4.5 45 35 4.07e+02 
D-maltotetraose C. paradoxa A 5.0 25 33 2.26e+02 
D-maltotetraose H. resinae p A 4.3 25 38 1.34e+02 
D-maltotetraose H. resinae p A 4.3 37 16 8 .9e+02 
D-maltotetraose H. resinae s A 4.3 25 29 1.02e+02 
D-maltotetraose H. resiaae S A 4.3 37 57 1 .5e-«-03 
D-maltotetraose T. reesei A 5.5 30 31 8.97e+01 
D-maltocetraose R. niveus B 4.5 0.5 19 1.40e+01 
D-maltotetraose Rhizopus sp. B 5.0 25 88 1.89e+02 
D-maltotetraose R. delemar B 4.5 25 32 1.32e+02 
D-roaltotetraose R. delemar G1 B 4.5 40 77 4 .5e+02 4.55e+02 
D-tnaltotetraose R. delemar G2 B 4.5 40 81 5 .le+02 5.94e+02 
D-maltotetraose R. delemar G3 B 4.5 40 73 2 .8e+02 3.70e+02 
D-maltotetraose S. diascacicus STA2 E 5.0 30 8 
D-maltotetraose S. diascacicus STA2 E 4.6 37 4 2.9e+01 
D-maltotetraose S. cerevisae E - 30 12 3 2e-01 1.31e+00 
D-maltotetraose Clostridium G0005 wt F 4.5 25 78 2.20e+02 
D-maltotetraose Clostriditm G0005 F 4.5 25 72 3.80e-^02 
Maltotetraose - Mutant Analysis 
D-maltotetraose A. awamori L3 A 4.5 45 78 1.24e+02 
D-maltotetraose A. awamori L5 A 4.5 45 22 1.41e+01 
D-maliotetraose A. awamori L3L5 A 4.5 45 22 7.80e+01 
D-maltotetraose A. niger Y48W A 4.5 45 92 2.82e+00 
D-maltotetraose A. awamori Y116A A 4.5 45 30 3.25e+01 
D-maltotetraose A. aweimori Y116W A 4.4 45 21 2.56e+02 
D-maltotetraose A. awamori S119Y A 4.5 45 22 2.00e*02 
D-maltotetraose A. niger W120F A 4.5 8 9 1.81e+00 
D-maltotetraose A. awamori W120Y A 4.4 50 23 4.30e+00 
D-maltotetraose A. awamori G121A A 4.4 45 4 1.02e+02 
D-maltotetraose A. awamori G12iy A 4.5 45 109 2.6861-02 
D-maltotetraose A. awamori R122Y A 4.5 45 17 6.19e+00 
D-maltotetraose A. awamori P123G A 4.5 25 26 6.93e+01 
D-maltotetraose A. awamori Q124H A 4.5 45 42 3.56e+01 
D-maltotetraose A. awamori R125K A 4.5 45 13 1.41e+02 
D-maltohexaose A. awamori D176N A 4.4 50 63 7.36e+00 
D-maltotetraose A. awamori E180Q A 4.5 45 23 8.27e-01 
D-maltotetraose A. awamori N182A A 4.5 50 32 2.13e+02 
D-maltotetraose A. awamori R241K A 4.4 45 18 1.646+02 
D-maltotetraose A. awamori Y306F A 4.5 45 45 9.93e+01 
D-maltotetraose A. awamori D3 09N A 4.5 45 23 1.44e+00 
D-maltotetraose A. niger E400Q A 4.5 45 89 1.80e+00 
D-maltotetraose A. niger Q401E A 4.5 45 37 1.13e+02 
D-maltotetraose A. awamori S411G A 4.4 45 45 e.49e+02 
D-maltotetraose Clostridium G0005 W321F F 4.5 25 296 1.50e+02 
D-maltotetraose {W52) Cioscridiiun G0005 W337F F 4.5 25 12526 4.00e-01 
D-maltotetraose (W178) Cioscridiiun G0005 W433F F 4.5 25 0 1.3 9e+02 
D-maltotetraose Closcridimn G0005 W569F F 4.5 25 53 2.06e+02 
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Vmax kcat KmorKi IC50 Sab/ d(dG)t d(dC}b •dG -dH TdS dS Reference 
(Unif-I) (»-i) (mM) (mM) Mcth •> -> (kaVmoO <• <- (kdl/nioLK) 
3 .34e+01 2.5*-01 0.4 0.5 5.1 Savel'ev et aL. 1982 
6 .45e+01 l.la-01 -0.4 -0.3 5.8 Fang, unpublished results 
3 .83e+01 1.2a-01 0.0 -0.2 5.7 Rerobe et al.. 1996 
4 .91e+01 3.1«-01 0.5 0.4 5.1 Naiarajan and Sierks. 1996 
8 .70e+01 5.3a-01 0.5 0.6 «.8 Sierks et ol.. 1989 
2 .9efOO 7.6«-01 2.5 1.1 4.4 Vandersall et aL. 1995 
2 -Ole+Ol 1.7a-01 0.3 0.5 5.1 Koyamaetal., 1984 
7 .33e+01 1.8a-01 -0.1 0.1 5.5 Abeetal.. 1990 
2 .71e+01 1.2«-01 -0.1 0.3 5.3 Monma et al.. 1989 
1 .94e+01 1.4a-01 0.2 0.4 5.2 19. 0 -13.7 -4 .6e--02 Fagerstronu 1991 
4 .5e+02 5.0«-01 0.9 4.7 19. 0 -14.3 -4 .6e- 02 McGearly and Anderson. 1980 
4 .03e+01 «.0«-01 0.4 1.0 4.S -4. 2 8.9 3 .06-•02 Fageistroni. 1991 
4 .6e+02 3.0a-01 0.6 5.0 -4. 2 9.2 3 .06-02 McCIearly and Andenon. 1980 
3 .41e+01 3.8e-01 0.5 0.9 4.7 Fagerstrom and Kalkkinen. 1995 
3 .50e+00 2.5a-01 1.0 1.4 4.5 Tanaka et al.. 1983 
3 .56e+01 1.9e-01 -0.0 0.6 5.1 Koyamaetal.. 1984 
3 .30e->-01 2.S«-01 0.2 0.8 4.9 Hiromi et al.. 1973a 
1 .Oe+02 2.3«-01 -0.3 0.3 5.2 Abeetal„ 1985 
1 .le+02 2.1a-01 -0.5 0.3 5.3 Abeetal., 1985 
7 .4e+01 2.6a-01 -0.2 0.4 5.1 Abeetal., 1985 
Tucker et al., 1984 
Modena et al.. 1986 
1 .3e+00 4.1a-i-00 3 .1 2.3 3.3 Kleinman et al., 1988 
5, .95e+01 2.7a-01 -0.1 0.8 4.9 Ohnishi et al.. 1994 
9, .50e+01 2.5a-01 -0.4 0.8 4.9 Ohnishi etal.. 1992 
2. .72e+01 2.2a-01 0.6 0.4 5.3 Rerobe et al., 1996 
2, .56e+00 1.8a-01 2.0 0.3 5.4 Rerobe et al.. 1996 
2. •Oee+Ol 2.6e-01 0.9 0.5 5.2 Rerobe et al., 1996 
8. .21e-01 2.9a-01 3 .0 0.6 5.1 Frandsen et al., 1994b 
1. ,66e*01 5.1a-01 1.0 0.3 4.8 Sierks and Svensson. 1996 
5. ,09e+01 2.0a-01 0.5 0.4 5.4 Fang, unpublished results 
4. 99e+01 2.Sa-01 -0.1 -0.4 5.2 Sierks and Svensson, 1994 
5. 80e-02 3.2a-02 2.2 0.0 5.8 Olsen et al., 1993 
5. 68e-01 1.3a-01 2.3 -0.9 5.7 Sierks etal.. 1989 
6. 28e+01 6.1a-01 1.1 1.1 4.7 Fang, unpublished results 
4. SSe+Ol 1.7a-01 -0.3 -0.4 5.5 Natarajan and Sierks, 1996 
2. 97e+00 4.8a-01 2.0 0.3 4.8 Natarajan and Sierks, 1996 
7. 62e+00 L.la-01 0.5 0.3 5.4 Natarajan and Sierks, 1996 
4. 24e+00 1.2a-01 0.9 -0.6 5.7 Naiarajan and Sierks, 1996 
2. 68et01 1.9a-0]. 0.1 -0.3 5.4 Natarajan and Sierks. 1996 
6. 406+00 8.7a-01 2.0 0.3 4.5 Sierks et al.. 1990 
1. 0261-01 1..2e-f01 3.3 2.1 2.8 Sierks and Svensson. 1993 
8. 96e»01 4.2a-01 -0.2 -0.1 5.0 Chen et al.. 1994 
7. 3 5e»01 4.5a-01 0.8 0.9 4.9 Fang, unpublished results 
1. 086-^02 l. la-t-00 0.3 0.5 4.3 Sierks and Svensson. 1993 
3. eOe-i- 0 0  2.5a-i-00 3 .0 1.1 3.8 Sierks and Svensson. 1993 
9. 23e-01 S.la-01 3.3 0.9 4.8 Frandsen et al., 1994b 
2. 606+01 2.3e-01 0.7 0.4 5.3 Frandsen et al., 1994b 
5. 97e+01 9.2a-02 -0.1 -0.1 5.9 Fang, unpublished results 
2. 866+01 1.9a-01 0.2 -0.2 5.1 Ohnishi et al., 1994 
5. 206-02 I.3a-01 3 .7 -0.4 5.3 Ohnishi et al., 1994 
4. 586+01 3.3a-01 0.3 0.1 4.7 Ohnishi et al.. 1994 
6. 176+01 3.0a-01 0 . 0  0.1 4.8 Ohnishi et al., 1994 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pam (O Ratio (Umt-l) (s-tmM-I) 
hnmaltntftrnnse 
-Hvdrolvsis 
D-isoraaltoteoaose A. awamori wt A 4.S 45 16 1.43e-01 
D-isomaltotetraose A. niger G1 A 4.5 35 8 5.8ee-02 
siigaaBBfeA. niger G2 A 4.5 35 8 4.80e-02 
D-isonialtotetraose H. resinae P A 4.3 25 13 1.69e+00 
D-isomaltotetraose H. resiaae S A 4.3 25 8 3.43e-02 
D-isomaltotetraose T. reesei A 5.5 30 11 2.40e-01 
D-isomaltotetiaose R. niveus B 4.5 25 7 2.84e-02 
tsomaltofetraose - Mutant Analysis 
D-isomaltotetraose A. awamori L3 A 4.5 45 3 2.69e-02 
D-isomaltotetraose A. awamori L5 A 4.5 45 8 1.30e-02 
D-isomaltotetraose A. awamori L3L5 A 4.5 45 11 2.39e-01 
D-isomaltotetraose A. awamori N182A A 4.5 50 7 1.63e-01 
Other - Hydrolysis 
6(3 )-alpha-D-giucosy I 
-maltotriose A. niger G1 A 4.3 25 1 6.4e+01 
6(3)-alpha-D-gIucosyI 
-maltotriose A. niger G2 A 4.3 25 1 6.7e+01 
6(3)-alpha-D-glucosyI 
-maltotriose A. niger G1 A 4.3 37 0.4 1 .4e+01 
6(3)-alpfaa-D-gIucosyl 
-maltotriose A. niger G2 A 4.3 37 0.5 1 .6e+0I 
6(3)-alpha-D-gIucosyt 
-maltotriose H. resinae P A 4.3 37 3 1, .9e+02 
6(3)-alpha-D-gIucosyl 
-maltotriose H. resinae S A 4.3 37 1 1, .9e+01 
alpha-D-maltotriulosyl-glydn A. niger A 4.8 60 0.4 1.3e+01 
-TRISACCHARIDES. 
Inhibitors and Analogs 
adiposin-l R. niveus B 5.0 40 
4-nitrophenyl-alpha-
D-maltoside A. niger G2 A 4.5 25 1.7Se+02 
4-nitrophenyI-aIpha-
D-maltoside R. delemar B 4.5 25 6.25e+01 
4-raethyIphenyl-alpha-
D-maltoside R. delemar B 4.5 25 1.3 8e+01 
4-ethyIphenyI-alpha-
D-maltoside R. delemar B 4.5 25 1.86e+01 
4-(dimethylethyl)phenyl-alpha-
D-maltoside R. delemar B 4.5 25 1.72e+01 
phenyl alpha-maltoside A. saicoi Ml A 6.0 37 1 1. Se+OO 2.76e+00 
phenyl alpha-maltoside A. sai coi M2 A 6.0 37 1 1. 4e+00 2.07e+00 
phenyl alpha-maltoside R. delemar B 4.5 25 B.lOe+00 
phenyl-alpha-maltoside R. delemar B 4.5 25 S.lOe+00 
phenyl-beta-maltoside R. niveus B 4.5 25 6.90e+00 
phenyl 6-O-acetyI-alpha-
D-maltoside R. delemar B 4.5 25 4.95e-01 
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Vmax kcat KmorKi IC50 s<M <l(dG)l d(dG)b -dG -dH TdS dS 
(U mc-l) (s-I) (mM) (niM) Meth -> -> (kcal/moO <• <- (kcalAnoLK) 
Reference 
1.93ei-00 1.4«4-01 
8.20e-01 1.4a4-01 
6.22e-01 1.3a-i-01 
5.35e-i-00 S.aa'fOO 
8.25e-01 2.4a-»01 
2.30e-i-00 9.6a-»00 
4.83e-01 1.7a+01 
6.30e-01 2.3a't '01 
5.70e-01 4.4a-»01 
1.29e+00 5.4a ' i-00 
2.93e+00 1.8a+01 
-0.1 
-0.8 
0.5 
;r^aapr -0.1 
: f,"' 
0^ 0.2  
2.7 
2 . 6  
2.7 
3.4 
2.2 
2 . 8  
2.4 
0.3 2.4 
0 . 7  2 . 0  
-Ji^O -0.6 3.3 
-Oi.'a 0.1 2.6 
Rerobe et al.. 1996 
Meagher etal„ 1989 
Meagher etal„ 1989 
Fageistrom. 1991 
Fagerstrom. 1991 
Fagerstrom and Kalkidnen. 1995 
Tanakaand Takeda. 1994 
Fierobe et al.. 1996 
Fietobe et al.. 19% 
Fierobe et al.. 1996 
Chenetal.. 1994 
3.Oe+01 
3.2e+01 
3.0e+02 
5.8e+01 
2.1a'f00 
2.0a4-00 
l .ea+OO 
S.Oa-fOO 
0 . 6  
0 . 6  
1.8 3.8 
1.7 3.8 
1.6 4.0 
2.0 3.6 
Svensson et al.. 1982 
Svensson et al., 1982 
McOearly and Andeison. 1980 
McOearly and Anderson. 1980 
McOearly and Andenon. 1980 
McOearly and Anderson. 1980 
Schumacher and Kroh. 1994 
1.4a-05 s -6.3 U.3 Kangouri et al.. 1982 
4 .20e+00 2.4a-02 -0 .7 -1.1 6.3 Ermeret al. 1993 
7 .50e+00 1.2a-01 -0 .1 -0.2 5.3 Suetsugu et al.. 1973 
5 .SOe-nOO 4.0a-01 0 .8 0.5 4 .6 Suetsugu et al.. 1973 
5 .40e+00 2.9a-01 0, .6 0.3 4.3 Sueuugu et al., 1973 
5 .50e*00 3.2a-01 0. .6 0.4 4.8 Suetsugu et al.. 1973 
1.8e+01 l-Oa+Ol 2. .0 2.2 2.8 Takahashi et al.. 1981 
1.4e+01 l .Oai-Ol 2. ,2 2.2 2.8 Inokuchi et al.. 1981 
4 .70e+00 5.8a-01 1. .1 0.8 4.4 Hiromi et al., 1973b 
4 .70e*00 5.8a-01 1. .1 0.8 4.4 Suetsugu et al.. 1973 
2 .90e+00 4.2a-01 1, .2 0.6 4.6 Suetsugu et al., 1978 
4 , .60e*00 9.3a')-00 2. .7 2.4 2.8 Hiromi et al.. 1973b 
Table 1. (continued) 
COMPOUND Source Former Sub PH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pan (O Ratio (U mt-l) (s-I inM-I) 
Maltotriose - HTdrolvsis 
D-maltocriose (#) A. niger G1 wt A 4.5 8 17 3.07e+01 
D-maliotriose (#) A. aiger G2 A 4.5 25 18 6.45e+01 
D-maltotriose (#) A. niger G2 A 4.5 25 22 4.77e+01 
D-maltotriose (#) A. niger G1 A 4.5 35 6 4.97e+01 
D-maliotriose (#) A. niger G2 A 4.5 35 11 5.80e+01 
D-maliotriose (#) A. niger G2 A 4.5 35 11 5.5Se+01 
D-maltotriose (#) A. niger A 4.5 40 13 7 .3e+01 9.53e+01 
D-malioiriose (#) A. aiger G1 wt A 4.5 45 14 1.20e+02 
D-nuUtotriose (#) A. niger G2 A 4.5 45 11 8.04e+01 
D-maltotriose A. niger A2 A 3.8 25 13 2.81e+01 
D-maltotriose A. niger A3 A 4.2 25 12 1.186+02 
D-maltotriose A. niger B1 A 
o
 
in 25 17 1.91e+01 
D-maltotriose A. aiger B2 A 4.2 25 17 5.32e+01 
D-maltotriose A. aiger B3 A 4.0 25 15 4.20e+01 
D-maltotriose A. niger G2 A 4.3 37 18 6 .4e+02 
D-maltotriose A. aiger A 4.5 55 45 1.83e+02 
D-maltotriose A. awamori A 4.5 37 15 5.62e+01 
D-maltotriose A. awamori wt A 4.5 45 11 7.44e+01 
D-maltotriose A. awamori wt A 4.5 45 20 1.24e+02 
D-maltotriose A. awamori wt A 4.4 45 10 1.96e+02 
D-maltotriose A. awamori wt A 4.4 50 10 8.49e+01 
D-maltotriose A. bacacae A 4.5 30 6 
D-maltotriose A. ficuum A 5.0 37 2 2. ,6e+00 3.13e+00 
D-maltotriose A. oryzae A 5.0 40 3 2.3e+01 
D-maltotriose A. oryzae A 5.0 40 3 6. .8e+00 7.81e+00 
D-maltotriose A. sai coi A 5.0 25 19 3.55e+01 
D-maltotriose A. sai coi Ml A 6.0 37 13 1. .9e+01 2.90e+01 
D-maltotriose A. sai coi M2 A 6.0 37 13 1, .7e+01 2.03e+01 
D-maltotriose A. cerreus NA-170 A 5.0 25 2 
D-maltotriose Asp. sp. K-27 A 4.5 45 13 1.44e+02 
D-maltotriose C. paradoxa A 5.0 25 9 6.17e+01 
D-maltotriose H. resinae P A 4.3 25 19 6.67e+01 
D-maltotriose H. resinae P A 4.3 37 11 6. .2ef02 
D-maltotriose H. resinae S A 4.3 25 14 4.83e+01 
D-maltotriose H. resinae S A 4.3 37 14 3. .8e+02 
D-maltotriose T. lanuginosus A 5.0 50 5 5.3e+01 
D-maltotriose T. reesei A 
in in 30 14 3.87e*01 
D-maltotriose R. niveus B 4.5 0.5 12 8.57e+00 
D-maltotriose Rhizopus sp. B 5.0 25 8 4.20e+01 
D-maltotriose R. delemar B 4.5 25 15 6.3 9e+01 
D-maltotriose R. delemar G2 B 4.5 40 12 7. 5e+01 8.80e+01 
D-maltotriose R. delemar G1 B 4.5 40 12 7. le+01 7.24e+01 
D-maltotriose R. delemar G3 B 4.5 40 13 5. 2e+01 6.70e+01 
D-maltotriose S. diascacicus STA2 E 5.0 30 5 
D-maltotriose S. diascacicus STA2 E 4.6 37 2 2.2e+01 6. 8e-01 3.42e+0a 
D-maltotriose s. cerevisae E - 30 6 1. 6e-01 6.49e-01 
D-maltotriose Clostridiwn G0005 wt F 4.5 25 39 l.lle*02 
D-maltotriose closcridiwn GOODS F 4.5 25 20 1.07e+02 
Maltotrisose - Mutant Analysis 
D-maltotriose A. awzmori L3 A 4.5 45 31 4.86e+01 
D-maltotriose A. awamori L5 A 4.5 45 8 5.15e+00 
D-maltotriose A. awamori L3L5 A 4.5 45 22 7.80e+01 
D-maltotriose A. niger Y4 8W A 4.5 45 29 8.95e-01 
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Vmax kcat KmorKi IC50 Sub/ d{dG^ d{dG)b •dG -dH TdS dS Reference 
(U nic-l) (»-H (mM) (mM) Meth -> -> (kcaVnoD <- <• (kdlAnoLK) 
1 .75e+00 S.7«-02 -0.0 -0.0 5.5 9 .6 -4.2 -1 .5e-02 Olsenetal.. 1993 
7 .lOe+00 l . la-01 -0.1 -0.2 5.4 9. 6 -4.4 -1 .5e-02 Ermeretal. 1993 
8 .73e+00 l .Sa-Ol 0.0 0.1 5.1 9, .6 -4.4 -1 .5e-02 Meagher and Reilly,1989 
1 .51e+01 3.0a-01 0.2 0.1 5.0 9, .6 -4.6 -1 .5e-02 Meagheretal.. 1989 
2 .lOe+01 3.6a-01 0.1 0.2 4.9 9. .6 -4.6 -1 .5e-02 Meagher and Reilly,1989 
2 .22e+01 4.0a-01 0.1 0.2 4.8 9. ,6 -4.6 -1 .5e-02 Meagheretal.. 1989 
2 .2e+01 2 .86e+01 3.0a-01 -0.1 -0.1 5.0 9. .6 -4.6 -1 .5e-02 Abeetal.. 1985 
3 .35e+01 2.8a-01 -0.2 -0.3 5.2 0 . ,6 -4.7 -1 . 5e-02 Frandsen et al.. 1994b 
4 .21e+01 5.2a-01 0.1 0.1 4.8 9, .6 -4.7 -1 . 5e-02 Meagher and Reilly. 1989 
5 .61e+00 3.0a-01 0.3 0.1 5.0 Ono et al.. 1988 
2 • Olei-Ol 1.7a-01 -0.5 0.0 5.1 Ono et al., 1988 
1 .07e+01 5.Sa-01 0.6 0.7 4.4 Ono et al.. 1988 
1 .Ole+01 1.9a-01 -0.0 0.1 5.1 Ono et al.. 1988 
8 .82e+00 2.1a-01 0.1 0.2 5.0 Ono et ol., 1988 
2 .5e+02 4.0a-01 0.2 4.8 McCIearly and Anderson. 1980 
9 .90e+01 5.4e-01 -0.3 -0.2 4.9 Nagy etal.. 1992 
2 .19e+01 3.9a-01 0.2 0.2 4.8 Savel'ev et al.. 1982 
3 .87e+01 5.2a-01 0.1 0.1 4.8 Natarajan and Sierks, 1996 
3 .09e+01 2.5a-01 -0.2 -0.4 5.2 Fierobe et al.. 1996 
4 .82e+01 2.5a-01 -0.5 -0.4 5.3 Fang, unpublished results 
6. .20e+01 7.3a-01 0.1 0.2 4.6 Sierks et al.. 1989 
Bendetskii et al.. 1974 
1 .9e+00 7.6a-01 1.9 0.6 4.4 Vandersail et al.. 1995 
Sahaetal.. 1979 
6 .le*00 9.08-01 T  ^ 0.6 4.4 Nagashima et al., 1995 
9. .36e+00 2.6a-01 0.2 0.3 4.9 Koyamaetal.. 1984 
2 .3e-01 1.2a+00 0.6 0.9 4.1 Takahashi et al., 1981 
2 .4e+01 1.4a4-00 0.8 0.9 4.1 Inokuchi et al., 1981 
l . la-t-Ol 2.5 2.7 Ghosh et al.. 1991 
6. SOe-Ol 4.5a-01 -0.3 0.0 4.9 Abe et al., 1990 
1. 79e-01 2.9e-01 -0.1 0.3 4 .8 Monmaetal., 1989 
1. 16e-01 1.7a-01 -0.2 0.0 5.1 19, .0 -13.8 -4. 6e-02 Fagerstrom. 1991 
3 , .7e-02 6.0a-01 0.4 4.6 19. .0 -14.4 -4 . 6e-02 McCIearly and Anderson. 1980 
2. 94e-01 6.1a-01 0.0 0.8 4.4 -0, .2 4.6 1. 5e-02 Fagerstrom. 1991 
2. .3e-02 6.0a-01 0.4 4.6 -0. .2 4.8 1. 5e-02 McCIearly and Anderson. 1980 
l . la-fOO 0.4 4.4 Rao etal.. 1981 
2. Ole-i-01 5.2a-01 0 . 3 0.5 4.6 Fagerstrom and Kalkkinen, 1995 
3. OOe+OO 3.Sa-01 0.5 1.2 4.3 Tanakaetal., 1983 
1. 47e*01 3.5a-01 0.1 C . 5 4.7 Koyamaetal., 1984 
2. 30e+01 3.6a-01 -0.1 0.5 4.7 Hiromi et al., 1973a 
4. .3e-01 5.7a-01 -0.1 0.3 4.6 Abe et al., 1985 
4. .2e*01 5.9a-01 0.0 0.3 4.6 Abe et al., 1985 
3 , .3e*01 6.4a-01 C . 1 0.4 4.6 Abe et al., 1985 
Tucker et al.. 1984 
1. . 6e*00 2.4a')-00 1.9 1 \ 3.7 Modenaetol., 1986 
5. .9e-01 3.8a'f00 2.7 1.7 3.4 Kleinman et al., 1988 
4. 55e-01 4.1a-01 -0.5 0.6 4.6 Ohnisht et al., 1994 
7. 41e-01 6.9a-01 -0.4 0.9 4.3 Ohnishi et al.. 1992 
2. 14e*01 4.4a-01 0.6 C.4 4.9 Fierobe et al., 1996 
1. 70e-00 3.3e-01 2.C 0.2 5.1 Fierobe et al., 1996 
2. 06e*01 2.6e-01 0.3 C . O  5.2 Fierobe et al., 1996 
4. 58e-Cl 5.1e-01 3 .: C . 4 4.8 Frandsen et al., 1994b 
Table 1. (continued) 
COMPOUND Source Fonn or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate OrgatUsm Mutant pam (q lueio (Umc-i) (s-imM-i) 
D-maltotriose A. awiuaori Y116A A 4.S 45 17 1.89e+0X 
D-maltotriose A. aviamori Y116W A 4.4 45 8 9.77e+01 
D-raaltotriose A. awamori S1X9Y A 4.5 45 13 1.16e+02 
D-maltotriose A. niger W120F A 4.5 8 4 7.73e-01 
D-raaltotiiose A. awamori W120Y A 4.4 50 11 2.12e+00 
D-maltotriose A. awamori G121A A 4.4 45 2 5.68e+01 
D-maltotriose A. awamori G121Y A 4.5 45 31 7.53e+01 
D-raaltotriose A. awamori R122Y A 4.5 45 11 3.92e+00 
D-maltotriose A. awamori P123G A 4.5 25 9 2.42e+01 
D-maltotriose A. awamori Q124H A 4.5 45 12 1.04e+01 
D-roaltotriose A. awamori R125K A 4.5 45 5 5.78e+01 
D-maltotriose A. awamori D176N A 4.4 50 16 1.87e+0C 
D-maltotriose A. awamori E180Q A 4.5 45 3 1.13e-01 
D-maltotriose A. awamori N182A A 4.5 50 13 8.51e+01 
D-maltotriose A. awamori R241K A 4.4 45 9 7.60e+01 
D-maltotriose A. awamori Y306F A 4.5 45 5 1.22e+01 
D-maltotriose A. awamori D309N A 4.5 45 4 2.73e-01 
D-maltotriose A. niger E400Q A 4.5 45 22 4.42e-01 
D-maltotriose A. niger Q4Q1E A 4.5 45 14 4.09e+01 
D-maltotriose A. awamori S4HG A 4.4 45 8 l.lOe+02 
D-maltotriose Clostridium G0005 W321F F 4.5 25 34 7.52e+01 
D-maltotriose fW52) Closcriditmi G0005 W337F F 4.5 25 15 1.78e-01 
D-maltotriose (WITS) Clostridium G0005 W433F F 4.5 25 44 7.14e+01 
D-maltotriose Clostridium G0005 W569F F 4.5 25 48 1.26e+02 
Panose- Hvdrolvsis 
D-panose(#) A. niger G1 A 4.5 25 16 (•) 2.45e-01 
D-panose (#) A. niger G1 A 4.5 35 8 (i) 5.32e-01 
D-panose (#) A. niger G1 A 4.5 45 7 (!) 9.11e-01 
D-panose (#) A. niger A 4.5 40 13 (i) 5.40e-01 
D-panose A. niger G1 A 4.3 37 22 (i) 1.7e*00 
D-panose A. niger G2 A 4.3 37 21 (i) 1.7e+00 
D-panose A. batatae A 4.5 30 6 (i) 
D-panose Asp. sp. K-27 A 4.5 45 32 (>) 3 .57e-01 
D-panose H. resinae P A 4.3 37 2 (i) 2.3e+01 
D-panose H. resinae S A 4.3 37 17 (i) 1.6e*00 
D-panose R. delemar G1 B 4.5 40 11 ( I )  5.1e-01 5.23e-01 
D-panose R. delemar G2 B 4.5 40 12 (1) 5.1e-01 5.92e-01 
D-panose R. delemar G3 B 4.5 40 9 I I )  4.1e-01 5.39e-01 
D-panose S. diasta ticus STA2 E 4.6 37 11(1) 6.3e-01 
Panose - Condensation 
D-panose (R) (#) A. niger G1 A 4.5 25 47656 (i) 8.14e-02 
D-panose (R) (#) A. niger G1 A 4.5 35 22962 (i) 1.77e-01 
D-panose (R) (#) A. niger G1 A 4.5 45 34547 I I I  1.76e-01 
Isomaltotrinse - Hvdrolvsis 
D-ison^tdbiose (#) A. niger G1 A 4.5 25 232 I I I  1.67e-02 
D-isotnaltqtiipse (#) •  i - A. niger G2 A 4.5 25 141 I I I  1.50e-02 
b-&o^t^ose (#) i - A. niger G2 A 4.5 35 109 (il 4.82e-02 
b-tspinalldtnose (#) 
t ' '  . V  
D^udmalti^ose (#) -
^ • 
A. niger G1 A 4.5 35 85 (i) 4.78e-02 
A. niger G2 A 4.5 45 50 I I I  1.48e-01 
Driipn^totnose (#) - A. niger G1 A 4.5 45 49 I I I  1.25e-01 
D-isomaltotriose A. awamori wt A 4.5 45 55 lil 1.12e-01 
D-isomaltolriose H. resinae P A 4.3 25 6 (il 6.10e-01 
D-isomaltoiriose H. resinae S A 4.3 25 151 I I I  2.3Se-02 
D-isomaltotriose T, reesei A 5.5 30 20 ( I I  1.44e-01 
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Vmaz Iccat Kmor Ki IC50 Sub/ d(dG)t d(dG)b -dG •dH TdS dS Reference 
(Umf-l) (»-i) (mM) (mM) McUi •> -> (kcal/raoD <- <* (^xal/moUO 
5 .30e-01 2.8a-03 0.9 -1.8 6.6 Sierks and Svensson. 1996 
1 .94e+01 2.0«-01 0.4 -0.1 S.4 Fang, unpublished results 
4 .54e+01 3.9a-01 -0.2 -0.3 5.0 Sierks and Svensson. 1994 
3 .40e-02 2.1 -0.1 5.6 Olsen et al.. 1993 
2 .56e-01 1.2a-01 2.4 -1.2 5.8 Sierks et al.. 1989 
3 .27e+01 5.7e-01 0.8 0.5 4.7 Fang, unpublished results 
2 .26e+01 3.0a-01 -0.0 -0.3 5.1 Natoiajan and Sierks. 1996 
9 .80e-01 2.5a-01 1.9 -0.5 5.2 Natarajan and Sierks. 1996 
5 • SOe-^OO 2.4a-01 0.7 0.2 4.9 Nataiajan and Sierks, 1996 
2 .32e+00 2.2a-01 1.2 -0.5 5.3 Natarajan and Sierks, 1996 
1 .33e+01 2.3a-01 0.2 -0.5 5.3 Natarajan and Sierks. 1996 
3 .28e+00 l.Sa-t-OO 2.4 0.6 4.1 Sierks et al.. 1990 
2 .94e+00 2.6a-i'01 4.2 2.3 2.3 Sierks and Svensson, 1993 
5 .02e+01 5.9a-01 -0.0 -0.1 4.8 Chenetal.. 1994 
4 .68e->-01 e. la-Ol 0.6 0.6 4.7 Fang, unpublished results 
3 .47e+01 2.9e-)-00 1.2 0.9 3.7 Sierks and Svensson, 1993 
1 .39e+00 S.la-i-OO 3.6 1.3 3.3 Sierks and Svensson, 1993 
5 .61e-01 1.3a-i-00 3.5 1.0 4.2 Frandsen et ol., 1994b 
1 .46e+01 3.6a-01 0.7 0.2 S.O Frandsen et al., 1994b 
5 .51e+01 5.0a-01 0.4 0.4 4.8 Fang, unpublished results 
2 .48e+01 3.3a-01 0.2 -0.1 4.7 Ohnishi et al., 1994 
3 .20e-02 1.8a-01 3.8 -0.5 5.1 Ohnishi et al., 1994 
3, .35e+01 «.7a-01 0.3 0.1 4.5 Ohnishi et al., 1994 
4. .66e+01 3.7e-01 -0.1 -0.1 4.7 Ohnishi et al., 1994 
2. .42e-^00 9.9a-)-00 0.0 0.0 2.7 3. , 2 -0.4 -1 .3e-03 Meagher and Reilly,1989 
4. ,79e+00 9.0a-i-00 -0.1 -0.1 2.9 3 . .2 -0.4 -1 .3e-03 Meagher and Reilly,1989 
1. .20e+01 1.3a-f01 -0.0 0.0 2.7 3 . 2 -0.4 -1 .3e-03 Meagher and Reilly, 1989 
7 . 02e+00 I.3a4.01 0.1 0.1 2.7 3. .2 -0.4 -1 .3e-03 Abe et al., 1985 
3 .7e+01 2.2a-^01 0.4 2.4 McCIearly and Andeison, 1980 
3 .8e+01 2.2a-i-01 0.4 2.4 McCIearly and Anderson. 1980 
Bendetskii et al., 1974 
2. ,00e+01 S.ea-t-Ol 0.6 0.9 1.8 Abe et al., 1990 
3 .Oe+02 1.384-01 0.1 2.7 McCIearly and Anderson, 1980 
3 .5e+01 2.284-01 0.4 2.4 McQearly and Anderson. 1980 
7 .2e-i-00 1.4a')-01 0.1 0.1 2.7 Abe et al., 1985 
6 .Se+OO 1.3a-(-01 0.1 0.1 2.7 Abeetal., 1985 
5 .8e+00 1.4a+01 0.1 0.1 2.7 Abeet al.. 1985 
Modenaet al., 1986 
8. 03e-01 S.Sa-f-OO 0.1 0.0 2.7 Z . 8 -Q.Q -1. .3e-Q5 Nikolov et al., 1989 
1. 59e-i-00 9 .Oa-i-OO -0.2 -0.1 2 . 9  E -0.0 -1, .3e-05 Nikolov e( al., 1989 
2. 32e+00 l .Sa-t-Ol 0.1 0.0 2 . 7  
- •  
P -0.0 -1. ,3e-05 Nikolov et al.. 1989 
2. OOe-01 1.2a4-01 -0.0 -0.1 2 . 6  - 2 .9 5.5 1. .8e-02 Meagher and Reilly, 1989 
2. 60e-01 1.78+01 0.0 0.1 2 . 4  -2 .9 5.5 1, .8e-02 Meagher and Reilly, 1989 
4. 50e-01 9.38+00 -0.0 -0.1 2 . 9  -2 .9 5.7 1. ,8e-02 Meagher and Reilly, 1989 
5. 33e-01 l.la+01 0.0 -0.0 2 . 8  -2 .9 5.7 1. 8e-02 Meagher and Reilly,1989 
1. 55e+00 l .Oa+Ol -0.1 0.0 2 . 9  -2 .9 5.9 1. ,8e-02 Meagher and Reilly, 1989 
1. 32e+00 l . la+Ol 0.0 c.o 2 . 9  -2 .9 5.9 1. 8e-02 Meagher and Reilly, 1989 
1. 29e+00 1.2a+01 0.1 0.1 2 . 8  Fierobe et al.. 1996 
2. 76e*00 4.58+00 -2.2 -0.6 3 . 2  Fagerstrom, 1991 
5. 23e-01 3.28+01 
-0.2 0.3 2 . 3  Fagerstrom. 1991 
1. 70e+00 1.28+01 -1.0 -0.0 2 . 7  Fagerstrom and Kalkkinen. 1995 
Table 1. (continued) 
COMPOUND 
Inhibitor or Substrate 
Source 
Organisin 
Form or 
Mutant 
Sub 
Pan 
pH T Activity 
(O RacIo 
Activity Vmax/Km Iccat/Km 
(U int-l)  (i-t  inM-I) 
D-isomaltotriose R. 
D-isomaltotriose S. 
D-isomaltotriose S. 
Isomaltntriaise - Mutants 
D-isonialtatriose A. 
D-isomaltotriose A. 
D-isomaltotriose A. 
D-isomaltotriose A. 
Isnmaltotrinsg - Condensation 
J3:JiidnMJtbtooig@^^^ A. 
nj.veus 
diascacicus 
cerevisae 
awamori 
awamori 
awamori 
awamori 
A. niger 
A. niger 
A. niger 
A. niger 
A. niger 
A. niger 
A. niger 
A. niger 
A. niger 
A. niger 
A. saicoi 
Rhizopus sp. 
• DISACCHARIDES -
Inhimgfg 
methyl aipha-acarvioniside 
methyl beta-acarvioniside 
methyl acarviosinide 
methyl 5'-tIuo-4-N-alpha-
-D-maltoside 
methyl alpha-4-thiomaltoside 
methyl beta-4-thiomaltoside 
methyl alpha-4^'-<lithiomaltoside 
methyl alpha-4.S'-dithiomaltoside 
methyl aIpha-4-Se-5'-
-thiomaltoside 
methyl alpha-S'-thiomaltoside 
D-maltitol 
D-maltitol 
gubrtraleAnatgg 
.methyl 6-deoxy-beta-
-D-maltoside A. awamori 
1-deoxy-D-maltose A. awamori 
methyl beta-D-maltoside A. awamori 
I,2-dideoxy-D-inaltose A. awamori 
methyl 2'-deoxy-beta-
-D-maltoside A. niger 
meihyl 3'-deoxy-beta-
-D-maltoside A. niger 
methyl 3-deoxy-beta-
-D-maitoside A. awamori 
6'-deoxy-D-maltose A. niger 
4'-deoxy-D-maltose A. niger 
Substrate Analogs - Mutants 
methyl beta-D-maltoside A. awamori 
1-deoxy-D-maltose A. awamori 
1,2-dideoxy-D-mallose A. awamori 
methyl 3-deoxy-beta-
-D-maltoside A. awamori 
methyl 6-deoxy-beta-
-D-maltoside A. awamori 
STA2 
L3 
L5 
L3L5 
N182A 
G2 
G2 
G1 
G2 
G2 
G2 
G2 
G2 
G2 
G2 
Ml 
G1 
G1 
G1 
G1 
EiaOQ 
E180Q 
ElBOQ 
E180Q 
ElBOQ 
4.5 
4.6 
25 
37 
30 
99 (il 
84 (i) 8.0e-02 
400 (i) 
niger CI A 4.5 25 
niger G1 A 
in 35 
niger G1 A 4.5 45 
238695 (i) 
85903 (i) 
48475 (!) 
A 4.5 27 
A 4.5 27 
A 4.5 25 
A 4.5 45 
A 4.5 27 
A 4.5 27 
A 4.5 27 
A 4.5 45 
A 4. .5 45 
A 4. .5 45 
A 5, .0 37 
B 5, .0 37 
4.5 45 
4.5 45 
A 4.5 45 1.3e-05 
A 4.5 45 3.2e-03 
2.05e-02 
A 4.5 45 94 (i) 1.67e-02 
A 4.5 45 144 (i) 4.45e-03 
A 4.5 45 17 (i) 2.13e-01 
A 4.5 50 33 (i) 2.02e-01 
1.62e-02 
4.73e-02 
1.25e-01 
A 4. .5 45 2 1. .50e+01 
A 4. .5 45 2 1. ,38e+01 
A 4. .5 45 1 7. .60e*00 
A 4. .5 45 2.fie-01 1. .90e+00 
6.54e+00 
2.21e-01 
A 4 .  5 45 1.5e-02 l.lOe-01 
A 4 . 5 45 1.02e-02 
A 4 . 5 45 5.87e-03 
A •• , .5 45 9.0e-04 6. .60e-03 
A 4 . 5 45 2.3e-03 1. .68e-02 
A 4. .5 45 3.0e-03 2. .16e-02 
9.40e-05 
2.32e-02 
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Vmax kcat KmorKi ICSO Sub/ d(dG)t d(dG)h -dG -dH TdS dS 
(Umc-l) (s-I) (inM) (mM) Mclh -> •> (kcaVmaO <• <- (kal/moLK) 
Reference 
4.08e-01 2.0a4>01 0 . 2  2.3 Tanakaond Takeda. 1994 
Modenaetal.. 1986 
Kleinman et al„ 1988 
3.50e-01 2.1«+01 
4.81e-01 l . l«-»'02 
l.iee-KOO 5.4a'f00 
1.78e+00 S.Sa-t-OO 
1.2 0.4 
2.0 1.5 
-0.4 -0.4 
-0.4 -0.2 
2.4 
1.4 
3.3 
3.0 
Fierobe et al.. 1996 
Fierobe et al.. 1996 
Rerobe et al.. 1996 
Qien et al„ 1994 
1.95e-01 1.2«+01 
5.30e-01 l . lA'fOl 
1.31e+00 l .Oe+01 
LOye. 0.2 
Sr-TOiO; 0.1 
- 0 . 0  
2.6 -1.3 3.9 1.3e-02 Nikolovetal.. 1989 
2.8 -1.3 4.0 1.3e-02 Nikolovetal.. 1989 
2.9 -1.3 4.1 1.3e-02 Nikolovetal.. 1989 
5.Q«-05 
2.9a-04 
1.6«-03 
4.0«-03 
3.1a-02 
1.7a-01 
3.3a-01 
2.0a')-00 
-5.6 10.0 5.4 4.6 1.5e-02 Sigurskjoldeial.. 1994 
-4.6 9.0 7.3 1.7 5.7e-03 Sigurskjoldeial.. 1994 
pd -3.5 7.9 Svensson and Sierks. 1992 
M -3.7 7.9 Andrews etal.. 1995 
-1.8 6.2 1.4 4.8 1.6e-02 Sigurskjoldetal.. 1994 
-0.7 5.2 3.3 1.9 6.3e-03 Sigurskjold etal., 1994 
-0.4 4.8 1.4 3.4 l.le-02 Sigurskjoldetal„ 1994 
M 0.2 3.9 Mehta etal.. 1995 
S.Oa-Ol 
l.Sa-i-OO 
4.6a-01 
l. la+OO 
M 
M 
M 
M 
-0.3 
- 0 . 0  
-0.5 
0.1 
4.5 
4.2 
4.7 
4.2 
Mehta etal.. 1995 
Mehta et al.. 1995 
Iwama, et al.. 1985 
Iwama. et al.. 1985 
-0 .7 Sierks and Svensson. 1992 
-0 .6 Sierks and Svensson, 1992 
-0 .2 Sierks and Svensson, 1992 
0.6 Sierks and Svensson. 1992 
-0.1 Sierks etal., 1992 
2.0 Sierks et al., 1992 
2 .4 Sierks and Svensson. 1992 
3 .9 Sierlcs et al., 1992 
4 .3 Sierks et al., 1992 
4 .4 Sierks and Svensson, 1992 
3 .8 Sierks and Svensson. 1992 
3 .7 Sierks and Svensson, 1992 
7 .1 Sierks and Svensson, 1992 
3 .6 Sierks and Svensson, 1992 
Table 1. (continued) 
COMPOUND Source Fonnor Sub pH T Activity Activity Vmaz/Km kcat/Km 
Inhibitor or Substrate Organism Mutant pam (q Ratio (u me-i) (s-i mM-i) 
Snhrtrate tTvdrolvsis 
D-maltose (#) A. ttiger G1 WC A 4.5 8 1.83e+00 
[^-maltose (#) A. niger G2 A 4.5 25 3.50e+00 
D-maltose (#) A. niger G1 A 4.5 25 2.98e+00 
D-maltose (#) A. niger G1 A 4.5 25 3.87e+00 
D-maliose (#) A. niger A 4.5 25 2.62e+00 
D-maltose (#) A. niger G2 A 4.5 25 2.12e+00 
D-maltose (#) A. niger G1 A 4.5 35 8.31e-t-00 
D-maltose (#) A. niger G2 A 4.5 35 5.24e+00 
D-maltose (#) A. niger G1 A 4.5 35 4.08e+00 
D-maltose (#) A. niger A 4.5 40 5 .5e+00 7.14e+00 
D-maltose (#) A. niger G1 wt A 4.5 45 l.Ole+01 
D-maltose (#) A. niger G1 wt A 4.5 45 8.84e+00 
D-maltose (#) A. niger G1 A 4.5 45 6.00e+00 
D-maltose (#) A. niger G2 A 4.5 45 7.40e+00 
D-maltose (#) A. niger G1 A 4.5 45 6.09e+00 
D-maltose A. niger G2 A 4.5 45 
D-maltose A. niger A2 A 3.8 25 2.24e+00 
D-maltose A. niger A3 A 4.2 25 1.02e+01 
D-maltose A. niger B1 A 5.0 25 - 1.13e+00 
D-maltose A. niger B2 A 4.2 25 - 3 .06e+00 
D-maltose A. niger B3 A 4.0 25 - 2.80e+00 
D-maltose A. niger G1 A 4.3 25 - 7 .7e+01 
D-maltose A. niger G2 A 4.3 25 - 7 .9e+01 
D-maltose A. niger G2 A 4.3 37 - 3 .  6e-^01 
D-maltose A. niger A 4.8 60 - 3 .2e+01 
D-maltose A. niger A 4.5 55 4.04e+00 
D-maltose A. niger -
D-maltose A. awamori wc A 4.5 35 - 1.20e+01 
D-maltose A. awamori wc A 4.5 35 - 8.17e+00 
D-maltose A. awamori A 4.5 37 - 3.68e*00 
D-maltose A. awamori V I Z  A 4.4 45 - 2.02e+01 
D-maltose A. awamori W L  A 4.5 45 - S.57e+00 
D-maltose A. awamori V I Z  A 4.5 45 - 6.57e+00 
D-tnaltose A. awamori V I Z  A 4.5 45 - 6.21e+00 
D-maltose A. awimori A 4.5 45 - 7.30e*00 
D-maltose A. awamori V I Z  A 4.4 50 - 8.32e+00 
D-maltose A. bacacae A 4.5 30 -
D-maltose A. ficuum A 5.0 37 - 1. .Oe+00 1.28e+00 
D-maltose A. oryzae A 5.0 40 - 2, . Oe+00 2.31e+00 
D-maltose A. oryzae A 5.0 40 - 9. , Oe+00 
D-maltose A. saitoi A 5.0 25 - 1.91e-t-00 
D-maltose A. saicoi HI A 6.0 37 - 1. .4e+00 2.17e+00 
D-maltose A. saicoi Ml A 4.8 37 -
D-maltose A. saicoi K2 A 6.0 37 - 1. .4e->-00 1.59e+00 
D-maltose Asp. sp. K-21 A 4.5 45 -
D-maltose Asp. sp. K-27 A 4.5 45 - 1.15e*01 
D-maltose C. paradoxa A 5.0 25 - 6.83e+00 
D-maltose H. grisea ctierm. A 5.0 55 - 1. 2e+01 1. ,le+00 1.16e+00 
D-maltose H. resinae P A 4.3 25 - 3 .54e+00 
D-maltose H. resinae P A 4.3 37 - 5. 6e+01 
D-maltose H. resinae S A 4.3 25 - 3 .54e+00 
D-maltose H. resinae c A 4.3 37 - 2. 7e*01 
D-maltose N .  crassa A 5.0 37 - 1. ,8e*01 2.47e+01 
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Vmax kcat Kmor Ki IC50 Sub/ d(dG)t d(dG)b •dG •dH TdS dS Reference 
(Umt-I) (mM) (mM) Meth -> •> (kcal/maD c- <• (kcal/moUO 
3 .30e-01 1.8«-01 -0.1 -0.1 4.8 8 7 -4.0 -1.4e-02 Olsenetal. 1992 
1 .40e+00 4.0«-01 -0.0 -0.2 4.e 8 7 -4.3 -1.4e-02 Enneretal.. 1993 
1 .37e+0a 4.6e-01 0.1 -0.1 4.6 8 7 -4.3 -1.4e-02 Olsenetal. 1992 
2 .13e+00 5.5e-01 -0.1 0.0 4.4 8 7 -4.3 -1.4e-02 Meagher and Reilly. 1989 
1 .65e+00 fi .3a-01 0.1 0.1 4.4 8 7 -4.3 -1.4e-02 Ohnishietal. 1990 
2 .27e+00 l . la-i-OO 0.3 0.4 4.1 8 7 -4.3 -1.4e-02 Meagher and Reilly, 1989 
5 .90e+00 7.1a-01 -0.3 -0.1 4.4 8 7 -4.4 -1.4e-02 Olsenetal. 1992 
5 .19e+00 9.9a-01 -0.0 0.1 4.2 8 7 -4.4 -1.4e-02 Meagher and Reilly. 1989 
5 .02e+00 1.2a-i-00 0.1 0.2 4.1 8 7 -4.4 -1.4e-02 Meagher and Reilly. 1989 
5 •Oe+OO 6 -SOe+OO 9.1a-01 -0.1 -0.1 4.4 8 7 -4.5 -1.4e-02 Abeetal.. 1985 
1 .14e+01 l. la+OO -0.2 -0.1 4.3 8 7 -4.5 -1.4e-02 Fiandsen et al.. 1994a 
1 .07e+01 1.2a-f00 -0.1 -0.1 4.2 8 7 -4.5 -1.4e-02 Frandsen et al.. 1994b 
7 .800+00 1.3a-i-00 0.2 -0.0 4.2 8 7 -4.5 -1.4e-02 Olsenetal. 1992 
1 .04e+01 1.4a't-00 0.0 0.0 4.2 8 7 -4.5 -1.4e-02 Meagher and Reilly.1989 
1 .06e+01 1.7a+00 0.1 0.1 4.0 8 7 -4.5 -1.4e-02 Meagher and Reilly, 1989 
1.2a+00 
-0.1 4.3 Mehtaetal.. 1995 
1 21e+00 5.4a-01 0.2 -0.0 4.5 Ono el al.. 1988 
4 58e+00 4.Se-01 -0.7 -0.1 4.6 Ono et al., 1988 
1 82e+00 l .Sa+OO 0.6 0.6 3.8 Onoetal., 1988 
2 05e+00 6.7a-01 0.0 0.1 4.3 Ono el al., 1988 
1 65e+00 5.9a-01 0.1 0.0 4.4 Ono et al., 1988 
Svensson et al., 1982 
Svensson et al.. 1982 
4 •Oe+Ol 1.le+00 0.1 4 .2 McCIeorly and Anderson. 1980 
Schumacher and Kroh. 1994 
1 90e+01 4.7a+00 0.7 0.5 3.5 Nagyetal., 1992 
8 67e+00 7.2a-01 -0.5 -0.1 4.4 Li, unpublished results 
S 9Xe+00 1.le+00 -0.3 0.1 4.2 Allen, unpublished results 
7 00e*00 1.9a+00 0.3 0.4 3.9 Savel'ev et al., 1982 
2. 04e+01 1.Oe+OO -0.6 -0.2 4.4 Fang, unpublished results 
9. 20e+00 1.4a+00 0.1 0.0 4.2 Natarajan and Sterks, 1996 
9. 20e+00 1.4a+00 0.1 0.0 4.2 Sierks and Svensson, 1993 
1. 13e+01 1.8e+00 0.1 0.2 4.0 Fierohe et al., 1996 
0.0 Sierks and Svensson, 1993 
1. 44e+01 1.7a+00 0.1 0.0 4.1 Sierks et a]., 1989 
1.4e+00 0.4 4.0 Bendelskii et al., 1974 
7 Oe-01 6.7e-01 0.9 -0.2 4.5 Vandersall et al., 1995 
2 4e-t-00 1.2a+00 0.6 0.1 4.2 Nagashima et at., 1995 
Sahaet al., 1979 
2. 20e+00 1.le+00 0.3 0.4 4.0 Koyama et al., 1984 
3 9e+00 2.7e+00 0.6 0.6 3.6 Takahashi et al., 1981 
2.4e+00 Pn 0.6 3.7 Takahashi el al.. 1981 
4 le+00 3.aa+00 0.8 0.7 3.6 Inokuchi eial., 1981 
2.4e+01 1.8 2.4 Ghosh el al., 1991 
1. 50e+01 1.3e+00 -0.3 -0.0 4.2 Abeetal.. 1990 
8. 20e+00 1.2e+00 -0.4 0.5 4.0 Monmaetal., 1989 
8 9e+00 S.3e+00 1.5 0.9 3.1 Tosieial., 1993 
3 . 92e+00 1.le+00 -0.0 0.4 4.0 10 5 -6.5 -2.2e-02 Fagentrom. 1991 
1 2e->-02 2.2e+00 0.5 3.8 10 5 -6.7 -2.2e-02 McCleariy and Anderson. 1980 
5. 03e+00 1.4e+00 -0.0 0.6 3.9 3. 6 0.3 8.5e-04 Fagerstrom. 1991 
4 8e+01 1.8e+00 0.4 3.9 3. 6 0.3 8.5e-04 McGearly and Anderson. 1980 
7 2e+01 4.Oe+OO 
-0.9 0.9 3.4 -2 2 5.6 I.Se-02 SIgmundeial., 1985 
Table 1. (continued) 
COMPOUND Source Former Sub pH T Activity Activity Vmax/Km iccat/Km 
Inhibitor or Substrate Organisin Mutant Pom tC) Ratio (U mc-l) (s-1 inM-l) 
D-maltose AT. crassa A 
o
 
in 60 - 1.30e+01 
D-maltose T. laauginosus A 
o
 
in 50 - l.le+01 
D-maltose T. reesei A 
in in 30 - 2.86e->-00 
D-maltose R. niveus B 4.5 0.5 - 7.32e-01 
D-maltose R. niveus B 4.5 25 - 2.02e-t-00 
D-maltose Rhizopus sp. B 5.0 25 - 2.16e+00 
D-maltose R. delemar B 
in 25 - 4.18e-i-00 
D-maltose R. delemar G1 B 4.5 40 - 5 .8e+00 5.89e+00 
D-maltose R. delemar G2 B 4.5 40 - 6 .3e+00 7.37e+00 
D-maltose R. delemar G3 B 4.5 40 - 3 .9e+00 5.07e+00 
D-maltose A. adenini vorans C 4.5 50 - 9 .7e-02 4.01e+00 
D-maltose A. adeninivorans C 4.5 50 - 4 .3e-01 3.35e+00 
D-maltose A. adenini vorans c 5.0 60 -
D-maltose S. fibuligera G1 D i
n
 in 37 -
D-maltose S. fibuligera G2 0 5.5 37 -
D-maltose S. fibuligera GLAl • 5.6 40 - 5.2e-^0a 
D-maltose S. diascacicus STA2 E 5.0 30 - 2. 3e+01 2.08e+00 
D-maltose S. diascacicus STA2 E 4.6 37 - 6.8e+00 3, .9e-01 1.94e+00 
D-maltose S. cerevisae E - 30 - 2. .7e-02 1.12e-01 
D-maltose Closeridxum G0005 wt F 
tn 25 - 2.81e-^00 
D-maltose cioscridium G0005 F 4.5 25 - 5.29e+00 
Mutant Analysis 
D-maltose A. awamori L3 A 
in 45 4 (i) 1.58e+00 
D-maltose A. awamori L5 A 4.5 45 10 (i) 6.41e-01 
D-maltose A. awcuaori L3L5 A 4.5 45 2 (i) 3.53e+00 
D-maltose A. awamori N20C A 4.5 35 2 (•) 5.67e+00 
D-maltose A. awamori N20C/A27C A 4.5 35 1 (i) 1.07e+01 
D-maltose A. awamori N20C/A27C 
/S30P A 4.5 35 1 (i> 7.60e+00 
D-maltose A. awamori N20C/A27C 
/S30P/G137A A 4.5 35 1 (i) a.l9e+00 
D-maltose A. awamori A27C A 4.5 35 1 li) 9.33e+00 
D-maltose A. awamori A27P A 4.5 35 1 I I )  1 .08e+01 
D-maltose A. awamori S30P A 4.5 35 1 ( i )  6.87e+00 
D-maltose A. awamori S30P/G137A A 4.5 35 1 ( i )  7.21e+00 
D-maltose A. niger y48W A 4.5 45 289 (i) 3.06e-02 
D-maltose A. awamori (Y48F49)W A 4.4 45 849 (i) 2.38e-02 
D-maltose A. niger R54L A 4.5 45 2850 (i) 3.10e-03 
D-maltose A. niger R54K A 4.5 45 SfiO ( i l  1.34e-02 
D-maltose A. awamori D55G A 4.5 45 452 ( i )  2.67e-02 
D-maltose A. awamori K61R A 4.5 35 1 ( I I  1.12e+01 
D-raaltose A. awamori T72C/A471C A 4.5 35 1 ( I l  1.17e+01 
D-tnaltose A. niger r)112Y A 4.5 45 1 (t) 6.80e->-00 
D-maltose A. awamori Y116A A 4.5 45 6 ( i l  1.0961-00 
D-maltose A. awamori Y116W A 4.4 45 2 I I I  1 .20e+01 
D-maltose A. awamori S119Y A 4.5 45 1 ( i l  9.18e+00 
D-raaltose A. niger W120F A 4.5 8 10 (1) 1.92e-01 
D-maltose A. awamori W120F A 4.4 50 43 I I I  1.96e-01 
D-maltose A. awamori W120H A 4.4 50 116 l i )  7.17e-02 
D-maltose A. awamori W120L A 4.4 50 17  l i )  4.81e-01 
D-maltose A. awamori W120Y A 4.4 50 45 ID  1 .86e-01 
D-maltose A. awamori G121A A 4.4 45 1 I I )  2.79e+01 
D-maltose A. awamori G12ly A 4.5 45 3 ID  2.47e+00 
D-maltose A. awamori R122Y A 4.5 45 18  I I I  3 .57e-01 
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Vmax kcat KmorKi ICSO SdV d(dG)t d(dG)b -dG •dH TdS dS Reference 
(Umt-I) (*•1) (mM) (mM) Metb -> -> (kcalAnal) < c- (lualAnoLK) 
3.1«+00 0.0 0.1 3.8 -2 .2 6 .0 1.8e-02 Spinellietol.. 1996 
2.3a-f00 0.2 3.9 Raoecai.. 1981 
6 .OOe+00 2.1a-»00 0.2 0.7 3.7 Fagerstrom and Kalkidnen. 
6 .OOe-01 8.2a-01 0.2 0.9 3.9 3. 5 0 .3 1.2e--03 Tanaka et al.. 1983 
2 .83e+00 1.4a-»00 0.3 0.6 3.9 3. 5 0 .4 1.2e--03 Ohnishietal. 1990 
3 .32e+00 l .Sa-i-OO 0.3 0.6 3.8 fCoyaniaetal.. 1984 
4 .eOe-i-00 l . la+OO -0.1 0.4 4.0 Hiromi et al.. 1973a 
1 -le+Ol l .Sa-fOO 0.0 0.3 3.9 Abeetai.. 1985 
1 .2e+01 i.ga+oo -0.1 0.3 3.9 Abeetal.. 1985 
7 .8e+00 2.0a-i-00 0.1 0.4 3.9 Abeetai., 1985 
1 •le+OO 1.4 1.2 2.9 Buttneret al.. 1987 
3 .3e+00 T.Sa-fOO 0.7 1.0 3.1 Bui et al.. 1996 
4.6a-i-00 0.4 3.6 Buttneret al.. 1991 
S.Sa-fOO 1.3 3.0 Futalsugi et al.. 1993 
2.6a-)-00 0.6 3.7 Futatsugi et al.. 1993 
Solovicova' et al.. 1996 
4 .le+02 l .Sa-i-Ol 0.4 2.0 2.4 Tucker etal.. 1984 
1 .2e+00 3.2a'f00 0.6 0.7 3.5 Modena et al.. 1986 
9 .5e-02 3.Sa-i-00 2.2 1.0 3.4 Kleinman et al.. 1988 
6 .92e+00 2.5a4-00 0.1 0.9 3.6 Ohnishi et al.. 1994 
1 .94e+01 S.Ta+OO -0.3 1.1 3.3 Ohnishi et al., 1992 
5 .65e+00 3.6a-«-00 0.9 0.4 3.6 Rerobe et al., 1996 
4. .lOe+00 6.4a4'00 1.4 0.8 3.2 Fierobe et al.. 1996 
5, .69ei-00 l .f ia-t-OO 0.4 -0.1 4.1 Fierobe et al., 1996 
3 , .97e*00 7.0a-01 0.5 -0.0 4.4 Li, unpublished results 
9, .61e*00 9.0e-01 0.1 0.1 4.3 U. unpublished results 
9. .95e+00 1.3a+00 0.0 0.1 4.1 Allen, unpublished results 
1. .06e+01 1.3a'«'00 -0.0 0.1 4.1 Allen, unpublished results 
8. .02e-^00 8.6a-01 0.2 0.1 4.3 Li. unpublished results 
1. ,15e+01 l . la-fOO 0.1 0.2 4.2 Li. unpublished results 
1. .02e+01 l-Sa+OO 0.1 0.2 4.0 Allen, unpublished results 
1. ,12e+01 l .Sa-fOO 0.1 0.2 4.0 Allen, unpublished results 
1. ,20e-01 3.9a-^00 3.6 0.7 3.5 Frandsen et al., 1994b 
2. 36e-01 9.984-00 4.3 1.4 2.9 Fang, unpublished results 
9. 40e-03 3.08-^00 5.1 0.6 3.7 Frandsen et al., 1995 
7 . 90e-03 5.9a-01 4.2 -0.5 4.7 Frandsen et al., 1995 
4 . OOe-02 1.584-00 3.5 0.0 4.1 Sierks and Svensson, 1993 
8. 40e+00 7.5a-01 0.0 0.0 4.4 Li. unpublished results 
1. 02e+01 8.7a-01 0.0 0.1 4.3 Li. unpublished results 
7. 62e+00 l . la-t-OO 0.2 -0.0 4.3 Frandsen et al.. 1994a 
6. 20e-01 5.7a-01 1.1 -0.6 4.7 Sierks and Svensson, 1996 
1. 17e+01 9.8e-01 0.3 -0.0 4.4 Fang, unpublished results 
1. Ole+01 l . la-fOO -0.2 -0.2 4.3 Sierks and Svensson, 1994 
1. OOe-02 5.2a-02 1.3 -0.7 5.5 12. 3 -6 .8 -2.4e-02 Olsenetal., 1993 
1. 78e-01 9.1a-01 2.4 -0.4 4.5 12. 3 -7, .8 -2.4e-02 Sierks etal., 1989 
6. 59e-02 9.28-01 3.1 -0.4 4.5 Sierks etal.. 1989 
2. 55e-01 5.3a-01 1.8 -0.8 4.8 Sierks et ol.. 1989 
1. 18e-01 6.38-01 2.4 -0.6 4.7 Sierks et al., 1989 
1. 78e^01 6.48-01 
-0.2 -0.3 4.7 Fang, unpublished results 
4. OOe+00 1.684^00 0.6 0.1 4.1 Natarajan and Sierks. 1996 
2. 75e-01 7.78-01 l.B -0.4 4.5 Natarajan and Sierks. 1996 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pan (O Ratio (U mc-l) (1-1 inM-I) 
D-maltose A. awamori P123G A 4.5 25 1 2.71e+00 
D-maltose A. awamori Q124H A 4.5 45 8 8.55G-01 
D-maltose A. awamori R125K A 4.5 45 1 l.lOe+01 
D-maltose A. niger D153N A 4.5 45 1 7.08e*00 
D-maltose A. aweimori D176N A 4.4 50 71 1.17e-01 
D-maltose A. awamori L177H A 4.4 50 17 4.9G-01 
D-maltose A. awamori W178R A 4.4 SO 7 1.22e+00 
D-maltose A. awamori E130Q A 4.4 50 225 3.70e-02 
D-maltose A. awamori E180Q A 4.5 45 183 3.60e-02 
D-maltose A. awamori N182A A 4.4 50 1 8.41e+00 
D-maltose A. awamori N182A A 4.5 50 1 6.74e+00 
D-maltose A. awamori G183K A 4.5 45 1 9.63e+00 
D-maltose A. awamori S184H A 4.5 45 1 1.09e+01 
D-maltose A. awcunori D238N A 4.5 35 1 9.16e+00 
D-maltose A. awamori D238N/G396S A 4.5 35 1 8.71e+00 
D-maltose A. awamori R241K A 4.4 45 2 S.86e-^00 
D-maltose A. awamori A246C A 4.5 45 4 1.69e+00 
D-maltose A. niger E259D A 4.5 45 1 l.OGe+01 
D-maltose A. niger E259Q A 4.5 45 1 9.43e+00 
D-maltose A. awamori K279R A 4.5 35 1 l.OOe+Ol 
D-maltose A. awamori D293P A 4.5 35 1 6.72e+00 
D-maltose A. niger R305K A 4.5 45 3685 2.40e-03 
D-maltose A. awcimori Y306F A 4.5 45 3 2.23e+00 
D-maltose A. niger D309E A 4.5 45 51 1.74e-01 
D-maltose A. awamori D309N A 4.5 45 103 6.40e-02 
D-maltose A. niger W317F A 4.5 45 21 4.29e-01 
D-maltose A. awamori C320A A 4.5 45 2 3.04e+00 
D-maliose A. awcimori D345P A 4.5 35 1 8.81e+00 
D-maltose A. awamori K352R A 4.5 35 1 8.03e+00 
D-maltose A. niger E389D A 4.5 45 1 8.04e-^00 
D-mal(ose A. niger E389Q A 4.5 45 1 9.17e+00 
D-maltose A. niger A392D A 4.5 45 2 6.15e+00 
D-maltose A. awamori A393P A 4.5 35 1 1.20e+01 
D-maltose A. awamori G396S A 4.5 35 1 8.30e+00 
D-maltose A. niger E400Q A 4.5 45 498 2.03e-02 
D-maltose A. niger E400Q A 4.5 45 438 2.02e-02 
D-maltose A. niger Q401E A 4.5 45 3 3.02e+00 
D-maltose A. niger Q401E A 4.5 45 3 3.20e+00 
D-maltose A. awamori K404R A 4.5 35 1 1.91e+01 
D-maltose A. awamori E408P A 4.5 35 1 9.30e+00 
D-maltose A. awamori S411G A 4.4 45 1 1.45e+01 
D-maltose A. awsunori S411A A 4.4 45 1 l.SOe+Ol 
D-maltose A. awamori S411C A 4.4 45 1 1.48e*01 
D-maliose A. awamori S411H A 4.4 45 14 1.45e*00 
D-maltose A. awamori S411D A 4.4 45 17 1.22e+00 
D-maltose A. awamori A435P A 4.5 35 1 1.25e+01 
D-maltose A. awctmori S436P A 4.5 35 1 1.15e+01 
D-maltose A. awamori s4eop A 4.5 35 1 9.89e+a0 
D-maltose Closcridium G0005 W321F F 4.5 25 1 2.19e+00 
D-maltose (W52) Closcridium G0005 W337F F 4.5 25 234 1.20e-02 
D-maltose (W178) Clostridium G0005W433F F 4.5 25 2 1.63e+00 
D-ntaltose Closcridium GOOOS W569F F 4.5 25 1 2.61e+00 
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kcat KmorKi IC50 Sab/ d(dG^ d(dG) b •dG -dH TdS dS Reference 
(*•1) (mM) (mM) Mcth •> •> (kalAnol) <- <- (kcal/nuLK) 
1.41e+00 5.2a-01 0.2 -0.0 4.S Noiarajan and Sierfcs. 1996 
6.30e-01 7.4«-01 1.3 -0.4 4.6 Natarajan and Sieifcs. 1996 
6.69e-t-00 6.1a-01 -0.3 -0.5 4.7 Natarajan and Sierfcs. 1996 
8.49e+00 1.2«'f00 0.2 0.0 4.3 Ftandsenetal.. 1994a 
7.28e-01 6.2m*00 2.7 0.8 3.3 Sierfcs ecal„ 1990 
2.60e+00 5.3a-f00 1.8 0.7 3.4 Sierfcs et al.. 1993 
1.86e+00 l.Sa+OO 1.2 -0.1 4.2 Sierfcs et al„ 1993 
1.53e+00 4.1a-»01 3.5 2.0 2.0 Sierfcs et al., 1990 
1.27e+00 3.5a+01 3.3 2.0 2.1 Sierfcs and Svensson. 1993 
1.16e+01 l.ia+'OO -0.0 -0.1 4.2 Sierfcs et al.. 1993 
1.22e+01 l.Ba-fOO 0.1 0.0 4.1 Chenetal„ 1994 
1.04e+01 l.la+00 -0.2 -0.2 4.3 Sierfcs and Svensson. 1994 
9.80e+00 9.0a-01 -0.3 -0.3 4.4 Sierfcs and Svensson. 1994 
1.08e+01 1.2a-i-00 -0.1 0.1 4.1 Allen, unpublished results 
8.88e-)-00 l.Oa+OO -0.0 -0.0 4.2 Allen, unpublished results 
2.01e+01 2.3a-i-00 0.5 0.5 3.8 Fang, unpublished results 
4.90e+00 3.9a-i-00 0.8 0.3 3.7 Fierobe et aL. 1996 
9.34e+00 
H
 
O
 
•
 
CO CD 
-0.0 -0.2 4.4 Frandsen et al.. 1994a 
S.SSei-OO 9.1a-01 0.0 -0.1 4.4 Frandsen et al.. 1994a 
7.82e+00 7.8a-01 0.1 0.0 4.4 Li. unpublished results 
1.57e+01 2.3a-)-00 0.1 
5.3 
0.5 3.7 Allen, unpublished results 
Frandsen et al.. 1995 
8.20e+00 3.7a'f00 0.7 0.6 3.5 Sierfcs and Svensson. 1993 
9.10e+00 S.2a't-01 2.6 2.4 1.9 Frandsen el al.. 1995 
3.20e-01 S.Oa-i'OO 2.9 0.8 3.3 Sierfcs and Svensson. 1993 
6.00e+00 1.4a '«'01 2.0 1.5 2.7 Frandsen et al.. 1995 
7.90e+00 2.6a+00 0.5 0.2 3.8 Rerobe et al.. 1996 
1.12e+01 1.3a-)-00 -0.0 0.1 4.1 Allen, unpublished results 
8.35e-t-00 l.Oa-fOO 0.2 0.2 4.2 Li. unpublished results 
9.33e+00 1.2a-)-00 0.1 0.0 4.3 Frandsen et al.. 1994a 
l.OOe+01 l.la'fOO 0.1 -0.0 4.3 Frandsen et al.. 1994a 
9.35e+00 l.Sa-i-OO 0.3 0.2 4.1 Frandsen et al.. 1994a 
l.OBe-^Ol 9.0a-01 0.0 0.1 4.3 Li. unpublished results 
7.72e+00 9.3a-01 -0.0 -0.1 4.3 Allen, unpublished results 
3.00e-01 l.Sa-fOl 3.9 1.6 2.7 Frandsen et al.. 1994a 
2.99e-01 l.Sa-fOl 3.8 1.6 2.7 Frandsen et al.. 1994b 
3.29e*Q0 l.la-t-OQ 0.7 -0.1 4.3 Frandsen et al.. 1994b 
3.49e+00 l.la-i-00 0.7 -0.0 4.3 Frandsen et al., 1994a 
8.42e+00 4.4e-01 
-0.3 -0.3 4.7 Li, unpublished results 
1.20e+01 1.3a'»00 -0.1 0.1 4.1 Allen, unpublished results 
2.30e+01 l.fie'fOO 0.2 0.3 4.1 Fang, unpublished results 
1.89e->-01 1.3a-)-00 0.2 0.1 4.2 Fang, unpublished results 
7 .78ef00 5.3a-01 0.2 -0.4 4.8 Fang, unpublished results 
5.31e-00 3.7a-t-00 1.7 0.8 3.5 Fang, unpublished results 
4.3 6e+00 3.6a-f00 1.8 0.8 3.6 Fang, unpublished results 
9.34e-^00 7.5a-01 
-0.0 0.0 4.4 Li. unpublished results 
9.816-00 8.5a-01 0.0 0.1 4.3 Li, unpublished results 
5.24e+00 5.3e-01 0.1 -0.2 4.S Li. unpublished results 
6.80e+00 3.1a-t'00 0.1 0.1 3.4 Ohnishi et al.. 1994 
6.00e-03 S.Oa-01 3.2 -0.9 4.5 Ohnishi et al.. 1994 
4.22e+00 2.6e'i-00 0.3 0.0 3.5 Ohnishi et al.. 1994 
6.67e+00 2.6a-i-00 0.0 0.0 3.5 Ohnishi et al.. 1994 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity V max/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pom (O Ratio (Umg-l) (s-l mM-I) 
Product Condensatioii 
D-maltose (R) (#) A. niger G1 A 4.5 25 3.88e+03 
D-maltose (R) (#) A. aiger G1 A 4.5 35 4.07e+03 
D-maitose (R) (#) A. niger G1 A 4.5 45 6.06e+03 
-DISACCHARIDES-
* alpba-(l,6)-Iinked * 
Inhibitors 
methyl alpha-'isofagomin-Uke"-
-isomalcoside A. awamori A 4.5 45 
methyl alpba-'isofagomin-Iike'-
-isomaitoside N-oxide A. awamori A 4.5 45 
methyl IS-N-methyl-alpha-
-"isofagomin-like'-isomaltoside A. awamori A 4.5 45 
methyl IR-N-methyl-alpha-
-"isofagomin-like'-isomalloside A. awamori A 4.5 45 
methyl 5'-thio-aipha-
-D-isomalloside R. niveus B 4.5 20 
Substrate Analoes 
methyl 6R-C-methyl-aIpha-
-D-isomaltoside A. niger G1 A 4.5 45 9.50e-01 
4'-deoxy-methyl 6R-C-methyl-
-alpha-D-isomalloside A. niger G1 A 4.5 45 5.23e-04 
6'-deoxy-methyl 6R-C-methyl-
-aipha-D-isomaltoside A. niger G1 A 4.5 45 6.65e-04 
methyl 4-deoxy-alpha-
-D-iscmaltoside A. niger G1 A 4.5 45 7.61e-05 
methyl 3-O-methyl-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 1.97e-03 
methyl 2-O-methyI-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 4.21e-02 
methyl 2-deoxy-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 2.62e-02 
methyl 4'-0-methyl-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 2.24e-06 
methyl-4'-deoxy-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 6.13e-06 
methyl-2'-deoxy-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 8.49e-03 
methyl-3-deoxy-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 1.49e-03 
methyl-4-O-methyl-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 1.64e-05 
methyl-6'-deoxy-alpha-
-D-isomalioside A. niger G1 A 4.5 45 3.85e-06 
methy 1-3'-deoxy-al pha-
-D-isomaltoside A. niger G1 A 4.5 45 1.67e-03 
methyl-6S-C-methyl-alpha-
-D-isomaltoside A. niger G1 A 4.5 45 1.20e-02 
methyI-2'-0-metliyl-aipha-
-D-isomaltoside A. niger G1 A 4.5 45 6.70e-05 
methyl-3'-0-methyl-a]pha-
-D-isomaltostde A. niger G1 A 4.5 45 3 .30e-05 
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Vmax kcat Km or Ki 
(U ms-l) (>-I) (mM) 
ICSO Snb/ d(dG)t d(dG)b -dG -dH TdS dS 
(mM) Melh -> -> (kaVmon <• <- (kcalAnoUO 
Reference 
2.13e-)-00 5.5a-0« 
S.OOe-^OO 1.2C-03 
1.06e+01 1.7»-03 
-0.0 -0.0 8.5 10.8 -2.3 -7 .8e-03 Nikolov et al.. 1989 
0.1 0.1 8.3 10.8 -2.4 -7.8e-03 Nikolovetal., 1989 
-0.0 -0.0 8.4 10.8 -2.5 -7 . 8e-03 Nikolov et al.. 1989 
S.3«-05 
2.4«-04 
9.4e-02 
1.6a-01 
S.Sa+Ol 
M 
M 
-8.1 10.5 
-7.3 9.6 
-3.5 5.9 
-3.2 5.5 
0.3 1.9 
Dong et al.. 1996 
Dong et al.. 1996 
Dong et al.. 1996 
Dong et al.. 1996 
Hashimoto et al.. 1996 
6.80e-01 7.1e-01 
6.70e-04 
2.30e-02 
5.60e-01 
5.00e-Cl 
4.70e-05 
1.30e-04 
1.80e-01 
3.60e-02 
5 .40e-04 
1.50e-04 
9.50e-02 
1.10e*00 
8.884-00 
1.2a-i-01 
I.3a+01 
1.9a-f01 
I.la+Ol 
2.1a-|.01 
2.184-01 
2.4a4>01 
a . S a + O l  
3.9a+01 
5.7e+01 
9.0a-)-01 
-2.6 -2.2 4.6 
2 . 2  
2 . 0  
3.4 -0.6 3.0 
1.3 -0.5 2.8 
-0.6 -0.4 2.7 
-0.3 -0.1 2.5 
5.6 -0.1 2.4 
5.0 -0.1 2.4 
0.4 -0.1 2.4 
1.5 0.0 2.4 
4.4 0.2 2.2 
5.3 0.3 2.1 
1.4 0.5 1.8 
0.2 0.8 1.5 
3.5 
3.9 
Palcic et al.. 1993 
Frandsen et al.. 1996 
Frandsen et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al., 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Lemieux et al.. 1996 
Palcic etal.. 1993 
Lemieux et al.. 1996 
Lemieux et al., 1996 
Table 1. (continued) 
COMPOUND 
Inhibitor or Substrate 
Source 
Organisin 
Form or 
Matant 
Sub pH T Activity Activity Vmax/Km Iccat/Km 
Fan (O Ratio (U ms-l) (s-lmM-l) 
A 4.5 45 1.60e-05 
A 4.5 45 3 .93e-02 
A 4.5 45 4.24e-02 
A 4.5 8 4714 ) 3 .89e-04 
A 4.5 25 1646 ) 1.59e-03 
A 4.5 25 1593 ) 2.43e-03 
A 4.5 25 1755 ) 1.70e-03 
A 4.5 35 565 ) 7.23e-03 
A 4.5 35 897 ) 5.84e-03 
A 4.5 35 1411 ) 5.89e-03 
A 4.5 45 427 2.07e-02 
A 4.5 45 533 1.89e-02 
A 4.5 45 429 1.40e-02 
A 4.5 45 403 1.51e-02 
A 4.5 40 288 1.9e-02 2.48e-02 
A 4.5 37 788 4.6e-02 
A 4.5 37 727 5.0e-02 
A 4.4 45 658 3.07e-02 
A 4.5 45 586 1.12e-02 
A 4.5 45 586 1.12e-02 
A 4.5 45 683 9.09e-03 
A 4.4 50 615 1.35e-02 
A 5.0 37 170 6.1e-03 7.54e-03 
A 6.0 37 1460 9.9e-04 1.48e-03 
A 6.0 37 1447 9.4e-04 l.lOe-03 
A 4.3 25 27 1.32e-01 
A 4.3 37 18 3.le+00 
A 4.3 25 808 4.38e-03 
A 4.3 37 236 l.le-01 
A 5.0 55 4 3.3e+00 
A 5.5 30 136 2.11e-02 
B 4.5 25 467 4.33e-03 
B 4.5 40 309 2.8e-02 2.81e-02 
B 4.5 40 198 3.2e-02 3.72e-02 
B 4.5 40 173 2.2e-02 2.92e-02 
E 4.6 37 169 4.0e-02 
E 
- 30 97 2.8e-04 1.15e-03 
F 4 .5 25 4 1.28e+00 
A 4.5 45 156 l.Ole-02 
A 4.5 45 400 1.60e-03 
A 4.5 45 165 2.14e-02 
A 4.5 45 604 4.42e-05 
A 4.5 45 419 1.62e-02 
A 4.5 45 227 4.78e-03 
A 4.4 45 501 2.39e-02 
A 4.5 45 1071 8.57e-03 
A 4.4 50 100 1.85e-03 
A 4.4 45 1203 2.32e-02 
A 4.5 45 157 1.57e-02 
A 4.5 45 189 1.89e-03 
A 4.5 25 1130 2.40e-03 
meihyl-6'-0-raethyI-aIpha-
-D-isomaltoside A. niger 
roethyl-alpbii-D-isomaltoside A. niger 
methyl-alpba-D-isonialtoside A. niger 
Substrate Hvdrolvroi 
p-bogMtoft(^y 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomallose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomallose 
D-isomaltose 
D-isomaltose 
D-isomallose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
D-isomaltose 
G1 
G1 
G1 
SA. niger G1 
S A .  niger 
p A .  niger G1 
A. niger G1 
!&• 
^ A .  niger G1 
P A .  niger G2 
^ A. niger G1 
jpA. niger G1 wt 
I ^ A .  niger G1 Wt 
&'A. niger G1 
niger G1 
A. niger 
A. niger G1 
A. niger G2 
A. awamori WC 
A. awaaori Wt 
A. awamori wt 
A. awamori wt 
A. awamori wt 
A. ficuwa 
A. saitoi Ml 
A. sai coi M2 
H. resinae P 
H. resinae P 
H. resinae S 
H. resinae S 
H. grisea therm. 
T. reesei 
R. niveus 
R. delemar G1 
R. delemar G2 
R. delemar G3 
S. diascacicus STA2 
S. cerevisae 
Mutant Analysis 
D-isomaltose A. awamori L3 
D-isomaltose A. awamori L5 
D-isomaltose A. awamori L3L5 
D-isomaltose A. awamori D55G 
D-isomaltose A. niger D112y 
D-isomaltose A. awamori Y116A 
D-isomaltose A. awamori Y116W 
D-isomaltose A. awamori S119Y 
D-isomaltose A. awamori W120Y 
D-isomaltose A. awamori G121A 
D-isomaltose A. awamori G121Y 
D-isomaltose A. awamori R122Y 
D-isomallose A. awamori P123G 
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Vmax kcat KmorKi IC50 Sub/ d(dG)t d(dG)b -dG -dH TdS dS Reference 
(U mc-l) (s-1) (mM) (mM) Metli •> -> (kcml/mol) <- <- (kal/knoUO 
Lemieux et al.. 1996 
8 .80e-01 2.2a4'01 
^ —-a* -• 
-0.0 2.4 Lemieux et al.. 1996 
1 .04e-»'00 2.5«'f01 ' -(Tiff 0.0 2.3 Palcicetal.. 1993 
7 .OOe-03 l.Sa-fOl -0.1 2.2 0 .4 1 .8 6 .3e-03 Olsenetal., 1992 
3 .50e-02 2.2a'»^01 0.2, -0.0 2.3 0 .4 1 .9 6 .3e-03 Ohnishi et al.. 1990 
5 .90e-02 2.4*4^01 -0.1 0.0 2.2 0 .4 1 .9 6 .3e-03 Meagher and Reilly. 1989 
5 .60e-02 3.3a+01 0.1 0.2 2.0 0 .4 1 .9 6 .3e-03 Olsen et al.. 1992 
1 .52e-01 2.1«4-01 -0.1 -0.1 2.4 0 .4 1 .9 6 .3e-03 Meagher and Reilly.1989 
1 .34e-01 2.3a+01 0.0 -0.0 2.3 0 .4 1 .9 6 .3e-03 Meagheretal.. 1989 
1 .59e-01 2.7a-f01 0.0 0.1 2.2 0 ,  .4 1 .9 6 .3e-03 Olsenetal.. 1992 
4 •lOe-Ol S-Oa+Ol -0.1 -0.1 2.5 0, .4 2 .0 S .3e-03 Frandsen et al.. 1994b 
4 .20e-01 2.2a'f01 -0.1 -0.0 2.4 0, .4 2 .0 6 . 3 e- 0 3 Frandsen et al.. 1994a 
3 .50e-01 2.5a>01 0.1 0.0 2.3 0, .4 2 .0 6, .3e-03 Olseneial„ 1992 
3 .85e-01 2.5a+01 0.1 0.0 2.3 0, .4 2 .0 6, .3e-03 Meagher and Reilly.1989 
8 -Oe-Ol 4.2a+01 -0.6 0.4 2.0 Abeetal.. 1985 
1 .2e+00 2.68+01 0.1 2.2 McOearly and Anderson. 1980 
1 .2e+00 2.484-01 0.0 2.3 McGearly and Anderson. 1980 
7 .23e-01 2.4a+01 -0.4 -0.0 2.4 Fang, unpublished results 
3 .40e-01 3.0e-f01 0.2 0.1 2.2 Natarajan and Sierks, 1996 
3 .40e-01 B-Oa-i-Ol 0.2 0.1 2.2 Sierks and Svensson. 1993 
3 , .30e-01 3.5a+01 0.4 0.3 2.1 Fierobe et al.. 1996 
4, .87e-01 3.6a'4-01 0.4 0.3 2.1 Sierks et al.. 1989 
7 .5e-01 1.28+02 
-0.0 1.0 1.3 Vandersall et al.. 1995 
3 .6e-02 3.6a+01 1.0 0.3 2.0 Talcahashi et al., 1981 
3, .4e-02 S.Se-fOl 1.2 0.3 2.0 Imokuchi et al.. 1981 
1. .92e*00 l.Sa+Ol -2.4 -0.3 2.5 5 1. 1 3 . 5e-03 Fagerstrom. 1991 
5, •Oe+Ol l.fia+Ol -0.2 2.5 1. 5 1. 1 3. 5e-03 McCIearly and Anderson. 1980 
1. .60e-01 3.7e-i'01 -0.4 0.3 2.0 -3 .5 5. 5 1. 8e-Q2 Fagerstrom. I99I 
3. .3e*00 2.9a-)-01 0.1 2.2 -3 .5 5. 7 1. 8e-02 McOearly and Anderson. 1980 
Tosietal., 1993 
S. OOe-01 2.98+01 
-1.1 0.1 2.1 Fagerstrom and Kalkkinen, 1995 
1. ,41e-01 3.38+01 -0.4 0.2 2.0 Tanaka and Takeda, 1994 
1. .3e+00 4.78+01 
-0.6 C.4 1.9 Abeetal.. 1985 
1. .5e+00 4.78+01 
-0.8 0.-; 1.9 Abeetal., 1985 
9. Oe-Ol 4.08+01 -0.7 0.3 2.0 Abeetal.. 1985 
Modenaetal., 1986 
1. ,0e-02 3.68+01 0.7 0.3 2.0 Kleinmanetal.. 1988 
7. 70e-01 6.08-01 -3.8 -2.2 4.4 Ohnishi etal., 1992 
2. 32e-01 2.38+01 -0.1 -C.3 2.4 Fierobe et al.. 1996 
1. 08e-01 6.78+01 1.1 0.4 1.7 Fierobe et al., 1996 
5. 90e-01 2.88+01 -0.5 -0.2 2.3 Fierobe et al., 1996 
1. 70e-03 3.98+01 3.5 0.2 2.1 Sierks and Svensson, 1993 
4. 30e-01 2.78+01 0.1 0.1 2.3 Frandsen et al.. 1994a 
1. lle-01 2.38+01 -0.4 -0.2 2.4 Sierks and Svensson. 1996 
6 .  86e-01 2.98+01 0.2 0.1 2.2 Fang, unpublished results 
3. 60e-01 4.28+01 0.2 0.2 2.0 Sierks and Svensson. 1994 
5. 88e-03 3.28+00 1.3 -1.6 3.7 Sierks etal., 1989 
5. 83e-01 2.58+01 0.2 0.0 2.3 Fang, unpublished results 
3 . 40e-01 2.28+01 -0.2 -0.2 2.4 Natarajan and Sierks. 1996 
2. 50e-02 1.38+01 1.1 -0.5 2.7 Natarajan and Sierks. 1996 
6. OOe-02 2.58+01 
-0.1 0.0 2.2 Natarajan and Sierks. 1996 
Table 1. (continued) 
COMPOUND Source Fotm or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Orgaiiisin Mutant Fam (O Rafcio (Unt-I) (s-lmM-l) 
D-isomaltose A. awamori Q124H A 4.5 45 376 6) 2.28e-03 
D-isomaltose A. awamori R125K A 4.5 45 320 (i) 3.43e-02 
D-isomaltose A. niger D153N A 4.5 45 434 (i) l.S3e-02 
D-isomaltose A. awamori D176N A 4.4 50 304 (i) 3.85e-04 
D-isomaltose A. awamori L177H A 4.4 50 557 (i) 8.81e-04 
D-isomaltose A. awamori W178R A 4.4 50 1229 (i) 9.96e-04 
D-isomaltose A. awamori E180Q A 4.4 50 19 (•) 1.94e-03 
D-isomaltose A. awamori N182A A 4.4 50 691 (i) 1.22e-02 
D-isomaltose A. awamori N182A A 4.5 50 301 (i) 2.24e-02 
D-isomaltose A. awamori G183K A 4.5 45 709 (i) 1.3 6e-02 
D-isomaltose A. awamori S184H A 4.5 45 1014 (n 1.07e-02 
D-isomaltose A. awamori R241K A 4.4 45 260 (i) 3.41e-02 
D-isomaltose A. awamori A246C A 4.5 45 676 (i) 2.50e-03 
D-isomaltose A. niger E259D A 4.5 45 545 (t) 1.95e-02 
D-isomaltose A. niger E259Q A 4.5 45 599 (i) 1.57e-02 
D-isomaltose A. niger R305K A 4.5 45 116 (i) 2.08e-05 
D-isomaltose A. awamori Y306F A 4.5 45 448 (•) 4.98e-03 
D-isomaltose A. niger D309E A 4.5 45 119 (i) 1.45e-03 
D-isomaltose A. awamori D309N A 4.5 45 2852 (i) 2.24e-05 
D-isomaltose A. niger W317F A 4.5 45 386 (il l.lle-03 
D-isomaltose A. awamori C320A A 4.5 45 412 li) 7.38e-03 
D-isomaltose A. niger E389D A 4.5 45 233 (•) 3.45e-02 
D-isomaltose A. niger E389Q A 4.5 45 404 (i) 2.27e-02 
D-isomaltose A. niger A392D A 4.5 45 389 (•) 1.58e-02 
D-isomaltose A. niger Q40XE A 4.5 45 418 (>) 7.22e-03 
D-isomaltose A. niger 040 IE A 4.5 45 447 (i) 7.16e-03 
D-isomaltose A. awamori S411G A 4.4 45 406 (i) 3 .56e-02 
D-isomaltose A. awamori S411A A 4.4 45 669 (i) 2.24e-02 
D-isomaltose A. awamori S411C A 4.4 45 817 11) 1.81e-02 
Product Condensation 
D-isomalt^ (R) (#) A. niger G1 A 4.5 25 1.6o-^06 (il 2.40e-03 
D-wijinaltose W A. niger G1 A 4.5 35 5.4e'<-05 (1) 7.59e-03 
A. niger G1 A 4.5 45 4.0e'«-05 (i) 1.52e-02 
D-isomaltose (R) A. niger A 45 3.60e-03 
D-isomaltose (R) A. niger A 60 9.00e-03 
• DISACCHARIDES -
• other * (vs D-G2) 
alpha-beta-D-trehalose A. niger G1 A 4.5 25 3482 (i) l.lle-03 
alpha-beta-D-trehalose A. niger G1 A 4.5 35 1607 (!) 2.54e-03 
olpha-beia-D-irehalose A. niger G1 n 4.5 45 1095 (1) 5.56e-03 
alpha-beta-D-uehalose (R) A. niger G1 A 4.5 25 3.5e'<-06 (1) l.lle-03 
alpha-beta-D-trehalose (R) A. niger G1 A 4.5 35 1.6a'«-06 ( I )  2.53e-03 
alpha-beta-D-trehalose (R) A. niger G1 A 4.5 45 l.le4'06 (11 5.58e-03 
D-nigerose A. niger G1 A 4.5 25 2331 (i) 1.66e-03 
D-nigerose A. niger G1 A 4.5 35 1168 ( I l  3 .49e-03 
D-nigerose A. niger G1 A 4.5 45 687 (i) 8.87e-03 
D-nigerose (R) A. niger G1 A 4.5 25 2.0a-»'06 (i) 1.92e-03 
D-nigerose (R) A. niger G1 A 4.5 35 1.3e'f06 (il 3 .50e-03 
D-nigerose (R) A. niger G1 A 4.5 45 6.9a'<-05 (i) 8.85e-03 
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Vmax kcat KmorKi ICSO SQb/ d(dG)t 4(dG)b -dG -dH TdS dS Reference 
(fl) (mM) (mM) Meth -> •> (kalAmO <. <- (kcal/moLK) 
3 .30e-02 l.Sat'Ol 1.0 -0.5 2.7 Natarajan and Sietics. 1996 
6 .lOe-01 l.Sat'Ol -0.7 -0.3 2.5 Nataiajan and Sierfcs, 1996 
3 .70e-01 2.3a-f01 0.1 0 .0 2.4 Fiandsen et al.. 1994a 
5 .20e-02 1.3«+02 2.3 2 .4 1.3 Sieilcs et al.. 1990 
4 .38e-02 S.Oa-fOl 1.8 2 .5 1.9 Sierks et al.. 1993 
7 .28e-02 T.aa-i-Ol 1.7 -1.7 1.7 Sierks et al., 1993 
1 .84e-01 9.5a+01 1.2 -0 1.2 1.5 Sierfcs et al.. 1990 
4 .22e-01 3.Sa4-01 0.1 0 .2 2.2 Sierks etal.. 1993 
6 .20e-01 2.8«-i'01 -0.3 0 .2 2.3 Qien et al.. 1994 
5 .30e-01 3.9«-i-01 -0.1 0 .2 2.1 Sierfcs and Svensson, 1994 
2 .90e-01 a.Ta-fOl 0.0 -0 .1 2.3 Sierks and Svensson, 1994 
1 .34e-K00 3.9a'i-01 -0.1 0 .3 2.0 Fang, unpublished results 
1 .90e-01 7.6«+01 0.8 0 .5 1.6 Fierobe et al.. 1996 
4 .60e-01 -0.0 0 .0 2.4 Frandsen et al.. 1994a 
3 .70e-01 2.4«-i-01 0.1 0 .0 2.4 Frandsen et al.. 1994a 
4 .36e-04 2.1«+01 4.3 0 .0 2.4 Frandsen et al.. 1995 
2 .35e-01 4.7«-i-01 0.5 0 .3 1.9 Sierfcs and Svensson. 1993 
9 .OOe-02 6.2a-t-01 1.6 0 .7 1.8 Frandsen et al.. 1995 
1 .60e-03 7.1a 'i-01 3.9 0, .5 1.7 Sierks and Svensson, 1993 
1, .70e-01 1.5a-)-02 1.8 1. .3 1.2 Frandsen et al., 1995 
3, .lOe-01 4.2a-)-01 0.1 0. .1 2.0 Fierobe et al., 1996 
7. .BOe-Ol 2.3a+01 -0.4 0, .0 2.4 Frandsen et al.. 1994a 
5. •OOe-Ol 2.2a '«-0t -0.1 -0 .0 2.4 Frandsen et al., 1994a 
4. ,40e-01 2.8a+01 0.1 0. .1 2.3 Frandsen et al., 1994a 
1. .40e-01 1.9a+01 0.6 -0 .1 2.5 Frandsen et al., 1994a 
1. .46e-01 2.0a-f01 0.7 0. .0 2.5 Frandsen et al.. 1994b 
9. .34e-01 2.6a-t-01 -0.1 0. ,1 2.3 Fang, unpublished results 
6. .26e-01 2.8e-t-01 0.2 0. ,1 2.3 Fang, unpublished results 
2. 22e-01 1.2a+01 0.3 -0 .4 2.8 Fang, unpublished results 
5. 83e-02 2.484-01 0.0 0. 0 2.2 0 .4 1. .8 6 .Oe-•03 Nikolov et al.. 1989 
1. 70e-01 2.284-01 -0 J. -0 .0 2.3 0 .4 1. .8 6 . Oe--03 Nikolov et al., 1989 
3. 85e-01 2.5a<)-01 0.0 0. 0 2.3 0 .4 1. .9 6 • Oe--03 Nikolov et al., 1989 
1.0 Roels and van Tilburg, 1979 
1.2 Roels and van Tilburg. 1979 
1. 26e-01 l.la<f02 5.0 2. 9 1.3 2 .4 -1 .1 -3. .8e-•03 Meagher and Reilly. 1989 
3. 05e-01 1.2a<f02 4.7 2. 9 1.3 2 .4 -1 .2 -3. .8e-•03 Meagher and Reilly, 1989 
8. 14e-01 1.5a<)-02 4.3 3. 0 1.2 2 .4 -1 .2 -3 . ,8e-•03 Meagher and Reilly, 1989 
1. 25e-01 l.la4-02 5.0 2. 9 1.3 2, .4 -1 .1 -3 . 8e-•03 Nikolov et al., 1989 
3. 03e-01 1.2a<f02 4.7 2. 9 1.3 2, .4 -1 .2 -3, .8e-•03 Nikolov et al., 1989 
8. 15e-01 1.5a<)-02 4.3 3. 0 1.2 2, .4 -1 .2 -3 . .8e-•03 Nikolov et al.. 1989 
5. 50e-02 3.3a-f01 4.8 2. 2 2.0 1. .1 0. 9 3. .2e-•03 Meagher and Reilly, 1989 
1. 16e-01 3.3a-i-01 4.5 2. 2 2.1 1. .1 1. 0 3 . 2e-•03 Meagher and Reilly, 1989 
3. 29e-01 3.7a+01 4.0 2. 2 2.1 1. .1 1. 0 3. .2e-•03 Meagher and Reilly, 1989 
6. 33e-02 3.3a-i-01 4.7 2. 2 2.0 1. .1 0. 9 3. , le-•03 Nikolov et al., 1989 
I. 16e-01 3.3a-t>01 4.5 2. 2 2.1 1. .1 0. 9 3 . , le-•03 Nikolov et al., 1989 
3. 28e-01 3.7a'*'01 4.0 2. 2 2.1 1. .1 1. 0 3 . le-03 Nikolov et al., 1989 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pan (C) Rat:i.o ajmcl) (s-1 mM-I) 
D-kojibiose A. niger G1 A 4.5 25 15636 (il 2.48e-04 
D-kpjibiose A. niger G1 A 4.5 35 6018 (i) 6.78e-04 
D-kojibiose A. aiger G1 A 4.5 45 3627 (i) 1.68e-03 
D-kojibiose (R) A. niger G1 A 4.5 25 1.4a't'07 (i) 2.80e-04 
D-kojibiose (R) A. niger G1 A 4.5 35 7 • 10*^06 (i) 5.76e-04 
D-kojibiose (R) A. niger G1 A 4.5 45 4.9«4'06 (i) 1.23e-03 
D-Nitrnohenvl-GIc - Kinetics 
4-mtrophenyl-alpha-D-gIucoside A. niger G2 A 4.5 25 132 (!) 2.66e-02 
4-nitrophenyl-alpha-D-glucoside (#) A. niger wc A 4.5 45 75 (i) 1.35e-01 
4-nitrophenyl-alpha-D-gIucoside A. saicoi Ml A 6.0 37 510 (!) 2.8e-•03 3.07e-03 
4-nitrophenyl-aipiia-D-gIucoside A. sai coi M2 A 6.0 37 450 (i) 3.0e-•03 3.29e-03 
4-nitn)phenyl-alpha-D-glucoside H. grisea cherm. A 5.0 55 28 (!) 2.Se-01 Ul (0 •02 4.18e-02 
4-[utn>phenyl-alpha-D-glucoside T. lanuginosus A 5.0 50 3 (i) 3.5e+00 
4-nitrophenyI-alpha-D-gIucoside R. delemar B 4.5 25 354 (i) 1.18e-02 
4-nitrophenyI-alpha-D-glucoside R. delemar B 4.5 25 359 (i) 1.16e-02 
4-nitrophenyl-alpha-D-gIucoside S. diastacicus STA2 E 4.6 37 169 (i) 4.0e-02 
phenyl-alpha-D-glucoside R. delemar B 4.5 25 4273 (i) 9.79e-04 
4-mettiylphenyI-alpha-D-glucoside R. delemar B 4.5 25 4630 (i) 9.03e-04 
4-(dimetliyietliyl)phenyl-alpha-
-D-glucoside R. delemar B 4.5 25 2118 (i) 1.97e-03 
4-mtrophenyl-beta-D-glucoside R. niveus B 4.5 25 
Nitrnohenvl-nic - Mutant Analvsu 
4-nitrophenyI-alpha-D-giucoside A. niger D309E A 4.5 45 1.31e-02 
Other Dissacharide Analoes 
3-bromo-l-{alpha-
-D-glucosyl)pyridinium A. niger A 5.0 25 6.52e-02 
4-methyl-1 -(alpha-
-D-giucosyI)pyridinium A. niger A 5.0 25 1.02e-02 
1 -(aJpha-D-glucosyDpyridinium A. niger A 5.0 25 1.68e-02 
phenyIseIeno-alpha-D-5-lhioglucosi( A. niger G2 A 4.5 45 
phenylseleno-alpha-D-glucoside A. niger G2 A 4.5 45 
phenyl alpha-D-glucoside R. delemar B 4.5 25 
phenyl beta-D-glucoside R. niveus B 4.5 10 
phenyl beta-D-glucoside R. delemar B 4.5 25 
D-gemiobiose R. delemar B 4.5 25 
alpha-alpha D-lrehalose A. saicoi Ml A 4.3 37 
alpha-alpha D-trehalose R. delemar B 4.5 25 
D-cellobiose R. delemar B 4.5 25 
D-melibiose R. delemar B 4.5 25 
D-sucrose R. delemar B 4.5 25 
D-Iaaose R. delemar B 4.5 25 
- MONOSACCHARIDES -
[nlubitoQ 
1 -deoxynojirimycin Ineescinal G 
-
37 
1 -deoxynojirimycin A. niger G: A 4.5 25 
1 -deoxynojirimycin A. niger G2 A 4.5 27 
1-deoxynojirimycin A. awamori A 4.5 45 
1 -deoxynojirimycin R. niveus B 4.5 5 
I -deoxynojirimycin R. niveus B 4.5 10 
1 -deoxynojirimycm R. niveus B 4.5 25 
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Vmax kcat KmorKi ICSO Sab/ d(dG)t d(dG) b w/G -dH TdS dS Reference 
(Umt-l) («-i) (mM) (mM) .Meth •> -> (kcal/moD <- <. (kal/moLK) 
3 .20e-02 1.3*4.02 5.9 3.0 1.2 1.0 0.2 7.5e-04 Meagberand ReiIIy.1989 
8 .60e-02 1.3«-»02 5.5 3.0 1.3 1.0 0.2 7.5e-04 MeagberandReilly, 1989 
2 .41e-01 1.4«-l'02 5.1 3.0 1.2 1.0 0.2 7. 5e-04 Meagberand Reilly.1989 
4 .17e-02 1.5a+02 5.8 3.1 1.1 -0.0 1.1 3 .8e-03 Nikolov et al., 1989 
8 .58e-02 1.584.02 5.6 3.1 1.2 -0.0 1.2 3.8e-03 Nikolov et al., 1989 
1 .83e-01 1.584-02 5.3 3.0 1.2 -0.0 1.2 3 . 8e-03 Nikolov et al., 1989 
5 .OOe-02 1.984.00 0.0 -0.2 3.7 6.4 -2.7 -8.9e-03 Ermeretal.. 1993 
5 •OOe-Ol 3.784-00 1 o
 
o
 
0.0 3.5 6.4 -2.8 -8.9e-03 Fmndsen et al.. 1995 
1.7e-02 6.084-00 1.9 0.4 3.2 Takabashi et al.. 1981 
1.7e-02 5.684-00 1.9 0.3 3.2 Inokuchi et al., 1981 
6.1e-01 1.68401 1.2 0.8 2.7 Tosietal., 1993 
2.884-00 -0.2 3.8 Raoet.'il., 1981 
1, .30e-02 1.184-00 0.5 -0.5 4.0 Hiromi et al.. 1973b 
1. .28e-02 1.184-00 0.5 -0.5 4.0 Suetsugu et al.. 1973 
Modenaetal.. 1986 
9. .20e-03 9.484-00 2.0 0.8 2.8 Suetsugu et al.. 1973 
5. .60e-03 6.28400 2.0 0.5 3.0 Suetsugu et al., 1973 
7.70e-03 3.9a+00 
8.9a-t-00 15 
1.5 0.3 3.3 
1.4 2.8 
Suetsugu et al.. 1973 
Tanaka and Takeda. 1994 
3.60e-01 2.Sa+01 1.5 1.3 2.3 Frandsen et aj., 1995 
4.50e-02 6.9e-01 2.6 -0.1 
9.00e-03 8.8e-01 3.7 0.1 
3.00e-02 1.8e+00 3.4 0.5 
4.0«+00 M 0.7 
S.Se-t-OO H 1.0 
9.«a4-00 Pa 1.5 
l.la+01 sp 1.7 
3.2a'*-01 Pa 2.2 
1.0a'*'02 Pa 2.9 
2.0a+02 Pn 3.2 
1.6e*03 Pa 3.2 
1.8a4'02 Pa 3.2 
1.884.02 Pa 3.2 
1.8a4-02 Pa 3.2 
3.Sa4-03 Pa 5.0 
4.3 Padmaperuma and Sinnot. 1992 
4.2 Padmapenima and Sinnoc. 1992 
3.7 Padmapenima and Sinnot, 1992 
3.5 Mehlaetal., 1995 
3.2 Mehia et al.. 1995 
2.8 Hiromi et al.. 1973b 
2.5 12.0 -9.5 -3.4e-02 Hiromi etal., 1982 
2.0 12.0-10.0 -3.4e-02 Hiromi et al.. 1973b 
1.4 Hiromi et al.. 1973b 
1.0 Takahashi et al.. 1981 
1.1 Hiromi et al.. 1973b 
1.0 Hiromi et al.. 1973b 
1.0 Hiromi et al.. 1973b 
1.0 Hiromi et al.. 1973b 
-0.8 Hiromi et al.. 1973b 
9.6e-05 S -7.4 10.0 Schmidt et aJ.. 1979 
2.1a-03 pd -5.2 7.7 Svensson and Sierks. 1992 
3.0a-02 - -3.6 6.2 2.7 3.5 1.2e-02 Sigurskjold«al.. 1994 
9.8a-03 M -4.7 7.3 Dong et al., 1996 
2.2O-03 Pn -4.6 7.2 Tanaka et al.. 1982 
2.5a-02 Pn -3.4 6.0 Tanaka et al.. 1982 
1.6a-02  Pn -3.7 6.2 1 . 0  5.3 1. ae-02 Tanaka et al.. 1982 
Table 1. (continued) 
COMPOUND Source Form or Sub pH T Activity Activity Vnus/Km kcat/Km 
Inhibitor or Substrate Organism Mutant pam (O Ratio (Umc-i) (s-imM-i) 
1 -deoxynojinnycin R. niveus B 4 .5 40 
I -deoxymannojinmycin A. awamori A 4 .5 45 
N-inethyH-deoxynojinnycin A. niger A 4 .5 25 
N-inethyl-l-deoxynojinnycin R. niveus B 4 .5 40 
N-[2-{4-ethoxycarbonylphenoxy) 
ethyl]-I-deoxynojiriniycin A. niger A 4 .5 25 
N-(2-hydiDxyetliyl)-
-I-deoxynojirraydn A. niger G1 A 4 .5 25 
N-{2-hydroxyethyl)-
-1-deoxynojirmycin R. niveus B 4 .5 40 
nojirimycin Intestinal G 37 
nojirimycin R. niveus B 4 .5 40 
nojirimycin R. niveus B 4 .5 40 
N-elhyl-1 -deoxynojirmycin R. niveus B 4 .5 40 
N-propyl-I-deoxynojirmycin R. niveus B 4 .5 40 
N-(p-bromobenzyl)-l-deoxynojirray' R. niveus B 4 .5 40 
N-(3-phenylptopyl)-l-deoxynojitmy P.. niveus B 4 .5 40 
N-{2-phenyIethyl)-l-deoxynojitmyci R. niveus B 4 .5 40 
N-(3-phenoxypropyl)-l-deoxynojinr R. niveus B 4 .5 40 
N-cynnamyl-1 -deoxynojirmycin R. niveus B 4 .5 40 
N-(p-methyIbenzyl)-I-deoxynojirmy R. niveus B 4. 5 40 
N-benzy 1-1 -deoxynojirmycin R. niveus B 4, .5 40 
N-(2-phenoxyetliyI)-l-deoxynojirmy R. niveus B 4, .5 40 
N-(n-butyI)-l-deoxynojirmycin R. niveus B 4. .5 40 
isofagomine A. awamori A 4. .5 45 
lentiginosine (-)•) A. niger A 45 
lentiginosine (-)•) (impure) A. niger A 5. ,0 37 
lenuginosine(-t-) A. niger A 5. 0 37 
lentiginosine (+) Rhizopus B 45 
7R-hydroxyl'Ientiginosine A. niger A 45 
7R-hydroxyI-lentiginosine Rhizopus B 45 
7S-hydn)xyI-Ientiginosine A. niger A 45 
7S-hydroxyl-lentiginosine Rhizopus B 45 
lentiginosine (-) A. niger A 45 
lentiginosine (-) Rhizopus B 45 
australine -
Glc-swainsonine A. niger A 5. 0 37 
castanospermine A. niger A 5. 0 37 
6-epicastanospernune A. niger A 5. 0 37 
6,7-diepicastanospermine A. niger A 5. 0 37 
7-deoxy-6-epicastanospermine A. niger A 5. 0 37 
australine A. niger A 5. 0 37 
I-epiaustraline A. niger A 5. 0 37 
D-glucono-1 ^ -lactone R. niveus B 4. 5 10 
D-glucono-1 ^ -lactone R. niveus B 4. 5 25 
D-glucono-1 ^ -lactone R. niveus B 4. 5 60 
D-glucono-1 ^ -lactone A. niger A 4. 2 25 
D-glucono-13-Iactone A. niger A 4. 5 25 
D-glucono-1 ^ -lactone H. resinae P A 4. 3 25 
D-glucono-1 ^ -lactone H. resinae P A 4. 3 25 
D-glucono-1 ^ -lactone H. resinae S A 4. 3 25 
D-glucono-1 ^ -lactone H. resinae S A 4. 3 25 
D-glucono-1 ^ -lactone T. lanuginosus 5. 0 50 
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Vmax kcat KmorKi ICSO Sob/ d(dG)t d(dG)b -dG -dH TdS dS Reference 
(U mf 1) (s-I) (mM) (mM) Meth -> •> (kcal/moO <• <- (kal/moUO 
8.6e-02 7 -3.3 5.8 Ezure et al.. 1989 
6.S«-02 M -3.5 6.1 Dong et al.. 1996 
2.0«-03 pd -5.2 7.8 Svensson and Sierks. 
l.le-02 •5 -4.5 7.1 Ezure et ai.. 1989 
0
 
•
 1 o
 
U) pd -4.8 7.4 Svensson and Sieilcs. 
5.9a-03 pd -4.6 7.1 Svensson and Sierks. 
8.7e-01 o -1.8 4.4 Ezuieetal.. 1989 
7.6e-04 S -6.1 8.7 Schmidt et al.. 1979 
3.2e-02 Ph -3.9 6.4 Niwa et al.. 1970 
7.1e-01 S -1.9 4.5 Niwaetal- 1970 
1.6e-01 7 -2.9 5.5 Ezure et al.. 1989 
2.9e-01 7 -2.5 5.1 Ezure et al.. 1989 
6.0e-01 7 -2.0 4.6 Ezure et al.. 1989 
6.3e-01 7 -2.0 4.6 Ezure et al.. 1989 
6.4e-01 7 -2.0 4.6 Ezure et al.. 1989 
6.7e-01 7 -2.0 4.5 Ezure et al.. 1989 
7.2e-01 7 -1.9 4.5 Ezure et al.. 1989 
7.5e-01 7 -1.9 4.5 Ezure et al.. 1989 
7.9e-01 7 -1.9 4.4 Ezure et al.. 1989 
l.le+00 7 -1.7 4.3 Ezure et al.. 1989 
1.3e+00 7 -1.6 4.1 Ezure et al.. 1989 
3.7a-03 M -5.3 7.9 Dong et al.. 1996 
2.0a-03 2.7e-03 Pn -5.7 8.3 Brandi et al.. 1995 
l.Oa-02 3.2e-02 Pn -4.5 7.1 Pastuszak et al., 1990 
3.2e-02 Pn -3.8 6.4 Molineux et al.. 1991 
3.0a-03 3.le-03 Pn -5.5 8.0 Brandi et al.. I99S 
t.4a-03 9.8e-03 Pn -5.2 7.8 Goti etal.. 1996 
7.2a-03 1.3e-02 Pn -4.9 7.5 Goti et al.. 1996 
£.98-02 2.9e-01 Pn -3.5 6.1 Goli et al.. 1996 
00
 
0
 
•
 1 o
 
u
 
4.0e-01 Pn -3.4 6.0 Goti etal.. 1996 
7.0a-02 l.le-01 Pn -3.5 6.0 Brandi et al.. 199S 
9.8a-02 1.8e-01 Pn -3.3 5.8 Brandi et al.. 1995 
5.2a-03 -4.0 6.6 
5.0a-02 Pn -3.5 6.1 Elbein et al., 1987 
8.0e-03 Pn -4.7 7.2 Molineux et al.. 1991 
2.0e-02 Pn -4.1 6.7 Molineux et al.. 1991 
8.4e-02 Pn -3.2 5.8 Molineux et al., 1991 
2.3e-01 Pn -2.S 5.3 Molineux et al.. 1991 
6.0e-03 Pn -4.8 7.4 Molineux et al.. 1991 
2.6e-02 Pn -3.9 6.5 Molineux et al.. 1991 
l.la-fOO sp -1.3 3.8 10. .3 -6. .1 -2, .2e-•02 Hiromietal.. 1982 
•
 
1 o
 
H
 
sp -1.7 4.2 10, .3 -6. .5 -2 .2e-02 Ohnishi. 1990 
1.28+01 S -0.4 2.9 10. .3 -7. .2 -2 . 2e-•02 Moriyama et al.. 1977 
l.Sa-fOO S -1.4 3.9 Laszloet al.. 1978 
2.18+00 sp 
-1.1 3.7 Ohnishi et al., 1990 
l.Oe-fOO M6 -1.5 4.1 Fagerstrom, 1991 
2.88-01 16 -2.3 4.8 Fagerstrom. 1991 
2.«8-t-00 M6 -1.0 3.6 Fagerstrom, 1991 
1.2s-t'00 16 -1.4 4.0 Fagerstrom. 1991 
5.28+00 7 - 0 . 8  3.4 Rao etal.. 1981 
Table 1. (continued) 
COMPOUND Source Fonnor Sub pH T Acthity Actnrity Vmax/Km kcat/Km 
Inhibitor or Substrate Organism Mutant Pam (Q Ratio (Umg-I) (s-lmM-l) 
D-glucono-1 ^ -lactone R. niveus B 4 . 5  25 
D-niannono-1 ^ -lactone R. aiveus B 4 . 5  25 
valienamine Rhizopus sp. B 6 . 8  37 
tns(hydroxynKthyl)aniinomethane Rhizopus sp. B 5 . 0  37 
tiis(hydroxytnethyl)anunome(hane A. saicoi Ml A 5 . 0  37 
2-aimno-2-ethy 1-13-
-propanediol Rhizopus sp. B 5 . 0  37 
2-amino-2-ethy 1-13-
-propanediol A. sai Coi Ml A 5 . 0  37 
2-amino-cycIobexanol A. saicoi Ml A 5 . 0  37 
2-aniino-cyclohexanoI Rhizopus sp. B 5 . 0  37 
2-amino-2-methy 1-13-
-propanediol Rhizopus sp. B 5 . 0  37 
2-aiiuno-2-meUiyI-1J-
-propanediol A. saicoi Ml A 5 . 0  37 
2-amino-2-eihyl-1 -propanol Rhizopus sp. B 5 . 0  37 
2-amino-2-etbyI-1 -propanol A. sai coi Ml A 5 . 0  37 
2-aininoethanol Rhizopus sp. B 5 . 0  37 
2-aminoethanoI A. saicoi Ml A 5 . 0  37 
1,3-<Iiamino-2-propanoI Rhizopus sp. B 5 . 0  37 
1.3-<liamioo-2-propanoI A. saicoi Ml A 5 . 0  37 
DL-2-amino-2-methylpropane Rhizopus sp. B 5 . 0  37 
DL-2-ainino-2-methyIpropane A. saicoi Ml A 5 . 0  37 
2-anuno-2-melhyIpropane A. sai coi Ml A 5 . 0  37 
Monosaccharide Analoes 
D-glucosamine A. saicoi Ml A 4 . 8  37 
D-glucosamine R. delemar B 4 . 5  25 
alpha D-glucose R. delemar B 4 . 5  25 
D-glucose A. saicoi Ml A 4 . 8  37 
D-glucose R. delemar B 4 . 5  25 
D-glucose R. niveus B 4 . 5  10 
D-glucose R. niveus B 4 . 5  60 
beta D-glucose R. delemar B 4 . 5  25 
2-deoxy-D-glucose R. delemar B 4 . 5  25 
beta D-mannose R. delemar B 4 . 5  25 
O-mannose R. delemar B 4 . 5  25 
alpha D-mannose R. delemar B 4 . 5  25 
D-allose R. delemar B 4 . 5  25 
beta D-galactose R. delemar B 4 . 5  25 
D-galactose R. delemar B 4 . 5  25 
alpha D-galaclose R. delemar B 4 . 5  25 
D-ribose A. niger A 4 . 5  35 
D-arabinose A. niger A 4 . 5  35 
beta D-xylose R. delemar B 4 . 5  25 
D-xylose R. delemar B 4 . 5  25 
alpha D-xylose R. delemar B 4 . 5  25 
D-lyxose A. niger A 4 . 5  35 
myo-inositol A. niger A 4 . 5  35 
N-acetyl-D-glucosamine A. saicoi Ml A 4 . 8  37 
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Vmax 
(Umc-l) 
kcat 
(»-i) 
KmorKi 
(mM) 
IC50 
(mM) 
SBb/ d(dG)t d(dG)b -dG -dH TdS 
Meth (kcaVmoO <-
dS 
(kcal/moLK) 
Reference 
l.lS'fOO 
«.5a-i'01 
IS 
A 
6.8e-i-00 S 
-1.5 
0 . 7  
- 0 . 5  
4.0 
1.8 
3.1 
Tonaka and Takeda. 1994 
Ohnishi and French. 1987 
Kameda et al.. 1984 
2.3«>00 
6.1«-i-00 
M 
M 
-1.2 
- 0 . 6  
3.7 
3.1 
Iwama. et al., 198S 
Iwania. et al„ 1985 
1.7«-i-00 -1.4 3.9 Iwama. et al.. 198S 
3.7a-f00 
2.6a+00 
3.2a+00 
5.4a-f00 
l.la-fOl 
l.Oa+Ol 
2.4a-i-01 
2.0a-f01 
3.1a'f01 
S.7a-i-00 
1.2a'f01 
l.Oai-Ol 
2.3a'»'01 
4.3a+01 
i.Sa-fOl 
1.4a-t.01 
e.Oa-fOl 
g-Aa-t-Ol 
1.0a->.02 
1.3a')-02 
2.4a-)-02 
1.6a-i-02 
1.8a4.02 
l.Oa't-02 
1.6a')-02 
l.fia-)-02 
1.7a-f02 
3.1a-t'02 
2.2a«02 
2.2m*02 
1.5a-)-02 
1.6a-i-02 
2.2e'»'02 
2.3e-f02 
2.4a4'02 
2.8a4-02 
3.4a-t-02 
7.4a-f02 
M 
M 
H 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
Pn 
M 
Pn 
Pn 
Pn 
sp 
s 
Pn 
M 
Pn 
Pn 
Pn 
Pn 
Pn 
Pn 
Pn 
M 
M 
Pn 
Pn 
Pn 
M 
M 
Pn 
- 0 . 9  3.5 Iwanuu et al.. 1985 
-1.1 3.7 Iwama. et al.. 1985 
-1.0 3.5 Iwama. et al.. 1985 
- 0 . 6  3.2 Iwama. et al.. 1985 
- 0 . 2  2.8 Iwama. et ol.. 1985 
- 0 . 3  2.8 Iwama. et al.. 1985 
0 . 3  2.3 Iwama. et al.. 1985 
0 . 2  2.4 lwama.etal., 1985 
0 . 4  2.1 Iwama. et al., 1985 
- 0 . 5  3.1 Iwama. et al.. 1985 
-0.1 2.7 Iwama. et al.. 1985 
- 0 . 2  2.8 Iwama. et al., 1985 
0 . 2  2.3 Iwama. et al.. 1985 
0 . 6  1.9 Iwama. el al., 1985 
0 . 7  1.9 Takahashi et al.. 1981 
0 . 0  2.5 Hiromi et al., 1973b 
0 . 9  1.7 Hiromi et al.. 1973b 
1 . 1  1.5 Takahashi et al., 1981 
1 . 2  1.4 Hiromi et al., 1973b 
1 . 4  1.2 2 . 4  -1.2 -4.3e-03 Hiromi et al.. 1982 
1 . 6  0.9 2 . 4  -1.4 -4.3e-03 Moriyamaetal.. 1977 
1 . 5  1.1 Hiromi el al., 1973b 
1 . 6  1.0 Hiromi et al., 1973b 
1 . 2  1.4 Hiromi et al., 1973b 
1 . 5  1.1 Hiromi et al., 1973b 
1 . 5  1.1 Hiromi et al.. 1973b 
1 . 5  1.0 Hiromi etal., t973b 
1 . 7  0.9 Hiromi et al.. 1973b 
1 . 7  0.9 Hiromi et al.. 1973b 
1 . 7  0.9 Hiromi et al.. 1973b 
1 . 4  1.2 Pestlin et al.. 1996 
1 . 5  1.1 Pestlin et al., 1996 
1 . 7  0.9 Hiromi et al.. 1973b 
1 . 7  0.9 Hiromi et al., 1973b 
1 . 7  0.8 Hiromi et al.. 1973b 
1 . 8  0.8 Pestlin et al., 1996 
1 . 9  0.7 Pestlin et al., 1996 
2 . 4  0.2 Takahashi et al., 1981 
Table 1. (continued) 
COMPOUND Source Fonn or Sub pH T Activity Activity Vmaz/Km kcat/Km 
Inhibitor or Substrate Organisin Mutant Paa (O Ratio (U mf-D (s-I niM-I) 
Substrates 
methyl alpha-D-gluctiside A.  awamori A 4 . 5  37 5.21e-05 
methyl alpha-D-glucoside A. sai coi Ml A 4 . 8  37 
methyl alpha-D-glucoside R.  delemar B 4 . 5  25 
methyl alpha-D-glucoside R.  niveus B 4 . 5  10 
methyl aIpha-0-gIucoside (R) A.  aiger A 4 . 8  50 
methyl beta-D-glucoside R.  delemar B 4 . 5  25 
methyl beta-D-glucoside (R) A.  niger A 4 . 8  50 
methyl alpha-D-mannoside R.  delemar B 4 . 5  25 
methyl alpha-D-galactoside R.  delemar B 4 . 5  25 
methyl alpha-D-xyloside R.  delemar B 4 . 5  25 
D-glucosyl fluoride (#) A.  awamori A 4 . 5  45 1.76e+00 
D-glucosyl fluoride A.  awamori A 4 . 5  25 6.10e+00 
D-glucosyl fluoride A.  awamori A 4 . 5  45 1.37e+01 
D-glucosyl fluoride A.  awamori wt A 4 . 5  45 1.33e+01 
D-glucosyl fluoride A 45 1.33e+01 
D-glucosyl fluoride A 45 
Glucosvl-nuoride - Mutants 
D-glucosyl fluoride A.  awamori yii6A A 4 . 5  45 1 (1) 1.38e+01 
D-glucosyl fluoride A.  awamori W120F A 4 . 5  45 0.5 (i) 2.44e+01 
D-glucosyl fluoride A.  awamori W120F A 4 . 5  45 1 (i) 1.26e+01 
D-glucosyl fluoride A.  awamori G121T A 4 . 5  45 1 (i) 1.17e+01 
D-glucosyl fluoride A.  awamori R122Y A 4 . 5  45 3 (i) 5.00e+00 
D-glucosyl fluoride A.  awamori P123G A 4 . 5  25 2 (i) 3.90e+00 
D-glucosyl fluoride A.  awamori Q124H A 4 . 5  45 3 (i) 4.60e-^00 
D-glucosyl fluoride A.  awamori R125K A 4 . 5  45 1 (1) 1.20e+01 
D-glucosyl fluoride A.  awamori D176N A 4 . 5  45 22 (i) 6.00e-01 
D-glucosyl fluoride A.  awamori E400Q A 4 . 5  45 665 (1) 2.00e-02 
(*)-Estimate 
(**)-Indirect Evidence 
(#)-Reference 
(R)-Reveise or Condensation Reaction 
GA Suth-Family 
A Aspergillus 
B Rhizopus 
C Arxula 
D Saccharomycopsis 
E Saccharomyces 
F Oosthdium 
G Other 
Inhibitor or Method in Inhibition Studies 
A Amylose 
G Glucose 
I Isomaltose 
15 Isomaltopentaose 
16 Isomaltohexose 
M Maltose 
M6 Maltohexose 
Pa phenyl 6-O-acetyI-alpha-maltoside 
Ph Phenyl-alpha-D-glucoside 
Pn 4-nitrophenyl-aipha-D-glucoside 
S Starch 
sp Spectrophotometry 
pd Peak-to-through Difference 
gr Graphically 
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Vmax Iccat Km or Ki IC 50 Sob/ d(dG)t d(dG) b -dG -dH TdS dS Reference 
(Unic-l) (s-t) (mM) (mM) Mdh •> -> (kcalAool) <- <- (kcalAnoLK) 
3.80e-03 7.3«+01 
T.fia+Ol 
6.3*+01 
5 .4a'f02 
T.BC'fOa 
2.6a'4-02 
l.Oa-t'Oa 
I.0a-f03 
l.da-fOa 
S.5a+02 
3.00e+01 1.7a+01 
3.4a')-01 
6.4 1.0 1.6 
Pn 1.0 1.6 
Pa 0.9 1.6 
sp 2.2 0.3 
G 3.9 -1.3 
Pa 1.8 0.8 
G 2.6 -0.0 
Pa 2.6 -0.0 
Pa 1.6 1.0 
Pa 2.2 0 .4 
- 0 . 0  0 . 0  2 .6  
-0.7 
-1.2 
-1.3 
-1.3 
0 . 4  2.1 
Savel'ev et al.. 1982 
Takahasbi et al.. 1981 
Hiromi et al.. 1973b 
Hiniini et al.. 1982 
El-Sayed and Laszlo. 1994 
Hiromi et al., 1973b 
B-Sayed and Laszlo. 1994 
Hiromi et al.. 1973b 
Hiromi et al.. 1973b 
Hiromi et al.. 1973b 
Natarajon and Sierks, 1996 
Natarajan and Sierks, 1996 
Natarajan and Sierks. 1996 
Sierks and Svensson. 1996 
Svensson et al.. 1994 
Konstantidinis and Sinnot, 1991 
- 0 . 0  
-0.4 
0 . 1  
0 . 1  
0 . 6  
0.3 
0.7 
O.I 
2 . 0  
4.1 
Sierks and Svensson, 1996 
Sierks and Svensson, 1996 
Natarajan and Sierks, 1996 
Natarajan and Sierks, 1996 
Natarajan and Sierks. 1996 
Natarajan and Sierks, 1996 
Natarajan and Sierks, 1996 
Natarajan and Sierks, 1996 
Sierks and Svensson, 1996 
Sierks and Svensson, 1996 
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Temperature appears to be the experimental variable that most influences the results, 
since in most cases the pH values used are near the expected optimal pH values. Therefore, the 
effea of temperature on kinetic behavior is given in Table 2. For any given temperature, a set of 
kcat and Km values derived from Equations (7) and (8) can be obtained, providing the proper 
reference for any other study. 
Effect of Temperature in A. niger Glucoamylase Selectivity 
The values in Table I less those of divergent studies were used to obtain values of the 
preexponential factor A and the energy of activation Ea, as well as the enthalpy and entropy of 
binding, AHb and ASi,, respectively (Table 2). It was then possible to calculate for any given 
case the difference in free energy of binding A(AG)i, or of that associated with the stabilization 
of the transition state A(AG)[, using always the same reference. 
Low energy of activation values are found for the maltooligosaccharides and for panose. 
The lowest values are obtained for maltotetraose and maltopentaose, tiie trisaccharides malto-
triose and panose having similar values od the activation energy. Clearer differences are found 
for binding enthalpy. While for maltooligosaccharides an increase in binding enthalpy is 
obtained with increases in chain length, increasing entropy rendering the effective binding more 
difficult, the two isomaltosides show that the driving force for binding is not enthalpic, and 
therefore heavily associated with features like hydrophobic and hydrogen-bonding interactions 
that confer some specificity, but rather entropic, suggesting that binding is more due to finding 
the right conformation that corresponds to a binding/catalytic mode. Panose, behaves more like 
a maltooligosaccharide, even though the enthalpic contribution for binding is not large. The 
peculiar behavior of panose is more easily understood when we learn (Coutinho et al., unpub­
lished results) that the binding mode of its third residue in the third GA subsite is between the 
two binding modes found crystallographically for acarbose and g/Mco-dihydroacarbose (Stof-
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Table 2. Calculated kinetic and binding parameters for A. niger GA. 
Compound A Ea -AHt, ASb 
(kcai moI-1) (kcal mol"^) (kcal mol'l K-^) 
oc,p-TrehaIose^ 9.26x10^1 17.6 2.4 -3.8x10-3 
Kojibiose^ 2.74X1012 19.0 1.0 7.5x10-4 
Nigerose® LllxlO" 16.8 1.1 3.2x10-3 
Maltose 2.84x1012 16.6 8.7 -1.4x10-2 
Maltotriose 8.84x1011 15.1 9.6 -1.5x10-2 
Maltotetraose 1.08X1011 13.5 8.2 -8.5x10-3 
Maltopentaose 1.71X1010 12.4 8.9 -1.Ox 10-2 
Maltohexaose 1.94x1012 15.3 10.7 -1.6x10-2 
Maltoheptaose 1.23x1012 15.0 11.7 -1.9x10-2 
Isomaltose 8.71x1012 19.4 0.4 6.3x10-3 
Isomaltotriose 9.61x1011 17.3 -2.9 1.8x10-2 
Panose 2.50x1011 15.0 3.2 -1.3x10-3 
® Results partially described in an earlier study (Meagher and Reilly, 1989). 
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fer et al., 1995; Aleshin et al., 1996), suggesting some enzyme specificity for this compound. 
The same is found for maliotriose but not for isomaltriose (Coutinho et al., unpublished re­
sults). 
The differences of mainly the sign of the entropic binding term is that variations in tem­
perature can have a strong impact on selectivity. Such influence is shown in Figure 1. The fact 
that for maltooligosaccharides the hydrolysis of chains longer than four or five glucosyl 
residues has an increasingly unfavorable entropic component leads with increasing temperature 
to a decrease of the selectivity of these compounds when compared to maltose hydrolysis. The 
results in Fig. 1 suggest that at very high temperatures the behavior of maltooligosaccharide 
chains four residues or longer would be very similar. However, when compared to maltose 
hydrolysis, the ability of A. niger GA to degrade panose, isomaltose and especially iso-
maltotriose is markedly increased with increasing temperatures. Given that the impact of 
condensation reactions, also analyzed in Table 1, is often associated the rate of hydrolysis, it is 
then expected that at higher temperatures more a-(l,6)-linked products will be formed. 
Increases in saccharification temperature can then have a negative impact in GA selectivity and 
so lead to reductions in yield. 
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Figure 1. Catalytic efficiency ratios of maltooligosaccharides (Gx), panose (Pn) and isomalto-
oligo-saccharides (iGx) as function of temperature using maltose as reference, where x is the 
number of glucosyl residues. 
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